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Abstract 
 The ubiquitous saprophytic filamentous fungus Aspergillus fumigatus is a 
significant pathogen among individuals undergoing chemotherapy, allogenic stem cell 
transplantation and in patients with underlying pulmonary conditions or chronic 
granulomatous disease patients. Central to the virulence of A. fumigatus is the 
production of various secondary metabolites, proteolytic enzymes and iron sequestering 
molecules which coupled to the rapidly growing nature of the fungus aid its persistence 
in host tissue. Assessment of the virulence of A. fumigatus isolates has previously 
centred on the use of murine models of aspergillosis however in recent years there has 
been an increasing body of evidence suggesting the use of invertebrates as a viable 
alternative. 
The work presented here sought to further develop the use of the Greater wax 
moth Galleria mellonella as a novel in vivo tool to assess the pathogenicity of A. 
fumigatus isolates as an alternative to murine models of infection. The data presented 
here characterises the pathogenicity of clinical and environmental isolates of A. 
fumigatus in G. mellonella. Results here suggest that mycotoxins are produced at 
varying levels in the A. fumigatus isolates with culture filtrates demonstrating 
immunosuppressive properties. In vivo mycotoxin production by A. fumigatus ATCC 
26933 in G. mellonella was characterised and demonstrated that high quantities of 
fumagillin were produced in the first 24 hours of invasive infection.  
A study was performed to assess the effect of fumagillin on human neutrophils 
and G. mellonella haemocytes. Fumagillin inhibited phagocytosis and pathogen directed 
killing in both cell types and disrupted oxygen consumption through reduced 
translocation of p47phox and its insect homologue. Exposure of neutrophils and 
haemocytes to fumagillin also disrupted degranulation. Experimental evidence 
presented here suggests that the inhibition to cellular processes is mediated by reduced
F-actin assembly. A proteomic analysis of G. mellonella haemolymph revealed 
evidence to suggest that fumagillin mediates an oxidative stress in vivo and disrupted 
the humoral immune response.  
 Recent literature has suggested that the immune system of G. mellonella could 
be primed to subsequent infection. Larvae primed with specific sub-lethal inocula of 
conidia demonstrated improved resistance to subsequent infection through increased 
haemocyte density, protein activity, and synthesis of proteins involved in oxygen 
transport, pathogen recognition and iron sequesterisation and increased expression of 
antimicrobial peptides.  
 This project has further developed the G. mellonella model as a model system to 
investigate the pathogenicity of A. fumigatus isolates and the immunomodulatory effects 
of fungal secondary metabolites due to an immune system which shows a high level of 
conservation with the human innate immune system.  
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1.1 Aspergillus fumigatus lifecycle. 
Aspergillus fumigatus is an ubiquitous, saprophytic filamentous fungus whose 
primary ecological niches are soil and decaying vegetation. As a result it is a common 
element of air-borne microflora (Tekaia and Latgé, 2005). Currently there are over 180 
identified Aspergillus species, with A. fumigatus (Figure 1.1 A) occurring as the most 
common mould pathogen in humans (Mabey et al., 2004). Other members of this genus 
include A. nidulans, A. oryzae, A. niger, A. terreus and A. flavus. These species are used 
as model organisms in molecular and cellular biology (A. nidulans), for commercial 
production in the biotechnology industry (A. terreus, A. niger, A. oryzae), or implicated 
in aflotoxin contamination of food in developing countries (A. flavus, A. parasiticus), 
(MacCabe et al., 2001; Adrio and Demain, 2003; Rashid et al., 2008; Andleeb et al., 
2010; Zambare, 2010). Although A. flavus, A. niger, and A. terreus have been recorded 
as contributors to fungal pathogenesis, the most pathogenic species is A. fumigatus and 
it is responsible for over 90% of cases of invasive diseases caused by Aspergilli, 
(Thompson and Patterson, 2008). A. fumigatus is a major component in compost and 
due to its thermophilic nature is capable of growing below 20ºC and above 50ºC 
(Bhabhra and Askew, 2005). The primary function of A. fumigatus is the recycling of 
carbon and nitrogen in the environment and the physiological versatility to assimilate 
various sources of these elements is central to its persistence in the environment and 
pathogenicity within host tissue (Rhodes, 2006).  
The life cycle of A. fumigatus begins with the asexual production of conidia (Figure 
1.1 B and C) which measure 2-3µm in diameter and are easily dispersed by air thus 
contributing to the ubiquitous nature of A. fumigatus (Morris et al., 2000). The surface 
of A. fumigatus conidia is covered in hydrophobic rodlets (RodAp and RodBp) which 
enhance the buoyancy and distribution of conidia by air currents (Paris et al., 2003). 
Conidia may break dormancy and germinate upon exposure to appropriate nutrients. A. 
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fumigatus conidia switch from isotropic to polar growth concurrent with the emergence 
of germ tubes and septation with mitotic division (Momany and Taylor, 2000). The 
development of asexual conidia in A. fumigatus is highly regulated. Mah and Yu, (2006) 
demonstrated that conidiation in A. fumigatus and A. nidulans is similarly activated by 
gene homologues therefore underlying conservation of development in both Aspergilli, 
however it was shown that A. fumigatus possesses distinct regulatory mechanisms 
controlling asexual development. In recent years a sexual cycle for A. fumigatus has 
been established by O’Gorman et al., (2009) where “mating-type” (MAT) genes are 
responsible for the heterothallic breeding system leading to the production of 
cleistothecia and ascospores. Szewczyk and Krappmann, (2010) further characterised 
this development in understanding the life cycle of A. fumigatus through the verification 
of MAT variants as elicitors of the sexual cycle in unrelated clinical isolates. O’ 
Gorman et al., (2009) annotated this sexual stage as Neosartorya fumigata and it is 
speculated that this development in the life cycle of A. fumigatus may play a role in 
virulence, resistance to harsh environmental conditions and the development of 
fungicide resistance.    
 
1.2 Environmental exposure to A. fumigatus. 
  A study undertaken by Guinea et al., (2006) indicated that the presence of 
Aspergillus conidia in the air was dependent upon meteorological parameters such as 
temperature, rainfall and windspeed however A. fumigatus appears to be affected the 
least by these factors. This study quantified the prevalence of Aspergillus colony 
forming units (c.f.u) in the air with the greatest numbers being recorded in the Autumn 
with A. fumigatus comprising of 54% of Aspergilli. Interestingly quantification of the 
number of conidia in air reached levels of 70 c.f.u (m3)-1 during the Autumn which 
would coincide with increasing quantities of decaying vegetation. A more recent study 
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based in Delhi concerned with the quantification of Aspergillus species in air verified 
that aerial counts of A. fumigatus is dependent upon the time of year and varied from 
1.25 to 15.6 c.f.u (m3)-1 with the prevalence of allergen content highest during the 
month of August (Vermani et al., 2010). While both studies demonstrate the ubiquity of 
A. fumigatus in air samples it is clear that the concentration of viable aerosolised conidia 
varies depending on geographical location, climate, decaying vegetation and other 
anthropocentric factors such as urbanisation and pollution.  
 The term “Sick Building Syndrome” has been used for over 25 years to describe 
illness where occupants of a particular building experience acute health complications 
as a result of spending time exposed to the micro-flora present indoors (Terr, 2009). The 
occurrence of water intrusion by means of flooding, leaks, condensation and poor 
insulation may contribute to the growth and persistence of moulds such as A. fumigatus 
in an indoor environment (Figure 1.2 B). Moulds such as A. fumigatus are capable of 
growth on surfaces as well as more concealed areas such as attics, sub-flooring, carpets 
and behind wallpaper. The saprophytic nature of A. fumigatus confers an ability to grow 
on materials which contain carbohydrates such as wood, plasterboard and wallpaper 
thus in conjunction with the availability of water and the thermotolerant nature of the 
fungus the rapid growth of A. fumigatus is possible (Li and Yang, 2004). Recent studies 
of flood damage have documented the increased prevalence of Aspergillus, Penicilium 
and Paecilomyces contamination in water damaged buildings in the aftermath of 
domestic flood damage caused by Hurricane Katrina (Chew et al., 2006). In this study 
the authors demonstrated levels of culturable mould from bioaerosol analysis ranging 
from 22,000 to 515,000 c.f.u (m3)-1 with spore counts ranging from 82,000 to 630,000 
spores (m3)-1. The prevalence of A. fumigatus has been documented in hospitals (Warris 
et al., 2001; Panagopoulou et al., 2002; Smedbold et al., 2002; Falvey and Streifel, 
2007). A recent article by Pini et al., (2008) identified the influence of hospital 
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Figure 1.1 A. fumigatus and the development of Aspergilloma. 
A. fumigatus grown on solid medium A, image of conidiophore B, and conidiophore 
with conidia dispersing C. A. fumigatus grows in a hyphal (vegetative) manner with the 
asexual production of conidia from the conidiophore which are wind dispersed. X-Ray 
Image of chest indicating the presence of fungal invasion D, and an aspergilloma 
removed from a lung by surgical excision E.  
 
Images: www.aspergillus.org.uk 
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Figure 1.2 Sick Building Syndrome. 
Fungal isolates are omnipresent in household dust A, Images from a water damaged 
house following flood damage B. The red arrow indicates extensive fungal growth on 
cellulose containing materials 
 
 Images: www.aspergillus.org.uk 
 
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renovation and construction work as a key factor in the prevalence of A. fumigatus in a 
nosocomial setting. It was found that cases of aspergillosis in the hallway of a 
haematology unit increased during a period of intense renovation work recording values 
of 2.98 cfu (m3)-1. Interestingly the values of 1.42 c.f.u (m3)-1 were recorded outside the 
hospital building further underlining the importance of regular surveillance of hospital 
units during periods of renovation. A subsequent study by Brenier-Pinchart et al., 
(2009) identified a correlation between high outdoor temperature and humidity with the 
occurrence of fungal flora in hospital wards. The requirement for particulate air 
filtration in high risk units coupled to partial air control and standard hygiene protocols 
in low risk wards as a means of controlling the level of fungal contamination was also 
emphasised.  
The distribution of A. fumigatus conidia is not limited to aerosolisation. Several 
cases of A. fumigatus and other filamentous fungi have been reported in public water 
supplies and in hospital water systems thus confirming the widespread distribution and 
omnipresent nature of conidia (Gottlich et al., 2002; Warris et al., 2002). Warris et al., 
(2002) demonstrated the absence of mould contamination in hospital ground water 
supplies but high levels of fungal contamination were present in surface water. A more 
recent report of microbial contamination in a Belgian hospital showed that 55% of 
samples recovered from the water distribution system demonstrated fungal 
contamination with Aspergillus species present in 6% of samples. Interestingly A. 
fumigatus comprised 66.6% of Aspergillus isolates (Hayette et al., 2010). Warris et al., 
(2003) used genotypic analysis to demonstrate that Aspergillus isolated from patients 
could originate from water of airborne source with aerosolisation of water borne conidia 
speculated as a major source of exposure to patients. Anaissie et al., (2002) 
recommended minimal exposure of high risk patients to contaminated aerosolised water 
such as that resulting from showers as a means of restricting exposure. A subsequent 
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study has identified the application of effective “point of use” filtration in water systems 
as a potential measure to reduce the risk of filamentous fungi exposure for patients 
(Warris et al., 2010). The beneficial implications of such measures to human health 
remain to be fully understood due to the cost and logistical implications of 
implementing such standard measures in hospital washrooms as filters would need to 
changed on a regular basis thus giving rise to the need for standard protocols for use. 
 
1.3 Aspergillosis; routes of infection and clinical manifestations. 
The successful colonisation by A. fumigatus of host tissue usually depends on the 
immunological status of the host. Successful infection relies on the presence of 
underlying factors such as existing pulmonary disorders, corticosteroid use, HIV 
infection, neutropenia, organ transplantation, allogenic stem cell transplantation or 
aggressive chemotherapy. Recent evidence suggests a role for single nucleotide 
polymorphisms present in affected hosts as a possible factor in predisposing patients to 
A. fumigatus infection (Mezger et al., 2010).  The most common region of A. fumigatus 
infection is pulmonary tissue however other tissues including skin, peritoneum, kidneys, 
eyes, bones, joints and the gastrointestinal tract have been reported as infected regions 
(Latgé, 1999; Bonfante et al., 2005; Eggiman et al., 2006; Tempkin et al., 2006; Camus 
et al., 2010; Golmia et al., 2010). The size of airborne A. fumigatus conidia enables 
access to the lower regions of the respiratory tract (Paris et al., 1997). In contrast larger 
conidia such as those of A. flavus and A. niger are less capable of such penetration (Ben-
Ami et al., 2010). In the majority of cases healthy immunocompetent individuals are not 
adversely affected by the presence of A. fumigatus due to the presence of a highly 
effective innate immune system (Latgé, 1999). In cases of infection the oxygenated 
nature of the lung coupled to the natural body temperature of 37ºC serves as an ideal 
environment for the growth of A. fumigatus with the fast growth rates associated with 
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more pathogenic strains (Paisly et al., 2005). Depending on the underlying health of 
affected individuals, as a result of the aforementioned factors affecting susceptibility to 
infection, three types of infection usually occur. These are allergic bronchopulmonary 
aspergillosis, aspergilloma and invasive aspergillosis. 
 
1.3.1 Allergic Bronchopulmonary Aspergillosis (ABPA). 
 ABPA occurs as a chronic lung condition in non-immunocompromised 
individuals resulting from hypersensitivity to A. fumigatus allergens which manifest as 
poor mucocilary clearance, bronchial obstruction and mucoid impactions (Greenberger, 
2002). The underlying predisposing conditions of ABPA are asthma and cystic fibrosis 
with 13% of the latter population affected by the fungus (Kraemer et al., 2006). The 
inhalation of spores from the environment stimulates an immune response involving 
Th2 CD4+ T-cells and IgE and IgG antibodies (Tillie-Leblond and Tonnel, 2005). It has 
been hypothesised that the abnormal nature of mucus in cystic fibrosis patients may 
promote the trapping of A. fumigatus in airways allowing for the growth of mycelia and 
further pulmonary colonisation by the fungus which in turn may promote T-helper cell 
responses which favour the development of ABPA (Kraemer et al., 2006). The 
activation of Th2 cells and resulting production of cytokines (Interleukin [IL] 4, 5 and 
13) result in the synthesis of Ig E, mast cell degranulation and eosinophil responses. In 
clinical settings ABPA may be diagnosed through a combination of Aspergillus antigen 
reactivity skin tests, elevated Ig E, serum reactivity against A. fumigatus, eosinophil 
counts exceeding 1000 cell µl-1, positive identification through sputum culturing and 
radiological imaging however many of these tests are non-specific therefore making the 
condition more difficult to treat (Agarwal, 2009).  
 The use of oral corticosteroids has been highlighted as a means of treating 
ABPA by suppressing the immune system and reducing levels of serum IgE. In recent 
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years the therapeutic use of an anti-Ig E antibody (omalizumab) has demonstrated 
success in terms of restoration of pulmonary function by reducing serum Ig E levels 
(van der Ent et al., 2007; Kanu and Patel, 2008). Recent reports using aerolised 
amphotericin B, voriconazole or itraconazole demonstrate the benefits of administering 
antifungal therapy as a viable replacement to the use of corticosteroids in ABPA 
patients (Hilliard et al., 2005; Seiberling and Wormaid, 2009; Hayes et al., 2010). 
 
1.3.2 Aspergilloma. 
 Pulmonary aspergilloma (mycetoma) are roughly spherical mobile fungal balls 
in a pre-existing lung cavity. Aspergillomas consist of tangled hyphal growth mixed 
with mucous and cellular debris within cavities which are usually fibrotic (Gefter, 1992; 
Franquet et al., 2001). The development of a pulmonary aspergilloma represents a 
significant problem in terms of resulting mortality due to the subsequent development 
of invasive aspergillosis. Other species such as Zygomycetes and Fusarium are also 
implicated in the development of fungal balls however A. fumigatus is the most 
common constituent (Zmeili and Soubani, 2007). The pre-existence of underlying 
pulmonary complications is associated with the condition with tuberculosis the most 
common (Kawamura et al., 2000). The fungal ball is capable of moving within cavities 
however without invading surrounding lung tissue or blood vessels. The development of 
haemoptysis as a result of aspergilloma has been linked to local invasion of blood 
vessels or mechanical irritation caused by the movement of the fungal ball (Zmeili and 
Soubani, 2007). In some cases the occurrence of haemoptysis may be fatal (Goreelik et 
al., 2000; Sagan et al., 2010). Diagnosis is usually possible by chest radiography (Kern 
and Lopert, 2010) or CT scan (Greene, 2005). The treatment of pulmonary aspergillosis 
is a challenging issue with surgical removal of the fungal ball (Figure 1.1 E) proving 
invasive to the patient and may result in mortality. In spite of this surgical removal has 
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demonstrated success in the treatment of aspergilloma (Sagan and Gozdziuk, 2010). 
Antifungal therapy for the treatment of aspergilloma has previously focussed on the use 
of amphotericin B, itraconazole or voriconazole however the use of these treatments is 
complicated by nephrotoxicity, severe reactions to therapy or drug resistance (Sagan et 
al., 2010). 
 
1.3.3 Invasive Aspergillosis (IA). 
 Invasive aspergillosis is a severe life threatening condition which commonly 
affects immunocompromised individuals undergoing chemotherapy, haematopoietic 
stem cell transplantation, corticosteroid therapy, HIV patients or individuals with 
chronic granulomatous disease (CGD) with mortality rates ranging from 40% to 90% 
depending on the immunological status of the host. Invasive aspergillosis occurs with 
the invasion of A. fumigatus hyphae into surrounding tissue where it may disseminate 
and spread to other organs (Dagenais and Keller, 2009). The occurrence of invasive 
aspergillosis in neutropenic individuals further highlights the role of neutrophils in host 
protection. The clinical manifestation of invasive aspergillosis is usually characterised 
by chest pain, coughing and haemoptysis however other symptoms such as weight loss 
and fever may also occur (Tomee and van der Werf, 2001). 
 The development of novel, high specificity diagnostic methods to detect the 
development of invasive aspergillosis is critical to the administration of appropriate 
chemotherapy and improvement of patient health. Currently positive identification of 
galactomannan and  1,3-glucan by ELISA from patient sera is regarded a reliable 
means to detect the development of IA (Chen and Kontoyiannis, 2010). The 
immunodetection of Aspf1 has also been commented upon as a useful means to detect 
IA in serological testing (Thornton, 2010). PCR based identification of I.A has focussed 
on the amplification of the 18s rRNA which is largely conserved in Aspergilli.  
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  Antifungal treatment of invasive aspergillosis has previously centred on the use 
of amphotericin B (AmB) and its lipid derivatives however its limited efficacy and 
financial cost has limited its use. Furthermore the nephrotoxic effects of AmB have 
been documented with studies demonstrating rates of renal failure as high as 30% in 
patients (Bates et al., 2001). In recent years the use of itraconazole, voriconazole and 
posaconazole has been evaluated with voriconazole proving to be the recommended 
therapy for most patients due to efficacy and reduced toxicity (Steinbach and Stevens, 
2003). A recent report by Bueid et al., (2010) highlights issues surrounding the use of 
azole resistance. In this study the authors report a growing shift towards itraconazole 
and posaconazole resistence with isolates still largely susceptible to voriconazole. 
Verweij et al., (2009) highlighted a potential resistance mechanism where genes 
encoding for a drug target protein cyp51A demonstrate a single mutation leading to 
reduced fungal susceptibility. The use of fungicides in the environment was identified 
as a selective agent in this case. Beuid et al., (2010) identified that 43% of azole 
resistant isolates carried the cyp51A mutation. It follows that other mechanisms of azole 
resistance may be developing.  
 The use of the echinocandin drugs caspofungin, micafungin, and anidulafungin 
have also been demonstrated as a combination therapy with azole antifungals. Initially 
caspofungin received regulatory approval in clinical trials however subsequent studies 
have endorsed the use of micafungin and anidulafungin. The echinocandins inhibit 
hyphal growth and demonstrate limited toxicity thus highlighting their utility in anti-
fungal treatment (Patterson, 2006, Sable et al., 2008).  
 
1.4 Immune responses to A. fumigatus. 
The first line of defence against A. fumigatus is the anatomical barrier of the 
host. The initial ciliary action of the tracheal epithelium which is lined with mucus, 
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proteins, lipids, ions and water eliminates the majority of conidia (Latgé, 2001). The 
presence of hydrophilic surfactant proteins SP-A and SP-D (calcium dependent lectins 
secreted by type II pneumocytes) support this arm of the immune response by binding 
to conidial surface carbohydrates, enhancing agglutination and phagocytosis by alveolar 
macrophages and modifying cytokine release (Wright, 2005). Complement is activated 
on the conidial surface and results in the cleavage of C3. The cleavage products of this 
activation serve to opsonise conidia for phagocytosis by neutrophils and macrophages 
(Behnsen et al., 2008). The initial cellular immune response to A. fumigatus conidia is 
performed by macrophages. The phagocytosis of conidia is mediated by pattern 
recognition receptors (PRRs) on host cells. Furthermore the production of chemokines 
and proinflammatory cytokines TNF-, IL-1, IL-6, IL-8, macrophage inflammatory 
protein 1 and monocytes chemoattractant protein 1 results from engagement of PRRs 
with A. fumigatus (Dagenais and Keller, 2009). Conidia are rapidly phagocytosed by 
alveolar macrophages and destroyed within intracellular phagosomes through reactive 
oxygen intermediate production mediated by NADPH oxidase formation and the 
phagosome acidification with the effect of conidial killing six hours post-phagocytosis 
(Phillipe et al., 2003). Although previous studies implicated the primary role of 
neutrophils in the immune response to swollen and germinated conidia Bonnett et al., 
(2006) demonstrated a role for neutrophils in the innate immune response to conidia. In 
that study BALB/c mice intranasally challenged with A. fumigatus conidia demonstrated 
significantly greater neutrophil recruitment coupled to the formation of “oxidase-active” 
aggregates with conidia than mice with impaired neutrophil function and recruitment. 
Zarember et al., (2007) demonstrated that lactoferrin degranulated by neutrophils 
contributes to the immune response by sequestering iron from the fungus thus 
ameliorating the local immune response. In addition to these processes serotonin stored 
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in the dense granules of platelets is released upon attachment with conidia with the 
effect of demonstrating fungicidal effects (Perkhofer et al., 2007).  
 The acquired immune response has also been implicated in protection against 
fungal pathogenesis. Following the maturation of dendritic and other antigen presenting 
cells Th1 cells become activated as evidenced by increased interferon-gamma 
production which inhibits the Th2 response of ABPA (Rivera et al., 2005). Interestingly 
the activation of Th1 cells appears to correlate with high concentrations of antigen 
detection while a Th2 response occurs in response to a low concentration therefore 
acting as a biomarker for the level of fungal pathogenesis within host tissue (Hosken et 
al., 1995).  
 
1.5 Virulence factors of A. fumigatus. 
 The success of A. fumigatus is due in part to several factors which create a more 
favourable environment for fungal growth, evading host immune responses and 
restricting immune function. 
 The surface of A. fumigatus conidia is largely comprised of melanin. Melanin is 
a polymeric polyketide and forms a dense layer on the surface of conidia. Jahn et al., 
(1997) demonstrated that conidia lacking in melanin production demonstrated increased 
susceptibility to oxidative stress and killing by human monocytes in vitro coupled to 
attenuated virulence in a murine model.  In addition the surface of conidia is covered in 
a thin layer of rodlets which are composed of hydrophobin proteins. These proteins are 
characterised as being small and moderately hydrophobic and demonstrate conserved 
spacing of eight cysteine residues (Wösten et al., 2000). Hydrophobins enhance the 
airborne dispersal of conidia. In A. fumigatus two hydrophobins encoded by rodA and 
rodB encode two homologous proteins. RodAp functions in the formation of rodlets 
with rodA mutant strains demonstrating a granular structure and enhanced 
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susceptibility to oxidative stress and alveolar macrophage killing. In contrast RodBp 
functions in the formation of cell wall structure and modulates the surface properties of 
rodA mutants (Paris et al., 2003). In addition to this, pathogenic species of A. 
fumigatus demonstrate sialic acid residues on the conidial surfaces through binding to 
fibrinogen and laminin has also been postulated as a virulence factor by enhancing 
attachment to the alveolar epithelium and previously damaged regions of the lung 
(Wasylnka et al., 2001; Dagenais and Keller, 2009). The composition of mycotoxins 
and other secondary metabolites on the surface of A. fumigatus has also received 
attention. A study by Hobson, (2000) demonstrated that conidial diffusates from A. 
fumigatus were capable of inhibiting neutrophil phagocytosis as evidenced by reduced 
pathogen phagocytosis. This work had been preceded by Mitchell et al., (1997) who 
characterised the presence of a water soluble component of the conidial surface of low 
molecular weight (<10 kDa) which disrupted superoxide production in neutrophils. 
Subsequent work has identified the presence of verruculogen, a tremorgenic mycotoxin 
on the conidial surface which decreased transepithelial electrical resistance and 
polarisation of the epithelium, (Khoufache et al., 2007). Panaccione and Coyle, (2005) 
describe the detection of four ergot alkaloids, fumigaclavine C, festuclavine, 
fumigaclavine A and fumigclavine B associated with conidial bodies. Ergot alkaloids 
have been demonstrated to interact with monoamine receptors thus negatively impacting 
on cardiovascular, reproductive, nervous and immune systems.  
Upon germination A. fumigatus produces and secretes a variety of proteases 
which aid in the exacerbation of fungal pathogenesis by degrading extracellular protein 
and assisting in the scavenging of nutrients. The work of Kothary et al., (1984) 
demonstrated that elastase producing strains were more virulent in mice than non-
elastase producing strains. This finding was further supported by evidence of advanced 
levels of tissue damage and hyphal development in vivo. An analysis of the elastase 
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activity index (EAI) of A. fumigatus isolates clearly demonstrates a strong correlation 
with pathogenicity. Interestingly this study demonstrated the presence of significant 
elastase activity in 30.9% of environmental A. fumigatus isolates and 96.9% of clinical 
strains. This feature highlights the issues surrounding elastase activity but also 
underlines the potential of environmental isolates to exhibit significant elastase activity 
(Blanco et al., 2002). In contrast, Alp and Arikan, (2008) found that there was not a 
direct correlation with the invasiveness of individual isolates and elastolytic activity 
therefore highlighting the need to fully understand the role of elastase and methods for 
detecting its production by A. fumigatus isolates.  
As previously mentioned the activation of the complement pathway plays a key 
role in the protection of the alveolar epithelium against A. fumigatus (Section 1.3). A 
recent article by Behnsen et al., (2010) described the role of an A. fumigatus protease 
Alp1 which was found to degrade complement proteins C3, C4, C5 and C1q as well as 
immunoglobulin G. A alp1 strain was found to be incapable of degrading these 
components therefore highlighting this protein as a virulence factor in the initial 
pathogenesis of A. fumigatus. Phospholipase activity has also been characterised in A. 
fumigatus isolates as a means of degrading phospholipids thus leading to cell death. 
Birch et al., (2004) demonstrated that clinical A. fumigatus isolates (n = 53) produced 
2.5 fold more phospholipase C activity than environmental isolates (n = 11). In contrast, 
environmental isolates produced higher levels of phospholipid acyl hydrolase activity. 
The total phospholipase activity was correlated with the advanced production of 
phospholipase C by clinical isolates thus highlighting this facet of the host tissue 
degradation in the secretome of A. fumigatus. The results of Alp and Arikan, (2008) 
strengthen the view that phospholipase activity is correlated with virulence as clinical 
isolates implicated in cases of invasive aspergillosis caused by A. fumigatus 
demonstrated high phospholipase activity.  
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The sequesterisation of iron is an important component is the pathogenesis of A. 
fumigatus as iron acts as a cofactor in enzymes and catalyses electron transport. A. 
fumigatus acquires iron through ferrous iron uptake, reductive iron assimilation and 
siderophores mediated iron uptake. Siderophores are of particular interest as they are 
produced in the presence of low levels of iron.  Triacetylfusarine C functions to capture 
extracellular iron while ferricrocin and hydroxyferricrocin function in the storage of 
iron in conidia and hyphae, respectively (Haas, 2003; Schrettl et al., 2004; Haas et al., 
2008). A deletion in the sidA gene resulted in the loss of siderophore synthesis coupled 
to reduced conidial germination and increased susceptibility to oxidative stress (Schrettl 
et al., 2007). In addition Seifert et al., (2008) demonstrated that siderophore production 
by A. fumigatus caused increased iron retention and ferritin synthesis in macrophage 
cell lines therefore placing a stress on the host innate cellular immune response.  
 
1.6 Mycotoxin production by A. fumigatus. 
The production of mycotoxins has been identified as a key facet in the 
modulation of the host immune system during fungal pathogenesis. Aspergillus 
fumigatus has been demonstrated to produce a range of secondary 
metabolites/mycotoxins with different harmful effects described. These include 
gliotoxin, fumagillin, helvolic acid, fumitremorgin, fumigaclavine C, aureperone C, 
restrictocin (Kamei and Wanatabe, 2005; Dagenais and Keller, 2009). 
 Fumagillin, (Figure 1.3) a cyclohexane derivative is produced by A. fumigatus 
upon hyphal development (Mitchell et al., 1997; Kamei and Watanabe, 2005). 
Fumagillin has been previously characterised as amoebicidal (Mc Cowen et al., 1951). 
Fumagillin has been identified as an inhibitor of angiogenesis through the covalent 
interaction of methionine aminopeptidase-2 (MetAP-2) a feature which is shared with 
its drug target analogue TNP-470 (Ingber et al., 1990).  Fumagillin has been 
 15  
demonstrated to retard the ciliary beat frequency of pulmonary epithelial cells at 
concentrations of 10 µg ml-1 however the physiological relevance of this concentration 
in terms of naturally occurring secondary metabolite secretions remains unclear 
(Amitani et al., 1995). In addition fumagillin has undergone clinical trials as an oral 
treatment for intestinal microsporidiasis in patients with HIV infection but adverse 
effects such as thrombocytopenia, neutropenia, hyperlipamaemia, and abdominal 
cramps were recorded (Molina et al., 2000). A recent report by Champion et al., (2010) 
further highlighted issues with the use of fumagillin for the treatment of intestinal 
microsporidiasis with patients reporting abdominal cramps. Successful therapeutic use 
of fumagillin has been reported when applied topically in cases of microsporicidal 
keratoconjunctivitis in humans (Diesenhouse et al., 1993). The fumagillin 
dicyclohexamine salt was found to induce sister chromatid exchanges at doses as low as 
0.34 µg ml-1 in human peripheral blood lymphocytes. Furthermore an increase in 
chromosome aberrations coupled to a reduction in mitotic index, proliferation index, 
and nuclear division index were observed in the same cell lines showing the clastogenic 
and cytotoxic potential of fumagillin (Stevanovic et al., 2008).  
Restrictocin blocks protein synthesis and exerts toxicity to mammalian cells 
however it is unclear as to the precise physiological relevance of restrictocin as strains 
deficient in its production did not demonstrate altered virulence (Smith, 1993). Helvolic 
acid, (Figure 1.3), has been demonstrated to affect the respiratory burst of macrophages 
Mitchell et al., 1997) and is capable of mediating ciliostasis of epithelial cells in vitro as 
well as causing cell damage at higher concentrations (Amitani et al., 1995; Khoufache 
et al., 2007). Fumitremorgin is an alkaloid produced by A. fumigatus and has been 
demonstrated to be tremorgenic. Recently, fumitremorgin been identified as a potent 
and specific inhibitor of breast cancer resistance protein (Kato et al., 2009) however its 
exact role in fungal pathogenesis remains to be fully understood. 
                   
   Fumagillin, C26H3407, M.W: 458.55  
 
                           
   
Helvolic acid, C33H44O8, M.W:568.698 
   
                      
Gliotoxin, C13H14N204S2, M.W: 326.393 
 
Figure 1.3 Mycotoxins produced by A. fumigatus. 
Fumagillin, Helvolic acid and Gliotoxin have are mycotoxins produced as secondary 
metabolites by A. fumigatus which mediate ciliostasis, epithelial cell damage and reduce 
cell function. 
 
Molecular structures: www.aspergillus.org.uk 
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Gliotoxin, (Figure 1.3) is arguably the most comprehensively studied secondary 
metabolite/mycotoxin produced by A. fumigatus. Gliotoxin is an 
epipolythiodioxopiperazine (ETP) molecule with a molecular weight of 326 Da. The 
toxicity of gliotoxin is mediated by the presence of an internal disulphide bond which 
forms mixed disulphides with mixed thiol groups (Hurne et al., 2000). There have been 
numerous articles published in the last few years describing the deletion of genes in 
gliotoxin biosynthetic cluster (Gardiner and Howlett, 2005). The gene gliP encodes a 
non ribosomal peptide synthetase (NRPS) which is capable of synthesising a gliotoxin 
precursor. Schrettl et al., (2010) have recently demonstrated that expression of gliT, a 
member of the gliotoxin biosynthetic culture protects A. fumigatus from restricted 
growth caused by gliotoxin. Bernardo et al., (2003) demonstrated a glutathione 
dependent reversible uptake mechanism for gliotoxin. Cells actively take up the 
oxidised form of gliotoxin and once within cells it binds to glutathione and remains in 
the reduced form. Upon the induction of apoptosis by gliotoxin glutathione levels are 
reduced and gliotoxin is released in its active form.  There is mixed information as to 
the percentage of Aspergillus strains that produce gliotoxin and there appears to be an ill 
defined consensus as to the concentration that pathogenic species are capable of 
producing in vivo (Kwon-Chung and Sugui, 2009). Gliotoxin has been demonstrated to 
inhibit ciliary beat frequency in epithelial cell lines (Amitani et al., 1995). Comera et 
al., (2007) demonstrated that gliotoxin disrupted the organisation of the neutrophil actin 
cytoskeleton at concentrations of 100ng ml-1. Other studies have demonstrated the 
inhibition of macrophage phagocytosis T-cell proliferation, mast cell activation and 
cytotoxic T-cell responses (Dagenais and Keller, 2009; Hof and Kupfahl, 2009). 
Gliotoxin inhibits the formation of the neutrophil NADPH oxidase complex by 
inhibiting the translocation of p47phox thus inhibiting the translocation of other cytosolic 
components to the membrane bound flavocytochrome b558 (Tsunawaki et al., 2004). The 
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formation of the NADPH oxidase complex and its role in neutrophil function will be 
discussed in more detail (Section 1.7). A recent article by Bruns et al., (2010) 
demonstrated that bio-film growth by A. fumigatus results in the advanced synthesis of 
gliotoxin which may also play a key role of the in vivo pathogenesis of the fungus. This 
finding may have serious implications for the health of immunocompetent individuals 
with cystic fibrosis as patients with the condition have been demonstrated to present 
with complications resulting from fungal colonisation of the respiratory epithelia (Pihet 
et al., 2009). 
 
1.7 Neutrophils. 
Neutrophils are highly effective phagocytes of the innate immune system and 
are a critical component of protection against pathogenic microorganisms. Neutrophils 
internalise pathogens into intracellular compartments called phagosomes. Neutrophils 
contain primary azurophilic, secondary, gelatinase and lysosome granules which 
contribute to the killing of internalised bacteria and fungi. A particularly interesting 
facet of the neutrophil is the formation of the NADPH oxidase complex (Figure 1.4). 
The components of this complex are flavocytochrome b558 which is composed of 
gp91phox and p22phox as the two membrane components (Cross and Segal, 2004). In 
addition to this a number of cytosolic proteins are also required to activate the the 
complex. These include p67phox, p47phox, p40phox and the small GTP-binding protein rac 
in the GTP bound form. The translocation of the cytosolic components of the NADPH 
oxidase to the membrane component is required to produce a functional complex 
capable of producing superoxide (Wientjes et al., 1993; Sumimito et al., 1996). Upon 
neutrophil activation p47phox becomes heavily phosphorylated and following 
translocation to the membrane through its affinity with the membrane regions of 
gp91phox, p47phox appears to act as an adaptor protein for the attachment of p40phox and 
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Figure 1.4 NADPH oxidase formation. 
The NADPH oxidase complex consists of a cytosolic (p40phox, p47phox, p67phox and rac) 
and a membrane flavocytochrome b558 which consists of gp91phox and p22phox (A). Upon 
neutrophil activation the cytosolic components translocate to the membrane and 
associate with flavocytochrome b558 thus forming the active NADPH oxidase complex 
leading to the production of superoxide (B). 
 
(A) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) 
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subsequently p67phox thus forming a functional NADPH oxidase complex (Wientjes and 
Segal, 2003). Molecular oxygen consumed during the phagocytosis of a pathogen is 
converted to superoxide (02-) by the transferral of electrons from NADPH to the 
molecular oxygen molecule (Segal, 1996). The superoxide anion may then be involved 
in downstream reactions with hydrogen with the formation of hydrogen peroxide 
(H2O2), hydroxyl radical (OH-) or may interact with nitric oxide (NO) to form 
peroxynitrite (Pryor and Squadrito, 1995).  
The commencement of degranulation has been demonstrated to occur with a lag 
phase of approximately twenty seconds (Segal et al., 1980). Myeloperoxidase (MPO) is 
a critical component of the degranulation process and comprises approximately 5% of 
the neutrophil proteome (Segal, 2005). MPO has been demonstrated to catalyse the 
H2O2 oxidation of halides that can kill microbes (Hampton et al., 1998). Data obtained 
from murine specimens have demonstrated that cases of MPO deficiency in neutrophils 
results in increased susceptibility to bacterial and fungal infections (Aratani et al., 
2000). Other primary granules secreted by neutrophils include cathespin G, elastase, 
defensins and lysozymes. These contribute to the permeabilisation of bacterial and 
fungal cells following liberation and activation through pH alterations mediated by the 
depolarization of the phagosome due to NADPH oxidase formation (Segal, 2005). 
Secondary granules include lactoferrin which is thought to play an important role in 
protection against conidia and other fungal entities by sequestering iron (Bonnet et al., 
2006). Defects associated with neutrophil granules include the inherited granule 
deficiency Chediak-Higashi syndrome which is a rare autosomal recessive disorder 
associated with a prominent defect in formation of neutrophil granules resulting in 
increased susceptibility to infection (Malech and Naseef, 1997). Chronic granulomatous 
disease (CGD) provides the most definitive evidence for the clinical importance of the 
NADPH oxidase as CGD patients are characterised by a predisposition to bacterial and 
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fungal infection. CGD is an immunodeficiency characterised by mutations in 
components of the NADPH oxidase complex thus resulting in the inability of the 
neutrophil to produced superoxide (Gallin and Zarember, 2007). The main genetic 
predisposing factors in CGD are mutations in gp91phox and p47phox which comprise 60% 
and 30% of CGD cases. Defects in the formation of p67phox and p22phox account for the 
remainder of CGD manifestations (Roos et al., 2003).  
 
1.8 Insects as models to study microbial pathogenesis 
Insects and vertebrates diverged approximately 500 million years ago however 
many similarities between both metazoans still exist at the biochemical and cellular 
level (Vilmos and Kurucz, 1998; Salzet, 2001). Insects do not possess an adaptive 
immune response however many similarities exist between the insect immune response 
and the innate immune response of mammals, therefore studies of infections requiring 
the activation of a strong innate immune response may be studied in insects. 
Furthermore in recent years insects have been used as a viable means to screen the 
efficacy of antimicrobial chemotherapeutic agents in vivo (Hamamoto et al., 2004; 
2009). Insects offer the benefits of a high throughput model and viable alternative to 
mammals due to lower costs, less laborious maintenance and speed of results. In 
addition employing insects for in vivo experimentation does not result in as many 
bioethical issues as using mice therefore making them a favorable model in modern 
laboratory practice. 
 
1.8.1 The insect cuticle as an initial defence barrier to infection. 
The insect cuticle forms an initial mechanical barrier to infection in a manner 
that is analogous to human skin. The cuticle is largely comprised of chitin with the outer 
layer of the cuticle covered in a waxy layer of lipids, fatty acids, and sterols (Böröczky 
 20  
et al., 2008). During entamopathogenic infection the insect cuticle is often broken down 
by chitinases (St Leger et al., 1987; Santi et al., 2010). Pathogenic microbes rarely 
degrade the epidermis however upon infection of broken tissue or during invasive 
pathogenesis microbes have been demonstrated to secrete extracellular proteases which 
facilitate the colonisation of host tissue (Walsh, 1998; Cowell et al., 2003). An intact 
insect cuticle is generally successful in preventing microbial infection however injury to 
the cuticle does activate immune responses comprising antimicrobial peptide 
expression, initiation of the phenoloxidase cascade and cellular activation (Kavanagh 
and Reeves, 2004; Lemaitre and Hoffmann, 2007).  
 
1.8.2 Clotting and melanisation 
The insect body cavity is known as the haemocoel which contains haemolymph 
and this structure is surrounded by the fat body. Both of these anatomical features 
function in a manner analogous to blood and the liver respectively (Søndergaard, 1993; 
Reeves and Kavanagh, 2004). Insect haemolymph is a protein and nutrient rich 
environment which functions in the transport of macromolecules and contains signal 
molecules, haemocytes and antimicrobial peptides which confer immunity to microbial 
challenge. The function of haemocytes will be discussed in greater detail in Section 
1.8.3. Upon physical injury the activation of two clotting mechanisms have been 
identified. The first is the polymerisation of vittellogenein-like proteins and lipophorins 
by a calcium-dependent transglutaminase which function in a manner similar to 
mammalian von Willebrand factor (Sritunyalucksana and Soderhall, 2000; Theopold et 
al., 2002). The second mechanism is initiated by the release of cytoplasmic L-granules. 
Gram negative bacteria activate the factor C component while the factor G component 
is activated by the presence of a fungal burden. The subsequent conformational change 
activates the proclotting enzyme which catalyses the conversion of soluble coagulogen 
  
         
 
 
 
Figure 1.5 The invertebrate phenoloxidase pathway. 
The system is activated by pattern recognition receptors for 1-3, glucan (GBP), 
peptidoglycan (PGBP) and lipopolysaccharide (LGBP). A cascade of serine proteases 
results in the cleavage of prophenoloxidase-activating  enzyme (Pro-ppA) to form ppA 
and thus cleave PPO to form PO. Some serine proteases can directly activate the 
pathway. The active phenoloxidase catalyses the o-hydroxylation of phenols to form 
quinines which polymerise to form melanin. 
 
Image: Cerenius and Soderhall, (2004) 
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to insoluble coagulin (Sritunyalucksana and Soderhall, 2000). The implications of blood 
clotting in insects has been discussed by Haine et al., (2007) who identified that 
infection mediated through injury in Periplaneta americana results in the localization of 
haemocytes to the site of infection and restricts microbial spread in the haemocoel. The 
cumulative effect of these measures is the compartmentalization of the open haemocoel 
thus limiting the development of microbial pathogenesis.  
The process of melanisation (Figure 1.5) is of central importance in insect 
immunity and conveys protection against a broad range of microorganisms as well as 
serving as a biomarker of the immunological status of insects. Activation of the 
phenoloxidase cascade results in the formation and deposition of melanin on the 
microbe. The native protein of phenoloxidase pathway is prophenoloxidase, a zymogen 
located within haemocytes. The process of phenoloxidase activation and subsequent 
melanin formation is initiated by the binding of soluble pattern recognition receptors 
which bind lipopolysaccharide, peptidoglycan and 1,3-glucan. Soluble pattern 
recognition receptors in insects include lectins, peptidoglycan recognition protein and 
1,3-glucan binding protein. In addition the insect lipoprotein Apolipophorin III has 
been demonstrated to activate the phenoloxidase pathway (Halwani et al., 2000; Park et 
al., 2005). This recognition leads to the serine protease mediated cleavage of 
prophenoloxidase by proPO-activating enzyme (PPA) (Cerenius and Soderhall, 2004). 
The active phenoloxidase protein catalyses the o-hydroxylation of monophenols to form 
diphenols, and oxidation of o-diphenols to o-quinones which polymerise to form 
melanin (Soderhall and Cerenius, 1998). Melanin and its precursors have been 
demonstrated as mediating direct toxicity against microbes (St Leger et al., 1988) 
however the controlled activation of the PO pathway is necessary as melanin at 
excessive levels is toxic to host tissue. Prophenoloxidase has been demonstrated to have 
sequence similarity with the thiol-ester region of vertebrate complement proteins C3 
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and C4 (Nair et al., 2005) thus indicating the possibility of a conserved evolutionary 
role in the initial host protection against microbes. 
 
1.8.3 Cellular Responses of Insects 
The insect haemolymph contains a cellular element in the form of haemocytes 
(Figure 1.6) which function in a manner similar to phagocytes of the vertebrate innate 
immune system. In the majority of cases haemocytes circulate freely through the 
haemolymph however it is estimated that up to 30% of haemocytes are associated with 
the fat body, trachea or wall of the haemocoel (Ratcliffe, 1985). Haemocytes have been 
further classisfied as prohameocytes, plamatocytes, granulocytes, coagulocytes, 
spherulocytes, and oenocytoids (Price and Ratcliffe, 1974). Prohaemocytes are 6-13 µm 
in diameter, have a high nuclear to cytoplasmic ratio and are believed to be the 
precursor of two differentiated haemocyte types (Ribeiro and Brehélin, 2006). 
Plasmatocytes are larger (up to 20 µm long). Plasmatocytes spread on coverslips and 
upon contact develop numerous pseudopodia thus leading some to suggest that they are 
involved in phagocytic reactions (Ling and Yu, 2006). Granulocytes measure 5-8 µm in 
diameter, possess pseudopodia and have been well demonstrated to phagocytose and to 
perform the initial interaction of the cellular immune response with pathogenic 
microorganisms. The release of their granular content acts as a chemoattractant for 
plasmatocytes thus ameliorating the immune response (Gillespie et al., 1997). 
Oenocytoids appear as large binucleate cells, have a low nuclear to cytoplasmic ratio, 
and have been demonstrated to contain phenoloxidase (Ribeiro and Brehélin, 2006). 
Spherulocytes are small rounded cells however their functions remain unknown. 
Coagulocytes and Adipohaemocytes are characterised by their roles in clotting and the 
presence of fat droplets, respectively (Kavanagh and Reeves, 2004). Dean et al., (2004) 
described the presence of a haemocyte with “ extreme phagocytic ability”  with a
  
 
                      
 
 
Figure 1.6 Different insect haemocyte subtypes. 
Haemocytes predominantly function in cellular mediated protection against microbes. 
The prohaemocyte is the precursor cell prior to cellular differentiation 
 
Image: Kavanagh and Reeves, (2004) 
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 capacity to phagocytose up to 500 bacteria per haemocyte therefore indicating that 
there may be other sub-classes of haemocytes which remain to be fully characterised in 
insects. 
 At a functional level phagocytosing haemocytes and vertebrate phagocytes both 
behave in a similar manner. Activation of the ProPO cascade is required for 
granulocytes to bind to non-self matter while calcium is required for plasmatocyte 
binding. Lectin mediated recognition in phagocytosis is conserved in vertebrates and 
invertebrates thus allowing for a diversity of pattern recognition sites specific to the 
infective microorganism (Kavanagh and Reeves, 2004). The discovery of proteins 
homologous to human p67phox and p47phox and subsequent production of superoxide 
demonstrated the parallels of the vertebrate innate immune system and insect immunity 
(Bergin et al., 2005). Furthermore Renwick et al., (2007) demonstrated that gliotoxin 
was capable of inhibiting the translocation of haemocyte p47 and p67 in a manner 
similar to neutrophils thus confirming a significant parallel in the field of comparative 
immunology.  
 
1.8.4 Antimicrobial Peptide Synthesis 
The production of antimicrobial peptides (AMPs) is a key element in the 
protection of insects against microbial infection. The main sites of AMP synthesis in 
insects are the haemocytes, fat body, salivary and reproductive glands. These molecules 
act to cause the lysis of microbial surfaces and are synthesized rapidly upon microbial 
sensing (Lowenbrger, 2001). The production of AMPs is largely due to the activation of 
the Toll and immunodeficiency (IMD) pathways which are NF- like. The Toll 
pathway is similar to the Toll like receptor (TLR)/IL-1 receptor pathway present in 
vertebrates and was originally described by Lemaitre et al., (1996). The Toll pathway, 
characteristic of a Gram positive bacteria or fungal response and is initiated by the 
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product of Spaetzle cleavage which is believed to bind the Toll receptor. Transduction 
through the MyD88 Tube molecules and Pelle leads to phosphorylation and activation 
of Cactus which in turn liberates Dif. Thereafter, Dif translocates to the nucleus to 
induce transcription (Salzet, 2001).  
The IMD pathway is comparable to the vertebrate tumour necrosis factor (TNF)-
 pathway and is mostly involved in the recognition of Gram negative bacterial 
infections. In the process peptidoglycan recognition protein, (PGRP) can recognise 
peptidoglycan and lipopolysaccharide and initiate the pathway. FADD associates with 
IMD. Meanwhile, TAK1 acts downstream of IMD/FADD where it exerts its function on 
signalosome to phosphorylate Relish. DREDD then associates with FADD to cleave 
Relish and produce REL-49 and REL-68, the latter translocating to the nucleus to act as 
a transcription factor (Hultmark, 2003). The regulation of the Toll and IMD pathways in 
insects in critical to the synthesis of appropriate antimicrobial defence and ensures a 
tailored immune response depending on the nature of infection. Gregorio et al., (2002) 
demonstrated that the absence of Toll and IMD in double knockout mutants of 
Drosphila resulted in the dysregulation of AMP gene activation and increased 
susceptibility to infection. 
 
1.9 Galleria mellonella as a model to study fungal pathogenesis 
 The Greater wax moth Galleria mellonella (Figure 1.7) is a common pest of 
beehives. The larval stage ofis naturally found in beehives where they feed on pollen, 
honey, wax and other organic material. G. mellonella colonises already weakened 
colonies whereby adult females fly at night and may deposit up to 102 eggs per minute 
in the cracks and crevices of the beehive. The larvae hatch from their eggs after a few 
days and commemnce feeding activity whereby thry tunnel through the honeycomb. In 
this action a protective silk trail during the prepupal stage of the lifecycle is spun which 
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effectively traps bees in the beehive and renders it unusable (Jafari et al., 2010, Schmolz 
et al., 1999). Following pupation male insects have been demonstrated to live an 
average of 21 days with females living for 12 days (Warren and Huddleston, 1962).  
Recent studies have demonstrated that G. mellonella larvae may be used as an 
effective model to study mycological virulence and the efficacy of anti-fungal drugs in 
vivo (Table 1.1). Cotter et al., (2000) demonstrated that they are a useful model to asses 
the relative pathogenicity of yeast species with statistically significant results obtained 
within 48 hours of infection. This initial concept in the study of fungal virulence was 
developed further by Brennan et al., (2002) with the discovery of a direct correlation 
between the virulence of C. albicans mutants in BalbC mice and G. mellonella larvae. 
An interesting development in the use of G. mellonella to assess the virulence of fungal 
pathogens was described by Scully and Bidochka, (2005) with the discovery that 
repeated serial passage of A. flavus results in the host specialization of the fungus as 
evidenced by increased fungal development in G. mellonella coupled to decreased 
growth on artificial media. Such findings are of particular importance given the 
requirement for a comprehensive understanding of virulence factors in emerging 
pathogens. 
The use of G. mellonella in A. fumigatus research has become recognised as a 
valuable alternative to the murine model. Reeves et al., (2004) demonstrated that A. 
fumigatus ATCC 26933 was pathogenic in G. mellonella. In addition it was 
demonstrated that the level of in vivo mycotoxin production by A. fumigatus could be 
evaluated through organic extraction and RP-HPLC analysis. Renwick et al., (2006) 
further developed this by using G. mellonella to assess the virulence of conidia 
undergoing germination and hyphal development. The authors demonstrated that an 
increased level of conidial development during the germination and outgrowth phase 
detrimentally affects the viability of larvae which is further supported by the finding 
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Figure 1.7 Galleria mellonella  
G. mellonella larvae A, and close up of larval pro-legs B. Uninfected healthy larvae 
(left) and heavily melanised dead larvae right C. 
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Reeves et al., 2006 Assessment of alteration of virulence of 
pes1 isolate in A. fumigatus 
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mutants of A. fumigatus 
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Cowen et al., 2009 Identification of Hsp90 as a drug target in an in vivo model 
Rowan et al., 2009 Evaluation of anti-fungal efficacy of 
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Table 1.1 Publications using G. mellonella for in vivo analysis. 
Selected examples of the utilisation of G. mellonella larvae with fungi and anti-fungal 
agents 
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that larval haemocytes are incapable of phagocytosing larger conidial bodies. 
Recent work by Cheema and Christians, (2010) demonstrated the differential 
pathogenicity of the mating types of A. fumigatus. Additionally Slater et al., (2010) 
identified that A. fumigatus isolates containing gene deletions of cpcA, sidA, sidC, sidD, 
sidF and paba demonstrated avirulence or attenuated virulence in G. mellonella and 
showed a strong correlation with murine data. 
G. mellonella larvae have been employed to evaluate the antifungal activity of 
amphotericin B, flucytosine and fluconazole following infection with Cryptococcus 
neoformans (Mylonakis et al., 2005). In addition, Rowan et al., (2009) demonstrated 
that novel silver compounds could be used as an effective means to assess in vivo 
antifungal activity. Inoculation of larvae with [Ag2(mal)(phen)3], AgNO3 or 1,10-phen 
resulted in a significant increase in haemocyte density 4 hours post inoculation coupled 
to the increased expression of gallerimycin as identified by RT-PCR. A recent 
publication by Kelly and Kavanagh, (2010) identified that administration of 
Caspofungin at concentrations of 0.19 µg ml-1 mediated protection against subsequent 
infection with Staphylococcus aureus or C. albicans. In this case increased impi and 
transferrin gene expression was observed coupled to the increased synthesis of 
Apolipophorin III and ferritin subunits. These two publications provide evidence for the 
use of G. mellonella as in vivo tools however they also raise the issue of immunological 
priming which is an important factor to consider when using larvae.  
The immunological status of G. mellonella may also be assessed depending on 
the administered treatments. Bergin et al., (2003 and 2006) demonstrated that larval 
haemocyte density and quantification of fungal load may be used as indicators of 
immune state and mycological progression. In these studies mildly pathogenic fungi 
resulted in a significant increase in circulating haemocyte density while highly 
pathogenic infections caused a loss in haemocyte density. In addition it was found that 
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higher fungal loads inversely correlated with this decrease in haemocyte density. 
Furthermore the application of 2-dimensional electrophoresis and RT-PCR may was 
demonstrated to be a useful indicator in understanding the larval immune status. 
Proteins identified through the application of proteomic methodologies in G. mellonella 
demonstrated homology with mammalian proteins or inclusion within a family of 
functionally related proteins in some cases. In addition to this Mowlds and Kavanagh, 
2008; Mowlds et al., (2008) and Mowlds et al., (2010) demonstrated that pre-incubation 
temperature, physical stress and exposure to glucan all effectively primed the immune 
system of G. mellonella through increased haemocyte density, elevated expression of 
antimicrobial peptide genes and alterations in the humoral proteome. Clearly the use of 
G. mellonella is a novel and highly beneficial approach to the study of microbial 
pathogenesis and chemotherapy however the characterisation of alterations to the 
immunological profile of larvae is warranted in order to fully utilise this model. 
 
1.10 Aims of study 
The primary aim of this project was to strengthen the current understanding of fungal 
pathogenesis mediated by A. fumigatus and its metabolites and to further develop the 
application of G. mellonella as an alternative model in innate immune system research.  
The aims of this study were: 
1. To further develop the body of knowledge that exists of the pathogenicity of 
clinical and environmental A. fumigatus isolates in the G. mellonella model of 
infection coupled to characterisation of these isolates through biochemical and 
microbiological methodologies.  
2. Contribute to the understanding of the impact of secondary metabolite 
production in vivo and in vitro through an analysis of the effect of one of these 
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mycotoxins on the cellular immune response of human neutrophils and G. 
mellonella haemocytes.  
3. Analyse the humoral profile and activity of insect haemolymph in response to 
mycotoxin exposure while undertaking a parallel study with human serum using 
a variety of biochemical methodologies.  
4. Characterise the immune response of G. mellonella to A. fumigatus infection 
with non-lethal inocula through changes in cellular responses, proteomic 
alterations and priming of antimicrobial peptide synthesis.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter 2 
 
 
Materials and Methods 
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2.1 General laboratory practice and sterilisation procedures. 
2.1.1 Chemicals and reagents. 
All reagents were of the highest purity and were purchased from Sigma Aldrich 
Ltd, Somerset, U.K unless otherwise stated. 
 
2.1.2 Statistical analysis. 
All experiments are the mean of at least three independent determinations ± 
standard error unless otherwise stated. Larval viability data were analysed using the Log 
rank test or Chi-Squared test. Differential expression of protein by 2-D electrophoresis 
was analysed by ANOVA. Experimental data were tested for statistical significance 
using a Students t-test (Minitab 14 package). For all experimentation a p-value of  
0.05 was deemed statistically significant.  
 
2.1.3 Sterilisation procedures. 
All micro-centrifuge tubes and pipette tips were stored in a sealed container and 
autoclaved at 121ºC for 15 minutes prior to use. All microbiological media with the 
exception of minimal essential medium / 5% (v/v) foetal calf serum (Section 2.2.7)   
were sterilised at 105ºC for 30 minutes prior to use. Semi-solid agar media were 
allowed to cool until hand hot, (approx 45-50ºC) and poured under sterile conditions 
using 90mm petri-dishes. All work involving A. fumigatus was performed using a class 
II safety cabinet. 
 
2.1.4 Cell enumeration and haemocytometry. 
Neutrophil, haemocyte and fungal cell counts were performed using an 
improved Neaubeur haemocytometer and all determinations were calculated from the 
average of three counts. 
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2.1.5 Galleria mellonella. 
Sixth - instar larvae of the greater wax moth G.  mellonella were purchased from 
Livefoods Direct Ltd, Sheffield, United Kingdom and were stored in the dark at 15ºC to 
prevent pupation. For experimental use all larvae were of a mass of 0.2–0.4 g, and were 
excluded if there was evidence of localised melanisation. Larvae were injected through 
the last left pro-leg (Figure 2.1 (A)), with a Myjector U-100 insulin syringe, (Terumo 
Europe N.V., 3001 Leuven, Belgium), while applying mild pressure to the insect to 
allow the opening of pro-legs (Figure 2.1 (B)). During experiments larvae were kept in 
9cm petri-dishes with 0.45 mm Whatmann filter paper inserted on the lids. Throughout 
all experimentation great care was taken to ensure the most accurate delivery of 
injection. In addition all in vivo assays were performed on three separate occasions 
using a group size of 10 larvae per dish and average results were calculated. For 
viability studies larvae were injected with sterile PBS as a positive control for the 
injection of larvae. 
 
2.2 Aspergillus fumigatus strains and culture conditions. 
2.2.1 Malt Extract agar. 
Malt extract agar was prepared by adding 50 grammes of extract per litre of 
deionised water and autoclaving at 105ºC for 30 minutes. Once the agar was hand hot it 
was poured into Petri-dish plates. 
 
2.2.2 Aspergillus Trace Elements. 
Na2B4O7.7H2O (0.04 g), CuSO4.(5H2O) (0.7 g)  FeSO4.7H2O (1.2 g), MnSO4 
(0.7 g), NaMoO.2H2O (0.8 g) and ZnSO4.7H2O (10 g) were added to 800 ml of distilled 
water and dissolved. The solution was made up to 1 L with distilled water and
           
             (A) 
            
  
 
 
             (B) 
              
 
 
 
Figure 2.1 Galleria mellonella pro-legs and inoculation.  
Pro-legs of larvae are exposed, (A), when mild pressure is applied to the larvae. Larvae 
were injected through the last left pro-leg with a 20 µl volume each time.  
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subsequently autoclaved. The solution was aliquoted in 50 ml volumes and stored at -
20ºC. 
 
2.2.3 Aspergillus Salt Solution. 
KCl (26 g), MgSO4.7H2O (26 g), KH2PO4 (76 g) and Aspergillus Trace elements 
50 ml were added to 800 ml distilled water and dissolved. The solution was made up to 
1 L with distilled water and autoclaved. Thereafter the solution was stored at room 
temperature. 
 
2.2.4 Ammonium Tartrate. 
  Ammonium Tartrate (92 g) was dissolved in 1L of distilled water and 
autoclaved. The solution was stored at room temperature 
 
2.2.5 Aspergillus Minimal Medium (AMM). 
Aspergillus minimal medium was prepared by adding Ammonium Tartrate, 
(10mls), Aspergillus Salt Solution, (20 mls), and Glucose, (10 g), to 800 mls of distilled 
water. AMM was adjusted to pH 6.8 and made up to 1 L using distilled water. The 
medium was autoclaved and stored at room temperature. 
 
2.2.6 Aspergillus Minimal Medium (Agar). 
AMM agar was prepared in the same way as liquid AMM however following 
the volume being adjusted to 1 L, 20 g of Agar was added and dissolved into solution 
and autoclaved. Following sterilisation AMM agar was cooled to approximately 50ºC 
and poured in clean Petri – dish under sterile conditions. 
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2.2.7 Minimal Essential Medium / 5% (v/v) Foetal Calf Serum. 
  All flasks were autoclaved at 121ºC for 15 minutes prior to use. Minimal 
Essential Medium supplemented with 5 % (v/v) Foetal Calf serum and aliquoted into 
each flask in a sterile environment and re-plugged with cotton wool ahead of 
inoculation with Aspergillus fumigatus. 
 
2.2.8 Phosphate Buffered Saline 0.01% (v/v) Tween. 
One PBS tablet was dissolved in 200 mls deionised water and was autoclaved at 
121ºC for 15 minutes. PBS was stored at room temperature. For PBS-T, PBS was 
supplemented with 0.01% Tween-80 (Merck), and was vortexed until mixed 
homogenously. PBS-T was filtered through a 0.22 µm filter (Millipore), prior to use. 
 
2.2.9 Aspergillus strain culture. 
A. fumigatus ATCC 26933 obtained from American Type Culture Collection 
Maryland USA, was grown and maintained on Malt Extract Agar (Oxoid Ltd 
Basingstoke UK) at 37ºC in thermally controlled incubator for a minimum of 4 days. In 
some experiments conidia were withdrawn from 37ºC incubation and stored at room 
temperature to monitor the effect of conidial maturation on the virulence of Aspergillus 
isolates on G. mellonella larvae. Environmental and clinical isolates of A. fumigatus  
(EAF 1-15 and CAF 1-15 respectively) and environmental A. flavus, A. terreus and A. 
niger were a kind gift from Professor Ricardo Araujo, Faculty of Medicine of Porto, 
Portugal. Environmental strains were isolated by air and surface sampling. Clinical 
isolates were isolated from patients with invasive aspergillosis. Aspergillus isolates 
AF293, ftmA, laeA, and psoA were a kind gift from Professor Elaine Bignell, 
(Imperial College London). All strains were stored in 50% (v/v) glycerol and 10 µl 
aliquot of this was used was stabbed in the centre of a Petri-dish containing Malt Extract 
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Agar prior to starting a new culture for every experiment. Plates were inspected on a 
daily basis for the level of growth. Once conidial development was achieved the plates 
were wrapped in parafilm and stored at 4ºC. 
 
2.2.10 Harvesting of Aspergillus conidia. 
Aspergillus conidia were harvested in a Class II safety cabinet. Plates were 
initially washed with 10 mls PBS-T and centrifuged at 1,500 x g for 5 minutes at room 
temperature. The supernatant was removed and the conidial pellet was washed twice in 
sterile PBS to remove excess Tween 80. The concentration of conidia in the suspension 
was calculated by haemocytometry. 
 
2.2.11 Liquid Culture of A.  fumigatus. 
For Aspergillus culture in MEM/5% (v/v) FCS or AMM sterile medium was 
inoculated in a sterile laminar flow hood and conidial inoculations were 5 x 107 cells per 
100 ml culture.  
 
2.2.12 Milk Agar. 
 Dry skimmed milk (5 g) and Agar (8 g) was mixed to a homogenous solution for 
60 minutes and was subsequently sterilised by autoclaving at 105ºC. Following 
sterilisation the agar was allowed to cool to hand warm and was spread on a 9 cm Petri-
dish. 
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2.3 Candida albicans strain growth and harvest. 
2.3.1 YEPD broth / agar. 
YEPD agar was prepared by dissolving Glucose (2% w/v), Yeast extract (1% 
w/v), and bacteriological peptone (2% w/v), in deionised water and autoclaving at 
105ºC for 30 minutes. 
For agar plates 2% (w/v) agar was added and autoclaved as described. In some 
cases erythromycin was added to the hand warm agar prior to pouring to control 
bacterial contamination. This was prepared by dissolving 5 mls of a 5 mg ml-1 solution 
of erythromycin in DMSO when the agar solution was hand warm. Once in the agar 
solution the plates were spread as per normal and stored at 4ºC. All erythromycin 
supplemented plates were used within 3 days. 
 
2.3.2 Candida albicans liquid culture and cell harvest.  
C. albicans MEN was a kind gift from Dr. D. Kerridge, Cambridge, UK. An 
individual colony of cells was transferred to sterile YEPD broth using a sterile 
inoculating loop. The flask was re-plugged with cotton and incubated at 30ºC shaking at 
200 rpm overnight. To obtain a suspension of cells, 50 ml culture was transferred to a 
sterile 50 ml tube and centrifuged at 500 x g for 5 minutes. The cellular pellet was 
washed twice in sterile PBS and the final cell concentration in a 10 ml volume of PBS 
was ascertained by haemocytometry. 
 
2.4 Pseudomonas aeruginosa maintenance, growth and cell culture. 
2.4.1 Luria Bertani (L.B) Broth. 
Difco L.B broth, (12.5 g) was dissolved in 500 mls deionised water. The broth 
was aliquoted 50 ml volumes in a conical flask and sterilised by autoclaving. 
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2.4.2 P.  aeruginosa isolation agar. 
Pseudomonas aeruginosa isolation agar powder (38 g) was dissolved in 1 L 
deionised water and sterilised by autoclaving. The agar was poured once hand hot. 
 
2.4.3 Liquid culture of P.  aeruginosa. 
P. aeruginosa PA01 cultures were obtained by transferring a single bacterial 
colony to L.B broth with a sterile inoculating loop and was grown overnight at 37ºC and 
200 r.p.m. 
 
2.4.4 Calculation of P. aeruginosa culture cell concentration. 
An overnight bacterial culture was spectrophometrically measured at an O.D. of 
600nm using L.B broth as a blank and the absorbance was measured. Cells were diluted 
to an O.D. of 1 and serially diluted by factors of ten using sterile PBS and 100 µl was 
plated out on Pseudomonas aeruginosa isolation agar. The dilution which produced 80-
100 cells per 100 µl spread was used to calculate the concentration of cells per ml of 
culture at 0.D 1.  
 
2.5 Aspergillus plate growth measurement and conidial size analysis. 
2.5.1 Plate analysis of Aspergillus growth. 
To compare the relative levels of growth of A. fumigatus isolates conidia from 
different isolates were harvested. Conidia were diluted in sterile PBS and 5 x 103 cells 
in a 5 µl volume were spotted on the centre of the AMM agar plate under sterile 
conditions. The droplet was allowed to dry and plates were incubated at 37ºC for 24, 48, 
and 72 hours. Radial growth was measured and calculated in terms of colony area 
(mm2).  
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2.5.2 Comparative analysis of conidial size using PAMAS counter. 
Conidia were extracted and a 10 ml suspension of 1 x 106 ml-1conidia was 
prepared. All samples were checked for the absence of spore agglutination prior to 
analysis. Conidial size analysis was performed using a PAMAS counter (SVSS-C) with 
analysis and size distribution software. The size variation of conidia was monitored at 
1-8 µm for A. fumigatus strains and from 1-16 µm for A. flavus. 
 
2.6 1-D and 2-D Sodium Dodecyl Sulphate–Polyacrylamide gel electrophoresis 
(SDS PAGE). 
2.6.1 1.5 M Tris–HCl. 
Tris – HCl (1.5 M) was prepared by dissolving 36.3 g Trizma Base, (Tris Base) 
in 170 mls deionised water and adjusted to pH 8.9 using HCl. Following pH adjustment 
1.5 M Tris – HCl was filter sterilised through a 0.22 µM cellulose filter (Millipore) and 
stored at 4ºC.  
 
2.6.2 0.5 M Tris – HCl. 
Tris-HCl (0.5 M) was prepared by dissolving 12.1 g Trizma Base in 175 mls 
deionised water and adjusted to pH 6.8 using HCl. Following pH adjustment 0.5 M Tris 
– HCl was filter sterilised through a 0.22 µM filter (Millipore) and stored at 4ºC. 
 
2.6.3 10% w/v Sodium Dodecyl Sulphate (SDS). 
Sodium Dodecyl Sulphate (SDS), (10% w/v) was prepared by adding 10 g SDS 
to 100 mls of deionised water and left to stir until all SDS had been solubilised. The 
solution was sterilised through a 0.22 µM filter and stored at room temperature. The 
solution was inspected for solubility prior to use. 
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2.6.4 10% Ammonium Persulphate (APS). 
APS (10% w/v) was prepared by adding 0.1 g APS into 1ml of deionised water 
and vortexed briefly to achieve solubility. APS (10% w/v) was prepared fresh every day 
and kept on ice when not in use. 
 
2.6.5 10X electrode Running Buffer. 
10 X running buffer, (electrode buffer), was prepared by dissolving Tris Base 
(30 g), Glycine (144 g), and SDS (10 g) using a magnetic stirrer in 800 mls distilled 
water. The mixture was allowed to solubilise overnight at room temperature and 
adjusted where required to pH 8.9. The buffer was made up to 1 litre and stored at room 
temperature. Electrode running buffer (10X) stock was diluted to different 1X, 2X and 
5X concentrations by making 1/10, 1/5, and 1/2 dilutions with distilled water when 
required. 
 
2.6.6 5X Solubilisation Buffer for 1-D SDS–PAGE. 
Solubilisation buffer was prepared by dissolving the following constituents to 
solubility. 
• Glycerol    8 mls 
• Deionised water   4 mls 
• 10% (w/v) SDS   1.6 mls 
• 0.5 M Tris – HCl   1 ml 
• Bromophenol Blue (0.5% w/v) 200 µl 
• 2 – Mercaptoethanol   400 µl 
 
The buffer was gently mixed for 1 hour at 4ºC and aliquoted in 500 µl volumes prior to 
storage at -20ºC. 
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2.6.7 Preparation of SDS–PAGE minigels. 
All glass plates were washed in warm soapy water and cleaned thoroughly with 
70% ethanol prior to use. SDS–PAGE minigels (cast using the Mini-Protean II gel 
casting apparatus), were made with a definite percentage concentration of acrylamide 
which was varied depending on the sample characteristics. A 12.5% acrylamide gel was 
normally used in experimental procedure however for samples where molecular weight 
was generally low the percentage of acrylamide was increased to 15% or 20% so as to 
aid greater separation and definition of bands. 
SDS–PAGE mingels contain a stacking buffer where proteins are loaded in 
wells and once an electrical current is applied they are sequentially separated depending 
on their size. The separating gel separates the proteins from each other depending on 
size therefore aiding visualisation. All gels were used within 24 hours of setting and 
were allowed to polymerise for at least one hour prior to being loaded. 
 
• Seperating gel composition 
 
 
% Acrylamide 
Solution component 12.50% 15% 20% 
1.5 M Tris-HCl 3 mls 3 mls 3 mls 
Deionised water 3.8 mls 2.8 mls 800 µl 
30% Acrylamide 5 mls 6 mls 8 mls 
10% v/v SDS 120 µl 120 µl 120 µl 
10% v/v APS 75 µl 75 µl 75 µl 
TEMED 3 µl 3 µl 3 µl 
 
These volumes were sufficient to make 3 minigels and volumes were adjusted 
accordingly where a larger volume was required. 
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• Stacking gel composition 
The following components were mixed together and applied on top of the separating 
gel; deionised water (3.4 mls), 30% acrylamide 830 µl, 0.5 M Tris – HCl (630 µl), 10% 
v/v SDS (50 µl), 10% v/v APS (50 µl), and N,N,N’ ,N’ -Tetramethylethylene-diamine 
(TEMED) (5 µl). Combs were placed in the gel matrix before it set to create wells for 
sample loading. These volumes were sufficient to make 2 minigels and volumes were 
adjusted accordingly where a larger volume was required. 
 
2.6.8 1-D SDS-PAGE sample loading and voltages. 
SDS-PAGE gels (12.5%, 15% or 20% w/v acrylamide) were immersed in 1X 
running buffer. Samples varied in sample volume and protein concentration depending 
on the experiment but were aliquoted using a sterile gel loading tip (Fisher). The gels 
were electrophoresed at 60V initially and the voltage was increased to 100 V once the 
protein had travelled sufficiently through the gel. Once the blue tracking dye had moved 
to the bottom of the gel the gels were transferred to a clean staining dish. 
 
2.7 2-D SDS-PAGE preparation and analysis. 
2.7.1 Isoelectric focussing (IEF) Buffer. 
The following constituents were dissolved in deionised water and were stored in 2 ml 
aliquots at -20ºC until required. 
 
• Urea     8 M 
• Triton X-100 (BDH)   1% (v/v) 
• CHAPS    4% (w/v) 
• Tris HCl    10 mM 
• Thiourea    2 mM 
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Prior to use DTT (65 mM) was added to the buffer and solubilised by vortexing 
 
2.7.2 Equilibration Buffer. 
• Tris-base 50 mM 
• Urea  6 M 
• SDS  2% (w/v) 
• Glycerol 30% (v/v) 
 
The solution was adjusted to pH 6.8 and aliquoted in 40 ml volumes prior to storage at -
20ºC. For equilibration the buffer was modified as either reducing or alkylating. For 
reduction, DTT (0.02 g ml -1) was added and dissolved thoroughly. For alkylation, IAA 
(0.04 g ml -1) was dissolved thoroughly in the buffer and a few grains of bromophenol 
blue were added to the buffer. 
 
2.7.3 Agarose sealing solution (1% w/v). 
Agarose (1 g) was dissolved in 100 mls 10X running Buffer and heated until 
boiling. A few grains of bromophenol blue was added to the mixture and was allowed to 
cool to hand hot prior to applying to the top of the gel.  
 
2.7.4 Gel preparation for 2-D electrophoresis. 
Glass plates were washed thoroughly with warm soapy water, rinsed and dried with 
70% ethanol to remove any residual contamination left on the glass. Glass plates were 
200 mm wide and were 200 mm in length on the front and 223 mm in length at the 
back. Gels (12.5 % acrylamide) were poured to approximately 190 mm x 160 mm in 
surface area and 1.5mm thick 
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• Tris – HCl (1.5 M)  60 mls 
• Deionised water  76 mls 
• Acrylamide (30% w/v) 100 mls 
• SDS (10% w/v)  2.4 mls 
• APS (10% w/v)  1.5 mls 
• TEMED   60 µl 
  
2.7.5 2-Dimensional Electrophoresis. 
Protein was extracted from haemolymph of G. mellonella larvae and 300 µg of 
protein was obtained via quantification by the Bradford method. The required aliquot of 
haemolymph was added to 100 µl of IEF buffer and allowed to solubilise fully with 
regular vortexing for 1 hour. Ampholytes (Immobline 3-10) (2 µl) were added directly 
to the sample and a further 150 µl of IEF buffer with a few grains of bromophenol blue 
added was added to the sample. The sample was briefly vortexed and applied to a 13cm 
Immobline DryStrip pH 3-10 (G.E. Healthcare). Prior to isoelectic focussing the strips 
were covered in Plus One drystrip cover fluid, (GE Healthcare). Focussing was 
performed on an Ettan IPGphor II (Amersham Biosciences, NJ, USA) system using the 
following programme. 
 
1. Step  50 Volts 12 hours 
2. Step  250 Volts 15 minutes 
3. Gradient 5000 Volts 2 hours 
4. Step  5000 Volts 5 hours 
5. Gradient 8000 Volts 2 hours 
6. Step     8000 Volts 1 hour 
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Following IEF IPG strips were frozen at -70ºC or were transferred directly to 
equilibration.  
Strips were initially equilibrated in 10 mls reducing equilibration buffer for 15 
minutes. Strips were transferred to the alkylation buffer for 15 minutes. Following 
equilibration IPG strips were rinsed briefly in 1X electrode running buffer. Strips were 
placed on top of homogenous 12.5% SDS-PAGE gels and sealed with 1% w/v agarose 
sealing solution. A piece of straw with filter paper inserted was placed to the left of the 
IPG strip and an aliquot of molecular weight marker was placed into the filter. The top 
of the gel was sealed with molten cooled sealing solution and allowed to set. The 
second dimension of protein separation was achieved by placing the gels in ProteanXi-
II vertical electrophoresis cells as per manufacturer’ s instructions. The inner chamber 
was filled to the top with 5X electrode running buffer while the outer chamber was 
filled with 2X running buffer. Gels were initially electrophoresed for 1 hour at 40 volts 
and at 80 volts for the remaining time. Gels were monitored regularly to assess the level 
of electrophoresis and were transferred to a staining dish which was previously washed 
with soap and subsequently with 70% ethanol to prevent any contamination to the gels 
during staining. 
 
2.7.6 Comparative analysis of protein expression. 
 2-D electrophoresis gel images (In triplicate) were analysed using Progenesis 
SameSpots software (Nonlinear Dynamics) in order to assess the fold change in protein 
expression in larvae injected with different treatments. In all experiments untreated 
larvae (U.T) incubated under the same conditions as injected larvae were used as 
control. The level of differential expression was analysed by ANOVA with p-values of 
 0.05 considered statistically significant for changes in expression. 
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2.8 General Protein Methodology. 
2.8.1 Bradford Protein assay. 
Bovine Serum Albumin standards ( 5 - 60 µg ml-1), were made in 800 µl 
deionised water and 200 µl Biorad Bradford protein assay reagent (Bio-Rad Munich 
Germany) and read on a spectrophotometer at 595 nm (Eppendorf Biophotometer). A 
standard curve was prepared. Bradford protein assay reagent was prepared by diluting 
the stock 1/5 using deionised water. Protein samples were added (20 µl) to 980 µl of 
Bradford protein assay reagent. The samples were inverted, allowed to stand for 5 
minutes and read spectrophotometrically.  
 
2.8.2 Acetone precipitation of protein samples. 
Acetone precipitation was used to concentrate protein from a dilute sample 
volume. The required volume of protein which corresponded to a calculated quantity of 
protein from Bradford assay quantification was aliquoted to a pre-chilled micro-
centrifuge tube and 100% ice-cold acetone was added to the tube at ratio of 1:3, (sample 
volume: 100% Acetone) ratio. Protein was left to precipitate overnight at -20ºC and 
centrifuged at 20,000 x g for 30 minutes at 4ºC to pellet protein. 
 
2.8.3 Colloidal Coomassie staining of 1-dimensional and 2-Dimensional SDS-PAGE 
gels. 
Upon finishing, electrophoresis gels were removed and immediately placed in a 
fixing solution of 50% (v/v) ethanol and 3% (v/v) phosphoric acid. After this time gels 
were washed 3 times in deionised water. Gels were pre-incubated for approximately 60 
minutes in a solution of 34% (v/v) methanol, 3% (v/v) phosphoric acid and 17% (w/v) 
ammonium sulphate. After 60 minutes a spatula tip of CBB, (Serva), was spread across 
the gels and the gels were sealed with parafilm for 3-5 days until maximal staining. At 
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this point gels were washed several times in deionised water to remove any excess or 
residual staining. 
 
2.8.4 Coomassie Brilliant Blue (CBB) Stain. 
The following constituents were mixed in a sealed Duran bottle and stored in the dark at 
room temperature.  
• Methanol   45% (v/v) 
• Deionised Water  44.8% (v/v) 
• Acetic acid   10% (v/v) 
• CBB (Brilliant Blue)  0.2% (w/v)  
   
2.8.5 Coomassie Destain. 
The following constituents were mixed in a sealed Duran bottle and stored in the 
dark at room temperature. 
• Methanol  25% 
• Deionised Water 65% 
• Acetic Acid  10% 
 
2.9 Western Blotting. 
2.9.1 TBS (10X). 
One litre of TBS was prepared by dissolving 0.5 M Tris–HCl, (78.7 g in 1 litre), 
and 1.5 M Tris HCl, (86.65 g in 1 litre). Prior to being made up to 1 litre volume the 
buffer was adjusted to pH 7.6 using NaOH. The buffer was autoclaved and stored at 
room temperature.  
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2.9.2 1X TBS-Tween. 
1X TBS-Tween was prepared by adding 100 mls 10X TBS to 900 mls distilled 
water. Tween–20 (500 µl) was added to the solution and mixed thoroughly. The 
solution was used immediately. 
 
2.9.3 Transfer Buffer. 
Transfer Buffer was prepared by dissolving 3.03 g Tris - Base and 14.4 g 
Glycine in 1 litre of 20% (v/v) methanol, 80% (v/v) deionised water. The buffer was 
allowed to dissolve thoroughly with a magnetic stirring bar and was made fresh on the 
day. 
 
2.9.4 Blocking Buffer. 
Blocking buffer was made by dissolving 3 g Dried Skimmed Milk, (Marvel), 
and 1 g Bovine Serum Albumin, (BSA) in 100 ml 1X TBS-Tween-20. Blocking buffer 
was stored at 4ºC and used within 24 hours. 
 
2.9.5 DAB Buffer. 
DAB buffer was prepared by dissolving 10 mg 3,3’  –Diaminobenzidine 
tetrahydrochloride hydrate in 15 ml 0.1 M Tris Base, (pH  7.6) supplemented with 7 µl 
Hydrogen Peroxide. DAB buffer was briefly vortexed to ensure complete solubility of 
DAB powder prior to use. 
 
2.9.6 Western Blotting method. 
Transfer of protein onto nitrocellulose paper was performed by electro-blotting 
using a wet blotter (Mini Trans Blot Cell, Bio-Rad). Prior to transfer filter paper, 
nitrocellulose paper, (Whatman) were cut to the size of the gel, (approximately 85 x 65 
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mm), and soaked with sponge inserts for 30 minutes. An assembly was constructed 
within the gel holder cassettes in the following order; 
 
•  Sponge insert 
• Whatman paper 
• Nitrocellulose membrane 
• SDS-PAGE gel  
• Whatman paper 
• Sponge insert 
 
The SDS-PAGE gels were transferred carefully from the glass plate to the surface of the 
nitrocellulose membrane to avoid tearing of the gel. The assembly was gently rolled to 
remove any air bubbles trapped between layers. The cassette was closed and placed into 
the tank with a cooling block. The apparatus was run at 100 V for 70 minutes and the 
nitrocellulose membrane was transferred to a staining dish of Ponceau S solution for 5 
minutes with gentle shaking to ascertain the quality of the transfer. The nitrocellulose 
membrane was rinsed in deionised water prior to further processing. The blots were 
initially blocked in blocking  buffer for approximately 1 hour and washed for 2 x ten 
minute washes in 1X TBS-T. The primary antibody was applied using different 
dilutions of the antibody stock overnight at 4ºC under mixing conditions. The blots were 
removed and subjected to 3 x twenty minute washes in 1X TBS-T and transferred to the 
secondary antibody buffer. Blots were incubated for 2 hours at room temperature with 
gentle mixing. Blots were washed 3 times in TBS-T for 20 minute intervals changing 
the 1X TBS-T buffer each time. Blots were washed then developed using ECL or DAB 
reagents. 
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2.9.7 Development of reactive protein bands analysis. 
  Blots were immersed in ECL reagent (Perkin Elmer) for 1 minute and developed 
on a developing film using a 1/3 dilution of developer, and fixed using a 1/4 dilution of 
fixer (Kodak).  
Alternatively DAB buffer (15 mls) was poured over the Western blot after 
sufficient washing of the nitrocellulose paper. Immunoreactive bands developed within 
a few seconds and the buffer was removed. The developed blot was washed 3 times in 
deionised water. 
Reactive protein bands were analysed by densitometry using the Image J image 
analysis software. 
 
2.10 Peptide extraction from G. mellonella haemolymph. 
 The extraction of peptides from G. mellonella larval haemolymph was 
performed as described by Cytrynska et al., (2007). 
 
2.10.1 Extraction (Acid/Methanol) buffer. 
Extraction buffer was prepared to a volume of 10 mls by preparing HPLC grade 
methanol, HPLC grade water and glacial acetic acid in a 9:0.9:0.1 ratio. The buffer was 
allowed to mix thoroughly and was chilled on ice prior to use. 
 
2.10.2 Peptide Extraction. 
Peptide extraction buffer was chilled on ice for approximately one hour prior to 
use. All micro-centrifuge tubes were pre-chilled on ice to prevent any subsequent 
breakdown of crude extract or activation of proteolytic cascades. 
Larvae (10) were bled into a micro-centrifuge tube and immediately centrifuged 
at 500 x g for 5 minutes at 4ºC to pellet haemocytes. The supernatant was removed and 
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transferred to a clean micro-centrifuge tube. The cell free haemolymph was centrifuged 
at 20,000 x g for 30 minutes to remove any remaining cell debris or tissue present from 
the original bleed. Haemolymph protein (7.5 mg) was diluted in extraction buffer by 
diluting 100µl of cell free haemolymph in 900 µl extraction buffer and the contents of 
the micro-centrifuge tube were mixed thoroughly to precipitate protein. The precipitated 
proteins were pelleted by centrifugation at 20,000 x g for 30 minutes at 4ºC. The 
supernatant (900 µl) was transferred to a fresh micro-centrifuge tube and stored at -20ºC 
overnight and subsequently centrifuged to ensure that all high molecular weight protein 
was removed from the extraction buffer. Two 400 µl volumes were removed from each 
treatment and lyophilised until dryness and stored at -70ºC until required. 
Extraction samples were resuspended in equivalent volumes of SDS-PAGE 
solubilisation buffer or apyrogenic water supplemented with 0.1% (v/v) TFA. Samples 
were subsequently subjected to 1-D SDS–PAGE or RP–HPLC. 
For lipid removal the extraction procedure was performed in a method adapted 
from Schoofs et al., (1990). Following reconstitution in 200 µl 0.1% (v/v) TFA the 
extract was further extracted in an equivalent volume of n-hexane and vortexed at room 
temperature. The upper lipid fraction was removed and the lower aqueous layer was 
extracted further with an equivalent volume of ethyl-acetate. The water fraction 
containing peptides was removed and freeze dried prior to reconstitution with 200 µl 
0.1% (v/v) TFA and HPLC analysis. 
 
2.11 Organic extraction from A. fumigatus infected larvae and Aspergillus culture 
filtrates. 
2.11.1 Mycotoxin extraction from G. mellonella. 
Extraction of mycotoxins from G. mellonella was performed using an adaptation 
of the method of Reeves et al., (2004). Larvae (25) were chosen at random and were 
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crushed in a pestle and mortar using liquid nitrogen. The crushed larvae were 
transferred to a 5 ml volume of 6 M HCl. The pestle and mortar was washed with two 
10 ml volumes 6 M HCl. Chloroform (50 ml) was added and the mixture was incubated 
with constant mixing at room temperature for 30 minutes. The mixture was centrifuged 
at 500 x g for 5 minutes and the chloroform layer was transferred to a separate tube. The 
chloroform extraction step was repeated with 50 ml chloroform and all organic extracts 
were pooled. Chloroform was evaporated at 37ºC using a rotary evaporator (Buchi 
rotavapor–R) which resulted in an insoluble lipid pellet (approximately 1 ml). This lipid 
pellet was extracted with four 1 ml volumes of HPLC grade methanol and these extracts 
were pooled and concentrated to a volume of 200 µl. Prior to RP-HPLC analysis all 
samples were vortexed briefly followed by centrifugation at 10,000 x g to separate out 
any particulate matter and transferred to a HPLC sample vial. 
 
2.11.2 Mycotoxin extraction from A. fumigatus culture filtrates. 
Culture filtrates were extracted using mira-cloth to exclude cellular fragments 
followed by filtration through a 0.22 µm filter. The culture filtrates were organically 
extracted for 2 hours in a 50ml sterile tube at room temperature at a 1:1 ratio using 
chloroform to extract fungal metabolites. Following centrifugation at 500 x g for 10 
minutes the lower chloroform layer was removed and transferred to a fresh tube. 
Chloroform was evaporated at 37ºC using a rotary evaporator (Buchi rotavapor – R) and 
the toxin pellet was resuspended in 200 µl HPLC grade methanol. 
Prior to RP-HPLC analysis all samples were vortexed briefly followed by 
centrifugation at 10,000 x g to separate out any particulate matter and transferred to a 
HPLC sample vial. 
 
 
 50  
2.12 Reverse Phase High Performance Liquid Chromatography (RP–HPLC). 
2.12.1 Buffer A. 
HPLC grade water (1 L) was placed in a darkened Duran bottle. 1 ml 
Triflouroacetic acid (1 ml) was added and the bottle was inverted to mix the contents 
thoroughly. This was made fresh on the day 
 
2.12.2 Buffer B. 
HPLC grade Acetonitrile (1 L) was placed in a clear Duran bottle. 
Triflouroacetic acid (1 ml) was added to the bottle and the bottle was inverted to mix the 
contents thoroughly. This was made fresh on the day. 
 
2.12.3 RP-HPLC analysis of mycotoxins. 
Organic extracts were analysed by reverse phase HPLC with multiple 
wavelength detection at 254, 351, and 220 nm Agilent 1200 series using a C-18 RP-
HPLC column at a flow rate of 1 ml min-1. The elution profile (Figure 2.2 A), was 5 min 
of Buffer B (Section 2.12.2) at 5% followed by a linear gradient mobile phase with 
Buffer B to 100% acetonitrile for 20 minutes. The column was eluted fully with 100% 
Buffer B for 3 minutes and was re-equilibrated with 95% Buffer A (Section 2.12.1), 5% 
Buffer B for 5 minutes prior to further analysis. The concentration of gliotoxin or 
fumagillin in a given sample was ascertained by performing standards with 
commercially available mycotoxins resuspended and diluted in HPLC-grade methanol 
(Figures 2.3 and 2.4). 
 
2.12.4 RP-HPLC analysis of haemolymph peptides and peak fractionation. 
Peptide samples which had been lyophilised and resuspended in HPLC grade 
water supplemented with 0.1% formic acid were initially loaded in a 10 µl volume on a 
        (A) 
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Figure 2.2 RP-HPLC acetonitrile gradient profiles.   
Acetonitrile increased as a gradient from 5% acetonitrile after 5 minutes to 100% 
acetonitrile after 25 minutes during culture filtrate mycotoxin analysis, (A). For analysis 
of G. mellonella haemolymph peptides (B), the gradient was between 5 and 29 minutes 
and was fully eluted for 3 minutes before allowing the column to re-equilibrate
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Figure 2.3 Detection of purified gliotoxin by RP-HPLC. 
Gliotoxin detection was performed at 254 nm with a retention time of approximately 
14.48 minutes. Image shows gliotoxin detection of 4 µg 20µl-1. 
 
 
 
        
 
 
 
Figure 2.4 Detection of purified fumagillin by RP-HPLC. 
Fumagillin detection was performed at 351 nm with a retention time of approximately 
20.130 minutes. Image shows detection of 4 µg 20µl-1. 
Time (mins) 
Time (mins) 
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C-18 Agilent HPLC column as before with diode array detection at 254, 220, and 
280nm. Samples were maintained at 4ºC in a thermally controlled sample tray to 
prevent peptide breakdown. The elution profile, (Figure 2.2 B) was 5 min of Buffer B at 
5% followed by a linear gradient mobile phase with Buffer B to 100% acetonitrile for 
24 minutes. The column was eluted fully with 100% Buffer B for 3 minutes and was re-
equilibrated with 95% Buffer A, 5% Buffer B for 15 minutes prior to further analysis. 
For peak fractionation a 100 µl aliquot of sample was loaded onto the column 
and fractionated by individual peak. Peak volumes were collected in glass vials on a 
sample collection tray and were stored at -20ºC prior to lyophilisation and tryptic 
digestion. 
 
2.13 In-gel trypsin digestion and LC/MS analysis. 
2.13.1 Preparation of micro-centrifuge tubes. 
All micro-centrifuge tubes were washed by vortexing and sonication in 100% 
acetonitrile prior to use. Acetonitrile was discarded prior to using the tube. Scalpels and 
pipette tips were immersed and sonicated in 2 x volumes of methanol prior to use to 
remove keratin or dust contamination. 
 
2.13.2 Trypsin digestion of 2-D SDS-PAGE protein spots for LC/MS analysis. 
Processing of bands and spots for LC-MS analysis was achieved by following 
the method of Shevchenko et al., (2006). Gel pieces were cut and transferred to a micro-
centrifuge tube and all residual water was removed. Gel pieces were sliced to 
approximately 1-2 mm max in thickness using a scalpel where required to ensure full 
exposure to the de-staining and digestion process. Gel pieces were de-stained by the 
addition of 100 mM Ammonium bicarbonate: Acetonitrile 1:1. The samples were 
vortexed occasionally and left on a rotating table to allow mixing of the sample. In 
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some cases gel pieces had not de-stained thoroughly within the first 30 minutes so all 
the buffer was removed and fresh buffer was added for another 30 minutes until 
destaining was complete. 
Acetonitrile (100 – 200 µl) was added to the sample until the gel pieces shrunk 
and became white. At this point the acetonitrile was removed and the sample was stored 
at -20ºC or processed further immediately. Tryptic digestion was achieved with the 
addition of approximately 50 µl of trypsin buffer, (13 ng µl-1 trypsin enzyme prepared 
in 10 mM ammonium bicarbonate, 10% (v/v) acetonitrile). At this point all samples 
were placed on ice to prevent trypsin auto-digestion and allow for the total penetration 
of trypsin buffer into the gel piece. After 30 minutes all samples were checked and more 
trypsin buffer was added where necessary. After a further 60 minutes all samples were 
checked for rehyration in the presence of trypsin buffer and were topped with 10 mM 
ammonium bicarbonate/10% (v/v) acetonitrile to prevent drying out. At this point all 
samples were transferred to an incubator held at 37ºC overnight.  
Following digestion the samples were centrifuged and the supernatant was 
transferred to clean micro-centrifuge tube. The original gel piece was extracted further 
with 5% Formic Acid: 100% Acetonitrile in a 1:2 ratio. Samples were incubated at 37ºC 
in a rotary shaker and all supernatant was transferred to the tryptic digest supernatant. 
All samples were dried in a vacuum centrifuge and resuspended with sonication in 10-
20 µl 0.1% formic acid. All digests were passed through 0.22 µM cellulose acetate filter 
tubes and transferred to mass spectrometry vials. Analysis of digested peptides was 
achieved using an Agilent 6340 Ion Trap LC/MS using acetonitrile elution.  
 
2.13.3 Trypsin digestion of 1-D SDS-PAGE protein bands for LC/MS analysis. 
Protein bands of interest resolved by 1-D SDS-PAGE were excised from the gel 
using a sterile scalpel and immediately transferred to a clean tube where the gel was 
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chopped into approximately 1 x 2 mm pieces. Ammonium bicarbonate (100 
mM/acetonitrile, (1:1) was added to the gel pieces to destain and incubated at room 
temperature for one hour with mild agitation and occasional vortexing. All the liquid 
was removed and 10 mM DTT (made using 100 mM ammonium bicarbonate) was 
added to cover the gel piece and incubated at 56ºC for one hour. The liquid was 
removed and 50 mM IAA solution (made using 100 mM ammonium bicarbonate) was 
added to the gel piece for 30 minutes at room temperature. The IAA buffer was 
removed and 100 mM ammonium bicarbonate was added to each tube and incubated at 
37ºC for 15 minutes. The buffer was removed and the gel pieces were shrunk with 
100% acetonitrile and digested with trypsin as described for the extraction of peptide 
digests for 2-D electrophoresis. Analysis of digested peptides was achieved using an 
Agilent 6340 Ion Trap LC/MS using acetonitrile elution according to the following: 
 
Time (mins) % Acetonitrile 
0 5 
1 5 
7 70 
8 100 
9 100 
10 5 
 
2.13.4 Bioinformatic analysis of LC/MS results. 
Resulting data were analysed using the mascot search engine, 
(www.matrixscience.com). The mass error tolerance was 1 Da allowing for a maximum 
of no more than two missed cleavages with a MASCOT score cutoff of 62. Verification 
of protein sequences was confirmed by blasting the protein sequence on the Uniprot, 
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(www.uniprot.org), and NCBI, (www.ncbi.nlm.nih.gov), databases. Identified proteins 
are listed by their gi number as accessed through www.ncbi.nlm.nih.gov. For 
comparative analysis of sequence similiarity between different proteins the ClustalW-
multiple sequences alignment tool (accessed through 
www.ebi.ac.uk/Tools/msa/clustalw2/) was used. 
 
2.14 Purification of neutrophils from fresh blood. 
2.14.1 Heparin. 
Sterile PBS (2.5 mls) was added to a 2.5 KU tube of Heparin sodium salt, Grade 
I-A from porcine intestinal mucosa and was kept in the fridge or on ice prior to use. 
 
2.14.2 Saline solutions (1X and 2X). 
Saline (1X) was prepared by dissolving 9 g of NaCl to 1 litre of deionised water. 
Saline (2X) was prepared by dissolving 18 g of NaCl to 1 litre of deionised water. Both 
solutions were autoclaved and used at room temperature. 
 
2.14.3 Dextran 10% (w/v). 
Dextran 10% (w/v) was prepared by adding 20 g of Dextran Sulphate to 180 mls 
1X Saline, (1.62 g NaCl in 180 mls deionised water). The solution was allowed to 
dissolve thoroughly on a magnetic stirrer. Once dissolved the solution was filter 
sterilised through a 0.22 µm filter and kept at room temperature. 
 
2.14.4 5 mM PBS – Glucose (PBS-G). 
PBS – Glucose (5 mM) was prepared by dissolving 0.9 g of glucose in 1 L of 
PBS, and was filter sterilised through a 0.22 µM filter and kept at room temperature. 
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2.14.5 Purification of neutrophils from fresh blood (method). 
1X and 2X Saline and 10% Dextran solution were supplemented with 50 µl 
Heparin solution/100 mls of buffer. Blood was obtained from consenting healthy donors 
and collected in heparinised tubes to prevent coagulation. Initially the majority of red 
blood cells were allowed to sediment by mixing 20 mls of the fresh blood with 25 mls 
of 1X Saline and 5 mls 10% Dextran solution in a 50 ml tube. The contents of the tube 
were allowed to sediment and the supernatant was transferred to a fresh tube. The 
supernatant was under-laid with 5 mls of Lymphoprep (Axis Shield) and centrifuged at 
500 x g for 10 minutes. The supernatant was discarded and 25 mls of deionised water 
was added to the tube. Following a brief mixing step a further 25 mls of heparinised 2X 
solution was added to the tube to prevent lysis of neutrophils. Following centrifugation 
at 200 x g for 5 minutes at room temperature the supernatant was removed and the 
neutrophil pellet was resuspended in 5 mM PBS-Glucose. Neutrophils were counted 
and tested for viability using the Trypan Blue exclusion assay. 
 
2.14.6 Trypan Blue exclusion assay. 
The trypan blue assay was used to ascertain the viability of neutrophils and 
haemocytes, (Eichner et al., 1986). The basis of the assay is that unhealthy cells will not 
form an intact membrane and form pores which allow the leakage of the dye into the 
cell which can be observed under light microscopy. Cells were suspended in trypan blue 
at the following volumes: 20 µl cells, 60 µl PBS and 20 µl 0.4% (v/v) Trypan Blue 
solution, (made by dissolving trypan blue powder in PBS and sterilising through a 0.22 
µm filter). Following 3 minutes standing at room temperature the cells were counted 
and recorded with regard to the percentage viability of the cell suspension. 
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2.15 Extraction of haemocytes from G. mellonella haemolymph and quantification 
of haemocyte density. 
2.15.1 Insect Physiological Saline (IPS).  
IPS was made by dissolving the following in 800 mls of deionised water; 8.76 g 
Sodium Chloride, 0.36 g Potassium Chloride, 15.76 g Tris HCl, 3.72 g EDTA, and 4.72 
g Sodium Citrate. The solution was allowed to mix but was adjusted to pH 6.9 to ensure 
solubility of EDTA. The solution was brought up to 1 litre with deionised water and 
was filter sterilised through a 0.22 µm filter and stored in 50 ml tubes at room 
temperature until required.  
 
2.15.2 Extraction of haemocytes from G. mellonella larvae. 
Larvae were bled through the head with a sterile 23G needle head and 
haemolymph was squeezed through the head region into 10mls of IPS. Haemocytes 
were pelleted by centrifugation at 500 x g for 5 minutes and washed in 5 mls IPS to 
remove any excess haemolymph. Following a further centrifugation step at 500 x g for 5 
minutes, the remaining supernatant was removed and the pelleted cells were 
resuspended gently in 5 mM PBS-Glucose. 
 
2.15.3 Haemocyte density from G. mellonella larval haemolymph. 
Larvae were bled through the anterior region into a pre-chilled micro-centrifuge 
tube with a few grains of phenyl-2-thiourea (PTU) to prevent melanisation. A 10 µl 
aliquot of haemolymph was diluted by a factor of ten in ice cold PBS and the number of 
cells was counted using an improved Neaubeur haemocytometer. The haemocyte 
density was expressed per µl of haemolymph.  
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2.16 Phagocytic cell mediated microbial killing assays. 
2.16.1 Neutrophil mediated killing using C.  albicans as a target. 
Neutrophils (1 x 107 ml-1), were isolated as described previously, (Section 
2.14.5), and were incubated in the presence of fumagillin, (1 or 2 µg ml-1) for 25 
minutes. A solvent control using the equivalent solvent concentration used in the 
highest concentration of fumagillin was used to assess the effect of solvent on 
neutrophils. Neutrophils were washed twice with 5 mM PBS-G. C.  albicans MEN, (5 x 
106 ml-1) were obtained from a stationary phase overnight culture and were opsonised in 
PBS supplemented with pooled human serum, (1/50 dilution in PBS) for 45 minutes at 
37ºC. C. albicans cells were washed twice in sterile PBS to remove any non-specifically 
bound serum protein following opsonisation and pelleted at 500 x g. C. albicans cells 
and neutrophils were mixed in a 1 ml volume and immediately transferred to a sterile 
thermostatically controlled stirred chamber in a 2:1 ratio. A 100 µl aliquot was 
immediately removed from the chamber (t = 0) and serially diluted in ice cold MEM to 
quench phagocytosis. The concentration of yeast cells was diluted to give 100 cells in a 
100 µl volume which was then spread on a sterile YEPD agar plate supplemented with 
erythromycin (Section 2.3.1). Plates were incubated overnight at 30ºC. The percentage 
of viable cells and subsequent reduction in viability was calculated based on the number 
of colony forming units at t = 0 and any subsequent changes in viability were expressed 
as a percentage of the t = 0 value. 
 
2.16.2 Haemocyte mediated killing using Candida albicans as a target. 
Haemocytes (5 x 106) were extracted from G. mellonella (Section 2.15.2) and 
incubated in the presence of fumagillin, (2 µg ml-1) or with a solvent control (0.002% 
(v/v) methanol) for 25 minutes at 37ºC. The cells were pelleted by centrifugation and 
washed twice in IPS. C. albicans (2.5 x 106 ml-1) were taken from a stationary phase 
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culture and incubated in the presence of a 1/10 dilution of cell free haemolymph to 
opsonise the target. C. albicans cells were pelleted by centrifugation at 500 x g for 5 
minutes and resuspended in a 1 ml volume in the presence of pre-treated haemocytes 
and transferred directly to a thermostatically controlled stirred chamber. The assay was 
performed in the same manner as section 2.15.2. The percentage of viable cells and 
subsequent reduction in viability was calculated based on the number of colony forming 
units at t = 0 calculated as 100% viability and any subsequent changes in viability were 
expressed as a percentage of that value. 
 
2.16.3 Neutrophil mediated killing using P.  aeruginosa as a target. 
P. aeruginosa PA01 cells were grown as per section 2.4.3 and diluted to a 
concentration of 5 x 106 ml-1 in 1 ml PBS supplemented with pooled human serum (2% 
v/v). The P. aeruginosa suspension was mixed at 37ºC for 25 minutes to opsonise the 
bacteria. Neutrophils (1 x 107) were prepared and pre-treated in the presence of 
fumagillin in the same manner as described in section 2.15.1, and were pelleted. The 
opsonised bacterial suspension, (containing 5 x 106 ml-1 bacterial cells), was transferred 
to the neutrophil pellet and resuspended by gently mixing with a Pasteur pipette. The 
neutrophil/opsonised bacterial suspension was transferred to a closed 50 x 12 mm 
specimen tube (Samco). A 100 µl aliquot was immediately removed from the tube and 
serially diluted in ice cold PBS to a concentration of 1 x 103 cells ml-1 to quench 
phagocytosis at t = 0. The tubes were mixed by gentle rotation on a daisy wheel and a 
100 µl aliquot was withdrawn at 30 and 60 minutes and serially diluted in the same 
manner. Cells (100 µl) were spread on P.  aeruginosa isolation agar (Section 2.4.2). 
Plates were incubated overnight at 37ºC and the percentage of viable cells and 
subsequent reduction in viability was calculated in the same manner as Section 2.16.1. 
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2.16.4 Neutrophil and haemocyte mediated phagocytosis of a pathogenic target. 
 In order to examine the effect of the phagocytic ability of neutrophils or 
haemocytes A. fumigatus conidia were used as a target as conidia could be easily 
visualised by microscopy. Neutrophils or haemocytes (5 x 106) were isolated and 
incubated in the presence of 2 µg ml-1 fumagillin or a solvent control, (0.002% v/v 
methanol) for 25 minutes. Cells were pelleted and incubated with 1 x 107 conidia which 
were incubated in the presence of a 1/10 dilution or serum or cell-free haemolymph to a 
final volume of 1 ml. The mixture was transferred to a thermally controlled chamber 
and a 100 µl aliquot was removed from the chamber at 0, 30, 60, and 120 minutes and 
serially diluted in ice cold minimal essential medium to quench subsequent 
phagocytosis. Three hundred phagocytic cells were observed by microscopy using a 
Neaubeur haemocytometer and the number of cells which clearly showed internalised 
conidia was recorded over this time. The internalisation of conidia was verified by 
making adjustments to the microscope focus as internalised conidia are not visible at the 
same focus as external conidia. 
 
2.17 Degranulation and MPO activity analysis. 
2.17.1 Neutrophil /haemocyte cell degranulation. 
Neutrophils or haemocytes, (5 x 107), were pre-treated for 25 minutes in the 
presence of fumagillin at 37ºC. Neutrophils were centrifuged at 500 x g for 5 minutes to 
pellet the cells and this pellet was washed twice to remove excess fumagillin. Cells were 
finally resuspended in 1 ml 5 mM PBS-G supplemented with protease inhibitors, (10 
µg/ml leupeptin, pepstatin A, aprotinin, and TLCK). Cells were transferred to a 
thermostatically controlled stirred chamber and were stimulated with 1 µg ml-1 PMA. 
After 6 minutes the contents of the chamber were transferred to a pre-chilled tube and 
were centrifuged at 700 x g for 5 minutes with soft acceleration and braking to prevent 
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cell rupture. The supernatant was removed and transferred to a pre-chilled tube. The 
samples were analysed for protein concentration using the Bradford assay, and were 
concentrated by acetone precipitation prior to electrophoresis and immunoblotting 
 
2.17.2 Myeloperoxidase peroxidation activity assay. 
Quantification of MPO activity was ascertained using a standard activity assay 
Invitrogen EnzCheck® and used according to manufacturer’ s specifications. 
Neutrophils were stimulated and protein was extracted as previously described (Section 
2.17.1). A 50 µl aliquot of degranulated protein sample (standardised to 10 µg protein 
following quantification by Bradford assay) was assessed for peroxidation activity by 
addition to 100 µl 2X Amplex® Ultra red reagent. The non-fluorescent substrate is 
oxidised by H2O2 redox intermediates of MPO to form a florescent product. Florescence 
intensity was read at excitation 530 nm and emission at 590 nm. All measurements were 
calculated with the absorbance for the blank subtracted from all values. A standard 
curve of activity was calculated based on the MPO standard supplied by the 
manufacturer. Fluorescence was recorded using a Synergy HT micro-plate reader 
(BioTek). 
 
2.18 Cellular fractionation of neutrophils and haemocytes, determination of 
oxygen consumption and quantification of F-actin assembly. 
2.18.1 Breaks Buffer. 
Breaks Buffer (10 mM KCl, 3 mM NaCl, 4 mM MgCl2 and 10 mM PIPES) was 
adjusted to pH 7.2 and was filter sterilised prior to use using 0.22 µM filter. Prior to use 
Breaks Buffer was chilled on ice and protease inhibitors were added, (10 µg ml-1 
leupeptin, pepstatin A, aprotinin, and TLCK). 
 
 61  
2.18.2 Neutrophil membrane solubilisation buffer. 
Neutrophil membrane solubilisation buffer (2% v/v Triton X–100, 150 mM 
NaCl, 1% w/v Sodium deoxycholate) was made using Breaks Buffer to solubilise. 
The reagents were dissolved and filter sterilised with a 0.22 µM filter. Prior to use 
neutrophil membrane solubilisation buffer was chilled on ice and protease inhibitors 
were added, (10 µg ml-1 leupeptin, pepstatin A, aprotinin, and TLCK).  
 
2.18.3 Haemocyte membrane solubilisation buffer. 
A minimal volume of Breaks Buffer was supplemented with 36 mM CHAPS 
and allowed to dissolve with continuous mixing for 30 minutes. The buffer was filter 
sterilised, chilled on ice and protease inhibitors were added, (10 µg ml-1 leupeptin, 
pepstatin A, aprotinin, and TLCK). 
 
2.18.4 Fractionation of neutrophils. 
Neutrophils were fractionated using an adaptation of the method of Renwick et 
al., (2007). Neutrophils, (1 x 108), were incubated in the presence of fumagillin, (2 µg 
ml-1) and incubated with regular mixing at 37ºC for 25 minutes. Cells were pelleted at 
500 x g for 5 minutes and washed twice in 5 mM PBS-G to remove excess mycotoxin. 
Neutrophils were stimulated with PMA (1 µg ml-1), and allowed to mix gently at 37ºC 
for 6 minutes. Neutrophils were immediately pelleted by centrifugation at 500 x g for 5 
minutes and resuspended in Breaks Buffer, with protease inhibitors added. Neutrophils 
were lysed using a sonication probe (Bendelin Senopuls), three times for 10 seconds at 
20% power and centrifuged at 200 x g for 10 min at 4oC.  
The post nuclear supernatant was transferred to pre-chilled Beckman SW60 Ti 
rotor and centrifuged at 100,000 x g for 60 minutes at 4ºC to separate membrane and 
pellet fractions. Tubes were carefully transferred to ice and the supernatant (cytosolic 
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fraction) and pellet (membrane fraction) were separated into pre-chilled micro-
centrifuge tubes. The membrane pellet was washed twice in Breaks Buffer with 
centrifugation at 20,000 x g for 5 minutes at 4ºC to remove any cytosolic residual 
protein. The washed membrane pellet was solubilised for 60 minutes at 4ºC with mild 
agitation in membrane solubilisation buffer, (Section 2.18.2). The solubilised membrane 
fraction was centrifuged at 7,000 x g for 10 minutes at 4ºC to pellet any debris. 
Cytosolic and membrane protein concentration was assessed using the Bradford assay 
and protein was concentrated by acetone precipitation prior to 1–D SDS-PAGE. 
 
2.18.5 Fractionation of haemocytes. 
Haemocytes, (1 x 108) were extracted from G. mellonella larvae, and were 
incubated in the presence of 2 µg fumagillin ml-1. Cells were stimulated, pelleted, 
washed, and lysed in the same way as neutrophils, (Section 2.18.4). The post nuclear 
supernatant was transferred to a pre-chilled Beckman SW60 Ti rotor and centrifuged at 
100,000 x g for 60 minutes at 4ºC to separate membrane and pellet fractions. Tubes 
were carefully transferred to ice and the supernatant (cytosolic fraction) and pellet 
(membrane fraction) were separated into pre-chilled micro-centrifuge tubes. The 
membrane pellet was washed twice in Breaks Buffer with centrifugation at 20,000 x g 
for 5 minutes at 4ºC to remove any cytosolic residual protein. Membrane pellets were 
solubilised with the addition of 500 µl haemocyte membrane solubilisation buffer and 
gentle mixing for 45 minutes. The membrane pellet was placed in a sonication bath for 
five 1 minute intervals with cooling on ice in between. The solubilised membrane 
fraction was centrifuged at 7,000 x g for 10 minutes and the supernatant was transferred 
to a pre-chilled micro-centrifuge tube. Cytosolic and membrane protein content was 
assessed using the Bradford assay. Protein was concentrated using acetone precipitation 
prior to 1–D SDS-PAGE. 
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2.18.6 Determination of oxygen consumption of neutrophils and haemocytes. 
Oxygen consumption was measured using a Clarke type oxygen electrode. The 
reaction chamber was thermostatically controlled at 37ºC. The electrode was covered in 
saturated Potassium chloride and a semi-permeable layer of plastic was placed over the 
detection electrode. The upper chamber sat on top of this layer and was tightened down. 
The level of oxygen from 100% to 0% was calibrated by the addition a few grains of 
sodium dithionate.  
Neutrophils, (1 x 107 ml-1), and haemocytes, (5 x 107 ml-1), were incubated in the 
presence of fumagillin for 35 minutes and washed twice in sterile PBS-G. Cells were 
resuspended in 1 ml of PBS-G and immediately transferred to the electrode chamber. 
Cells were allowed to stabilise for approximately 3 minutes before stimulation with 
addition of 1 µg ml-1 PMA, (Figure 2.3). The rate of oxygen consumption was observed 
over a ten minute period and the consumption of oxygen was calculated based on the 
following equation.  
 
                  Units travelled in x minutes x 230 = nmol ml -1 oxygen consumed 
                                 Total units 
• x is the number of minutes passed since PMA stimulation. 
• 230 is the molarity of dissolved oxygen present in water at 37ºC 
• Total units are the distance in small squares on the graph paper which covered 
the span of 0–100% oxygen availability. 
 
2.18.7 Quantification of F-actin assembly. 
To investigate the effect of fumagillin on F-actin assembly neutrophils or 
haemocytes (5 x 107 ml -1) were incubated in the presence fumagillin (2 µg ml-1) or the 
0.002% (v/v) methanol for 25 minutes and then stimulated with 1µg PMA ml-1 for 6 
                                    
 
 
Figure 2.5 Calibration of oxygen consumption using a Clarke-oxygen electrode. 
The image above represents the span of oxygen at 100% oxygen and with the addition 
of sodium dithionate oxygen drops to 0% giving a span of units for the consumption of 
oxygen over time. The chamber is washed with 5 mM PBS-G and neutrophils are added 
and allowed to adjust to the chamber for a few minutes. PMA (1 µg ml -1) was added 
and the amount of oxygen consumed was monitored over a ten minute period
100% oxygen  
0% oxygen 
    Span 34 units    
    
Neutrophils        
added    
PMA added 
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minutes and washed and lysed as per section 2.18.4. The supernatant was transferred to 
a pre-chilled micro-centrifuge tube and protein was concentrated using acetone 
precipitation prior to electrophoresis and immunoblotting. 
 
2.19 Confocal Immunoflouresence microscopy. 
2.19.1 Confocal microscopy of neutrophil translocation and degranulation. 
Neutrophils (1 x 106 ml -1) were pre-incubated in the presence of fumagillin and 
washed twice in sterile PBS-G.  Cells were allowed to adhere to saline-preparation 
slides for 5 minutes at room temperature in a sterile laminar flow hood. Cells were 
incubated at 37ºC in the presence of 1 µg PMA ml -1 for 6 minutes. Cells were washed 
twice in PBS and fixed in 4% paraformaldehyde for 10 minutes. Cells were washed 
twice and permeabilised in 0.2% Triton X-100. Cells were blocked for 1 hour in 10 mM 
NaBH4 for one hour and washed with PBS prior to incubation with anti-p47phox or anti 
MPO antisera at a dilution of 1/2500 or 1/650 respectively. Following overnight 
incubation the slides were washed in PBS and incubated with tetramethyl rodamine iso-
thiocyanate (TRITC) goat anti-rabbit IgG secondary antibody (The Jackson Laboratory, 
Bar Harbour, Maine, USA) for 1 hour in the dark at a concentration of 1/3000 against 
anti-p47phox and 1/1000 for anti-MPO probed slides. Cells were washed again and a 
cover-slip was placed over the cell area. The perimeter of the cover-slip was sealed to 
prevent the slides from drying out. The controls for this experiment included cells alone 
and cells exposed to secondary antibody. Cells were viewed with an Olympus Flouview 
1000 confocal microscope under the supervision of Dr. Ica Dix. 
 
2.19.2 Observation of neutrophil F-actin assembly. 
For observation of changes in F-actin distribution cells were pre-treated, fixed, 
and permeabilised in the same manner as previously described (Section 2.19.1) however 
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there was only one probing step whereby cells were stained with 0.8 µM rhodamine 
coupled phalloidin overnight at 4ºC and washed 3 times in PBS. Cells were viewed with 
an Olympus Flouview 1000 confocal microscope under the supervision of Dr. Ica Dix. 
 
2.20 G. mellonella haemolymph activity assays. 
2.20.1 Cacolydate Buffer supplemented with L-DOPA. 
Sodium Cacolydate (2.14 g), NaCl (26.298 g), CaCl2 (1.12 g), MgCl2 (2.39 g) 
was added to 800 mls deionised water. The solution was adjusted to pH 6.5 and made 
up to 1 L using deionised water. The solution was autoclaved and stored at room 
temperature. L-3,4-Dihydroxyphenylalanine (L-DOPA) (150 mg) was added to 
cacolydate buffer (50 mls) to give a working concentration of 3 mg/ml. The solution 
was wrapped in aluminium foil to prevent light degradation and left to mix for 
approximately 1 hour or until all the L-DOPA was solubilised. 
 
2.20.2 Phenoloxidase Activity using G. mellonella haemolymph. 
Phenoloxidase activity was determined by an adaption of the method used by 
Liu et al., 2004. After the relevant treatment and duration of incubation 10 larvae were 
bled into a pre-chilled micro-centrifuge tube. Following centrifugation at 800 x g for 2 
minutes at 4ºC the cell free extract was removed to a fresh pre-chilled tube. The cell free 
haemolymph protein extract (1.5 mg protein approximates to 20 µl of cell free 
haemolymph as ascertained by Bradford assay) was added to 1 ml cacolydate buffer 
supplemented with L-DOPA in a plastic cuvette and inverted briefly. The mixture was 
left to stand for 3 minutes at room temperature and was read spectrophotometricaly at 
490 nm. 
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2.20.3 Comparative analysis of protein binding of haemolymph proteins to conidia. 
Conidia were isolated as previously described and were concentrated to a pellet 
of 5 x 108 cells. G. mellonella larvae were bled through the anterior region into a pre-
chilled micro-centrifuge tube and centrifuged immediately at 800 x g for 2 minutes at 
4ºC. A 150 µl aliquot of cell free haemolymph was removed and quantified for protein 
concentration by Bradford assay. Approximately 100 µl of cell free haemolymph 
(approximately 7.5 mg of protein) standardised to contain the same amount of protein in 
the assay for comparative analysis was diluted in ice-cold IPS and transferred to the 
conidia to resuspend the pellet. The 5 x 108 conidia/haemolymph suspension was mixed 
gently for 40 minutes at 4ºC and immediately centrifuged at 500 x g for 5 minutes to 
pellet conidia. Conidia were washed 3 times with 1 ml sterile IPS to remove any non-
specifically bound proteins and a 10 µl aliquot was withdrawn and enumerated by 
haemocytometry to ensure that no loss of conidia had occurred. Protein was then lysed 
from the conidial surface by the addition of 5X solubilisation buffer and brief sonication 
in a water bath followed by boiling at 95ºC for 5 minutes. The samples were centrifuged 
at 1000 x g for 5 minutes at 4ºC and the protein supernatant was transferred to a pre-
chilled micro-centrifuge tube. Samples were frozen immediately at -20ºC or subjected 
to 1-D SDS-PAGE.  
For analysis of serum proteins bound to conidia whole blood was centrifuged at 
500 x g for 5 minutes. Serum was pooled from multiple donors and the quantity of 
protein was ascertained. A diluted protein solution (7.5 mg ml-1) was prepared using 
sterile PBS and the binding protocol was performed as described for the haemolymph 
study. Conidia were washed in PBS prior to protein extraction in 5X solubilisation 
buffer. 
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2.21 RT-PCR analysis of larval antimicrobial peptide expression. 
2.21.1 RNase treatment of water and lab apparatus. 
All water was treated with diethyl pyrocarbonate (DEPC) at a concentration of 
0.1% (v/v). DEPC treated water was left to stir at room temperature for 4 hours and left 
overnight at 37ºC. Water was autoclaved twice and was subsequently used in the 
preparation of all buffers. Pestles and mortars were left to soak in a large beaker of 
DEPC treated water prior to being wrapped in aluminium foil and autoclaved twice 
prior to use. RNase free filter tips (Fisher) were used and all tubes were taken from a 
previously unopened bag and autoclaved twice prior to use. For RNA visualisation all 
gel casting, and gel electrophoresis equipment was washed in DEPC water 
supplemented with 2% (v/v) hydrogen peroxide. Gloves were worn at all times and 
changed at regular intervals. 
 
2.21.2 RNA extraction from G. mellonella. 
Larvae were injected and incubated at 30ºC for 4, 24 or 48 hours. Three larvae 
per treatment were selected at random from a plate of ten and were crushed to a fine 
powder using liquid nitrogen and a pestle and mortar. TRI-Reagent (3 mls) was added, 
mixed and allowed to rise to room temperature for 15 minutes. The mixture was 
transferred to a pre-chilled micro-centrifuge tube and centrifuged at 12,000 x g for 10 
minutes at 4ºC. The supernatants were transferred to a fresh tube and the pellets were 
discarded. Two hundred micro-litres of chloroform were added and mixed by vortexing. 
The solution was allowed to stand at room temperature for 10 minutes and centrifuged 
for 10 minutes at 12,000 x g for 4ºC. The top “ clear layer”  was transferred to a fresh 
tube and 500µl of molecular grade 2-propanol was added. The tube was inverted 10 
times and left to stand for ten minutes at room temperature. The samples were 
centrifuged at 12,000 x g for 10 minutes at 4ºC. The supernatant was discarded and the 
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pellet was washed in 100 µl 75% (v/v) molecular grade ethanol and was centrifuged at 
12,000 x g for 10 minutes at 4ºC. The supernatant was removed and the resulting pellet 
was allowed to air dry prior to resuspending in 80 µl molecular grade RNase free water. 
RNA was aliquoted in 20 µl volumes and stored at -70ºC or used immediately. 
 
2.21.3 DNase digestion of RNA. 
Contaminating DNA was removed by DNase treating the RNA extract with a 
Deoxyribose I (AMP-D1) kit. RNA (4 µg) quantified by spectrometry, was brought up 
to a volume of 8 µl using DEPC treated water. This was followed by the addition of 1 µl 
10X reaction buffer and 1 µl DNase 1 (1 unit/µl) to the RNA mixture and incubation at 
room temperature for 15 minutes. The enzyme activity was stopped by adding 1µl of 
Stop Solution (50 mM EDTA). Samples were incubated at 70ºC for ten minutes and 
cooled on ice. RNA was further processed for cDNA synthesis or frozen at -70ºC. 
 
2.21.4 cDNA synthesis. 
cDNA was synthesised using the Superscript III First Strand Synthesis System 
for RT-PCR kit from Invitrogen (CA, USA). RNA concentration was determined and 
all samples contained equal amounts of RNA prior to cDNA synthesis following 
adjustment to 8 µl using DEPC treated water. The 10 mM dNTP (1 µl) mix and 1 µl 50 
mM oligo (dT) were added to the RNA. The solution was incubated at 65ºC for 5 
minutes and then cooled to 4ºC. A master-mix was prepared (Per reaction: 2 µl 10X RT 
Buffer, 4 µl 25 mM MgCl2, 2 µl 0.1 mM DTT, 1 µl RNaseOUT) according to the 
number of reactions necessary. Mastermix (9 µl) was added to each of the RNA samples 
and mixed gently followed by incubation at 42ºC for 2 minutes and then 4ºC for 5 
minutes. Superscript III RT (200 U µl-1) was added to each reaction tube and incubated 
as follows: 42º for 50 minutes, 70º for 5 minutes, and held on ice. RNase H (1 µl) was 
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added to each tube and incubated for 20 minutes at 37ºC. cDNA was aliquoted and 
stored at -20ºC.  
 
2.21.5 PCR primers and cycle conditions. 
The following PCR primer pairs used to amplify regions of four genes involved 
in the immune system and resistance to microbial challenge were used (Bergin et al., 
2006). G. mellonella –actin was used as a control housekeeping gene to demonstrate 
equal loading of RNA. The concentration of RNA was checked using a ThermoFisher 
Nanodrop 1000 V3.7 spectrophotometer for all samples prior to the commencement of 
PCR reactions to and adjusted to give equal loading of RNA in each reaction. 
 
Primer Name   Oligonucleotides            Fragment Size b.p 
 – actin F  GGGACGATATGGAGAAGATCTG  400 
 – actin R  CACGCTCTGTGAGGATCTTC 
 
Transferrin F  CCCGAAGATGAACGATCAC   535 
Transferrin R  CGAAAGGCCTAGAACGTTTG 
 
IMPI F  ATTTGTAACGGTGGACACGA   409 
IMPI R  CGCAAATTGGTATGCATGG 
 
Galiomycin F  CCTCTGATTGCAATGCTGAGTG   359 
Galiomycin R  GCTGCCAAGTTAGTCAACAGG 
 
Gallerimycin F GAAGATCGCTTTCATAGTCGC   175 
Gallerimycin R TACTCCTGCAGTTAGCAATGC 
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The PCR cycle conditions were 98ºC, 2 min, [94ºC - 1 minute, 55ºC – 1 minute, 72ºC – 
1.5 minutes] x 30 cycles and 72ºC – 10 minutes as optimised by Bergin et al., (2006). 
 
2.21.6 DNA gel electrophoresis of PCR products. 
DNA was visualised by running samples on a 1% agarose gel. Agarose (1 g) 
(Melford Labs Ltd., Ipswich England) was dissolved in 100 ml 1 X TAE Buffer, (1/50 
dilution of 50X stock: 24.2% (w/v) Tris-Base, 5.71% (v/v) Acetic acid, 0.05 M EDTA 
(pH8), with the addition of 4 µl of 5 mg ethidium bromide ml-1. Samples (8 µl) were 
mixed with 2 µl of Blue Orange 6X loading dye (Promega). The sample was placed into 
the wells of the agarose gel. Samples were run at 80 V Embi-Tech and viewed using a 
UV-tranilluminator (Alpha Innotech). Densitometric analysis of resulting bands were 
performed using Imaje J software and all values were expressed against untreated larvae 
incubated over the same period of time and with the same temperature condions. 
 
2.21.7 RNA electrophoresis. 
Prior to use the gel rig and tank was washed in RNase ZAP, (Ambion) and 
rinsed thoroughly with sterile DEPC treated water and all apparatus was allowed to air 
dry in a  sterile safety cabinet that was previously sterilised in 70% ethanol. A 1% (v/v) 
agarose gel was prepared. Agarose (1 g) was boiled in 100 mls 1X FA buffer made from 
a 1/10 dilution of 10X stock: (200 mM 3-[N-morpholino]propanesulfonic acid (MOPS), 
50 mM sodium acetate, 10mM EDTA adjusted to pH 7) In DEPC treated water. RNA 
sample (4 µl) was mixed with 3 µl formamide and 3 µl 6X loading dye. Samples were 
run at 80 V Embi-Tech and viewed using a UV-transilluminator (Alpha Innotech).
  
 
 
 
Chapter 3 
 
 
Characterisation of the virulence of clinical and 
environmental Aspergillus fumigatus isolates 
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3.0 Introduction. 
 
 G. mellonella larvae have been validated in recent years as a highly 
advantageous tool to determine the pathogenicity of bacteria and fungi, (Cotter et al., 
2000; Bergin et al., 2005; Mylonakis et al., 2005; Joyce and Gahan, 2010). Additionally 
this model has been used to determine the pathogenicity of genetically manipulated 
micro-organisms as an alternative to murine screening, (Reeves et al., 2006; Jackson et 
al., 2009). G. mellonella larvae have also been used to detect mycotoxins and 
insecticidal toxins produced in vivo (Fuguet and Vey, 2004; Reeves et al., 2004). 
Despite recent advances in published literature in the use of this organism it is evident 
that there are many facets of the larval immune response and ability to cope with 
microbial burden that remain to be elucidated.  
 The use of G. mellonella as a novel means to determine the relative virulence of 
Aspergillus spp. was initially characterised by Reeves et al., (2004). This work 
correlated the production of gliotoxin with larval pathogenicity. Since then 
understanding the process of A. fumigatus mediated larval pathogenicity has been 
expanded to include the onset of hyphal development (Renwick et al., 2006) and more 
recently differential virulence based on mating type (Cheema and Christians, 2010). 
Therefore, a study of the effect of differentially sourced or genetically manipulated 
isolates of A. fumigatus on G. mellonella is necessary in order to establish the model as 
a comprehensively used means of measuring fungal pathogenesis.  
 Gliotoxin produced by A. fumigatus has been widely studied and identified as a 
potent inhibitor of phagocytosis and superoxide production in macrophages (Eichner et 
al., 1986) and restricts the formation of the neutrophil NADPH oxidase complex 
(Tsunawaki et al., 2004). Due to its potent toxicity and production by A. fumigatus 
quantitative analysis of gliotoxin may be an indicator of potential isolate pathogenicity. 
Fumagillin, another secondary metabolite produced by A. fumigatus is produced upon 
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hyphal development and has been characterised as a potent amoebicide, (Mitchell et al., 
1997, McCowen et al., 1951). Amitani et al., (1995) described fumagillin as an inhibitor 
of ciliary beat frequency of pulmonary epithelial cells. As a result of this previous 
research an analysis of the production of fumagillin in vivo and its implication in fungal 
pathogenesis requires further characterisation. 
The work presented in this Chapter was to characterise the relative pathogenicity 
of clinically and environmentally sourced A. fumigatus isolates following 
characterisation of the larval response to conidial infection at different temperatures and 
with strains containing deletions for secondary metabolite biosynthesis. Due to the 
significance of secondary metabolite biosynthesis in the pathobiology of A. fumigatus 
an analysis of in vitro and in vivo mycotoxin production coupled to the analysis of 
immunosuppressive properties of cell free culture filtrate was performed. As the 
virulence and persistence of A. fumigatus is dependent on strong growth and an ability 
to assimilate nutrients from a variety of sources an investigation of these parameters 
was performed to further understand the link between virulence traits and pathogenicity 
of A. fumigatus isolates. 
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3.1 Analysis of parameters affecting A. fumigatus infection in G. mellonella larvae. 
In order to perform an analysis of the pathogenicity of different strains it was 
necessary to examine the effect of inoculum concentration and incubation temperature 
on larval viability. Mowlds and Kavanagh, (2008) established that the immune status of 
G. mellonella may be influenced by incubating larvae at 37ºC as evidenced by increased 
haemocyte density and antimicrobial peptide gene expression relative to larvae 
incubated at 30ºC. In this section the variation in larval viability mediated by changes in 
the concentration of conidial inoculum and incubation temperature were investigated. In 
addition a study investigating the virulence of mutant strains of A. fumigatus compared 
to a wild type strain was performed. 
 
3.1.1 Determination of virulence of A. fumigatus in G. mellonella larvae. 
 A. fumigatus (ATCC 26933) conidia were harvested as described (Section 
2.2.10). Larvae were injected with PBS or increasing concentrations of conidia, (1 x 
104, 1 x 105, 1 x 106 or 1 x 107) 20µl-1 and were incubated at 30ºC or 37ºC. Larvae were 
assessed for viability at 24, 48 and 72 hours (Figure 3.1). Inspection of larvae at 24 and 
48 hours showed that larvae melanised and died at a much faster rate at 37ºC than 30ºC 
when injected with the same conidial inoculum. Larvae injected with 1 x 104 conidia did 
not die when incubated at 30ºC or 37ºC. Larvae injected with 1 x 105 conidia remained 
viable when incubated at 30º; however at 37ºC there was a 16.6 ± 5.7% reduction in 
viability at the 72 hours. Larvae injected with 1 x 106 conidia remained viable at 30ºC. 
Larvae incubated at 37ºC showed evidence of melanisation and reduced movement 24 
hours post-infection which culminated in a 30 ± 5.7% and 90 ± 3.3% reduction in 
viability at 48 and 72 hours. Larvae inoculated with 1 x 107 conidia demonstrated a 33 ± 
3.3% loss of viability 24 hours post-infection and demonstrated no viability at 48 hours 
when incubated at 37ºC. Larvae injected with the same concentration of conidia and 
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Figure 3.1 Analysis of the pathogenicity of different concentrations of A. fumigatus in G. mellonella at 30ºC and 37º. 
Larvae were infected with conidia of A. fumigatus ATCC 26933 at different concentrations. Larvae were incubated at 30ºC or 37ºC and viability was 
recorded 24, 48 and 72 hours post infection. As an additional control larvae were injected with PBS however this did not affect larvae (data not 
shown).                                                          
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Figure 3.2 G. mellonella larvae at different stages of A. fumigatus pathogenesis. 
Larvae were injected with 1 x 107 A. fumigatus ATCC 26933 conidia and incubated at 
30ºC. Larvae demonstrated localised melanisation 24 hours post infection. There is 
reduced larval movement coupled to advance melanisation after 48 hours while the 
majority of larvae do not demonstrate viability at 72 hours as evidenced by lack of 
movement following mild physical stimulation.  
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incubated at 30ºC demonstrated a more gradual reduction in viability recording values 
of 100%, 80 ± 5.7% and 16.6 ± 3.3% at 24, 48 and 72 hours, respectively. From the data 
presented it is clear that incubating larvae at 30ºC following infection with 1 x 107 
conidia resulted in a similar level of larval mortality as incubating at 37ºC following 
infection with 1 x 106 conidia. As mentioned previously (Section 3.1), Mowlds and 
Kavanagh, (2008) demonstrated that incubation of larvae at 37ºC causes a significant 
increase in haemocyte density and expression of antimicrobial peptides. Considering 
this finding and the similarities in larval viability when injected with 1 x 106 conidia and 
incubated at 37ºC, or incubated at 30ºC following infection with 1 x 107 conidia it was 
decided that further investigations of the relative pathogenicity of A. fumigatus in G. 
mellonella would be performed at 30ºC. The visual progression of fungal pathogenesis 
using this condition in G. mellonella is presented in Figure 3.2. It was hoped that such 
an approach would negate any effect that incubation temperature would have on altering 
the larval immune response independent of infection. 
 
3.1.2 Analysis of the effect of A. fumigatus secondary metabolite mutants on larval 
viability. 
 Conidia from A. fumigatus isolates containing gene deletions for ftmA, psoA and 
laeA from the “ parent”  Af293 strain were prepared as described and G. mellonella 
larvae were inoculated with 1 x 107 conidia. Larvae were incubated at 30ºC and 
viability was monitored at 24, 48 and 72 hours (Figure 3.3). Larvae injected with the 
Af293 strain demonstrated 70 ± 5.7%, 3.3 ± 3.3% and 0% viability at 24, 48 and 72 
hours, respectively. Larvae injected with the ftmA isolate demonstrated 100%, 90 ± 
10% and 63.3 ± 12% viability at 24, 48 and 72 hours, respectively. Injection of larvae 
with psoA resulted in 96.6 ± 3.3%, 73.3 ± 6.6% and 30 ± 5.7% viability at 24, 48 and 
72 hours respectively. Inoculation of larvae laeA mutant resulted in 93.3 ± 6.6%, 43.3 
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Figure 3.3 Evaluation of pathogenicity of A. fumigatus wild type and mutant 
isolates in G. mellonella. 
Larvae were inoculated with A. fumigatus Af293 and mutant stains (ftmA, psoA and 
laeA) and were incubated at 30ºC. Larval viability was ascertained 24, 48 and 72 
hours post inoculation. 
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± 8.8% and 10 ± 10% viability at 24, 48 and 72 hours respectively. Statistical analysis 
of these data revealed that at 24 hours the mutant strains were less virulent than the 
wild-type, (p  0.02). Furthermore analysis of the 48 hour survival data revealed that 
larvae infected with the mutant strains demonstrated significantly greater viability than 
those infected with Af293 (p  0.001). At 72 hours larvae infected with the ftmA and 
psoA strains demonstrated significantly more viability relative to the Af293 strain (p = 
0.001 and 0.004 respectively). Injection of larvae with laeA resulted in slightly 
increased viability however this value was deemed less significant (p = 0.076).  
 
3.1.3 Analysis of the relative pathogenicity of clinical and environmental isolates of 
A. fumigatus in G. mellonella. 
 The relative pathogenicity of 15 clinical and 15 environmental isolates of A. 
fumigatus was analysed in G. mellonella larvae. In order to assess the effect of conidial 
maturation in A. fumigatus isolates plates were allowed to age for 3, 14 or 28 days from 
the onset of conidiation at room temperature. Plates were harvested and conidia were 
injected at a concentration of 1 x 107 per larva and incubated at 30ºC. Larvae were 
assessed for viability at 24, 48, and 72 hours. Figures 3.4, 3.5, 3.6, 3.7, 3.8 and 3.9 
demonstrate that clinical and environmental isolates show differential pathogenicity 
which was variable depending on the extent of conidial maturation. It was hoped to 
compare the pathogenicity of environmental and clinical isolates as grouped data from 
the G. mellonella viability data. Furthermore an analysis of alterations to the 
pathogenicity of these isolates as a result of conidial ageing was performed. Figure 3.10 
shows the mean larval viability from this study with bars indicating standard deviation.  
 Larvae injected with clinical isolates of A. fumigatus demonstrated no significant 
difference in relative pathogenicity in comparisons made between differentially aged 
conidia 24 hours post-infection, (p  0.05). At 48 hours 3 day old conidia were 
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Figure 3.4 Pathogenicity of 3 day old conidia from clinical strains. 
Clinical isolates of A. fumigatus (n = 15) were matured for 3 days. Conidia were 
harvested and injected (1 x 107) into G. mellonella larvae. Larvae were incubated at 
30ºC and viability was recorded 24, 48 and 72 hours post infection. 
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Figure 3.5 Pathogenicity of 3 day old conidia from environmental strains. 
Environmental isolates of A. fumigatus (n = 15) were matured for 3 days. Conidia were 
harvested and injected (1 x 107) into G. mellonella larvae. Larvae were incubated at 
30ºC and viability was recorded 24, 48 and 72 hours post infection. 
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Figure 3.6 Pathogenicity of 14 day old conidia from clinical strains. 
Larvae were infected with 14 day old conidia grown from clinical isolates (n = 15). 
Larvae were incubated at 30ºC and viability was recorded 24, 48 and 72 hours post-
infection. 
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Figure 3.7 Pathogenicity of 14 day old conidia from environmental strains. 
Larvae were infected with 14 day old conidia grown from environmental isolates (n = 
15). Larvae were incubated at 30ºC and viability was recorded 24, 48 and 72 hours post-
infection. 
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Figure 3.8 Pathogenicity of 28 day old conidia from clinical strains. 
Clinical A. fumigatus isolates (n = 15) were grown and conidia allowed to mature for 28 
days. Conidia were harvested and subsequently injected into G. mellonella larvae. 
Larvae were incubated at 30ºC and viability was recorded 24, 48 and 72 hours post 
infection. 
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Figure 3.9 Pathogenicity of 28 day old conidia from environmental strains. 
Environmental A. fumigatus isolates (n = 15) were grown and conidia allowed to mature 
for 28 days. Conidia were harvested and subsequently injected into G. mellonella 
larvae. Larvae were incubated at 30ºC and viability was recorded 24, 48 and 72 hours 
post infection. 
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Figure 3.10 Pooled survival data of G. mellonella viability following infection with clinical and environmental strains of A. fumigatus. 
The viability of G. mellonella larvae following infection with different aged conidia of clinical and environmental isolates of A. fumigatus (n = 15). 
Bars indicate standard deviation from mean larval survival with the different isolates. The average viability of larvae infected with clinical or 
environmental isolates varied with the stage of conidial maturation.                                            
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significantly more pathogenic than conidia aged for 14 or 28 days, (p  0.001). 
Interestingly, 14 day old clinical conidia were significantly less pathogenic 48 hours 
post-infection (p = 0.001). Analysis of survival 72 hours post-infection revealed that 3 
day old conidia remained more pathogenic at this timepoint than 14 or 28 day old 
conidia (p  0.001). Comparisons of larval viability when infected with 14 or 28 day old 
conidia demonstrated that there was no statistically significant difference. The data 
obtained here show 3 day old clinical conidia is more pathogenic to G. mellonella larvae 
than inoculating with older conidia thus indicating that conidia lose virulence with 
maturity. 
 Larvae inoculated with conidia of environmental isolates of A. fumigatus also 
showed variations in survival depending on the level of conidial maturation. Larvae 
injected with 3 day old environmentally sourced conidia demonstrated significantly less 
viability 24 hours post-infection than those infected with 14 day old conidia (p = 0.014). 
Comparisons of larval viability following infection with 28 day old conidia showed no 
significant difference compared to 3 day old conidia (p = 0.270) but larval survival was 
significantly higher than larvae infected with 14 day old conidia (p = 0.001). This trend 
in larval viability was continued 48 hours post-infection. Larvae injected with 3 day old 
conidia demonstrated significantly reduced viability compared to those injected with 14 
day old conidia (p = 0.013). Larvae inoculated with 28 day old conidia did not 
demonstrate a significant alteration in viability compared to those infected with 3 day 
old conidia (p = 0.687) but did demonstrate reduced larval survival compared to those 
larvae infected with 14 day old conidia (p = 0.039). Analysis of 72 hour larval survival 
following infection with 3 day old conidia revealed that larval viability was 
significantly reduced compared to that obtained using 14 and 28 day old conidia (p  
0.005). Comparisons of larval survival following infection with 14 and 28 day old 
conidia showed that there was no statistically significant difference between these two 
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treatments. This result indicates that “ younger”  environmentally sourced conidia are 
more pathogenic in the G. mellonella model of infection than older conidia. 
 The relative mean pathogenicity of environmental and clinical isolates in G. 
mellonella was also compared at the different post-infection time-points. The mean 
pathogenicity of  3 day old clinical and environmental isolates in G. mellonella was not 
found to be significantly different at 24 or 72 hours (p = 0.665 and 1 respectively) but 
larvae inoculated with clinical isolates did demonstrate reduced viability 48 hours post-
infection (p = 0.041). An analysis of the relative pathogenicity of 14 day old clinical and 
environmental conidia revealed that clinical isolates were more pathogenic 24 hours 
post-infection (p = 0.044) but larval viability was similar at 48  and 72 hours (p = 0.285 
and 1 respectively). Infecting larvae with 28 day old clinical conidia resulted in reduced 
larval viability 24 and 48 hours post-infection compared to 28 day old environmental 
conidia (p = 0.011 and 0.001 respectively). However at 72 hours larval survival was 
found not to be significantly different between the two conidial sources (p = 1).  
 
3.1.4 Analysis of the pathogenicity of non-fumigatus Aspergillus strains in G. 
mellonella. 
 The pathogenicity of environmental isolates of A. flavus, A. niger, and A. terreus 
was also assessed in G. mellonella with differentially aged conidia (3, 14 or 28 days 
old). Larvae were injected with 1 x 107 conidia of each strain and incubated at 30ºC. 
Larval viability was assessed 24, 48 and 72 hours post-infection (Figure 3.11). 
Larvae injected with A. flavus immediately developed extensive melanisation. 
Assessment of larval viability 24 hours post-infection with 3 day old conidia showed 
that all larvae infected with A. flavus died quickly and showed extensive melanisation. 
Larvae injected with A. niger demonstrated 93.3 ± 3.3%, 90 ± 0% and 53.3 ± 3.3% 
viability 24, 48 and 72 hours post-infection, respectively. Larvae injected with A. 
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3.11 Viability of larvae following injection with environmental isolates of “non-
fumigatus” Aspergillus spp. 
Larvae were injected with conidia harvested from 3 day old, (A), 14 day old, (B) and 28 
day old (C) matured plates of environmental isolates of A. flavus, A. niger, or A. terreus 
conidia. Infection with A. flavus resulted in drastically reduced morality at 24 hours. A. 
terreus demonstrated attenuated pathogenicity with increasing conidial maturation. A. 
niger showed variable pathogenicity depending on conidial maturation. 
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Figure 3.12 Images of G. mellonella 72 hours post infection with A. flavus. 
Larvae were infected with 1 x 107 A. flavus conidia and were incubated at 30ºC. Larvae 
demonstrated no viability 24 hours post infection. Inspection of larvae under a light 
microscope demonstrated hyphal growth and conidiophore formation through the insect 
cuticle (A and D), anterior region (B) and through the pro-legs (C). 
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terreus demonstrated 100%, 23.3 ± 8.8 and 6.6 ± 6.6% viability over the same time 
period, respectively. Inspection of larvae 48 hours post-infection with A. flavus 
demonstrated the appearance of hyphae growing through the insect cuticle which 
culminated in the presence of conidiophore development at 72 hours as demonstrated by 
observing the insect cuticle through a binocular microscope (Figure 3.12).  
Analysis of the pathogenicity of 14 day old conidia revealed that larvae infected 
with A. flavus demonstrated no viability 24 hours post-infection and the same outgrowth 
of hyphae and conidiophores 48 and 72 hours post-infection respectively. Infection of 
larvae with A. niger resulted in 93.3 ± 3.3%, 70 ± 5.7 and 0% viability 24, 48 and 72 
hours post-infection. Larvae infected with A. terreus demonstrated 100%, 86.7 ± 3.3% 
and 40 ± 5.8% over the same time period.  
Infection of larvae with 28 day old conidia revealed that infection with A. flavus 
did not cause the development of rapid melanisation immediately after infection 
however 3.3 ± 3.3%  of larvae showed viability at 24 hours. Larvae did not develop 
hyphal outgrowth and until 72 hours post-infection. Larvae infected with A. niger 
demonstrated 96.6 ± 3.3%, 80 ± 11.6% and 23.3 ± 3.3% viability 24, 48 and 72 hours 
post-infection. A. terreus infection resulted in 93.3 ± 3.3%, 80 ± 5.8% and 63.3 ± 6.6% 
viability at the 24, 48 and 72 hour time-points respectively.  
Inspection of data obtained from experiments where larvae were infected with 3, 
14 and 28 day old conidia from A. terreus showed that larval viability appeared to 
increase with increasing conidial age. This was evident at the 48 and 72 hour post-
infection time-points. Statistical analysis of larval viability 48 hours subsequent to 
infection with A. terreus demonstrated that this increase in viability was significant with 
14 or 28 day old conidia compared to 3 day old conidia (p  0.001). Comparisons 
between 14 and 28 day old conidia pathogenicity at this time-point revealed no 
significant difference (p = 0.488). Analysis of 72 hour viability demonstrated that 3 day 
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Figure 3.13 Comparative size distributions of A. fumigatus and A. flavus conidia. 
Conidia were matured for 5 days and the size distribution of conidia was determined 
using particle sizing counter (PAMAS). The size distribution of A. flavus conidia was 
greater than that observed for A. fumigatus conidia.  
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old conidia were significantly more pathogenic in larvae than 14 or 28 day old conidia 
(p = 0.002 and 0.001 respectively). Analysis of statistical significance between 14 and 
28 day old conidia revealed a p – value of 0.071. This result shows that A. terreus 
infection in G. mellonella larvae becomes attenuated with increasing conidial age. This 
decrease in pathogenicity appears most prevalent in comparisons between 3 day old 
conidia and 28 day old conidia indicating a loss in virulence over time.  
 
3.1.5 Determination of conidial size in A. fumigatus and A. flavus. 
A. fumigatus ATCC 26933 and A. flavus conidia were matured for 5 days and 
harvested. The conidial size distribution of both conidial types was ascertained as 
described (Section 2.5.2). Microscopic analysis of conidial suspensions observed no 
agglutination of spores. From the data presented (Figure 3.13) it is clear that A. flavus 
conidia show a wider distribution of conidial size relative to A. fumigatus. Analysis of 
A. fumigatus conidia showed that the largest size distribution of conidia occurred 
between 1-2 µm (44.34 ± 0.057%). It was found that that 85% of A. fumigatus conidia 
measured 1-4 µm in diameter with the remaining population measuring slightly larger. 
A. flavus conidia were clearly quite large with 19.78 ± 5.7% of the conidial population 
measuring 4-5µm. This result indicates the variability in conidial size in A. flavus. In 
contrast to A. fumigatus only 1.71 ± 0.9 of conidia were found to measure 1-2 µm in 
diameter. It was found that 93% of the conidial population demonstrated diameters in 
excess of 3 µm.  
 
3.1.6 Summary. 
 The results presented here show that infection of G. mellonella with A. 
fumigatus followed by incubation at 37ºC results in larval death at a faster rate than 
incubation at 30ºC. The inoculation of larvae with 1 x 106 conidia and incubating at 
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37ºC causes a similar reduction in larval death to infection with 1 x 107 conidia and 
incubation at 30ºC. As the immune profile of G. mellonella is affected by incubating 
larvae at 37ºC it was decided to use a temperature of 30ºC for subsequent experiments. 
 The relative pathogenicity of A. fumigatus Af293 which contained deletions for 
laeA, psoA or ftmA was also assessed. The mutants demonstrated significantly reduced 
pathogenicity 24 and 48 hours post-infection relative to the “ wild-type”  Af293 isolate. 
The ftmA and psoA demonstrated significantly attenuated pathogenicity at 72 hours, 
however larvae infected with laeA demonstrated an increased, but statistically 
insignificant, level of viability. 
 An analysis of different aged clinical and environmental A. fumigatus conidia 
pathogenicity was also performed. There was a large amount of variability in larval 
viability when infected with conidia of isolates indicating differential pathogenicity of 
clinical and environmental strains. Larvae infected with 3 day old conidia demonstrated 
reduced viability compared to older conidia from clinical and environmental isolates.  
 An analysis of the pathogenicity of environmental isolates of A. flavus, A. niger 
and A. terreus with 3, 14 or 28 day old conidia was also performed. A. flavus 
demonstrated a high level of pathogenicity in G. mellonella larvae culminating in rapid 
melanisation, loss of larval viability and development of hyphae and conidiophores. 
Infection of larvae with A. terreus resulted in loss of viability. The pathogenicity of A. 
terreus appears to be reduced with increasing conidial age with 3 day old conidia more 
virulent than 14 or 28 day old conidia. An analysis of conidial size demonstrated that A. 
fumigatus conidia measured 1-4 µm in diameter with A. flavus conidia demonstrating a 
wider distribution and average size. 
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3.2 Analysis of A. fumigatus mycotoxin production in vivo and analysis of culture 
filtrate mediated immunosuppression in G. mellonella. 
 A. fumigatus produces a variety of enzymes and secondary metabolites which 
facilitate the growth and persistence of the fungus within pulmonary tissue (Bennet and 
Klich, 2003; Ben-Ami et al., 2010). As a result an analysis of the production of 
mycotoxins within G. mellonella was necessary to facilitate an improved understanding 
of A. fumigatus pathogenesis in vivo. Reeves et al., (2004) demonstrated that gliotoxin 
was produced in significant quantities in vitro and reached peak production after 72 
hours and it has been speculated that this production may be implicated in fungal 
pathogenesis.  As a result G. mellonella larvae were used as an in vivo tool to assess the 
potential immunocompromising effect of clinical and environmental 72 hour culture 
filtrates. 
 
3.2.1 Determination of the concentration of mycotoxins in vivo. 
 In order to facilitate an understanding of the host-microbe interaction between 
G. mellonella and A. fumigatus an analysis of the in vivo concentration of gliotoxin and 
fumagillin in larvae was performed. Larvae were inoculated with A. fumigatus ATCC 
26933, incubated at 30ºC and mycotoxins were extracted as described 24, 48 and 72 
hours post-infection (Section 2.11.1). RP-HPLC analysis of larval extracts (Figure 3.14) 
revealed that the presence of fumagillin was high 24 hours post-infection (3837 ± 
56.4535 ng larval tissue g-1). The presence of fumagillin decreased 48 hours post-
infection (1745.2 ± 49.477 ng larval tissue g-1) and was undetectable at 72 hours. In 
contrast gliotoxin production was detected at concentrations of 1863 ± 34.641, 2480 ± 
43.301 and 2312.33 ± 5.025 ng larval tissue g-1 at 24, 48 and 72 hours. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Time post infection (hours) 
 
Figure 3.14 In vivo mycotoxin concentrations in G. mellonella following infection 
with A. fumigatus. 
Larvae were inoculated with A. fumigatus ATCC 26933 conidia and incubated at 30ºC. 
Following incubation for 24, 48 and 72 hours larvae (n = 25) were crushed and 
organically extracted. Mycotoxin production was quantitatively analysed by RP-HPLC. 
Gliotoxin was detected at all time-points. Fumagillin was detected at high 
concentrations 24 hours post infection but declined to undetectable levels after 72 hours.   
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3.2.2 Determination of the presence of mycotoxins in clinical and environmental A. 
fumigatus culture filtrate. 
 Clinical and environmental isolates of A. fumigatus (CAF 1 – 10 and EAF 1 – 
10) were grown in MEM supplemented with 5% (v/v) FCS and were cultured at 37ºC 
for 72 hours (Section 2.2.11). This was extracted using chloroform as described 
(Section 2.11.2). RP-HPLC analysis was performed (Section 2.12.3) and the 
concentration of mycotoxin was calculated by analysing the resulting peak areas and 
retention times from standards of gliotoxin and fumagillin of known concentration.  
 Figure 3.15 shows the mycotoxin concentrations calculated from 72 hour culture 
filtrates. The concentration of gliotoxin and fumagillin in these samples showed great 
variability. All of the isolates surveyed in this analysis demonstrated fumagillin 
production. However, two environmental isolates and one clinical isolate did not 
produce, (or produced undetectable quantities of), gliotoxin. The quantified mycotoxin 
concentrations from clinical and environmental isolates were pooled in order to 
ascertain the type of isolate which produced more mycotoxins on average (Figure 3.16). 
Analysis of mycotoxin production from clinical isolates of A. fumigatus demonstrated 
mean gliotoxin and fumagillin production values of 87 ± 24.9 and 15.5 ± 3.1 ng hyphae 
mg-1 respectively. The environmental isolates in this study demonstrated gliotoxin and 
fumagillin production of 63.5 ± 27.7 and 22.6 ± 6.6 ng hyphae mg-1 respectively. 
Analysis of these data revealed that production of gliotoxin by clinical and 
environmental isolates was not statistically different. Fumagillin production in 
environmental isolates was significantly higher than that from clinical isolates at this 
timepoint (p = 0.041). 
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Figure 3.15 RP-HPLC analyses of gliotoxin and fumagillin concentrations in A. 
fumigatus culture filtrates. 
Clinical (A) and environmental (B) isolates of A. fumigatus were grown in MEM/5% 
(v/v) FCS for 72 hours. Following organic extraction of culture filtrates and RP-HPLC 
analysis the quantity of gliotoxin or fumagillin as a function of fungal biomass was 
quantified.  
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Figure 3.16 Average production of gliotoxin and fumagillin by clinical and 
environmental isolates of A. fumigatus.  
The mycotoxin concentration values were grouped according to isolate source. 
Environmental isolates produced more fumagillin on average (*p = 0.041). Gliotoxin 
production was highly variable with comparisons between clinical and environmental 
culture filtrates not demonstrating significant difference. 
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3.2.3 Determination of the ability of clinical and environmental A. fumigatus 72 
hour culture filtrates to immunocompromise G. mellonella larvae. 
Larvae were injected with 20µl of clinical or environmental culture filtrates 
(filter sterilised) or sterile MEM supplemented with 5% foetal calf serum as a control 
and incubated at 30ºC for 4 hours after which larvae were inoculated with a follow up 
dose of 1 x 107 A. fumigatus ATCC 26933 conidia. Larval viability was assessed 24, 48 
and 72 hours post-infection and the results are shown in Figure 3.17. It was noted that 
injection with culture filtrate without subsequent fungal infection did not result in a loss 
of larval viability over 72 hours. Larvae injected with MEM/5% (v/v) FCS and 
subsequently infected with A. fumigatus demonstrated 100%, 70 ± 5.8% and 16.6 ± 
3.3% viability at 24, 48 and 72 hours, respectively. Larvae injected with clinical and 
environmental 72 hour culture filtrates prior to infection with 1 x 107 conidia clearly 
demonstrated reduced viability at 24 and 48 hours relative to the control treatment with 
no viability present at 72 hours (Figure 3.18). Analysis of these data revealed that 
viabilities were significantly lower than the media control at 24 and 48 hours (p  
0.048). This finding indicates that A. fumigatus culture filtrates are immunosuppressive 
in G. mellonella as evidenced by a reduced viability relative to the control. 
As it was not feasible to conduct a direct comparison between different isolates 
due to the number of culture filtrates analysed, viability data from the clinical and 
environmental culture filtrate pre-treatments were pooled to calculate the mean and 
standard deviation in order to facilitate a comparison of their immunosuppressive effect 
(Figure 3.18). Exposing larvae to clinical A. fumigatus culture filtrates and subsequent 
infection with conidia resulted in 67 ± 24.1% and 31.6 ± 21.8% viability after 24 and 48 
hours respectively. Larvae injected with environmental A. fumigatus culture filtrates 
prior to conidial inoculation demonstrated 56.6 ± 23.5% and 22.3 ± 18.3% viability 
after 24 and 48 hours. Statistical analysis of larval survival demonstrated that the 
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Figure 3.17 Larval viability following pre-exposure to environmental or clinical A. 
fumigatus culture filtrate and subsequent conidial inoculation. 
Larvae were inoculated with clinical (A) or environmental (B) sterilised culture filtrate 
and incubated at 30ºC for 4 hours. Larvae were infected with 1 x 107 A. fumigatus 
ATCC 26933 conidia and incubated at 30ºC. Larval viability was ascertained 24, 48 and 
72 hours post infection. Sterile MEM/5% (v/v) FCS was used a pre-treatment control 
prior to infection with A. fumigatus. Larvae administered a prior injection of A. 
fumigatus culture filtrate demonstrated significantly reduced viability at 24 and 48 
hours post fungal inoculation (p  0.048).  
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Figure 3.18 Mean larval viability following infection with A. fumigatus ATCC 
26933 subsequent to exposure to environmental or clinical culture filtrates. 
The mean larval viability data from larvae injected with culture filtrate prior to 
subsequent infection with A. fumigatus ATCC 26933 were grouped according to the 
source of culture filtrate. Prior inoculation with environmental culture filtrate resulted in 
reduced larval viability at 24 and 48 hours (**p = 0.009, ***p = 0.001). 
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relative decrease in larval viability caused by inoculating G. mellonella with 
environmental culture filtrates prior to fungal infection was significant in comparison to 
clinical culture filtrates at 24 and 48 hours (p = 0.009 and 0.001). These data indicate 
that the environmental A. fumigatus culture filtrates employed in this study are 
significantly more immunosuppressive in G. mellonella than clinical culture filtrates.  
 
3.2.4 Summary. 
 In this section an analysis of A. fumigatus ATCC 26933 mycotoxin production 
in G. mellonella was performed. The results demonstrate that fumagillin production is 
highest 24 hours post-infection. This quantity of fumagillin appears to be reduced 48 
hours post-infection with an absence (or undetectable quantity) at 72 hours. In contrast 
gliotoxin production was detected at all time-points and was significantly high 48 and 
72 hours post-infection. This finding indicates production of mycotoxins is variable 
over time occurring at different stages of fungal growth.  
 An analysis of the production of mycotoxins from ten clinical and ten 
environmental isolates of A. fumigatus grown in MEM/5% (v/v) FCS was also 
performed using RP-HPLC analysis of organically extracted culture filtrate. The 
different strains demonstrated variable mycotoxin production with respect to each other. 
Combining the data obtained from clinical and environmental isolates of A. fumigatus 
revealed that in vitro gliotoxin production was similar between clinical and 
environmental isolates. The production of fumagillin in environmental isolates appeared 
to be significantly higher than in clinical isolates.  
 The culture filtrates were filter sterilised and were used to investigate their 
ability to weaken the G. mellonella response to fungal colonisation using A. fumigatus 
ATCC 26933. The results indicate that all larvae exposed to fungal culture filtrates 
(irrespective of the source of the isolate) showed reduced viability when subsequently 
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infected with conidia. Additionally, analysis of mean larval viability when inoculated 
with environmental culture filtrates prior to infection with conidia was lower than larvae 
inoculated with clinical isolate culture filtrates. This finding was particularly interesting 
as it may indicate a differential secretory profile in A. fumigatus isolates which results in 
immunosuppression in G. mellonella larvae. 
 
3.3 Determination of the growth rate of clinical and environmental A. fumigatus 
isolates. 
 A. fumigatus is capable of growing rapidly on a range of carbon sources and in 
harsh environments which is a major contributing factor to its ubiquitous nature in the 
environment and facilitates its opportunistic nature as a fungal pathogen (Tekaia and 
Latgé, 2005). This saprophytic growth and pathogenic virulence of A. fumigatus appears 
to be intrinsically linked to the secretion of enzymes which allow for the acquisition of 
nutrients from different sources (Gifford et al., 2002; Tekaia and Latge, 2005; Robson 
et al., 2005). In this section the growth of clinical and environmental A. fumigatus 
isolates (n = 10) on Aspegillus Minimal Medium (AMM) was determined. Furthermore 
the growth of these A. fumigatus isolates on milk agar was investigated as a means of 
determining their relative growth on complex media due to protease secretion as 
performed by Richie et al., (2009).  
 
3.3.1 Growth of clinical and environmental isolates of A. fumigatus on AMM. 
 A. fumigatus isolates were initially grown on Malt Extract Agar (MEA). As 
MEA is a very rich nutrient source the rate of growth between different isolates was 
almost identical. A. fumigatus conidia were harvested as described (Section 2.2.10) and 
the cells were enumerated by haemocytometry. The final concentration was adjusted to 
1 x 106 conidia ml-1 and a 5 µl drop of this suspension was placed on an AMM agar 
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Figure 3.19 Growth of clinical and environmental isolates of A. fumigatus on 
AMM. 
Conidia (5 x 103) from environmental (A) and clinical (B) A. fumigatus isolates was 
spotted on to AMM, incubated at 37ºC and growth was monitored at 24, 48 and 72 
hours. Analysis of the average growth of A. fumigatus isolates (C) indicates that 
environmental isolates demonstrated improved growth after 24, 48 and 72 hours (***p 
= 0.001). 
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plate to give a fixed cell concentration of 5 x 103 (Figure 2.5.1). The agar plates were 
incubated at 37ºC and radial growth of the A. fumigatus isolates was measured at 24, 48 
and 72 hours and is presented in Figure 3.19 A and B. Inoculation of plates with 
environmental and clinical isolates of A. fumigatus resulted in variable growth at the 
different time-points with colony size variability most evident after 72 hours. The data 
from the environmental and clinical area recordings were grouped to give the mean 
growth of clinical and environmental A. fumigatus isolates at 24, 48 and 72 hours thus 
facilitating a comparison between the different sources (Figure 3.19 C). The colony area 
of environmental A. fumigatus isolates on AMM was calculated as 60.11 ± 14.32 mm2, 
479.89 ± 69.62 mm2  and 1377.72 ± 188.72 mm2 at 24, 48 and 72 hours, respectively. 
Clinical isolates grew to 40.96 ± 11.13 mm2, 354.17 ± 91.11 mm2 and 1120.75 ± 249.97 
mm2 over the same period. Statistical analysis of these data showed that environmental 
isolates demonstrated significantly faster growth than clinical isolates at 24, 48 and 72 
hours (p  0.001). 
 
3.3.2 Growth of clinical and environmental isolates of A. fumigatus on milk agar. 
Conidia were harvested as described (Section 2.2.10) and the concentration of 
conidia was adjusted to give a final concentration of 1 x 106 conidia ml-1. A 5 µl droplet 
was placed on the surface of a milk agar plate (Section 2.2.12) and was allowed to air 
dry. The plates were incubated at 37ºC and radial growth was measured 24, 48 and 72 
hours post inoculation. Analysis of the growth of environmental and clinical isolates 
(Figure 3.20 A and B) demonstrated strong growth on milk agar however due to the 
rapid nature of A. fumigatus mycelial growth the expected zone of precipitation (“ halo-
like”  in appearance) was not visible. The pattern of A. fumigatus growth did appear to 
be different from that observed on AMM. For this reason the data obtained from each 
isolate were pooled into respective clinical and environmental groups and was 
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Figure 3.20 Growth of environmental and clinical isolates of A. fumigatus on milk 
agar. 
Conidia (5 x 103) from environmental (A) and clinical (B) A. fumigatus isolates were 
spotted on milk agar plates and incubated at 37ºC. The growth of A. fumigatus was 
recorded 24, 48 and 72 hours post inoculation. The average growth of environmental 
and clinical isolates was grouped and expressed as mean hyphal growth (C). Average 
growth was similar after 24 and 72 hours. Environmental isolates demonstrated 
improved growth after 48 hours (*p = 0.035). 
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expressed in terms of mean and standard deviation (Figure 3.20 C). Environmental 
isolates grew to 66.52 ± 18.65 mm2, 650.85 ± 47.92 mm2 and 1616.28 ± 149.83 mm2 
24, 48 and 72 hours post-inoculation, respectively. Clinical isolates grew to 69.12 ± 
21.08 mm2, 619.86 ± 67.57 mm2 and 1573.68 ± 136.644 mm2 at the same times. 
Comparisons of clinical and environmental growth revealed that the rate of growth was 
similar at 24 and 72 hours (p = 0.597 and 0.275, respectively). The rate of growth of 
environmental isolates was higher relative to clinical isolates at 48 hours post 
inoculation (p = 0.035). 
. 
3.3.4 Summary 
 In this section the growth of clinical and environmental A. fumigatus isolates on 
AMM and milk agar was compared. Environmental isolates of A. fumigatus 
demonstrated significantly higher growth over clinical isolates at 24, 48 and 72 hours on 
AMM. 
 The growth of A. fumigatus isolates on milk agar was also ascertained. It was 
interesting to note that colony growth was similar at 24 and 72 hours with 
environmental isolates demonstrating faster mean growth 48 post-inoculation.  
  
3.4 Discussion 
 The use of G. mellonella larvae as useful, high throughput and ethical in vivo 
tools to ascertain microbial pathogenicity has increased in the last decade (Cotter et al., 
2000; Brennan et al., 2002; Mahar et al., 2004; Mylonakis et al., 2005; Jackson et al., 
2009). The concentration of microbe required in these studies to initiate pathogenicity 
shows a high level of variation with infection of 2 x 106 C. albicans cells, 1 x 106 A. 
fumigatus conidia and concentrations as low as 20 Cryptococcus c.f.u per larvae 
resulting in larval death. Jackson et al., (2009) demonstrated that a 1 x 106 inoculum of 
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A. fumigatus Af293 conidia incubated at 37ºC should be used in G. mellonella studies. 
This contrasted with the work of Reeves et al., (2004) and Renwick et al., (2006) where 
a temperature of 30ºC was used. Mowlds et al., (2008) characterised the effect of 
different temperatures on haemocyte density and the expression of genes encoding 
antimicrobial peptides in G. mellonella. This work demonstrated a 3 - fold increase in 
haemocyte density in larvae incubated at 37ºC relative to larvae incubated at 30ºC. 
Furthermore the expression of gallerimycin and transferrin are significantly increased at 
37ºC. Considering that the optimal growing temperature of A. fumigatus is 37ºC, the 
finding that this temperature modulates the immune status of G. mellonella is an 
additional factor which must be considered in such studies. It was found that 
concentrations of 1 x 104 conidia larvae-1 were avirulent a 30ºC or 37ºC. Inoculating 
larvae with 1 x 105 conidia resulted in no significant change in larval viability but 
demonstrated some pathogenicity at 37ºC. Infecting larvae with 1 x 106 or 1 x 107 
conidia larvae-1 demonstrated a distinct change in larval viability depending on the 
incubation temperature. Infecting larvae with 1 x 106 conidia resulted in a small change 
to larval viability at 30ºC over 72 hours, however incubating larvae at 37ºC caused a 
significant loss in viability over the same period of time. The effect of larval incubation 
at 37ºC is exacerbated further when infected with 1 x 107 conidia with no viability 48 
hours post-infection. In contrast infections with the same concentration of conidia and 
incubating at 30ºC resulted in larval viability being reduced in a manner that was similar 
to infection with 1 x 106 conidia and incubating at 37ºC. It is therefore clear that studies 
using A. fumigatus may be performed at 30ºC or 37ºC. Mowlds et al., (2008), and 
Wojda and Jacubowicz, (2007) clearly demonstrate that the cellular and humoral 
immune response of G. mellonella is primed at 37ºC. It was decided that for subsequent 
experimentation a temperature of 30ºC would be used in order to negate the effect of 
temperature priming of the larval immune response.  
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 The relative pathogenicity of A. fumigatus isolates with deletions for genes 
encoding fumitremorgin (ftmA), pseurotin A (psoA) and the nuclear associated 
secondary metabolite regulation protein laeA (laeA) from the Af293 parent strain was 
determined. Larval infection with Af293 resulted in a complete loss of viability 72 
hours post-infection. The mutant strains used in this study all demonstrated attenuated 
virulence over the same time period. The laeA strain showed the least attenuation of 
the three mutant strains. This is interesting as laeA has been identified as a global 
regulator of secondary metabolite biosynthesis thus acting as a significant virulence 
factor (Bok and Keller, 2004; Bok et al., 2005). Perrin et al., (2007) showed that laeA 
contributes to the expression of approximately 9.5% of the A. fumigatus genome with 
13 of 22 metabolite gene clusters adversely affected by laeA gene deletion thus 
confirming the role of this protein in fungal virulence. PsoA is a NRPS gene which 
encodes for the production of pseurotin A. Pseurotin A is a neuritogenic agent and a 
competitive inhibitor of chitin synthase, (Maiya et al., 2007). Recent work by Ishiwika 
et al., (2009) demonstrated that B-cell Ig-E production is suppressed by pseurotin A and 
its analogues. FtmA encodes the brevianamide synthethase which produces 
brevianamide F, a precursor of fumitremorgins A, B and C which are tremorigenic 
(Maiya et al., 2006). Deletion of a gene encoding for ftmA resulted in the most 
attenuated virulence in larvae thus highlighting the need for improved characterisation 
of fumitremorgins in vivo. Preliminary analysis of psoA and ftmA virulence in 
neutropenic mice demonstrated significantly reduced virulence of psoA deletants (p < 
0.02) but no significant difference was observed in comparisons between Af293 and 
ftmA (Dr. E. Bignell, personal communication). It was perhaps surprising that laeA 
was the least attenuated isolate as its role as a global regulator of secondary metabolite 
biosynthesis means that mycotoxin production would have been extremely restricted. 
Furthermore, Bok et al., (2005) demonstrated that deletion of laeA resulted in increased 
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phagocytosis of conidia, reduced fungal burden in the murine lung and reduced 
production of gliotoxin. However the authors found that deletion of laeA caused 
minimal changes to growth rate thus indicating that any changes in virulence are as a 
result of diminished secondary metabolite production.  The finding that deletion of ftmA 
and psoA resulted in more attenuated virulence may highlight the requirement for 
further analysis of laeA in fungal pathogenesis. Furthermore it has been previously 
shown that deletants of psoA and ftmA do not demonstrate significantly reduced growth 
(Maiya et al., 2006 and 2007). Therefore it would appear likely that the observed 
attenuation in virulence is as a result of impaired secondary metabolite fuction. The 
notable discrepancy in virulence of the ftmA isolate between G. mellonella and 
neutropenic mouse model is an issue which needs to be addressed through more 
experimental data. 
 Comparative analysis of clinical and environmental isolates of A. fumigatus has 
focussed on studies in murine models and relative mycotoxin production with evidence 
suggesting that a high degree of variability exists between strains (Mondon et al., 1996; 
Aufauvre-Brown et al., 1998; Kosalec and Pepeljnjak, 2005). Recent work on 
characterising the source of these isolates has pointed to azole resistance occurring from 
the use of fungicides in the environment resulting in a TR/L98H mutations becoming 
evident in clinical and environmental isolates (Verweij et al., 2009). In this Chapter it 
was hoped to characterise a range of clinical and environmental isolates of A. fumigatus 
at different stages of conidial maturation with regard to their pathogenicity in G. 
mellonella. The results reveal that both clinical and environmental isolates of A. 
fumigatus demonstrated significant variability in larvae with 3 day old conidia showing 
increased pathogenicity. Infection with 3 day old environmental conidia demonstrated 
the greatest variation in larval pathogenicity. A comparison between mean larval 
viability data when larvae were infected with clinical or environmental isolates showed 
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that virulence is similar for both isolate types. These findings are particularly interesting 
as a screen of clinical and environmental A. fumigatus isolates at different stages of 
conidial maturation has not been published to date. Significantly the viability data 
obtained from infecting larvae with environmental isolates would appear to suggest that 
pathogenicity is variable depending on the stage of conidial maturation. The reasons for 
this appear unclear although it may be possible that alterations to the quantity of 
melanin on the conidial surface may play a role in pathogenesis. Jahn et al., (1997 and 
2000) demonstrated that conidia lacking melanin were less virulent in murine models of 
infection. In contrast Jackson et al., (2009) demonstrated that a loss of melanin on the 
conidial surface resulted in increased virulence in G. mellonella. It may therefore be 
possible that the structure and quantity of melanin on differentially matured conidia 
may be a virulence factor which may need to be considered in future studies. 
 The pathogenicity of environmental “ non-fumigatus”  Aspergillus isolates in G. 
mellonella was also determined. A. flavus demonstrated a high level of pathogenicity in 
larvae with complete mortality present at 24 hours and the observation of condiophores 
protruding from the larval cuticle at 72 hours. The data obtained from this experiment 
must be interpreted with a note of caution as it is clear that the infecting dose used in 
these experiments was excessive. A. flavus has been recently described as a major cause 
of aspergillosis in developing countries (Chakrabarti et al., 2010), thus, characterising 
the pathogenicity of isolates of this fungus may be required on a larger scale. The use of 
G. mellonella to study A. flavus pathogenesis has been documented to show host 
restriction following several propagations through larvae, (Scully and Bidochka, 2005). 
The large size of A. flavus conidia, (Pasqualotto, 2008) may also be contribute to its 
virulence as Renwick et al., (2006) demonstrated that haemocytes were not able to 
efficiently phagocytose swollen or germinating conidia of A. fumigatus. In this Chapter 
it is clear that A. flavus conidia demonstrate a much larger size distribution than A. 
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fumigatus conidia. It may be possible that A. flavus conidia are too large to be 
phagocytosed thus serving as a potential virulence factor in G. mellonella. Further 
clarifiaction regarding the apporapriate level of infection administered to larvae is 
necessary for future work and may place the occurrence of differential pathogenicity 
from matured conidia into context. A. niger is less documented in fungal pathogenesis 
studies however it has been extensively studied as a producer of citric acid, (Baker, 
2006). Reeves et al., (2004) demonstrated that A. niger was virulent in G. mellonella 
therefore it is not surprising that pathogenicity was observed in this case. Larval 
viability following infection with A. niger conidia was variable depending on the level 
of conidial maturation. A. terreus has been also been described as a significant emerging 
pathogen among immunocompromised individuals (Malani and Kauffman, 2007). 
Larval infection with 3, 14 and 28 day old conidia of A. terreus resulted in loss of larval 
viability. The observed pathogenicity was attenuated with increased conidial 
maturation. These results coupled to observations of variable pathogenicity of A. 
fumigatus and A. niger with different aged conidia further validate the use of G. 
mellonella to screen potentially pathogenic Aspergilli however the role of conidial 
maturation is clearly a factor which must be considered. 
 The role of A. fumigatus mycotoxin production has often focussed on the 
secretion of gliotoxin as the principle effector of secondary metabolite mediated 
immunosuppression (Ben-Ami et al., 2010). In this work gliotoxin was detected in G. 
mellonella larvae at 24, 48 and 72 hours with the highest amount being evident at 48 
hours. This corresponded to the time-point where the greatest variation in larval 
viability following fungal infection was observed (Figure 3.1). Reeves et al., (2004) had 
previously highlighted the correlation between gliotoxin production and virulence of 
Aspergillus species in larvae. In this study fumagillin was detected at high 
concentrations in vivo 24 hours post-infection. The concentration of fumagillin per 
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gramme of larval tissue appeared to be reduced at subsequent time-points thus 
indicating it as a mediator of early fungal pathogenesis. Clearly the production of 
fumagillin warrants further investigation as it has been shown to be highly bioactive and 
capable of mediating significant toxicity (Amitani et al., 1995; Stevanovic et al., 2008).  
 The mycotoxin concentration in A. fumigatus culture filtrates and the potential 
immunosuppressive effect of these culture filtrates were also assessed. There was 
variability in the production of gliotoxin and fumagillin in clinical and environmental 
isolates. The variability in gliotoxin production between different isolates has been 
previously documented and has been demonstrated to be strongly influenced by 
conditions which favour mycelial growth (Lewis et al., 2005, Kosalec et al, 2005) with 
fumagillin production apparently dependent on the nature of carbon and nitrogen 
sources, (Yang et al., 2003). In this work the average quantity of gliotoxin produced by 
clinical and environmental isolates of A. fumigatus isolates was found to be quite 
similar. Environmental isolates produced higher concentrations of fumagillin on 
average thus raising the possibility that its synthesis is based on conferring a 
competitive advantage against other microbes in nature. The culture filtrates 
characterised by mycotoxin concentration were also injected into G. mellonella larvae 
prior to infection with A. fumigatus ATCC 26933. The data demonstrated the 
immunosuppressive effect of these culture filtrates as evidenced by reduced larval 
viability following fungal infection relative to prior inoculation with media alone. 
Notably the highest producing mycotoxin strains did not correlate entirely with the 
greatest loss in larval viability when subsequently infected. Therefore it would appear 
that weakening of the host immune response by secreted factors produced by A. 
fumigatus is not dependent on mycotoxin production alone. It is suggested here that a 
cumulation of multiple factors (enzymes, mycotoxins) are responsible for the 
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exacerbation of fungal pathogenesis in vivo which mycotoxins play a major, but not 
exclusive role.  
A point of note is the temperatures which were employed in these studies. 
Genomic sequence analysis performed by Nierman et al., (2005) demonstrated that the 
expression of virulence factor related genes in A. fumigatus is highly temperature 
dependant. In that study it was shown that pathogenicity associated genes demonstrated 
higher levels of expression at higher tempetures such as 48ºC. Analysis identified 323 
genes which showed higher expression at 48ºC with 135 demonstrating higher 
expression at 37ºC. Interestingly gene expression was markedly increased as 
temperature increased to 37ºC or 48ºC increased following initial incubation at 30ºC. 
These findings would therefore suggest that gene expression is likely to be severely 
reduced when incubated at 30ºC. Therefore it is likely that the observed production of 
mycotoxins in vivo and in vitro may not be at optimal levels in these experiments. 
However, considering the work of Mowlds et al., 2008 it is clear that higher 
temperatures have a priming effect on the immune system of G. mellonella larvae 
therefore strengthening the argument for using a temperature of  30ºC for A. fumigatus 
pathogenicity studies. 
 The growth of clinical and environmental isolates on defined minimal medium 
and milk agar was also ascertained in order to characterise the relative growth rates of 
strains. Environmental isolates demonstrated significantly more growth on AMM than 
clinical isolates on this media thus indicating a higher capacity to grow on limited 
nutrients.  
The growth of clinical and environmental isolates on milk agar was similar thus 
indicating conservation of protease activity. Milk agar has been used in bacteriology 
studies to examine general protease activity evidenced by a zone of precipitation around 
a growing colony, (DeShazer et al., 1999). Applying this method to A. fumigatus is 
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difficult as rapid hyphal growth into assimilated carbon sources is a feature of the 
saprophytic nature of this fungus.  Richie et al., (2009) used this media to characterise 
the unfolded protein response in A. fumigatus. In that particular study hacA, a strain 
deficient in an unfolded protein response transcriptional regulator, demonstrated 
reduced growth on this medium coupled to a diminution of protease activity. The data 
presented here would appear to demonstrate that the clinical and environmental isolates 
used in this study demonstrated equivalent growth on this media therefore it would 
appear that general protease activity is conserved.  
  In conclusion this Chapter further validates the use of G. mellonella 
larvae as a novel, reproducible, high throughput tool for the study of systemic 
Aspergillus infections. A. fumigatus pathogenicity would appear to be mediated by a 
combination of in vivo mycotoxin production, rapid growth in nutritionally depleted 
environments coupled to the secretion of protein degrading factors which result in 
favourable conditions for fungal pathogenesis. 
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Investigation of the effect of fumagillin on 
neutrophil and haemocyte function 
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4.0 Introduction. 
 Neutrophils form a primary line of defence against invading microbes by 
phagocytosing opsonised pathogens, producing superoxide and nitric oxide and the 
degranulation of azurophilic granules to the phagosome. Degradation of the ingested 
microbe occurs in the phagocytic vacuole by a combination of oxidative and non-
oxidative mechanisms (Babior et al., 1973; Curnutte et al., 1987; Wheeler et al., 1997; 
Bellochio et al., 2004). Central to the oxidative process, the translocation of cytosolic 
p40phox, p47phox, p67phox and Rac to the membrane is required to form a fully functional 
NADPH oxidase complex capable of producing superoxide which shows limited bio-
accumulation in vivo but is rapidly protonated to form hydrogen peroxide (Wientjes et 
al., 1993; Sumimoto et al., 1996).  
 Non-oxidative mechanisms are due to neutral serine proteases, hydrolytic 
enzymes, and cationic proteins which are packaged in cytoplasmic lysosomes and are 
released to the phagosome upon cell activation (Spitznagel, 1990). Myeloperoxidase is a 
key component of these primary granules and catalyses the production of hypochlorous 
acid upon cell activation and subsequent degranulation, with the additive effect of 
demonstrating microbicidal activity (Spitznagel, 1990; Standish and Weiser, 2009).  
 In recent years an increasing amount of evidence has shown that the processes 
involved in neutrophil function are intricately linked to the formation and subsequent 
disassembly of F-actin. The work of Zhan et al., (2004) demonstrated this principle 
whereby translocation of p47phox is dependent upon interactions between the PX domain 
of p47phox and moesin thus acting as the primary mediator for the formation of the 
NADPH oxidase complex. Additionally, the regulation of F-actin disassembly appears 
to be intricately linked to this process. Antisense oligonucleotides to cofilin, an actin 
depolymerising factor, have been demonstrated to reduce the rate of phagocytosis and 
lower superoxide production (Adachi et al., 2002). It follows that tight regulation of the 
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process of F-actin assembly is essential in the activation process of neutrophils with the 
effect of eliminating the microbe from the host.  
A. fumigatus is capable of producing a variety of toxins and enzymes which 
facilitate the initial colonisation of lung tissue, exacerbate fungal growth and impair 
host immune responses (Tekaia and Latgé, 2005). Fumagillin is produced upon hyphal 
development (Mitchell et al., 1997), however the role it plays in the pathogenesis of A. 
fumigatus remains poorly characterised. The most significant evidence to date would 
appear to show that fumagillin is capable of retarding ciliary beat frequency at a 
concentration of 10 µg ml-1. Tsunawaki et al., (2004) employed concentrations up 128 
µg fumagillin ml-1 with a cellular exposure time of 7 minutes but failed to see any 
significant effect on the process of neutrophil degranulation. It would appear however 
that this concentration is abnormally high as experimental data (presented in Chapter 3) 
would suggest that the concentration of fumagillin is much lower in vivo. Furthermore, 
it is not clear if the concentration used harms cellular viability therefore normal cellular 
function could not be possible.  
 The primary aim of this study was to perform a comprehensive analysis of the 
effect of fumagillin on neutrophil function. Furthermore, considering the work of 
Renwick et al., (2007), it was deemed necessary to evaluate the effect of equivalent 
fumagillin concentrations on G. mellonella immunocompetence, and haemocyte 
function in order to clarify if any possible effects viewed in neutrophils are equivalent to 
those of haemocytes. It is clear that understanding such conservation of cellular 
responses is crucial to the validation of G. mellonella as an accurate in vivo model to 
screen host physiological responses to mycotoxins and other fungal virulence factors, 
therefore extending the biotechnological utility of this organism. 
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4.1 Analysis of the effect of fumagillin on the ability of neutrophils to phagocytose 
and kill a pathogenic target in vitro. 
 In order to understand if fumagillin was capable of inhibiting neutrophil function 
it was necessary to understand if neutrophil mediated phagocytosis and killing were 
adversely affected by fumagillin. Considering conflicting data as to the minimum 
concentration of fumagillin capable of inhibiting function, (Amitani et al., 1995, 
Tsunawaki et al. 2004), initial work focussed on identifying a concentration of 
fumagillin which significantly reduced neutrophil mediated killing of fungal and 
bacterial human pathogens.  
 
4.1.1 Analysis of the effect of fumagillin on neutrophil mediated killing. 
Neutrophils were extracted as described (Section 2.14). A killing assay using C. 
albicans as a target was performed, (Section 2.16.1) and the results are presented in 
Figure 4.1. The viability of neutrophils did not change significantly throughout the 
course of the assay, reducing from 98.1 ± 2.2% before the assay to 94.5% ± 1.5% after 
60 minutes therefore excluding the possibility that any alteration in C. albicans viability 
resulted from a loss of neutrophil viability.  
 The viability of C. albicans was found to be greatly reduced after 60 minutes 
when incubated with neutrophils exposed to PBS alone or the methanol control (5.01 ± 
4.23% and 5.29 ± 4.31% respectively). Neutrophils incubated with 1µg fumagillin ml-1 
demonstrated a slight but not statistically significant difference in the ability to kill C. 
albicans recording 11.56 ± 5.12% viability after 60 minutes (p = 0.6). Neutrophils 
exposed to 2 µg fumagillin ml-1 did not show a statistically significant difference in the 
rate of killing compared to the control up to 20 minutes with C. albicans viability at 
63.6 ± 10.98% (p = 0.247) however this rate was found to change considerably 
thereafter. Neutrophils incubated with 2 µg fumagillin ml-1 demonstrated a marked
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1 Effect of fumagillin on neutrophil mediated C. albicans killing. 
Neutrophils were isolated and exposed to 1 or 2 µg fumagillin ml-1 for 25 minutes at 
37ºC and subsequently used in a killing assay using a stirred chamber. Cells exposed to 
2 µg fumagillin ml-1 demonstrated a reduced capacity to kill C. albicans MEN while 
neutrophils exposed to the solvent control treatment or 1 µg fumagillin ml-1 
demonstrated insignificant changes compared to the PBS control. 
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Figure 4.2 Effect of fumagillin on neutrophil mediated killing of P.  aeruginosa. 
Neutrophils were isolated and a killing assay using P. aeruginosa as a pathogenic target 
was performed as described, (Section 2.16.3). Neutrophils exposed to fumagillin (2 µg 
ml-1) killed significantly less bacterial cells after 60 minutes (*p  0.05) than either 
positive control treatment.   
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decreasing in killing activity with yeast viability 58.1 ± 7.4% viability after 60 minutes 
(p  0.02). 
 Analysis of the fumagillin mediated modulation of neutrophil antimicrobial 
activity was extended to identifying if the inhibitory effect was applicable to bacteria. 
Neutrophils were extracted and a killing assay using P. aeruginosa was performed as 
described, (Section 2.16.3). Analysis of the data (Figure 4.2) revealed that there was 
negligible variability in bacterial viability after 30 minutes. Neutrophils incubated in the 
presence of PBS or incubated in the presence of 0.002% (v/v) methanol prior to 
incubation with bacteria killed 67 ± 4.13% and 66.98 ± 2.3% of the P. aeruginosa cell 
population respectively at 60 minutes (p = 0.991). This contrasted with the figure 
observed for neutrophils exposed to 2 µg fumagillin ml-1 where 52.26 ± 3.35% of 
bacteria remained viable. Statistical analysis of the capacity of neutrophils to kill P. 
aeruginosa revealed a significant reduction in cell mediated killing, (p  0.05). It was 
decided for subsequent experimentation that studies on the effect of inhibitory 
concentrations of fumagillin would focus on the 2 µg ml-1 concentration as being the 
lowest concentration which elicited a physiologically relevant response. As a result this 
would facilitate a more in depth analysis of the effect of fumagillin on the various 
cellular parameters involved in neutrophil function. 
 
4.1.2 Analysis of the effect of fumagillin on the ability of neutrophils to 
phagocytose. 
Based on the results in Section 4.1.1 initial work was focussed on investigating 
the effect of fumagillin on the process of neutrophil mediated phagocytosis as described 
in Section 2.16.4. Figure 4.3 shows that the rate of phagocytosis increased rapidly in the 
PBS and methanol control treatments up to 60 minutes with 46.24 ± 1.72% and 44.61 ± 
3.11% of cells showing phagocytosis, respectively. However at 60 minutes it is evident 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3 Effect of fumagillin on neutrophil mediated phagocytosis. 
Neutrophils (1 x 107) were exposed to fumagillin (2 µg ml-1) and were employed in a 
phagocytosis assay as described, (Section 2.16.4). Neutrophils exposed to fumagillin 
phagocytosed less conidia than PBS or the 0.002% (v/v) methanol treated control, (p = 
0.023* and 0.015* respectively). 
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that the rate of neutrophil mediated phagocytosis in the 2 µg fumagillin ml-1 pre-
treatment shows a decrease with 27.94 ± 3.86% of cells demonstrating phagocytosis. 
This decrease in the rate of phagocytosis was found to be significant compared to PBS, 
(p = 0.023) and methanol control treated neutrophils, (p = 0.015). The increase in rate of 
phagocytosis was reduced from 60 to 120 minutes in all treatments compared to the first 
60 minutes. At 120 minutes the level of phagocytosis had increased to 52.75 ± 2.82% in 
the PBS treatment and 46.02 ± 0.736% in the methanol control. This contrasted with the 
rate of phagocytosis observed in neutrophils exposed to 2 µg fumagillin ml-1 where 
32.85 ± 1.09% of the cell population had internalised conidia with p – values of 0.013 
and 0.01 relative to the PBS and methanol controls respectively.  
 
4.1.3 Summary. 
 The results presented in this section demonstrates that fumagillin at a 
concentration of 2 µg ml-1 reduces the neutrophil mediated killing of C. albicans and P. 
aeruginosa. Lower concentrations of fumagillin were analysed for their effect on 
neutrophil mediated killing of C. albicans however no statistically significant effect was 
observed. An analysis of the effect of fumagillin on neutrophil mediated phagocytosis 
showed that exposure of neutrophils to a functionally inhibiting concentration of 
fumagillin (2 µg ml-1) resulted in reduced internalisation of A. fumigatus conidia than 
the control treatments.  
  
4.2 Analysis of the effect of fumagillin on oxygen consumption and the formation 
of a functional NADPH oxidase complex. 
 The work of Tsunawaki et al., (2004) demonstrated that the gliotoxin produced 
by A. fumigatus effectively blocks the formation of a functional NADPH oxidase 
complex by inhibiting the translocation of p47phox and p67phox from the cytosol to the 
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membrane effectively reducing the association with the flavocytochrome b558 complex 
with the additive effect of a loss of superoxide production. Considering the role of 
oxygen consumption and the resulting production of superoxide mediated by the 
formation of this complex it was necessary to undertake an analysis of the effect of 
inhibitory concentrations of fumagillin on this process. As a result this would 
potentially demonstrate the effect of fumagillin on a key facet of the antimicrobial 
activity of neutrophils thus facilitating an understanding of the effect of fumagillin on 
the balance of the cytosolic and membrane proteome following stimulation. 
 
4.2.1 Effect of fumagillin on oxygen consumption. 
 Neutrophils were isolated and an assay to determine the effect of fumagillin on 
the consumption of oxygen was performed as described, (Section 2.18.6). Phorbol-12-
mytistate-13-acetate (PMA) at a concentration of 1µg ml-1 was used as an artificial 
stimulus as this has been demonstrated to elicit the activation of neutrophils (Reeves et 
al., 2002). Neutrophils, (1 x 107 ml-1) were placed in a stirred chamber and allowed to 
stabilise for approximately 3 minutes prior to stimulation. The rate of oxygen 
consumption was monitored as shown in Figure 4.4 over a ten minute period consistent 
with the methodology described by Bergin et al., (2005). Control neutrophils and those 
exposed to 0.002% (v/v) methanol consumed 55.48 ± 13.12 and 72.63 ± 2.09 nmol ml-1 
oxygen after 5 minutes respectively. Importantly this value was not deemed as 
significant, (p = 0.262). It is clear that 5 minutes post stimulation the rate of oxygen 
depletion by neutrophils pre-treated with 2 µg fumagillin ml-1 was significantly reduced 
relative to the control treatments with 21.48 ± 8.02 nmol ml-1 oxygen consumed (p  
0.025). This apparent reduction in the ability of neutrophils previously exposed to 
fumagillin to consume oxygen continued to the ten minute timepoint. Neutrophils 
previously incubated in the presence of fumagillin consumed 29.03 ± 11.77 nmol 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Effect of fumagillin on the ability of neutrophils to consume oxygen. 
Neutrophils, (1 x 107) were isolated and incubated in the presence of fumagillin. Cells 
were washed and the rate of oxygen consumption following PMA stimulation (1 µg ml-
1) was observed (Section 2.18.6). Neutrophils exposed to fumagillin consumed 
significantly less oxygen than cells incubated in PBS or 0.002% (v/v) methanol, (p = 
0.032* and 0.017** respectively). 
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oxygen ml-1. This rate of oxygen consumption contrasted with the rate observed in PBS 
and solvent control treatments where 106.07 ± 11.92 and 95.84 ± 8.97 nmol oxygen ml-1 
was consumed respectively (p = 0.032 and 0.017). Comparisons between both control 
treatments demonstrate no statistically significant difference, (p = 0.198) therefore 
confirming that the reduction in the rate of oxygen consumption is a result of inhibition 
mediated by fumagillin. 
 
4.2.2 Analysis of the effect of fumagillin on the translocation of p47phox. 
 As a result of the work presented in Section 4.2.1 an analysis of the formation of 
a functional NADPH oxidase complex was performed. Neutrophils, (1 x 108 ml-1) were 
isolated and fractionated as described, (Section 2.18.4). The resulting cytosolic and 
membrane protein components were subjected to 1–D SDS-PAGE and immunoblotting, 
(Section 2.7 and 2.9). Rabbit polyclonal antisera raised in rabbits immunised with 
recombinant p47phox was used at a dilution of 1/2000 in the primary antibody solution. 
Following washing and probing with secondary anti-rabbit horseradish peroxidase, 
(HRP) conjugated antibody blots were developed with ECL reagent or DAB staining, 
(Section 2.9.7). Analysis of p47phox reactivity revealed the identification of a band 
which displayed size resolution of approximately 47 kDa to be present in the membrane 
fraction of all treatments, (Figure 4.5 B) confirming the presence of the protein. 
Importantly, identification of p47phox in membrane fractions demonstrated increased 
translocation in all treatments where cells received PMA stimulation relative to 
unstimulated cells. The fluctuation in membrane p47phox was quantified by densitometry 
and the data resulting from this analysis are presented in Figure 4.5 (C). Cells which 
were stimulated with PMA and were not pre-incubated in the presence of fumagillin or 
0.002% (v/v) methanol demonstrated a 2.59 fold increase in the presence of p47phox in 
the membrane fraction (p = 0.011). Similarly the solvent control for this experiment 
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Figure 4.5 Effect of fumagillin on the translocation of p47phox from the cytosol to 
the membrane. 
Neutrophils, (1 x 108) were isolated and incubated in the presence of fumagillin (2 µg 
ml-1). Cells were washed and subsequently fractionated (Section 2.18). Following SDS-
PAGE (A) and immunoblotting (B) the relative translocation of p47phox to the 
membrane was ascertained by densitometry (C). Neutrophils exposed to fumagillin 
demonstrated significantly reduced membrane associated p47phox relative to PMA and 
solvent incubated or PMA stimulated cells (*p  0.022). Unstimulated neutrophils (U.T) 
demonstrated some evidence of p47phox in the membrane. 
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displayed a 2.67 fold increase in the presence of p47phox in the membrane fraction 
following PMA stimulation, (p = 0.022). Importantly, neutrophils in receipt of PMA 
stimulation alone and those incubated in the presence of 0.002% (v/v) methanol and 
then subsequently stimulated with PMA demonstrated almost equivalent levels of 
p47phox in the membrane fraction, (p = 0.481). This finding indicates that the presence of 
the solvent used to solubilise fumagillin had a negligible impact on the formation of the 
NADPH oxidase complex thus supporting the data obtained from the oxygen 
consumption assay, (Section 4.2.1). Cells previously exposed to fumagillin and 
subsequently stimulated with PMA showed a marked decrease in the presence of 
p47phox in the membrane demonstrating 52.08% and 50.65% p47phox translocation 
compared to PMA and solvent control cells, (p = 0.026 and 0.045 respectively). Cells 
exposed to fumagillin demonstrated a 1.35 fold increase in membrane p47phox content 
however it was found that this value was not statistically significant, (p = 0.072). It is 
clear that exposure of neutrophils to fumagillin prior to PMA stimulation results in the 
level of membrane bound p47phox to be maintained at near basal levels.  
 
4.2.3 Confocal immunoflouresence microscopy examining the localisation of 
p47phox following exposure to fumagillin and PMA stimulation. 
The translocation event and its inhibition by fumagillin was visualised by 
immunoflouresence microscopy as described, (Section 2.19). Figure 4.6 clearly shows a 
wide distribution of p47phox in unstimulated cells demonstrating very few clusters of 
p47phox. Cells which were stimulated with PMA demonstrated localisation of p47phox to 
the inner periphery of the cell with evidence of localised clustering within the cell which 
may be a result of association with intracellular membranes. Cells incubated in the 
presence of 2 µg fumagillin ml-1 demonstrate partial translocation to the membrane 
however the majority of p47phox is retained in the cytosol. This finding further validates 
  
 
 
 
 
              
Figure 4.6 Confocal Immunofluoresence imaging of disruption to p47phox 
translocation mediated by exposure of neutrophils to fumagillin.  
Neutrophils were incubated in the presence or absence of fumagillin, (2 µg ml-1) and 
subsequently stimulated with PMA, (1 µg ml-1) in preparation for immunofluoresence 
microscopy (Section 2.19.1). Unstimulated neutrophils demonstrate widespread 
distribution of p47phox throughout. Cells stimulated with PMA demonstrated localised 
fluorescence to the cell periphery and localised intracellular regions consistent with a 
translocation event, (highlighted by arrow). Cells previously exposed to fumagillin and 
subsequently stimulated with PMA show minimal localisation to the cell membrane 
with the majority of p47phox remaining widely distributed in the cytosol. 
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previous immunoblot and densitometric analysis, (Section 4.2.2), thus confirming that 
fumagillin inhibits NADPH oxidase formation by reducing the translocation of p47phox 
from the cytosol to the membrane.  
 
4.2.4 Summary. 
In this series of experiments, the effect of fumagillin as a potential inhibitor of 
neutrophil function mediated by restriction of the assembly of a functional NADPH 
oxidase resulting in reduced oxygen consumption was examined. The results confirm 
that fumagillin is inhibitory to neutrophil function and caused a significant reduction in 
membrane associated p47phox. The downstream effect of this was monitored by 
assessing the amount of oxygen consumed over a fixed period of time. The results 
indicate that the restriction of oxygen consumption mediated by fumagillin is possibly 
as a consequence of reduced p47phox translocation to the membrane therefore reducing 
the antimicrobial capacity of the cell. 
 
4.3 Analysis of the effect of fumagillin on the process of neutrophil degranulation. 
The production of superoxide by PMA-stimulated neutrophils is associated with 
degranulation and the release of proteolytic enzymes into the phagocytic vacuole and 
around the cell periphery, thus acting as an essential element of neutrophil antimicrobial 
response (Spitznagel, 1990; Standish and Weiser, 2009). A comprehensive study of 
potential mycotoxin mediated inhibition of neutrophil degranulation and activity was 
warranted to further understand the effect of fumagillin on cellular function. 
 
4.3.1 Analysis of neutrophil myeloperoxidase degranulation. 
Neutrophils, (5 x 107), were isolated and a degranulation assay was performed as 
described, (Section 2.17.1). The degranulated protein extract was concentrated by 
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acetone precipitation. A 15 µg protein sample from each treatment was subjected to 1–
D SDS–PAGE and immunoblotting, (Figure 4.7 A and B). Western blots were initially 
probed with anti-human myeloperoxidase, (Genway), overnight at a dilution of 1/650. 
Following washing of the nitrocellulose membrane blots were probed with secondary 
anti-rabbit HRP conjugated antibody at a dilution of 1/650. The blots were subsequently 
developed with ECL reagent, (Section 2.9.7). Analysis of the blots identified reactivity 
against the 59.5 kDa fragment, which was expected as MPO is a heme protein 
(Reumaux et al., 2003) and electrophoresis was performed under reducing conditions 
thus clarifying the larger fragment. Visualisation of MPO reactivity showed a variation 
in MPO reactivity between different treatments and these blots were analysed by 
densitometry in order to quantify the relative levels of MPO degranulation. 
 Figure 4.7 C shows that the MPO content in neutrophil degranulation extracts 
was increased 1.55 and 1.56 fold in the PBS and solvent controls respectively relative to 
unstimulated cells, (p = 0.001). Neutrophils which had been previously exposed to 2µg 
fumagillin ml-1 did demonstrate 1.33 fold increase in MPO degranulation with PMA 
stimulation compared to untreated cells, (p = 0.001) however this was reduced relative 
to neutrophils stimulated with PBS or with 0.002% (v/v) methanol expressing a 1.47 
and 1.48 fold increase in graduation respectively (p  0.035).  
 In order to strengthen this finding the process of degranulation was visualised by 
employing confocal immunoflouresence microscopy, (Section 2.19). Examination of the 
localisation of MPO from neutrophils (Figure 4.8) demonstrated that unstimulated cells 
show a high level of intracellular fluorescence corresponding to concentration of MPO. 
In contrast cells stimulated with PMA in the absence of prior exposure to 2 µg 
fumagillin ml-1 demonstrated MPO degranulation as evidenced by a loss of intracellular 
fluorescence and small clusters of fluorescence external to the cell. This finding is 
interesting as MPO is normally stored within intracellular granules, where it accounts 
            
                          
                 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 Analysis of the effect of fumagillin on neutrophil degranulation. 
Neutrophils (5 x 107) were incubated in the presence of fumagillin, (2 µg ml-1) for 25 
minutes and were stimulated with PMA, (1 µg ml-1) in a thermally controlled stirred 
chamber at 37ºC, (Section 2.17.1). SDS-PAGE (A) and immunoblotting (B) against 
human myeloperoxidase identified a 59.5 kDa subunit of MPO which showed 
variability in degranulation profile depending on the cell exposure conditions. 
Densitometric analysis (C) demonstrates that the level of MPO degranulation decreased 
significantly in cells exposed to fumagillin and stimulated with PMA compared to both 
positive controls, (*p  0.035). 
 
R
el
at
iv
e 
de
n
sit
o
m
et
ric
 
u
n
its
 
0
50000
100000
150000
200000
250000
300000
350000
400000
450000
    U.T                   PMA           Fum & PMA     Solv & PMA 
 
 Area of 
MPO reactivity 
59.5kDa 
 
 
 
(A) 
 
kDA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(B) 
 
 
(C) 
 
 
 
 
 
 
Cell treatment 
   * 
 
MPO 
59.5kDa 
subunit 
  M                U.T               PMA         
 
Solv & 
PMA 
 
Fum & 
PMA 
     U.T                PMA           Solv & PMA  Fum & PMA 
175	 
80	 
 
 
46	 
 
 
 
30	 
 
25	 
 
 
 
17	 
56	
  
 
Figure 4.8 Immunoflouresence imaging of inhibition to degranulation of MPO in 
cells exposed to fumagillin. 
Neutrophils were exposed to fumagillin, (2 µg ml-1) and were stimulated with PMA (1 
µg ml-1) prior to preparation for immunoflouresence microscopy. Visualisation of the 
localisation of MPO revealed a high level of intracellular MPO in unstimulated cells 
with the majority exocytosed extracellulary in distinct granules upon PMA stimulation. 
Neutrophils exposed to fumagillin and stimulated with PMA demonstrated a partial 
degranulation of MPO evidenced by some intracellular fluorescence and partial 
exocytosis of MPO (arrow ). 
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for approximately 25% of granule protein and 5% of the total neutrophil proteome, 
(Segal, 2005). These granules fuse to a phagocytic vacuole or are exocytosed at the site 
of infection which is demonstrated in this case upon PMA stimulation. The 
degranulation of MPO in cells previously exposed to 2µg fumagillin ml-1 appears to 
occur in a more restricted manner. There is evidence of partial exocytosis of MPO and 
the formation of clusters of fluorescence close to the cell periphery however it would 
appear that this process is frustrated to an extent. Furthermore there is relatively little 
extracellular granule fluorescence as indicated in Figure 4.8.  
 In order to gain a comprehensive understanding of the inhibition of neutrophil 
degranulation mediated by fumagillin it was necessary to quantify the activity of MPO 
in degranulated cell supernatants following PMA stimulation. The peroxidation activity 
of MPO was ascertained using a commercially available activity assay kit as described, 
(Section 2.17.2). Following assay calibration by constructing a standard line using the 
supplied MPO standards, (Figure 4.9), MPO peroxidation activity was calculated 
(Figure 4.10). Analysis of the peroxidation activity revealed that unstimulated cells did 
not show any activity, however extracts from PMA stimulated neutrophils or 
neutrophils stimulated with PMA subsequent to prior incubation with 0.002% (v/v) 
methanol did demonstrate peroxidation activity (25.15 ± 1.31 ng MPO ml-1 and 25.44 ± 
2.08 ng MPO ml-1 respectively). This contrasted with experimental data using 
neutrophils previously incubated with 2 µg fumagillin ml-1. In this case the activity was 
reduced to 15.38 ± 0.83 ng MPO ml-1. Importantly, this figure was statistically different 
to both positive controls, (p  0.019). In addition comparisons between both positive 
controls demonstrated that there was no statistically significant difference between cells 
stimulated with PMA or treated as a solvent control and PMA stimulated, (p = 0.924) 
therefore highlighting fumagillin as an inhibitor. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
                       
 
 
                                                                 MPO (ng/ml) 
 
Figure 4.9 MPO peroxidation activity calibration. 
MPO standards were prepared according to manufacturer’ s guidelines and a standard 
curve was prepared. R2 = 0.9813, Equation of line: y = 0.2145x – 0.5877. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.10 Effect of fumagillin on MPO mediated peroxidation activity. 
Neutrophils, (5 x 107) were incubated in the presence of fumagillin, (2 µg ml-1) and 
stimulated with PMA (1 µg ml-1) for 6 minutes. The quantity of protein in the cell free 
supernatant was standardised for all samples and the peroxidation activity was 
ascertained according to manufacturers guidelines as described, (Section 2.17.2). Cells 
exposed to fumagillin demonstrated reduced peroxidation activity relative to both 
positive controls, (*p  0.019). 
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4.3.2 Summary 
It is clear that a concentration of fumagillin which is inhibitory to neutrophil 
function, (2 µg ml-1), the process of degranulation appears to be reduced significantly as 
evidenced by reduced detection of MPO from the supernatant of PMA stimulated 
neutrophils previously exposed to 2 µg fumagillin ml-1. The immunoblot and 
densitometric analysis is strengthened by the confocal immunoflouresence microscopy 
images presented in Figure 4.8. Cells stimulated with PMA show a far higher level of 
MPO degranulation as demonstrated by a loss of intracellular fluorescence and 
appearance of external granules. The increase in the detection of peroxidation activity 
further supports this work as neutrophils exposed to fumagillin show almost 40% less 
activity than that of both positive controls. Neutrophils previously incubated with 2 µg 
fumagillin ml-1 showed evidence of significantly more degranulation than unstimulated 
cells therefore fumagillin does not entirely block neutrophil function but suppresses it 
significantly compared to uninhibited cells.   
 
4.4 Analysis of the effect of fumagillin on the assembly of F-actin. 
Actin in unstimulated neutrophils exists in a globular, (G) form however upon 
stimulation it is converted to filamentous (F) actin in order to mediate cellular processes 
such as phagocytosis, protein translocation and degranulation, (Zhan et al., 2004; 
Comera et al., 2007). The work of Zhan et al., (2004) has particular relevance to this 
study as it demonstrates the p47phox PX domain associates directly with moesin and it is 
this association which allows the translocation of p47phox from the cytosol to the 
membrane thus initiating the assembly with flavocytochrome b558. In this section the 
effect of fumagillin on the process of F-actin assembly which plays a key role in this 
process is examined using immunoblot analysis and confocal immunoflouresence 
microscopy imaging. 
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4.4.1 Immunoblot detection of F-actin assembly in stimulated neutrophils. 
Immunoblot detection of F-actin assembly was performed as described, (Section 
2.18.7). Following the identification of the reactive band (Figure 4.11) it was clear that 
the level of reactivity increased following 1 µg PMA ml-1 stimulation. This finding is 
important as it validated the hypothesis that F-actin band reactivity would increase with 
cellular activation mediated by PMA. Neutrophils stimulated with PMA and cells 
exposed to 0.002% (v/v) methanol prior to PMA stimulation demonstrated a 1.4 and 
1.48 fold increase in the formation of F-actin relative to unstimulated cells, (p  0.05). 
Consistent with previous experimentation densitometric values for both positive 
controls did not record any statistical difference, (p = 0.221). Additionally, neutrophils 
exposed to 2 µg fumagillin ml-1 did show a statistically significant increase in F-actin 
assembly over unstimulated cells further strengthening the hypothesis that the effective 
concentration of fumagillin employed in this study significantly inhibited but did not 
completely diminish cellular processes. Neutrophils exposed to 2 µg fumagillin ml-1 
demonstrated approximately 15% less F-actin formation that that observed for the 
positive controls, (p  0.05).  
  
4.4.2 Rhodamine coupled phalloidin staining of F-actin assembly. 
In order to strengthen the hypothesis that neutrophil function was being inhibited 
by fumagillin it was necessary to assess the formation of F-actin using confocal 
immunoflouresence microscopy with rhodamine coupled phalloidin as described, 
(Section 2.19.2). Comera et al., (2007) and Misu et al., (2009), demonstrated the use of 
rhodamine coupled phalloidin in studies of F-actin assembly as it has affinity for F-actin 
filaments. Figure 4.12 demonstrates variable localised fluorescence intensity across 
different treatments. Neutrophils stimulated with PMA clearly demonstrate increased 
fluorescence compared to unstimulated cells consistent with the formation of F-actin. 
              
 
 
    
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.11 Effect of fumagillin on the formation of neutrophil F-actin.  
Neutrophils (5 x 107) were incubated in the presence of fumagillin, (2 µg ml-1), and 
were subsequently stimulated with PMA (1 µg ml-1) prior to whole cell protein 
extraction as described, (Section 2.18.7). SDS-PAGE (A) and immunoblotting (B) 
coupled to densitometric analysis (C) demonstrates reduction of F-actin assembly in 
neutrophils exposed to fumagillin when subsequently stimulated with PMA compared 
to both positive control treatments, (p  0.05). 
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Figure 4.12 Fluorescent visualisation of rhodamine coupled phalloidin stained F-
actin assembly in neutrophils following PMA stimulation. 
Cells were incubated in the presence or absence of fumagillin, (2 µg ml-1) and were 
subsequently stimulated with PMA (1 µg ml-1) or left untreated. Neutrophils were then 
prepared for rhodamine coupled phalloidin staining as described, (Section 2.19.2). 
Unstimulated neutrophils showed a low level of fluorescence consistent with basal 
levels of F-actin. This contrasted with the level of fluorescence present in PMA 
stimulated cells, (indicated by arrow) with localised F-actin staining occurring 
throughout. Neutrophils exposed to fumagillin and subsequently stimulated with PMA 
demonstrate some reactivity but this is clearly reduced relative to the positive control 
 
 
 
 
      Untreated                     PMA stimulated       Fum & PMA stimulated 
      Untreated                     PMA stimulated     Fum & PMA stimulated 
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Neutrophils previously exposed to 2 µg fumagillin ml-1 and subsequently stimulated 
with PMA demonstrated only moderate rhodamine coupled phalloidin F-actin staining 
compared to the positive control. This finding further validates the immunoblot analysis 
presented in this section where disruption to F-actin assembly is caused by exposure of 
neutrophils to fumagillin. 
 
4.4.3 Summary. 
The data presented in this section demonstrated that the minimum inhibitory 
concentration of fumagillin (2 µg ml-1) causes disruption to the formation of F-actin in 
neutrophils subsequently stimulated with 1 µg PMA ml-1. This is evidenced by 
immunoblot detection of neutrophil F-actin assembly. In addition rhodamine coupled 
phalloidin staining of neutrophils demonstrated reduced F-actin assembly where 
neutrophils were previously exposed to fumagillin.  
 
4.5 Analysis of the effect of fumagillin on G. mellonella viability and haemocyte 
function. 
 In recent years G. mellonella larvae have been validated as useful models for in 
vivo studies of immunological pathways common to both vertebrates and invertebrates, 
(Kavanagh and Reeves, 2004; Fuchs and Myolonakis, 2006). Central to their utility as 
model organisms, there exists a high level of similiarity between insect haemocytes and 
human neutrophils. Bergin et al., (2005) highlighted that G. mellonella haemocytes are 
able to consume oxygen and produce superoxide mediated by a NADPH oxidase 
complex that contains proteins homologous to p40phox, p47phox, p67phox and gp91phox of 
human neutrophils. In addition, Renwick et al., (2007) demonstrated that haemocyte 
p40, p47 and p67 proteins translocate from the cytosol to the membrane in a comparable 
manner to neutrophils. Furthermore, it was found that gliotoxin disrupted this 
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translocation process in haemocytes with the effect of lowering superoxide production 
thus limiting pathogen targeted killing. Therefore the effect of fumagillin on the cellular 
immune response of G. mellonella was investigated, as characterising any potential 
modulatory effect on immune function would serve to further validate G. mellonella as 
an alternative model to assess mycotoxin/immune system interactions. In addition, the 
same analysis may lead to identification of previously unknown effects of fumagillin 
not seen in human neutrophils. 
 
4.5.1 Analysis of the modulation of larval viability by fumagillin. 
 Considering the data presented elsewhere in this Chapter an initial study to 
assess if fumagillin was capable of immunosuppressing larvae to A. fumigatus infection 
was employed. As the lowest inhibitory concentration of fumagillin identified as 
capable of restricting cellular function in human neutrophils was 2 µg ml-1 it was 
decided that an initial study assessing any immuno-modulatory effect would use this 
mycotoxin concentration. Larvae were injected (Section 2.1.5) with 2, 1, and 0.1 µg 
fumagillin 20 µl-1. As a control larvae were injected with a concentration of methanol 
corresponding to the highest concentration of solvent in the fumagillin treatment. 
Larvae were incubated for four hours at 30ºC and were subsequently injected with 1 x 
107 A. fumigatus ATCC 26933 conidia. As an additional control, larvae which were 
initially left untreated but incubated for 4 hours at 30ºC were injected with 1 x 107 A. 
fumigatus. Larvae were incubated at 30ºC and larval viability was recorded at 24, 48 
and 72 hours (Figure 4.13). 
 Examination of larvae at 24 hours showed no adverse effect on viability. 
However inspection of larvae 48 hours post A. fumigatus infection identified the first 
significant change in viability. Larvae previously injected with 2µg 20 µl-1 fumagillin 
demonstrated 60 ± 10% viability. This contrasted with viability data observed for larvae 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.13 Analysis of the effect of fumagillin on G. mellonella susceptibility to A. 
fumigatus infection. 
Larvae were injected with different concentrations of fumagillin, (0.1, 1 or 2 µg 20 µl-1) 
or a methanol control and were incubated at 30ºC for 4 hours when they were 
administered a follow up inoculum of 1 x 107 A. fumigatus ATCC 26933 conidia. 
Larval viability was monitored at 24, 48 and 72 hours post conidial infection. Larvae 
previously injected with 2 µg fumagillin demonstrated reduced viability at 48 and 72 
hours compared to larvae injected with conidia alone (p = 0.045* and 0.015**, 
respectively).  
 
 
 
 
 
 
 
Time (hours) 
La
rv
al
 
v
ia
bi
lit
y 
(%
) 
      *                         
 
 
 
 
 
                                ** 
0
10
20
30
40
50
60
70
80
90
100
0 24 48 72
ATCC 26933
2µg Fum + conidia
1µg Fum + conidia
0.1µg Fum + conidia
Solv Ctrl + conidia
 111  
injected with A. fumigatus alone, (83.3 ± 6.6%, p = 0.045). It was noted that viability of 
larvae injected with fumagillin (1 and 0.1 µg fumagillin 20 µl-1) and the solvent control 
and subsequently followed up with 1 x 107 conidia displayed viabilities of 83.3 ± 3.3%, 
80 ± 5.7% and 76.6 ± 3.3%. Statistical analysis revealed that none of these values were 
significantly different to the A. fumigatus infected control, (p  0.519), thus the 
inoculation of 2 µg fumagillin per larva demonstrated the first statistically significant 
alteration to viability when subsequently challenged with conidia at 48 hours. 
 Larvae injected with 2 µg fumagillin and inoculated with 1 x 107 conidia 
demonstrated significantly reduced viability at 72 hours (20 ± 5.7%). This contrasted 
sharply with data recorded for larvae injected with only A. fumigatus, where 53.3 ± 12% 
of larvae remained viable, (p = 0.007). In comparison larvae administered an equivalent 
concentration of solvent and subsequently infected with 1 x 107 conidia demonstrated 
51.1 ± 8.9% viability. Larvae inoculated with A. fumigatus alone did not demonstrate 
significantly altered viability compared to the solvent control, (p = 0.796), however 
comparisons between the solvent control and larvae immunologically challenged with 2 
µg fumagillin demonstrated a p – value of 0.015.  These findings exclude the possibility 
that the alteration in viability was mediated by the solvent used to solubilise fumagillin. 
Larvae injected with 1 or 0.1 µg fumagillin larvae-1 prior to fungal challenge 
demonstrated 53.3 ± 6.6 and 46.6 ± 8.8% at 72 hours respectively. These treatments 
were not statistically different, (p  0.606) compared to both positive controls. However 
in comparisons with the 2µg fumagillin larvae-1 pre-treatment a p – value of 0.007 and 
0.028 was recorded for 1 and 0.1 µg fumagillin larvae-1 respectively. This finding 
confirmed that larvae exposed to 2µg fumagillin are more susceptible to subsequent 
fungal infection.  
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4.5.2 Analysis of in vivo haemocyte densities of larvae injected with fumagillin. 
G. mellonella larvae were injected with PBS, 2µg fumagillin or 10% (v/v) 
methanol in a 20µl volume and incubated at 37ºC for 4 or 24 hours. Larvae were bled 
and haemocyte density µl-1 of haemolymph was ascertained, (Section 2.15.3). Larvae 
injected with PBS, 10% methanol or 2µg fumagillin demonstrated 2.44 ± 0.244 x 103, 
2.86 ± 0.48 x 103, and 2.41 ± 0.19 x 103 haemocytes µl-1 24 hours post-inoculation 
respectively (Figure 4.14). Statistical analysis of this data revealed that there were no 
significant differences between any of these treatments, (p  0.132). This finding was 
interesting as it eliminated the possibility that the immunosuppressive effect mediated 
by pre-exposing larvae to 2 µg fumagillin was mediated by cytotoxicity to the larval 
haemocyte population. 
 
4.5.3 Analysis of the effect of fumagillin on haemocyte mediated pathogen killing. 
Considering the observation that 2 µg fumagillin ml-1 mediated an 
immunosuppressive effect with in vitro neutrophil experimentation coupled to the 
immunosuppressive effect mediated by the same concentration of fumagillin using G. 
mellonella, it was hypothesised that the cellular function of larval haemocytes could be 
diminished. To test this hypothesis a killing assay using C. albicans MEN as a target 
was performed, (Section 2.16.2). Haemocytes previously exposed to 2 µg fumagillin ml-
1
 for 25 minutes killed 66.44 ± 4.36% of C. albicans MEN cells after 60 minutes 
(Figure 4.15). This figure contrasted with 85.11 ± 2.81 % and 88.41 ± 1.06% C. 
albicans MEN viability where yeast cells were incubated with the PBS and 0.002% 
(v/v) methanol treated haemocytes respectively, (p  0.048). Crucially, there was no 
statistical significance recorded between the two positive controls therefore the 
inhibitory effect was mediated by fumagillin.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.14 Effect of fumagillin on in vivo haemocyte density of G. mellonella 
larvae. 
Larvae were injected with fumagillin (2 µg), PBS, or 10% methanol as an equivalent 
solvent control for the injection of fumagillin. Haemocyte density µl-1 haemolymph was 
ascertained as described, (Section 2.15.3). Haemocyte density was found to be reduced 
slightly in all treatments however there was no statistically significant difference 
between the different treatments. 
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Figure 4.15 Effect of fumagillin on the ability of haemocytes to kill C. albicans. 
Haemocytes (5 x 106) were incubated in the presence or absence of fumagillin, (2 µg 
ml-1) and were prepared for a killing assay using C. albicans MEN as described, 
(Section 2.16.2). Cells exposed to fumagillin exhibited a significantly reduced ability to 
kill C. albicans relative to both positive controls, (*p  0.048). 
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4.5.4 Analysis of the effect of fumagillin on haemocyte phagocytosis. 
 In section 4.1.2 it was demonstrated that neutrophils previously exposed to 2 µg 
fumagillin ml-1 were significantly less capable of phagocytosing conidia thus inhibiting 
the initial neutrophil killing process. Considering the reduction in haemocyte mediated 
pathogen killing, (Section 4.5.3), an analysis of the effect of fumagillin on haemocyte 
phagocytosis was performed. 
 Analysis of phagocytosis data, (Figure 4.16) revealed that the rate of 
phagocytosis occurred in a manner that was comparable to the same process in human 
neutrophils (Figure 4.3). The rate of phagocytosis increased sharply in the first 60 
minutes however the number of haemocytes identified to have engulfed conidia 
appeared to remain relatively stable up to 120 minutes. Statistical analysis of the rate of 
phagocytosis revealed that there was no significant increase in the second 60 minutes of 
the assay, (p  0.376), for all three treatments. After 30 minutes the rate of phagocytosis 
between the different haemocyte treatments revealed only very slight alterations in the 
number of engulfed conidia. However, after 60 minutes 50.93 ± 2.78%, 54.95 ± 2.12% 
and 41.45 ± 1.48% phagocytosis was observed in haemocytes in receipt of the PBS, 
0.002% (v/v) methanol or 2 µg fumagillin ml-1 treatments. Comparative analysis of 
these rates demonstrated that haemocytes exposed to fumagillin demonstrated 
significantly reduced phagocytosis, (p  0.05), compared to the controls. However the 
relatively small difference between these treatments would suggest that the inhibitory 
process observed in this case is not the main feature of how fumagillin functions. 
Therefore a more detailed analysis of the biochemical pathways affected by exposing 
haemocytes to 2 µg fumagillin ml-1 was required.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.16 Effect of fumagillin on haemocyte phagocytosis. 
Haemocytes, (5 x 106) were isolated and a phagocytosis assay using A. fumigatus 
conidia as a target was performed. Haemocytes incubated with fumagillin, (2 µg ml-1) 
demonstrated a reduced capacity to engulf conidia, (*p  0.05) 
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4.5.5 Summary. 
 The possibility that G. mellonella larvae could be immunocompromised by 
fumagillin and the killing function of haemocytes could be reduced in a similar manner 
to neutrophils was investigated. The results demonstrate that inoculating larvae with 
2µg fumagillin larva-1 reduced immunocompetence in vivo thus increasing their 
susceptibility to fungal colonisation. This was not mediated by a significant reduction in 
circulating haemocyte density in vivo but as a result of a reduction in haemocyte 
function as indicated by decreased ability to kill pathogens and reduced levels of 
phagocytosis. 
 
4.6 Analysis of the effect of fumagillin on NADPH oxidase complex-like formation 
and resulting oxygen consumption. 
Bergin et al., (2005) and Renwick et al., (2007) identified the presence of p47, 
p67 and p40 homologues in G. mellonella haemocytes. Furthermore the production of 
superoxide coincided with the translocation of these proteins from the cytosol to the 
membrane. Inhibition of this process mediated by neutrophil inhibitors, (DPI, gliotoxin) 
points to a conservation of functional pathways between both cell types. As a result of 
these findings and the inhibition of NADPH oxidase formation resulting in a loss of 
oxygen consumption observed by exposing human neutrophils to 2 µg fumagillin ml-1 
(Section 4.2) an analysis of the same cellular pathway in haemocytes was performed. 
 
4.6.1 Analysis of the effect of fumagillin on the ability of G. mellonella haemocytes 
to consume oxygen. 
 The rate of oxygen consumption of haemocytes following PMA stimulation was 
investigated as described, (Section 2.18.6). Analysis of the rate of oxygen consumption, 
(Figure 4.17), 5 minutes post PMA stimulation revealed that there was a slight but not 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.17 Effect of fumagillin on haemocyte mediated oxygen consumption. 
Haemocytes (5 x 107) were extracted and incubated in the presence or absence of 
fumagillin (2 µg ml-1) and were PMA stimulated (1 µg ml-1) in a Clark type oxygen 
electrode as outlined, (Section 2.18.6). Haemocytes that were exposed to fumagillin 
demonstrated reduced oxygen consumption over a ten minute time period relative to 
controls (*p  0.041). 
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statistically significant change in the rate of oxygen consumption, (p  0.098), however 
there is a clear separation in the rate of oxygen consumption at this point. Haemocytes 
previously exposed to 2 µg fumagillin ml-1 consumed 39.9 ± 3.99 nmol oxygen ml-1 ten 
minutes post PMA stimulation. This figure contrasted with the rate observed for the 
PBS and 0.002% (v/v) methanol treatments where haemocytes consumed 75.59 ± 3.49 
and 78.38 ± 6.05 nmol oxygen ml-1 respectively, (p  0.041). The positive controls for 
this experiment both yielded rates of oxygen consumption that were not regarded as 
significantly different, (p = 0.797).  
 
4.6.2 Analysis of the effect of fumagillin on haemocyte p47 translocation. 
Haemocytes were incubated in the presence or absence of 2 µg fumagillin ml-1, 
stimulated with 1µg PMA ml-1 for 6 minutes and were fractionated as described 
(Section 2.18.5). Following acetone precipitation, solubilisation of concentrated protein 
and SDS - PAGE of cytosolic and membrane fractions, the resulting gels were subjected 
to immunoblotting, (Figure 4.18). Rabbit polyclonal antisera raised in rabbits 
immunised with recombinant p47phox was used at a dilution of 1/2000 in the primary 
antibody solution overnight. Following membrane washing the blots were exposed to 
secondary anti-rabbit HRP conjugated antisera used at a dilution of 1/2000 and were 
subsequently developed using DAB, (Section 2.9.7). 
 Analysis of membrane development identified a protein of 47 kDa which 
showed variability in membrane and cytosolic fractions consistent with the presence or 
absence of PMA stimulation, (Figure 4.18 B). Following densitometric analysis, (Figure 
4.18 C) the relative p47 content in the cytosolic and membrane fractions for all the 
treatments was ascertained by densitometry and was expressed as a percentage of the 
total p47 content between the treatments. Analysis of untreated haemocyte fractions 
revealed that 84.11 ± 6.62% of p47 protein remained in the cytosol with only a very 
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Figure 4.18 Effect of fumagillin on haemocyte p47 translocation. 
Haemocytes (1 x 108) were extracted and incubated in the presence or absence of 
fumagillin, (2 µg ml-1). Following stimulation and fractionation, (Section 2.18.5) the 
cytosolic and membrane components were electrophoresed (A) and probed for the 
presence of p47 (B). Densitometric analysis (C) revealed that the percentage of p47 
bound to the membrane was decreased relative to both positive controls (p  0.034). 
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small amount of protein residing in the membrane fraction. This value contrasted 
sharply with data obtained from haemocytes stimulated with 1 µg PMA ml-1 whereby 
62.51 ± 1.09% p47 had translocated to the membrane (p = 0.014). This trend in the 
localisation of p47 is mirrored in haemocytes previously exposed to 0.002% (v/v) 
methanol as a control where 63.34 ± 2.52% of p47 was in the membrane, (p = 0.717). In 
contrast haemocytes exposed to 2µg ml-1 fumagillin and subsequently stimulated with 1 
µg ml-1 PMA demonstrated 49.74 ± 2.52% of p47 in the membrane. This reduction of 
membrane p47 was significantly less than that of the positive controls, (p  0.034), but 
was significantly greater than the value observed for unstimulated haemocytes, (p = 
0.016).  
 
4.6.3 Summary. 
 The effect of fumagillin (2 µg ml-1) on the process of haemocyte mediated 
oxygen consumption was investigated. In addition an analysis of the translocation of a 
protein homologous to neutrophil p47phox was performed. The process of oxygen 
consumption in haemocytes was inhibited by exposing haemocytes to fumagillin. 
Immunoblot and densitometric analysis of haemocyte p47 translocation demonstrated 
that this process was significantly reduced by fumagillin compared to PBS or 0.002% 
(v/v) methanol treated haemocytes. 
 
4.7 Analysis of the effect of fumagillin on haemocyte degranulation and F-actin 
assembly. 
Considering homology between neutrophil and haemocyte responses to 
fumagillin presented elsewhere in this Chapter it was deemed necessary to expand the 
study to analyse any possible effects on haemocyte degranulation. It was hypothesised 
that degranulated haemocyte extract would identify a protein with immunoreactivity to 
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human myeloperoxidase antisera, and could be identified using LC/MS analysis. 
Furthermore, a study of other degranulated proteins identified as being differentially 
released was deemed necessary to acquire a more comprehensive understanding of 
PMA stimulated degranulation and inhibition of this process in haemocytes. 
 
4.7.1 Analysis of the effect of fumagillin on a protein with anti-MPO reactivity and 
identification using LC/MS analysis. 
Haemocytes, (5 x 107), were isolated and a degranulation assay was performed 
as described, (Section 2.17.1). The degranulated protein extract was concentrated by 
acetone precipitation and a 15 µg protein sample from each treatment was subjected to 
1–D SDS–PAGE and immunoblotting, (Figure 4.19 A and B). Western Blots were 
initially probed with anti-human myeloperoxidase, overnight at a dilution of 1/650. 
Following washing of the nitrocellulose membrane blots were probed with secondary 
anti-rabbit HRP conjugated antibody at a dilution of 1/650. The blots were subsequently 
developed with ECL reagent, (Section 2.9.7) and differences between resulting 
reactivity were quantified by densitometry. As the identity of the reactive proteins were 
unknown the corresponding proteins were excised and subjected to tryptic digestion 
followed my LC/MS analysis, (Section 2.13.3). The upper protein band of interest (59 
kDa) was identified as prophenoloxidase subunit 2 (Table 4.1). As band 
immunoreactivity revealed the detection of two bands the entire reactive region from a 
corresponsding SDS-PAGE gel was analysed and was identified as prophenoloxidase 
(Band 1* from Table 4.1). 
Densitometric analysis of prophenoloxidase subunit 2 immunoreactivity (Figure 
4.1 C) revealed clear differences in the relative level of degranulation. Haemocytes 
stimulated with 1 µg PMA ml-1 demonstrated a 1.75 fold increase in reactivity relative 
to unstimulated cells, (p = 0.005). This increase was also evident in the solvent control 
  
                 
 
 
                               
                                
                                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.19 Analysis of the effect of fumagillin against a protein with MPO-like 
immunoreactivity. 
Haemocytes (5 x 107) were isolated and were incubated in the presence or absence of 
fumagillin (2 µg ml-1). The cells were washed and a degranulation procedure was 
performed as outlined, (Section 2.17.1). SDS-PAGE (A) followed by immunoblotting 
with human MPO antisera identified reactivity at 59.5 kDa (B). The band of interest 
was excised from a stained gel and was identified by LC/MS, (Table 4.1) as 
prophenoloxidase subunit 2. Densitometric analysis (C) revealed that the degranulation 
of this protein was significantly reduced compared to other PMA stimulated treatments, 
(*p  0.049). Bands 2 and 3 were also analysed by densitometry and identified by 
LC/MS and presented in Figure 4.21. 
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Figure 4.20 CLUSTAL sequence alignment of Human MPO and G. mellonella 
PPO. 
The sequences of human MPO and G. mellonella PPO were aligned using CLUSTAL 
W to identify regions of conservation. The points of similiarity are highlighted (*)-
identical, (:) conserved amino acid substitution and (.) semi-conserved substitution thus 
identifying potential regions to explain cross-reactivity between PPO and human MPO.  
 
Residues 
Red: Small hydrophobic amino acids 
Blue: Acidic amino acids 
Magenta: Basic amino acids 
Green: Hydroxyl amine basic amino acids 
 
gi 4557759 : Myeloperoxidase (Homo sapiens) 
gi 14517795: Prophenoloxidase (Galleria mellonella)  
  
 
 
 
Table 4.1 Proteins identified by LC/MS analysis demonstrating alternative 
abundances from degranulated haemocytes.  
Numbered bands of interest which showed notable changes from SDS-PAGE and 
immunoblot analysis in Figure 4.19 were excised and subjected to trypsin digestion. 
The identified bands are listed along with identification of two low molecular weight 
proteins, (cellular retinoic acid binding and actin depolymerisation factor 
homologue/cofilin) which show differential levels of degranulation from haemocytes 
upon PMA stimulation.    
 
 
 
Band No. Band I.D gi Score Peptides 
matched Coverage 
1 Prophenoloxidase 
subunit 2 34556399 501 10 24% 
  1* Prophenoloxidase 14517795 309 5 13% 
2 Cellular retinoic acid binding protein 112983600 212 8 25% 
3 
Cofilin/ Actin 
depolymerisation 
factor 
110751158 182 10 20% 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                              
                                                                  Cell pre-treatment 
 
Figure 4.21 Densitometric analysis of degranulation of cellular retinoic acid 
binding protein from G. mellonella haemocytes (Band 2 from Figure 4.19 A). 
Identification of CRABP, (Figure 4.19 A Table 4.1) coupled to densitometric analysis 
demonstrates CRABP degranulation is significantly reduced in haemocytes previously 
exposed to fumagillin compared to both positive controls, (**p  0.006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                  Cell pre-treatment 
 
Figure 4.22 Densitometric analysis of degranulation of cofilin from G. mellonella 
haemocytes (Band 3 from Figure 4.19 A). 
Densitometric analysis of cofilin degranulation (Figure 4.19 A and Table 4.1) from 
haemocytes exposed to fumagillin (2 µg ml-1) and stimulated with PMA. Haemocytes 
exposed to fumagillin demonstrate reduced exocytosis of cofilin relative to both positive 
controls, (*p  0.028). 
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treatment where a 1.87 fold increase in the level of PPO subunit 2 reactivity compared 
to the negative control, (p = 0.039). There was no significant difference between PBS 
and 0.002% (v/v) methanol controls, (p = 0.920). Haemocytes previously exposed to 
fumagillin (2 µg ml-1) and subsequently stimulated with PMA demonstrated a 1.08 fold 
increase in the PPO subunit 2 reactivity compared to the negative control however this 
was not deemed significant, (p = 0.506). In contrast haemocytes exposed to fumagillin 
and stimulated with PMA and both positive controls showed that the reduction in PPO 
subunit 2 attributed to incubating cells with fumagillin was statistically significant, (p  
0.049). Figure 4.20 demonstrates sequence alignment between the full sequence of PPO 
and MPO using ClustalW software. It was observed that there are localised regions of 
sequence similiarity between both sequences, with evidence of conserved and semi-
conserved substitutions along the sequence alignment.  
 
4.7.2 Identification and densitometric analysis of low molecular weight haemocyte 
proteins with altered degranulation profiles following exposure of haemocytes to 
fumagillin. 
SDS–PAGE analysis of degranulated haemocyte extracts identified low 
molecular weight bands which show alterations in abundance between different 
treatments. These bands were excised and subjected to tryptic digestion prior to LC/MS 
analysis as described, (Section 2.13.3) and are presented in Table 4.1. Following 
identification, densitometric analysis was performed on these bands and is presented in 
Figure 4.21 and 4.22.  
A protein of 14.9 kDa was identified as homologous to haemocyte cellular 
retinoic acid binding protein, (CRABP) from Bombyx mori. Densitometric analysis of 
CRABP identified variable levels of degranulation following PMA stimulation (Figure 
4.21). Larvae stimulated with 1 µg PMA ml-1 showed a 2.38 fold increase in CRABP 
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degranulation. This figure compared favourably with a 2.15 fold increase observed in 
the solvent control following PMA stimulation, (p = 0.2). Analysis of degranulated 
CRABP from stimulated cells previously exposed to 2 µg fumagillin ml-1 identified a 
1.19 fold increase in CRABP degranulation however this value was not deemed to be 
significant compared to unstimulated cells, (p = 0.211). In contrast cells stimulated with 
PMA or methanol treated cells which were subsequently stimulated with PMA showed 
significantly increased CRABP degranulation, (p  0.006).         
The second protein of interest to be identified was a 17.05 kDa protein identified 
as having homology with cofilin/actin-depolymerising factor homologue from Apis 
mellifera. Bioinfomatic analysis of this protein using BLAST identified this protein as a 
member of the ADF superfamily with a high level of similiarity to other actin 
depolymerising factors in B. mori and Drosophila species. Densitometric analysis of 
degranulated actin depolymerising factor/cofilin (Figure 4.22) demonstrated a 1.72 and 
1.59 fold increase in the release of this protein in PMA stimulated cells and solvent 
control cells relative to unstimulated haemocytes, (p  0.021). Cells previously exposed 
to 2 µg fumagillin ml-1 and subsequently exposed to 1 µg PMA ml-1 demonstrated only 
a 1.14 fold increase in the degranulation of cofilin relative to unstimulated cells, (p = 
0.186) however the reduced degranulation of this protein compared to both positive 
control treatments was considered significant, (p  0.028).  
 
4.7.3 Analysis of F-actin immunoreactivity following haemocyte exposure to 
fumagillin. 
Immunoblot detection of haemocyte F-actin assembly was performed as 
described, (Section 2.18.7). SDS-PAGE and immunoblot detection of F-actin antisera 
raised against the human form of the protein revealed reactivity (Figure 4.23). Analysis 
of this blot demonstrated insignificant variation in F-actin immunoreactivity following 
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Figure 4.23 Analysis of F-actin in haemocytes following exposure to fumagillin. 
Haemocytes (5 x 107) were isolated and were incubated in the presence or absence of 
fumagillin (2 µg ml-1). Following PMA stimulation (1 µg ml-1) immunoblot detection of 
F-actin assembly was performed. Immunoblot detection (B) demonstrated no significant 
variation in F-actin assembly. Excision of corresponding stained band from SDS-PAGE 
gel (A) revealed identification of invertebrate actin (C). 
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PMA stimulation or incubation of cells with fumagillin (2 µg ml-1). The corresponding 
protein band from a stained SDS-PAGE gel of the same extract was excised and 
subjected to trypsin digestion and LC/MS analysis. The immunoreactive band was 
identified as actin from Aedes aegypti (Yellowfever mosquito).  
 
4.7.4 Summary. 
 The effect of fumagillin (2 µg ml-1) on haemocyte degranulation and F-actin 
assembly was investigated. Analysis of degranulated extract immunoreactivity with 
antisera raised against human MPO demonstrated reactivity at 59 kDa. LC/MS analysis 
of this band revealed the identification of prophenoloxidase subunit 2. Haemocytes 
previously exposed to fumagillin and subsequently stimulated with PMA demonstrated 
a significant reduction in PPO degranulation relative to haemocytes stimulated with 
PMA alone or stimulated with PMA subsequent to incubation with 0.002% (v/v) 
methanol. Furthermore LC/MS analysis of two low molecular weight bands from the 
degranulated samples identified the presence of CRABP and actin depolymerising 
factor/cofilin which demonstrated reduced degranulation in cells previously incubated 
in the presence of fumagillin. Immunoblot detection of haemocyte F-actin assembly 
demonstrated no alteration in the formation of F-actin. LC/MS analysis of the 
immunoreactive band from a corresponding SDS-PAGE gel demonstrated the 
identification of actin from Aedes aegyptii.  
 
4.8 Discussion. 
 Mycotoxin production by A. fumigatus is a key factor in the development and 
persistence of aspergillosis in vivo. This was highlighted by Bok et al., (2005) with the 
finding that isolates containing deletions of the laeA gene demonstrated reduced 
virulence in murine models characterised by low levels of fungal invasion in murine 
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host tissue. Moreover laeA strains were less capable of initiating cytotoxicity in 
neutrophil cell lines. One of the toxins under the control of laeA, fumagillin, was 
demonstrated to be produced at high amounts using G. mellonella larvae (Chapter 3). It 
was hypothesised that detection of fumagillin 24 hours post infection with A. fumigatus 
ATCC 26933 may indicate a role for fumagillin in the earlier phases of invasive 
infection. Fumagillin has previously been demonstrated as cilio-inhibitory at 
concentrations of 10 µg ml-1 (Amitani et al., 1995). Tsunawaki et al., (2004) examined 
the interaction of fumagillin with neutrophils using concentrations up to 125 µg ml-1. 
No statistically significant changes in superoxide production were observed at 
concentrations of 64 µg fumagillin ml-1. This article used incubation times of seven 
minutes with the mycotoxin prior to conducting any of the assays. Amitani et al., (1995) 
demonstrated ciliostasis mediated by fumagillin when cells were incubated for between 
1-6 hours. In this work the duration of incubation was extended to 25 minutes to 
investigate the effect of fumagillin on neutrophil function. In addition to this an analysis 
of the effect of fumagillin was performed using haemocytes isolated from larvae of G. 
mellonella. Bergin et al., (2005) and Renwick et al., (2007) identified that G. mellonella 
haemocytes demonstrated superoxide production coinciding with the consumption of 
oxygen in response to PMA stimulation which was inhibited by the presence of 
gliotoxin and DPI. In addition an investigation of the cytosolic proteome of G. 
mellonella demonstrated the presence of conserved immunoreactivity and sequence 
homology with neutrophil p47phox and p67phox. Considering these previous findings, an 
analysis of the effect of fumagillin on haemocyte function was warranted.  
 The work presented in this Chapter indicates that incubation of neutrophils with 
fumagillin (2 µg ml-1) inhibits cellular function. This finding was conserved, albeit at 
different levels of inhibition, when C. albicans MEN and P. aeruginosa were used as 
pathogenic targets in the phagocyte killing assay. Furthermore due to the prevalence of 
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A. fumigatus in the sputum of patients with cystic fibrosis (Pihet et al., 2008) the finding 
that fumagillin is capable of inhibiting neutrophil mediated killing is of particular 
importance due to the diverse array of bacterial and fungal pathogens which commonly 
populate the airway mucosa (Festini et al., 2006). P. aeruginosa is the most common 
respiratory pathogen in the cystic fibrosis airway mucosa resulting in debilitating illness 
and significant mortality (Davies, 2002). The finding that fumagillin inhibits neutrophil 
mediated killing of this pathogen is of particular interest given the importance of a 
competent local immune response in cystic fibrosis patients.  
The process of phagocytosis is the initial phase of the neutrophil mediated 
killing and is initiated through the recognition of non-self entities through the binding of 
antibody by Fc receptors or through the recognition of complement on the microbial 
surface (Aderem and Underhill, 1999). The work presented here demonstrates that 
fumagillin is capable of inhibiting phagocytosis evidenced by the reduced 
internalisation of conidia within neutrophils. The mycotoxin mediated inhibition of 
phagocytosis has been previously demonstrated by Comera et al., (2007) with the 
finding that gliotoxin is capable of reducing phagocytosis through the collapse of F-
actin filaments.  The results presented in this Chapter suggest that the successful 
formation of F-actin is an integral element in this process and the inhibition of its 
formation in neutrophils exposed to a functionally inhibiting concentration of fumagillin 
suggest that the decrease in phagocytosis may be mediated by actin disruption.  
The consumption of oxygen coinciding with superoxide production mediated by 
the formation of a functional NADPH oxidase complex is an integral element in 
neutrophil function. The formation of the NADPH oxidase complex in neutrophils is 
dependent on the translocation of p40phox, p47phox and p67phox from the cytosol to the 
membrane bound flavocytochrome b558 (Segal, 2005). Dang et al., (2002), identified 
that the phosphorylation of p47phox enhanced the binding of p40phox to the cytochrome 
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complex. The association of both proteins effectively enhanced the binding of p67phox 
by acting as an adapter. The work of Mizuki et al., (2005) demonstrated that in 
stimulated cells p47phox interacts with p67phox via simultaneous binding of the p67phox C-
terminal SH3 domain to both the proline rich region of amino-acid residues 360-369 
and the C-terminally flanking region of p47phox.This complex then translocates as a unit 
to membrane flavocytochrome b558 where the activate NADPH oxidase complex is 
formed.  Therefore, the translocation of p47phox plays an essential role in the formation 
of a functional NADPH oxidase complex. In this Chapter, exposure of neutrophils to 
fumagillin (2 µg ml-1) caused reduced oxygen consumption. Furthermore immunoblot 
detection of p47phox in the cytosolic and membrane components of fractionated 
neutrophils following PMA stimulation revealed that cells exposed to fumagillin 
demonstrated evidence of reduced translocation to the membrane. This finding is further 
supported by immunoflouresence microscopy. Unstimulated neutrophils demonstrate a 
wide dispersal of p47phox immunoflouresence in the cytosol with PMA stimulated cells 
demonstrating a significant level of localisation with the cell periphery. Neutrophils 
exposed to fumagillin (2 µg ml-1) demonstrated limited association with the cell 
membrane consistent with the immunoblot data with the majority of 
immunoflouresence maintained in the cytosol. This restriction in translocation would 
explain the reduction in oxygen consumption mediated by incubating neutrophils with 
fumagillin. Considering the restriction in F-actin assembly mediated by fumagillin the 
reduced translocation of p47phox is particularly interesting. This finding is significant 
considering the work of Zhan et al., (2002) as it was demonstrated that p47phox PX 
domain lipid binding domain mutants were able to translocate to the membrane 
independent of phosphoinositide binding therefore limiting the argument that 
association of p47phox with the membrane is a result of lipid affinity. Zhan et al., (2004) 
demonstrated that the p47phox PX domain was responsible for protein translocation via 
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moesin mediated associations with F-actin. In this process it was shown that F-actin 
polymerisation on membranes accompanied by p47phox interaction with moesin serves 
to initiate this translocation process. Therefore disruption to F-actin assembly would 
diminish any potential translocation event due to a lack of membrane association. 
Considering the work of Zhan et al., (2004), in parallel with the data presented here, it 
would appear that disruption to F-actin assembly reduces translocation in addition to 
alterations to cell structure and phagocytic capacity as demonstrated by Yürüker and 
Niggli, (1992). 
The process of degranulation plays an important role in the micro-biocidal 
activity of neutrophils, (Segal, 2005). Segal et al., (1980) identified that degranulation 
coincides with NADPH oxidase activity with an estimated lag-phase of approximately 
twenty seconds.  Additionally, MPO has been identified as an important mediator of this 
process by catalysing the formation of hypochlorous acid from hydrogen peroxide, a 
product of NADPH oxidase mediated superoxide formation, (Kettle and Winterbourn, 
2001). A review by Nauseef, (2007) identified that MPO-hydrogen peroxide system 
oxidises Br- and SCN- thus leading to the formation of HOBr and HOSCN respectively 
which in turn have toxic effects in vivo depending on pH. A recent study by Allen and 
Stephens, (2010) identified that MPO is capable of selectively binding to E. coli, P. 
aeruginosa and S. aureus and furthermore mediating selective killing on these 
microbes, therefore the degranulation of MPO in the phagosome and extracellularly 
may be a method by which neutrophils kill pathogenic bacteria. Considering the 
experimental results discussed previously, (Section 4.2), it was therefore necessary to 
employ a comprehensive analysis of the process of degranulation and resulting MPO 
activity from degranulated cell extracts. The data in this Chapter demonstrate that the 
degranulation of MPO is reduced in neutrophils exposed to fumagillin as evidenced by 
immunoblot analysis and immunoflouresence imaging of neutrophils following PMA 
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stimulation. In addition to this the peroxidation activity in cell free supernatants is 
strongly reduced where neutrophils were exposed to fumagillin relative to both positive 
control treatments. Considering the synergy between NADPH oxidase formation and 
myeloperoxidase degranulation and activity, the finding that both of these factors are 
inhibited by fumagillin is an interesting development in the interplay between the innate 
immune system and fungal mycotoxins. Furthermore it may be possible that the 
restriction in neutrophil mediated pathogen killing is a result of the additive effect of 
restrictions to phagocytosis, NADPH oxidase formation and degranulation. The finding 
that PMA induced F-actin assembly in neutrophils is restricted as a result of exposure to 
fumagillin may also point to an underlying cause for the restriction of cell function. 
The effect of fumagillin on increasing the susceptibility of G. mellonella to 
infection was investigated. Larvae injected with 2 µg fumagillin 20µl-1 prior to infection 
with A. fumigatus conidia demonstrated reduced viability relative to larvae injected with 
A. fumigatus alone, or following pre-injection with 1µg fumagillin or the solvent control 
prior to fungal infection. This finding indicates a systemic weakening of the larval 
immune response following injection with fumagillin. From an entomological point of 
view it is significant as fumagillin has been routinely used as an anti-microsporidial 
agent in the treatment of nosemosis in honeybees however it is no longer licensed for 
use in the EU (Porrini et al., 2010).  
Larvae injected with fumagillin demonstrated an insignificant change in 
haemocyte density relative to other treatments therefore eliminating the possibility that 
the alteration in susceptibility was a direct result of reduced haemocyte circulation. 
Considering the finding that fumagillin (2 µg) was capable of increasing the 
susceptibility of G. mellonella larvae to infection and in light of the finding that 
neutrophil function was impaired following exposure to fumagillin (2 µg ml-1) an 
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analysis of the effect of fumagillin at this concentration on haemocyte function was 
performed.  
Incubation of haemocytes with 2 µg fumagillin ml-1 caused a significant 
reduction in haemocyte mediated killing of C. albicans. As A. fumigatus conidia are 
visible once phagocytosed under light microscopy an analysis of the effect of fumagillin 
on haemocyte phagocytosis was performed. Haemocytes incubated with fumagillin (2 
µg ml-1) demonstrated reduced phagocytosis of A. fumigatus conidia. The restriction in 
haemocyte killing and phagocytosis showed a high level of similarity with the data 
obtained from neutrophils. The rate of killing and phagocytosis, while occurring at 
slightly different rates to neutrophils demonstrated a similar level of statistical 
significance at the endpoint of the experiment. The level of phagocytosis appears to 
stabilise between 60 and 120 minutes for both cell types with cells exposed to 
fumagillin demonstrating significantly reduced phagocytosis relative to the control 
treatments. The effect of inhibition of G. mellonella phagocytosis has been documented 
with mycotoxins produced by the entamopathogen Metarhizum anisopliae capable of 
inhibiting phagocytosis through the secretion of destruxins which cause disruption to 
the actin cytoskeleton (Vilcinskas et al., 1997). The finding that fumagillin inhibits 
haemocyte phagocytosis is a novel finding and represents a detrimental effect on the 
first phase of insect phagocyte activity. 
Bergin et al., (2005) identified that G. mellonella haemocytes were capable of 
producing superoxide following PMA stimulation (1 µg ml-1) and identified the 
presence of proteins which demonstrated homology to neutrophil p47phox and p67phox. 
The production of superoxide was inversely related to the consumption of oxygen by 
haemocytes. Renwick et al., (2007) demonstrated that the p47 and p67 homologue 
translocation was inhibited relative to control treatments by incubating haemocytes in 
the presence of gliotoxin prior to PMA stimulation. In this work fumagillin (2 µg ml-1) 
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reduced the consumption of oxygen by G. mellonella. The experimental data resemble 
that observed in neutrophils. Furthermore densitometric analysis of p47 translocation 
following PMA stimulation subsequent to fumagillin exposure revealed that 
approximately 50% of the haemocyte p47 content was translocated to the membrane 
with approximately 60% translocation occurring in the PMA, and 0.002% (v/v) 
methanol plus PMA treatments. This reduction in translocation was significant relative 
to these control treatments but was notably higher than that observed for unstimulated 
haemocytes. These data indicate that fumagillin, (2µg ml-1) causes a reduction in the 
level of oxygen consumption. This is mediated by diminished translocation of a protein 
homologous to p47phox and is similar to comparative neutrophil/haemocyte data 
presented by Renwick et al., (2007) although the concentration of gliotoxin required to 
elicit an inhibitory response is much less than that of fumagillin. Nevertheless, the data 
adds another parallel where an inhibitory response mediated by mycotoxins is similar in 
neutrophils and haemocytes. 
The process of degranulation is poorly understood in G. mellonella haemocytes. 
Some work on haemocyte degranulation has been undertaken with other invertebrate 
species (Kurata et al., 2006) however the issue of proteins homologous to the 
invertebrate immune response has not been addressed. In this study we attempted to 
assess the effect of fumagillin on G. mellonella haemocyte degranulation and to employ 
a proteomic approach in conjunction with immunoblot and densitometric analysis to 
identify proteins of significance in this process. Haemocytes exposed to fumagillin (2 
µg ml-1) demonstrated reduced degranulation of a protein of approximately 59 kDa 
following PMA stimulation relative to the positive and solvent control using an 
antibody raised against human MPO. LC/MS analysis of the immunoreactive protein 
from a corresponding SDS-PAGE gel revealed the identification of prophenoloxidase 
subunit 2. Prophenoloxidase (PPO) is the native zymogen of the phenoloxidase (PO) 
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pathway and its role in insect immunity has been discussed in Section 1.5.2.  The 
degranulation of components of the PPO activating system has been previously 
discussed in other invertebrates (Johansson and Söderhall, 1985) however the 
degranulation of PPO has not been described. The data presented here indicate that not 
only is PPO released upon haemocyte activation but mycotoxins such as fumagillin can 
inhibit its release. In addition ClustalW linear alignment of PPO and MPO amino acid 
sequences identified regions of similarity between both protein sequences with 
conserved and semi-conserved regions also present however an analysis of conserved 
epitope binding would be necessary to understand how cross-reactivity occurs. 
Densitometry coupled to LC/MS analysis identified fluctuating degranulation of 
two low molecular weight proteins, CRABP and cofilin following PMA stimulation 
subsequent to the presence or absence of fumagillin. Retinoic acid (RA) derived from 
dietary vitamin A plays a key role in the regulation of embryo development and cell 
morphogenesis, and CRABP plays a key role in the transportation of RA (Mansfield et 
al., 1998). Nakamura et al., (2007) demonstrated that injection of retinoic acid into 
larvae of Rhodnius prolixus reduced phenoloxidase activity thus potentially acting as a 
regulator of the humoral immune response. This hypothesis was supported by Wang et 
al., (2007) where it was shown that CRABP from B. mori reduced the physiological 
activity of R.A. thus furthering the concept that this protein modulates immune 
function.  In this study the finding that CRABP is degranulated may point to a 
regulatory mechanism employed by larvae to control the level of phenoloxidase activity 
in haemolymph however the precise mechanism of how this may occur remains to be 
elucidated. 
The increased degranulation of cofilin following PMA stimulation is a novel 
development in the understanding of G. mellonella haemocyte function. Haemocytes 
exposed to fumagillin demonstrated decreased cofilin degranulation following PMA 
 129  
stimulation. In B. mori actin depolymerising factor homologues are identified as being 
crucial in the recycling and regulation of F-actin and contribute to the regulation of 
cellular function, (Zhang et al., 2006). Considering the reduction in intracellular cofilin 
it is possible that degranulation of a protein involved in the depolymerisation of F-actin 
may play a role in the regulation of assembly. Adachi et al., (2002) demonstrated 
disruption to cofilin expression which resulted in increased phagocytic cell respiratory 
burst and pathogen internalisation thus cell stimulation may cause a reduction in the 
degranulation of this protein. The reduction in oxygen consumption caused by 
disruption to the translocation of p47 may be influenced by reduced depolymerisation of 
F-actin mediated by cofilin. The significantly reduced cofilin titres from stimulated 
haemocytes previously exposed to 2 µg ml-1 fumagillin points to its intracellular 
sequesterisation resulting in F-actin depolymerisation and subsequent limiting of 
phagocytosis and NADPH oxidase complex formation. 
The identification of cross-reactivity between an antibody raised against human 
F-actin and an invertebrate actin is not surprising as actin is a highly conserved protein 
in nature (Mullins et al., 1997). Surprisingly, considering the previous findings with the 
alterations in cofilin degranulation there was no statistically significant alteration 
observed in F-actin assembly. The reasons for this remain unclear and conflict with 
previous parallels in the haemocyte function in response to PMA stimulation following 
exposure to mycotoxins. It may be possible that the different antibody specificity may 
account for some loss of sensitivity however this is an area which requires further 
investigation or a different methodological approach to fully understand the interplay 
between F-actin formation and subsequent depolymerisation on haemocyte function.  
This Chapter clearly demonstrates that fumagillin at a concentration of 2 µg ml-1 
causes a reduction in neutrophil and haemocyte function through decreased killing of a 
pathogenic target and reduced phagocytosis. The translocation neutrophil p47phox and its 
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haemocyte homologue is disrupted following cellular exposure to fumagillin and results 
in similar levels of reduced oxygen consumption. The process of degranulation is 
inhibited in both cell types with MPO degranulation and activity reduced in neutrophil 
samples following exposure to fumagillin. A parallel study in haemocytes revealed 
cross reactivity of MPO anti-sera with G. mellonella prophenoloxidase with haemocytes 
exposed to fumagillin demonstrating significantly reduced PPO degranulation following 
PMA stimulation. In addition the decreased degranulation of an actin depolymerising 
factor (cofilin) following haemocyte exposure to fumagillin may explain a reduction in 
F-actin assembly. It is postulated that this inhibition may be the underlying reason for 
the observed loss of neutrophil function following exposure to fumagillin. However, 
immunoblot analysis of F-actin assembly in haemocytes revealed no significant changes 
in any of the treatments applied to haemocytes. It remains to be understood if the 
parallels between neutrophil and haemocyte function following exposure to fumagillin 
are also extended to the process of F-actin assembly. Nevertheless the work presented 
here clearly illustrates that fumagillin is capable of inhibiting neutrophil and haemocyte 
activity following PMA stimulation and it is speculated that a diminution of F-actin 
assembly may be the underlying cause. 
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5.0 Introduction 
 In order to comprehensively understand the immune response to infection it is 
necessary to complement data obtained from cellular studies with studies concerning 
humoral immunity. The recognition of pathogens is a key process in the initiation of an 
effective immune response leading to successful eradication of microbes from host 
tissue, and is reliant on the detection of pathogen associated molecular patterns (Lavine 
and Strand, 2001; Janeway and Medzhitov, 2002). In mammals, studies concerning 
humoral defences against invading microbes tend to focus on the levels of pathogen 
specific antibodies initially secreted by memory B-cells and subsequently by terminally 
differentiated plasma cells, (Abney et al., 1978; Ahmed and Gray, 1996). In insects a 
direct comparison is not possible due to the absence of an adaptive immune response 
however various elements of the innate immune system are conserved between 
mammals and insects, (Vilmos and Kurucz, 1998; Salzet, 2001). In recent years the 
application of 2-Dimensional electrophoresis coupled to mass spectrometry analysis of 
proteomic profile changes in G. mellonella larvae has provided novel insights into 
alterations to the larval humoral proteome following microbial, microbial subunit or 
physical stimuli, (Bergin et al., 2006; Mowlds et al., 2008; Mowlds et al., 2010). As a 
result an analysis of the effect of mycotoxins in vivo is required to further validate the 
G. mellonella model.  
The effect of gliotoxin on the ability of G. mellonella to combat fungal infection 
has been discussed by Reeves et al., (2004) and provides an interesting insight into the 
effect of mycotoxins in vivo. In the work presented here a profile of proteins capable of 
binding to A. fumigatus conidia was analysed. Furthermore, the effect of fumagillin on 
the ability of haemolymph proteins to bind A. fumigatus conidia is discussed thus 
offering an insight into the in vivo effects of fumagillin. An analysis of pooled human 
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serum binding to conidia and the effects of fumagillin on this binding was performed 
thus facilitating a comparative analysis of serum/haemolymph pathogen recognition.  
 
5.1 Proteomic and enzymatic analysis of changes in G. mellonella cell free 
haemolymph in response to fumagillin. 
In this section a proteomic approach was employed to further understand the 
effect of an immunosuppressive concentration of fumagillin on G. mellonella. The aim 
of this work was to identify alterations in the expression of proteins/peptides in larval 
haemolymph thus allowing a comprehensive understanding of the physiological and 
immunological impact of exposing larvae to this toxin 
 
5.1.1 2-Dimensional electrophoresis of haemolymph and LC/MS analysis of spots 
showing altered expression in G. mellonella larvae. 
 Larvae were injected with PBS, 2 µg fumagillin or 10% (v/v) methanol. As an 
additional control larvae were left un-injected. Larvae were incubated at 30ºC for 24h 
prior to haemolymph extraction. Larval haemolymph was subjected to isoelectric 
focussing and 12.5% SDS-PAGE (Figure 5.1) as described, (Section 2.7.2) followed by 
Colloidal Coomassie staining, (Section 2.8.3) and Progenesis SameSpot™ analysis. The 
protein profile of haemolymph from larvae that were left untreated and incubated at 
30ºC was used as a reference point for comparisons with other treatments, (Figure 5.2). 
 Following Progenesis SameSpot analysis protein spots of interest were excised 
and subjected to trypsin digestion prior to LC/MS analysis, (Section 2.13). Thirteen 
spots were identified by LC/MS analysis with eleven, (Figure 5.3 A) showing a 
statistically significant alteration in expression in fumagillin injected larvae, (p  0.05). 
Identified proteins are presented in Table 5.1. 
              (A)                                                                  (B) 
                                 
                3 10                     3 10 
              (C)                                                                  (D) 
                                
Figure 5.1 Larval haemolymph proteomic profile following fumagillin injection. 
Larvae were left unstimulated (A), injected with PBS (B), injected with 2 µg fumagillin 
(C) or injected with 10% methanol as a solvent control (D). Following 2-dimensional 
electrophoresis of cell free haemolymph protein spots were visualised using Colloidal 
Coomassie staining prior to Progenesis™ same spot analysis. 
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Figure 5.2 Spots excised for fold change analysis from G. mellonella haemolymph 
profiles. 
An unstimulated larval treatment was used to excise spots which showed alterations in 
expression as determined using Progenesis™ same spot analysis. Highlighted spots are 
comparatively analysed in Figure 5.3 
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Spot 1 was identified as 27 kDa haemolymph protein (P27K) from G.  
mellonella and demonstrated a 7.6 and 4.24 fold increase in expression in larvae 
injected with PBS and 10% (v/v) methanol, respectively. Larvae injected with 
fumagillin (2 µg) expressed a 1.47 fold increase in P27K expression compared to 
untreated larvae however this was significantly less than that observed for both positive 
controls. Uniprot analysis reveals that P27K is a member of the UPF0408 family which 
consists of two other 27 kDa glycoproteins from Manduca sexta and Bombyx mori 
however the functions of these proteins remain unknown.  
 Spot 2 demonstrated homology with Glyceraldehyde-3-phosphate 
dehydrogenase, (GAPDH) from Staphylococcus sciuri. Larvae demonstrated a 3.76, 
4.97 and 2.14 fold change in GAPDH expression relative to untreated larvae following 
injection with PBS, 2 µg fumagillin or 10% (v/v) methanol injected larvae.  GAPDH 
catalyses NAD+ dependent oxidative phosphorylation of glyceraldehyde-3-phosphate to 
1,3-biphosphoglycerate and has been demonstrated to play a role in DNA repair and 
interaction with cellular components such as RNA and nitric oxide (Sirover, 1996 and 
1999). Expression of GAPDH has been demonstrated to be increased in the presence of 
reactive oxygen species, (Ito et al., 1996).  
Spots 3 and 4 showed homology to alkyl hydroperoxide reductase (AHP) C22 
subunit and peroxiredoxin from Acinetobacter johnsonii SHO46 and Acinetobacter 
calcoceticus respectively which are annotated as functionally related proteins. Larvae 
injected with fumagillin demonstrated a 4.9 fold increase in the expression of AHP 
relative to untreated larvae. In comparison, PBS and methanol control injected larvae 
showed 3.11 and 3.32 fold increases in AHP expression respectively compared to 
untreated larvae. AHP has been demonstrated to protect host organisms from oxidative 
stress by reducing hydrogen peroxide, peroxynitrite and organic hydroperoxides, 
(Jacobson et al., 1989; Storz et al., 1989). Larvae injected with fumagillin demonstrated 
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Figure 5.3 (A) Identification of proteins with significantly altered expression 
following larval injection with fumagillin. 
Proteins demonstrating significant alterations in expression, (p  0.05) identified using 
Progenesis™ same spots software are presented with the fold change expressed relative 
to unstimulated larvae. 
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Figure 5.3 (B) Individual spot analyses of proteins which did not show significantly 
changed expression following injection with fumagillin. 
Proteins identified by LC/MS analysis subsequent to Progenesis™ same spots 
identification. The expression of spots identified as JHBP and translation elongation 
factor did not vary significantly with different stimuli. 
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Spot I.D gi Species Score Peptides Matched Coverage 
27 kDa haemolymph protein 46396271 Galleria mellonella 333 6 41% 
Glyceraldehyde 3 phosphate dehydrogenase 20799626 Stapylococcus sciuri 368 7 20% 
Alkyl hydroperoxide dehydrogenase C22 
subunit 262369692 
Acinetobacter johnsonii 
SHO46 415 8 51% 
Peroxiredoxin 262279671 Acinetobacter calcoceticus 206 3 20% 
Eukaryotic Initiation factor 159482685 Chlamyldomonas reinhardtii 69 1 3% 
Cellular retinoic acid binding protein 112983600 Bombyx mori 96 2 15% 
Arylphorin 159078 Galleria mellonella 490 9 11% 
Hexamerin 347090 Galleria mellonella 170 3 4% 
Membrane bound ATP synthase 262371347 Acinetobacter johnsonii SHO46 673 11 41% 
GI20232 195120978 Drosophila mojavensis 91 2 6% 
32 kDa ferritin subunit 17901818 Galleria mellonella 69 2 9% 
Juvenile hormone binding protein 158515746 Galleria mellonella 372 11 31% 
Translation elongation factor 59806076 Stapylococcus sciuri 89 1 12% 
 
Table 5.1 Summary of proteins identified by LC/MS analysis. 
MASCOT identification of spots presented in Figure 5.3 (A) and (B). The proteins demonstrating the greatest fold change relative to untreated larvae 
(p  0.05) down to the lowest (non-significant) changes are presented in order. For identification a MASCOT score lower limit of 62 was used.  
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a 4.92 fold increase in peroxiredoxin (PRX) expression. This contrasts with the 1.38 and 
2.05 fold increases in expression demonstrated by larvae injected with PBS or solvent 
control. Peroxiredoxins are a ubiquitous family of proteins of ancient origin which play 
a key role in the protection of host tissue to damaging oxidative stresses whereby 
hydroperoxides are reduced and detoxified, (Wood et al., 2003; Knoops et al., 2007). In 
mammalian cells Prx’ s may comprise of 0.1-0.8% of soluble protein where, in the 
presence of thioredoxin, they play an integral role in the regulation of oxidative stress 
responses in host tissue, (Chae et al., 1999). Furthermore, studies using other 
lepidopteran species have demonstrated that alterations in the expression and synthesis 
of Prxs are intricately linked to the need to detoxify host tissue and other aberrant 
stimuli, (Wang et al., 2008; Fang et al., 2010) 
Spot 5 was identified as a protein with homology with eukaryotic initiation 
factor from Chlamyldomonas reinhardtii. Larvae injected with fumagillin demonstrated 
a 3.85 fold increase in eukaryotic initiation factor relative to untreated larvae. 
Eukaryotic initiation factors function in the initiation of protein translation in eukaryotic 
species, (Pestova and Hellen, 2000). In addition the synthesis of eukaryotic initiation 
factors increases at the onset of metamorphosis in some insect species indicate that 
altered expression of this protein is developmentally regulated, (Dong et al., 2009). 
Spot 6 was identified as cellular retinoic acid binding protein, (CRABP). 
Interestingly, larvae injected with fumagillin expressed CRABP 0.51 fold relative to 
untreated larvae. Larvae injected with PBS or the methanol control demonstrated a 1.12 
and 1.52 increases in the expression of CRABP respectively. Considering the reduction 
in haemolymph CRABP and the results presented in Section 4.7.2 it is apparent that 
fumagillin, (2 µg) is capable of reducing the presence of this protein in vivo as well as 
the limiting degranulation of CRABP from haemocytes. Mehta et al., (1994) 
demonstrated that CRABP reduced the expression of TNF- and nitric oxide production 
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in macrophage cell lines however it remains to be understood if a similar process takes 
place in haemocytes.  
Spots 7 and 8 were identified as arylphorin and hexamerin respectively. Larvae 
injected with PBS or 10% (v/v) methanol demonstrated a 1.68 and 1.82 fold increase in 
arylphorin expression relative to unstimulated larvae. This contrasted with the reduced 
levels of arylphorin present in the haemolymph of larvae injected with fumagillin where 
it was expressed 0.67 fold relative to untreated larvae. The expression of hexamerin in 
larvae injected with fumagillin was 0.82 fold of untreated larvae. Larvae injected with 
PBS or 10% (v/v) methanol demonstrated increased hexamerin synthesis, (1.51 and 
1.24 fold, respectively). Arylphorin and hexamerin are annotated as members of the 
haemocyanin superfamily, and primarily function to store macromolecules and in 
oxygen transportation.  
 Spot 9 was identified as a membrane bound ATP synthase. Larvae injected with 
PBS, 10% (v/v) methanol or 2 µg fumagillin demonstrated a 1.32, 1.31 and 1.76 fold 
increase in the expression of ATP synthase relative to untreated larvae, respectively. 
ATP synthases are ubiquitous and function to convert ADP and inorganic phosphates to 
form ATP, (Mitchell, 1961; Boyer, 1997). Due to the membrane localisation of ATP 
synthases, drastic increases in expression are associated with disruption to cell structure 
and cell lysis, (Lian et al., 2008). 
 Spot 10 showed sequence homology with GI20232 in D. mojavensis. Annotation 
of this protein identified it as an aldo-keto reductase (AKR). Larvae injected with 
fumagillin demonstrate a 1.7 fold increase in the expression of GI20232 compared to 
untreated larvae. AKRs are a well characterised family of proteins which comprise over 
150 members, and are linked to the metabolism of molecules with aldehyde or ketone 
groups, drugs or carcinogens, (Jez et al., 1997, Masser, 2004). 
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 Spot 11 was the last protein which demonstrated a significant variation in the 
level of expression in larvae injected with fumagillin compared to other treatments and 
was identified as 32 kDa ferritin subunit from G. mellonella. Larvae injected with PBS 
or 10% (v/v) methanol demonstrated a 1.43 and 1.62 fold increase in the expression of 
32 kDa ferritin subunit. In contrast, larvae injected with fumagillin demonstrated a 1.19 
fold increase in the level of 32 kDa ferritin subunit expression which was found to be 
significantly less than both positive controls. Ferritin plays an important role in the 
regulation of iron homeostasis as aberrant iron levels in host tissue contribute to the 
formation of free radicals, (You and Wang, 2005). Ferritin is a highly conserved protein 
which has been isolated from plant, vertebrate and invertebrate sources and is 
intrinsically linked to the acute phase response in infected tissues thus serving as 
potential biomarker of host immunological status, (Beck et al., 2002). 
 Spots 12 and 13 did not demonstrate significant alterations in expression and are 
presented in Figure 5.3 (B). Spot 12 was identified as juvenile hormone binding protein, 
(JHBP). JHBP acts as a carrier protein for juvenile hormone which in turn acts to 
regulate development and metamorphosis in insects, (Truman and Riddiford, 1999; 
Gilbert et al., 2000). The work of Zalewska et al., (2009), identified that the exocytosis 
of JHBP from fat body cells to the haemolymph is mediated by interactions with ATP 
synthase. Larvae injected with PBS, fumagillin or solvent control demonstrated 1.2, 
0.81 and 1.03 fold expression values compared to unstimulated larvae. 
 Spot 13 was identified as a translation elongation factor. In eukaryotes 
translation elongation factors function in polypeptide chain synthesis through 
interactions with t-RNA and m-RNA in the ribosome (Lamberti et al., 2004). Larvae 
injected with PBS, fumagillin or 10% (v/v) methanol demonstrated diminished levels of 
translation elongation factor expressing 0.72, 0.98 and 0.73 fold of untreated larvae 
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respectively compared to unstimulated larvae, however these reductions were calculated 
as insignificant, (p  0.12). 
 
5.1.2 Analysis of the effect of fumagillin on phenoloxidase activity in larval 
haemolymph. 
 In order to ascertain if fumagillin affected the activation of the phenoloxidase 
(PO) pathway in larval haemolymph it was necessary to establish a means of activating 
the pathway in the absence of infection. Mowlds and Kavanagh (2008) demonstrated 
that humoral immunity in G. mellonella larvae may be affected by increases in 
temperature as evidenced by increases in antimicrobial peptide production and changes 
to the proteomic profile. Therefore the effect of increasing temperature on PO activity 
was assessed. Larvae were incubated at 30ºC or 37ºC for 24 hours and a PO activity 
assay was performed as described, (Section 2.20.2). Figure 5.4 demonstrates that larvae 
incubated at 37ºC show a 1.77 fold increase in PO activity compared to larvae incubated 
at 30ºC, (p  0.001). This finding was interesting as it indicated that the phenoloxidase 
cascade may be affected by non-microbial stimuli. As a non-infective means to affect 
PO activation was established the effect of an immunosuppressive concentration of 
fumagillin on the activity of PO in vivo was assessed. Larvae were left untreated or 
injected with PBS, 2 µg fumagillin or 10% (v/v) methanol and incubated at 37ºC prior 
to performing PO activity analysis. Haemolymph from untreated larvae demonstrated 
approximately the same level of absorbance at 490nm as the 37ºC treatment described 
in Figure 5.4, (0.124 ± 0.005). This figure contrasted with the absorbance observed for 
haemolymph from larvae injected with PBS or 0.002% (v/v) methanol where figures of 
0.158 ± 0.006 and 0.157 ± 0.005 were recorded, (p  0.007). Haemolymph from larvae 
injected with PBS or 10% (v/v) methanol did not demonstrate statistically significant 
absorbance values from each other, (p = 0.15). Haemolymph extracted from larvae
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Phenoloxidase activity of G. mellonella haemolymph following 
incubation at 30ºC or 37ºC. 
Larvae were incubated at 30ºC or 37ºC for 24 hours and phenoloxidase activity was 
ascertained at 490 nm. Larvae incubated at 37ºC demonstrated significantly increased 
phenoloxidase activity, (p = 0.001). 
 
 
 
 
 
 
 
 
 
 
 
 
 
             
 
 
 
 
 
 
 
 
Figure 5.5 Effect of fumagillin on G. mellonella haemolymph phenoloxidase 
activity. 
Larvae were injected with PBS, 2 µg fumagillin or 10% methanol or were left untreated 
and incubated at 37ºC for 24 hours. Larvae injected with fumagillin demonstrated 
reduced phenoloxidase activity compared to all other treatments, (p  0.001). 
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 injected with fumagillin (2 µg) demonstrated greatly reduced PO activity compared to 
all other treatments with absorbance at 0.055 ± 0.001. The reduction in absorbance was 
significant compared to all other treatments, (p  0.001).  
 
5.1.3 Summary. 
 In this section the effects of fumagillin on the haemolymph profile and the 
phenoloxidase cascade of G. mellonella larvae was assessed. Larvae injected with an 
immunosuppressive concentration of fumagillin (2µg), demonstrated significant 
increases in expression of enzymes that catalyse the glycolytic pathway, peroxide 
breakdown, initiation of protein translation, ATP synthesis, and an aldo-keto reductase. 
These increases are coupled to the reduced expression of CRABP, haemocyanins and 
ferritin. In addition the effect of fumagillin on the activation of the phenoloxidase 
cascade was determined. Phenoloxidase activity is significantly reduced in larvae 
injected with fumagillin. These results indicate that larval exposure to fumagillin 
appears to reduce PO activity and leads to the induction of oxidative stress in vivo as 
evidenced by the increased expression of detoxification enzymes. 
 
5.2 Analysis of the binding profiles of haemolymph proteins with affinity for A. 
fumigatus conidia. 
The insect humoral immune system has been demonstrated to participate in the 
recognition of pathogens and the cellular neutralisation of invading microbes, (Dunphy 
et al., 1986; da Silva et al., 2000). In order to develop a more comprehensive 
understanding of the interaction between A. fumigatus and G. mellonella larvae at the 
point of infection a study to assess the interaction of the humoral response with A. 
fumigatus conidia was performed.  
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5.2.1 SDS-PAGE and LC/MS identification of larval haemolymph proteins binding 
to A. fumigatus conidia in vitro. 
 Larvae (10) were bled and a haemolymph binding assay was performed as 
described, (Section 2.20). Following protein solubilisation and SDS-PAGE analysis, 
(Figure 5.6) all visible bands were excised and subjected to trypsin digestion prior to 
LC/MS analysis. Four bands of interest were identified and are presented in Table 5.2. 
 Band 1 was identified as apolipophorin, (apo 1). Apo 1 primarily functions in 
lipid transport and lipoprotein metabolism, (Weers and Ryan, 2006) however the work 
of Ma et al., (2006) identified a role for this protein in oligomeric interactions with LPS 
thus initiating particle neutralisation. This process is further complexed by interactions 
with lipids, glycolipids and hemolin leading to a “ cage-like”  sequesterisation of LPS 
moieties within the haemocoel, (Schmidt et al., 2010).  
 Band 2 was identified as arylphorin. Arylphorin has been discussed previously 
in this Chapter as an amino acid storage and transport protein, (Telfer, 1991). However 
the work of Beresford et al., (1997) indicated an additional role for arylphorin as an 
antimicrobial. The N-terminus of gallysin-1, a potent elicitor of the antimicrobial 
response of G. mellonella haemolytically active material, (HAM) is identical to the first 
20 amino acids of the arylphorin sequence. 
 Band 3 was identified as prophenoloxidase subunit 2. PPO is a key component 
of the melanisation pathway which catalyses o-hydroxylation of monophenols and 
oxidation of phenols to quinines which polymerise to form melanin, (Soderhall and 
Cerenius, 1998). The activation of PO is mediated by the prophenoloxidase activating 
system, (ProPO-AS) consisting of C-type lectins which bind LPS, peptidoglycan and -
1,3 glucan and thus initiate the controlled activation of PO, (Kavanagh and Reeves, 
2004). 
  
                             Marker                      Bound haemolymph protein                      
                             
 
 
Figure 5.6 SDS-PAGE analysis of proteins bound to conidia. 
The haemolymph binding assay was performed as described (Section 2.20). Following 
protein extraction and 12.5% SDS-PAGE bands of interest were excised and trypsin 
digested prior to subsequent identification by LC/MS analysis. 
 
 
Band 
No. Identified gi Score 
Peptides 
matched Coverage 
1 Apolipophorin 50404098 151 3 4% 
2 Arylphorin 159078 271 6 10% 
3 Prophenoloxidase subunit 2 34556399 167 3 4% 
4 Apolipophorin III 5915688 170 4 29% 
 
Table 5.2 Identified proteins from G. mellonella haemolymph interaction study.  
Bands of interest (Figure 5.6) were excised and enzymatically digested using trypsin. 
Following peptide extraction LC/MS analysis yielded identification of four major 
proteins with binding affinity for A. fumigatus conidia. 
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 Band 4 was identified as apolipophorin III, (apoLp III). ApoLp III mediates 
binding to lipotechtoic acid and the detoxification of LPS, (Kato et al., 1994; Dunphy 
and Halwani, 1997). In addition apoLp III enhances haemolymph antibacterial activity 
by promoting phagocytosis and haemocyte mediated superoxide production, (Wiesener 
et al., 1997). ApoLp III activates the PPO cascade and demonstrates functional and 
structural homology with mammalian apolipoprotein E, (Cole et al., 1987). At normal 
physiological levels apoLp III is involved in lipid transport and provides diacylglycerol 
(DAG) to flight muscles, (van der Horst et al., 2002; van der Horst 2003).  
 
5.2.2 Comparative analysis of the effect of fumagillin on haemolymph protein 
binding to conidia in vitro. 
 The haemolymph binding assay was performed as described, (Section 2.20.3) 
however haemolymph was spiked with fumagillin (1 or 2 µg ml-1) for 25 minutes or 
methanol (0.002% v/v). From there the assay was performed as normal with the 
concentration of conidia in each extraction sample checked for equal loading. The 
protein lysates were separated and visualised by 1-D SDS-PAGE and Colloidal 
Coomassie staining, (Figure 5.7). The profiles of identified bands were analysed by 
densitometry to ascertain if differential binding took place in the presence or absence of 
immunomodulatory concentrations of fumagillin. Densitometric analysis of larval 
haemolymph proteins revealed that bands identified as arylphorin, prophenoloxidase 
subunit 2 and apolipophorin IIII demonstrated altered levels of binding to conidia 
following co-incubation with fumagillin.  
 In Figure 5.8 densitometric quantification of differential arylphorin binding to 
conidia is presented. Arylphorin binding was reduced 0.57 and 0.66 fold where 
haemolymph was pre-incubated with 2 or 1 µg fumagillin ml-1 respectively compared to 
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Figure 5.7 Haemolymph binding profiles of proteins bound to conidia following 
incubation of haemolymph with fumagillin. 
Larvae were bled and resulting cell free haemolymph was incubated with 2 or 1 µg 
fumagillin ml-1 for 25 minutes or incubated in the presence of 0.002% (v/v) methanol as 
a solvent control. Resulting proteins were visualised by SDS-PAGE and Colloidal 
Comassie staining.  
 
Lanes 
1. Full Haemolymph profile (20 µg protein) 
2. Conidia surface extraction 
3. Control haemolymph interaction 
4. 2 µg fumagillin ml-1 haemolymph interaction 
5. 1 µg fumagillin ml-1 haemolymph interaction 
6. Solvent control (0.002% v/v methanol) haemolymph interaction 
 
Bands marked 1 (arylphorin), 2 (PPO subunit 2) and 3 (apolipophorin III) were 
identified and relative binding was ascertained by densitometry 
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Figure 5.8 Densitometric analysis of arylphorin binding to A. fumigatus conidia. 
The conidial binding of arylphorin from larval haemolymph pre-treated with fumagillin, 
(2 or 1 µg ml-1) is presented. Haemolymph pre-treated with fumagillin demonstrated 
reduced binding to conidia, (**p  0.006) relative to control haemolymph. 
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Figure 5.9 Densitometric analysis of prophenoloxidase subunit 2 binding to A. 
fumigatus conidia. 
The conidial binding of prophenoloxidase subunit 2 from larval haemolymph pre-
treated with fumagillin, (2 or 1 µg ml-1) is presented. Haemolymph pre-treated with 
fumagillin demonstrated reduced binding to conidia, (p  0.014) relative to control 
haemolymph. 
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Figure 5.10 Densitometric analysis of Apolipophorin III binding to A. fumigatus 
conidia. 
The conidial binding of apolipophorin III from larval haemolymph pre-treated with 
fumagillin, (2 or 1 µg ml-1) is presented. There was a reduction in the level of 
apolipophorin III binding however the alteration was not considered statistically 
significant, (p  0.064). 
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untreated haemolymph (p  0.006). Haemolymph pre-treated with 0.002% (v/v) 
methanol did not demonstrate a notable change in arylphorin binding (p = 0.593).  
 Exposure of haemolymph to fumagillin caused significant alterations in the 
binding of prophenoloxidase subunit 2 to conidia, (Figure 5.9). Haemolymph incubated 
with fumagillin (1 or 2 µg ml-1) demonstrated a 0.55 and 0.63 fold decrease in 
prophenoloxidase subunit 2 binding respectively compared to control haemolymph, (p  
0.014). Haemolymph incubated in the presence of 0.002% (v/v) methanol did not 
demonstrate a significant change in prophenoloxidase binding (p = 0.754). 
 The binding of apoLp III was altered by incubating haemolymph with fumagillin 
(Figure 5.10). Haemolymph incubated with fumagillin (1 or 2 µg ml-1) demonstrated a 
0.65 and 0.74 fold decrease in apoLp III binding compared to control haemolymph 
however the reduction in binding was not considered to be significant, (p  0.064). This 
finding indicates that while alterations in protein binding occurs following exposure of 
haemolymph to fumagillin the relative change is not universally significant thus 
indicating specific inhibition to pathogen recognition. This is supported by the finding 
that apolipophorin 1 did not demonstrate altered binding to A. fumigatus conidia when 
previously incubated in the presence of fumagillin. 
 
5.2.3 SDS-PAGE and LC/MS identification of human serum proteins with binding 
activity to A. fumigatus conidia in vitro. 
 In order to perform a comparison with the human innate immune system cell 
free serum pooled from multiple donors was used in an identical manner to that of 
haemolymph (Section 2.20.3). The resulting binding profile is presented in Figure 5.11 
and a list of analysed proteins is presented in Table 5.3. 
 Band number 1 was identified as inter-alpha-trypsin inhibitor family: heavy 
chain related protein (ITIH4). ITIH4 is highly conserved in pigs, humans and cattle and 
 142  
is regarded as a biomarker for the acute phase reactions to aberrant stress and may be 
regulated by IL-6, (Pineiro et al., 1996; Pineiro et al, 2004). It has been demonstrated 
that ITIH4 may play a role in the restriction of actin polymerisation and phagocytosis in 
neutrophils, (Choi-Mura et al., 2000). 
 Band number 2 was identified as a gelsolin isoform. Intracellular gelsolin is 
involved in the reorganisation of actin filaments thus modulating cell shape and 
motility, (Yin et al., 1979; Kwiatkowski, 1989). Recent work performed by Bucki et al., 
2008 demonstrated a role for this protein in the binding of liotechtoic acid, (LTA) and 
LPS. The interaction of gelsolin with LPS and LTA causes a reduction in aggregate size 
of endotoxins resulting in restrictions to F-actin depolymerisation activity leading to the 
formation of an immune response in vivo.  
Band number 3 was identified as angiotensinogen. Angiotensinogen is the parent 
molecule of angiotensin which functions in blood pressure regulation, renal 
haemodynamics, and electrolyte homeostaisis, (Chen et al., 2004). The work of Naim et 
al., (2004) demonstrated that Angiotensin II, (the main effector peptide of the rennin 
angiotensin system) is capable of inducing rapid neutrophil recruitment mediated by the 
CXC chemokines CINC/KC and MIP-2 and IL-8 in humans. The role of Angiotensin II 
in the proinflammatory reaction is supported by work of Ito et al., (2001) where it was 
demonstrated that neutrophils possessed Angiotensin II receptor. 
 Band number 4 was identified as alpha-1 antitrypsin: A canonical template for 
active serpins, (AAT). AAT is annotated as a member of the serpin superfamily and 
primarily functions as a scavenger of neutrophil elastase. Abnormal variants of this 
protein cause affected individuals to lose lung elasticity, (Carrell et al., 1982). Apart 
from eliciting an antiprotease function AAT can inhibit LPS stimulated synthesis of 
TNF- and IL-1 but can enhance IL-10, (Janciauskiene et al., 2004). Luisetti et al., 
                                   
 
 
Figure 5.11 1-D SDS-PAGE profile of serum proteins with affinity for A. fumigatus 
conidia. 
Serum proteins bound to conidia were analysed by 1-D SDS-PAGE and visualised with 
Colloidal Comassie staining. Resulting bands were excised and trypsin digested prior to 
LC/MS identifiaction  
 
 
Band 
No. Identified gi Score 
Peptides 
matched Coverage 
1 
inter-alpha-trypsin inhibitor 
family: heavy chain related 
protein (HRP) 
1483187 1018 21 27% 
2 gelsolin isoform 4504165 243 7 8% 
3 Angiotensinogen 532198 154 6 13% 
4 
Alpha-1antitrypsin: A 
canonical tamplate for active 
serpins 
6137432 828 16 44% 
5 Apolipoprotein A-IV precursor 71773110 823 18 49% 
6 Apolipoprotein E 178849 162 10 10% 
7 Immunoglobulin kappa - light chain 3169770 105 8 24% 
8 Apolipoprotein C III 521205 144 2 27% 
 
Table 5.3 Identification of serum proteins with binding affinity to A. fumigatus 
conidia. 
Bands of interest from Figure 5.11 were excised and subjected to trypsin digestion and 
LC/MS analysis.  
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(1991), did demonstrated that sepharose a protease produced by A. mellus was not 
inhibited by AAT.  
 Band number 5 was identified as apolipoprotein A-IV precursor, (apoA-IV). 
ApoA-IV is a 46 kDa serum protein synthesised in the enterocytes of the small intestine. 
ApoA-IV is believed to participate in lipid absorption and cholesterol transport in 
addition to anti-oxidant properties, and may play a role in the immune response by 
inhibiting LPS-induced stimulation of monocytes, (Stan et al., 2003; Recalde et al., 
2004). Khovidhunkit et al., (2004) identified that the expression of apo A-IV is 
substantially increased in mice injected with LPS further highlighting the role of apo A-
IV in vivo. 
 Band number 6 was identified as apolipoprotein E (apoE). ApoE plays a key 
role in the activation of the immune response by reducing endotoxic shock mediated by 
LPS, promoting phagocytosis and nitric oxide release, (Feingold et al., 1995; de Bont et 
al., 2000; Carvalho et al., 2000; Riddell et al., 1997). Vonk et al., (2004) indicated that 
apoE deficient mice demonstrated increased candidemia mediated by higher lipid 
availability and the neutralisation of candidacidal factors by very low density 
lipoproteins, (VLDL). 
Band number 7 was identified as immunoglobulin kappa-light chain. 
Immunoglobulin kappa-light chain is a component of the variable domain of the light 
chain of immunoglobulin and shows a great level of variation through conservation of 
amino acid replacements at multiple positions thus conferring moiety specificity, and 
pathogen recognition (Hill et al., 1966; Das et al., 2008).  
Band number 8 was identified as apolipoprotein CIII (Apo CIII). Apo CIII is a 
very low density lipoprotein (VLDL) and may serve as a ligand for TLR-2 thus 
mediating inflammatory activation of endothelial cells, (Kawakami et al., 2008). 
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5.2.4 An analysis of the effect of fumagillin on binding of serum proteins to conidia 
in vitro. 
The serum binding assay was performed as described, (Section 2.20.3) however 
serum was spiked with fumagillin (1 or 2 µg ml-1) for 25 minutes or 0.002% (v/v) 
methanol. From there the assay was performed as previously described with the 
concentration of conidia in each extraction sample checked for equal loading. The 
protein lysates were separated and visualised by 1-D SDS-PAGE and Colloidal 
Coomassie staining, (Figure 5.12). The profiles of identified bands were then analysed 
by densitometry to ascertain if differential binding took place in the presence of 
fumagillin. From the results only 2 identified bands showed differential binding in 
response to the toxin, however due to the homology that exists between apoLp III and 
apoE (Cole et al., 1987) and the identification of apoLp III binding to conidia (Sections 
5.2.1 and 5.2.2) it was deemed necessary to apply densitometric analysis to the binding 
profile of apoE.  
In Figure 5.13 serum pre-treated with fumagillin (2 or 1 µg ml-1) demonstrated 
0.44 and 0.83 fold decrease in angiotensinogen binding to conidia relative to control 
serum, (p  0.007). Serum incubated in the presence of 0.002% (v/v) methanol did not 
demonstrate any significant differences compared to control haemolymph (p = 0.874) 
but did demonstrate significantly increased angiotensinogen binding compared to 
fumagillin treated serum, (p  0.026). 
Immunoglobulin kappa binding to conidia was also altered (Figure 5.14). Serum 
pre-treated with fumagillin (1 or 2 µg ml-1) demonstrated 0.84 and 0.85 fold reduced 
binding of immunoglobulin to conidial surfaces, (p  0.009) relative to control serum. 
Serum incubated in the presence of 0.002% (v/v) methanol demonstrated no significant 
difference compared to the control (p = 0.3) but did show a higher level of binding 
compared to the fumagillin treatments (p = 0.014).  
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Figure 5.12 Binding profiles of proteins bound to conidia following incubation of 
human serum with fumagillin. 
Serum was pooled from a variety of donors (n = 10) was diluted 1/10 (approx 7.5 mg 
protein ml-1). Serum was incubated with 2 or 1 µg fumagillin ml-1 for 25 minutes or 
incubated in the presence of 0.002% v/v methanol as a solvent control. Resulting 
proteins were visualised by SDS-PAGE and Colloidal Coomassie staining.  
 
Lanes 
1. Full Haemolymph profile (20µg protein) 
2. Conidia surface extraction 
3. Control haemolymph interaction 
4. 2 µg fumagillin ml-1 serum interaction 
5. 1 µg fumagillin ml-1 serum interaction 
6. Solvent control (0.002% v/v methanol) haemolymph interaction 
 
Bands marked 1 (angiotensinogen), 2 (apolipoprotein E) and 3 (immunoglobulin kappa-
light chain) were identified and relative binding was ascertained by densitometry 
(Figures 5.13, 5.14 and 5.15). 
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Figure 5.13 Densitometric analysis of angiotensinogen binding to A. fumigatus 
conidia. 
The conidial binding of angiotensinogen from human serum pre-treated with fumagillin, 
(2 or 1 µg ml-1) is presented. Serum pre-treated with fumagillin (2 or 1 µg ml-1) 
demonstrated significantly reduced angiotensinogen binding relative to the control, (**p 
 0.007). 
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Figure 5.14 Densitometric analysis of immunoglobulin kappa binding to A. 
fumigatus conidia. 
The conidial binding of Ig-kappa from human serum pre-treated with fumagillin, (2 or 
1µg ml-1) is presented. Serum pre-treated with fumagillin (2 or 1 µg ml-1) demonstrated 
significantly reduced Ig-kappa binding relative to the control, (**p  0.009). 
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Figure 5.15 Densitometric analysis of apolipoprotein E binding to A. fumigatus 
conidia. 
The binding of apolipoprotein E from human serum following exposure to fumagillin is 
presented. Serum pre-treated with fumagillin did not demonstrate any significant 
variability in apoE binding (NS). 
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There was a minimal change in the level of apolipoprotein E binding to conidia 
following incubation of serum with fumagillin, (Figure 5.15). Comparisons between 
control and serum control treatments revealed no significant alterations to binding, (p = 
0.45). Furthermore, comparisons with both control treatments and serum exposed to 
fumagillin (1 or 2 µg ml-1) show that apolipoprotein E binding was not affected (p  
0.1).  
 
5.2.5 Summary. 
 An analysis of the binding of proteins from G. mellonella larval haemolymph 
identified by LC/MS analysis to conidia was performed to further understand the 
interactions between the larval immune system and A. fumigatus conidia. This analysis 
identified four proteins which demonstrated binding to conidia using an in vitro assay. 
The four proteins, (apolipophorin, arylphorin, prophenoloxidase subunit 2 and 
apolipophorin III) have been previously implicated in immune reactions in G. 
mellonella larvae. A parallel study with pooled human serum identified 8 proteins 
binding to conidia (Figure 5.11 and Table 5.3). The proteins have been previously 
identified as components of the inflammatory response, pathogen recognition, mediators 
of leukocyte pathogen recognition and as biomarkers for the acute phase response to 
infection. An analysis of the effect of fumagillin on serum binding to conidia revealed 
that only two proteins varied in binding to conidia, (angiotensinogen and 
immunoglobulin kappa light chain). Due to the structural and functional similiarity that 
human apoE shares with invertebrate apoLp III, a densitometric analysis of apoE 
binding was performed. Densitometric analysis of both protein profiles revealed that 
variations in the binding of to conidia were present but not statistically significant. 
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5.3 Discussion. 
 The ability of A. fumigatus to evade the host immune response has received 
considerable attention throughout the course of research on this pathogen. The 
production of a variety of enzymes and toxins which impair immune function and alter 
the physiology of host tissue create a favourable environment for fungal growth and 
further microbial colonisation (Kolattukudy et al., 1993; Sutton et al., 1996; Bertout et 
al., 2002; Ben-Ami et al., 2010). The work presented in this Chapter serves to 
complement the cellular data presented in Chapter four where the effect of fumagillin 
on neutrophils and haemocytes was characterised. 
The effect of an immunosuppressive concentration of fumagillin on the 
proteome of larval haemolymph was described, (Figures 5.1, 5.2 and 5.3). It was 
hypothesised that analysis of the humoral proteomic profile of G. mellonella may 
identify other effects of fumagillin which were not directly related to an immune 
response. The significant increase in expression of proteins demonstrating homology 
with glyceraldehyde-3-phosphate dehydrogenase, alkyl hydroperoxide dehydrogenase 
and peroxiredoxin in larvae injected with fumagillin (2 µg) may be indicative of the 
development of mycotoxin mediated oxidative stress in vivo. Schütze et al., (2010) 
provided a recent insight into this process. Using Balb/c mice, exposure to gliotoxin and 
patulin induced lipid peroxidation which was corrected by the administration of N-
acetylcysteine or glutathione ethyl ester. In addition studies concerning the effect of 
TNP-470 (a synthetic derivative of fumagillin and inhibitor of angiogenesis), 
demonstrated induction of cell death through the generation of reactive oxygen species 
thus mediating toxicity in murine endothelium cell lines. In this case the addition of N-
acetylcysteine caused a reduction in cell death mediated by TNP-470 (Okroj et al., 
2005). Considering the inhibition of phagocytic cell oxidative responses mediated by 
mycotoxins in vitro, (Tsunawaki et al., 2004; Renwick et al., 2007), it is interesting that 
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fumagillin at an immunosuppressive concentration mediates an oxidative stress in host 
tissue. The increased expression of GAPDH, peroxiredoxin and alkyl hydroperoxide 
dehydrogenase may be indicative of such an oxidative stress mediated by fumagillin. 
The increase in expression of an aldo-keto reductase is also indicative of the presence of 
an oxidative stress mediated by fumagillin possibly as a result of lipid peroxidation. A 
human aldo-keto reductase (AKR1C1) mediates reduction of ,-unsaturated aldehydes 
produced during lipid peroxidation caused by the presence of reactive oxygen species 
thus indicating a role for AKRs in oxidative stress response in vivo (Burczynski et al., 
2001). 
The increased expression of a protein showing homology with eukaryotic 
initiation factor in response to fumagillin is interesting. Datta et al., (2004) revealed that 
fumagillin inhibited the turnover of eukaryotic initiation factor 2-associated 
glycoprotein p67 in murine C3C12 myoblasts. The biochemical implication of this 
interaction is that the stabilisation of p67 leads to reduced phosphorylation of eukaryotic 
elongation factor 2. To date there is no record of such a process in G. mellonella 
however given the conservation of cellular pathways between vertebrates and 
invertebrates such an occurrence may occur. 
Haemocyanins, (arylphorin, hexamerin) function as oxygen transporters and 
amino acid storage molecules (Beintema et al., 1994). The decrease in the expression of 
two haemocyanin proteins following larval exposure to fumagillin may be a result of 
reduced oxygen transportation and alterations to physiological processes in vivo. 
The reduction of ferritin expression in fumagillin treated larvae may contribute 
to the weakening of the immune response prior to a microbial insult. Ferritin plays a key 
role in iron homeostasis and in restricting the availability of iron to pathogenic micro-
organisms (Haas et al., 2008; Schrettl et al., 2004). It is evident that the inability of 
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larvae to sequester iron may have a negative effect on larval fitness prior to pathogenic 
stimuli. 
The activation of the phenoloxidase cascade plays a key role in protection 
against infection in invertebrates and is activated upon physical and microbial stress, 
(Soderhall and Cerenius, 1998; Bogus et al., 2007). Temperature mediated alterations to 
phenoloxidase activity have been previously discussed for other invertebrates, (Sung et 
al., 1998). Increasing the incubation temperature of G. mellonella resulted in a 
significant increase in phenoloxidase activity therefore establishing a non-infective 
method for inducing activity. Larvae injected with fumagillin demonstrated extremely 
low levels of activity. The finding that phenoloxidase activity may be reduced in insects 
following mycotoxin exposure has been previously demonstrated by Huxham et al., 
(1989), where exposure of Periplaneta americana and Schistocerca gregaria to 
destruxin produced by Metarhizium anisopliae caused a reduction in phenoloxidase 
activity. The result presented here potentially implies that fumagillin may mediate 
reductions in the activity of this enzyme thus leaving larvae incapable of effective 
clotting and melanin production against microbial stimuli. The identification of four 
larval haemolymph proteins with binding affinity for A. fumigatus conidia offers a 
further insight into the recognition of fungal pathogens by the larval immune system. 
Apolipophorin binding to LPS has been demonstrated by Ma et al., (2006) and reviewed 
in Schmidt et al., (2010) with the latter suggesting the formation of a “ cage-like”  
structure resulting in the neutralisation of LPS. The finding that apolipophorin is 
capable of binding to conidia may highlight that a related mechanism may take place 
with the effect of sequestering conidia upstream of other humoral or cellular processes. 
The binding of this protein to A. fumigatus was not significantly affected by 
haemolymph exposed to fumagillin. The binding of prophenoloxidase subunit 2 and 
arylphorin is a novel development on the interaction of the insect humoral immune 
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response to A. fumigatus. Beresford et al., (1997) demonstrated that the N-terminus of 
gallysin-1 a potent elicitor of the antimicrobial response of G. mellonella haemolytically 
active material, (HAM) is identical to the first 20 amino acids of the arylphorin 
sequence. This work was preceded by Phipps et al., (1994), where it was demonstrated 
that gallysin-1 was capable of causing cell damage but not cell death but could elicit 
cytotoxicity in the presence of lysozyme. It may be possible that the binding of 
arylphorin to conidia may be linked to this process by functioning as an adaptor protein 
for other effector protein(s). The binding of a subunit of phenoloxidase may offer an 
additional insight to the already well characterised mechanism of phenoloxidase cascade 
activation. The activation of the phenoloxidase cascade has been shown to be dependent 
on the Ca2+ dependent serine protease cascade which results in the activation of a 
prophenoloxidase activating enzyme which catalyses the formation quinones. The 
subsequent phenoloxidase mediated oxidation of phenols to form cytotoxic quinones 
can be toxic to the host if not regulated and localised to the site of infection, (Ashida, 
1990). Thus the association of prophenoloxidase with conidia may result in the 
localisation of this response to the pathogen of interest with beneficial effects to the host 
in vivo. Furthermore the fumagillin mediated inhibition of binding, (Figure 5.9) may 
offer support to the hypothesis that mycotoxins initiate toxic effects to host tissue by 
dysregulation of immunological cascades. The identification of apoLp III binding to A. 
fumigatus conidia is not surprising as Whitten et al., (2004) identified a role for this 
protein in the binding to 1,3-glucan thus positively affecting phagocytosis and 
eradication of conidia from the haemocoel.  Therefore it is possible that apoLp III 
binding to A. fumigatus initiates a similar process. Exposure of haemolymph to 
fumagillin resulted in non-significant alterations in apolipophorin III binding to conidia. 
The reason for this occurrence is not clear however it does demonstrate that the 
identified haemolymph proteins bound to conidia display variable levels of pathogen 
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affinity in the presence of fumagillin therefore suggesting the observed inhibitions were 
protein specific. 
 A comparative analysis of protein binding from human serum yielded 
identification of eight proteins. The functions of these proteins vary from regulation of 
F-actin assembly, neutrophil recruitment, inflammation, phagocytosis, endotoxin 
neutralisation, pathogen recognition, digestion of neutrophil elastase and as biomarkers 
for the acute phase response to infection. Of the eight proteins identified only two 
demonstrated significantly altered binding when incubated in the presence of 
fumagillin, (Angiotensinogen and immunoglobulin kappa light chain). It is of particular 
interest to note that both immunoglobulins and angiotensin II (the digested product of 
angiotensinogen) have receptors on the surface of neutrophils, (Ito et al., 2001; Cutler et 
al., 1991; Gordon et al., 1986). It is therefore possible that a loss of protein binding may 
result in reduced opsonisation of target conidia. The finding that apoLp III and apoE 
binding to conidia was not significantly affected by fumagillin is of particular interest as 
it has been commented that both proteins share functional and structural homology, 
(Cole et al 1987; Whitten et al., 2004). The work presented here describes how both 
lipoproteins can bind to conidia and may play a role in the phagocyte mediated 
eradication of the pathogen from the host. Similarly, both proteins are not significantly 
affected by previous exposure to fumagillin, (Figures 5.10 and 5.15).  
 In conclusion this Chapter demonstrates that exposure of G. mellonella larvae to 
fumagillin results in the expression of proteins indicative of oxidative stress in vivo and 
alterations to proteins involved in normal larval physiology. Furthermore the 
temperature induced activation of the phenoloxidase pathway is significantly reduced by 
in vivo exposure to fumagillin thus limiting the ability of G. mellonella to form 
melanin. These findings are complemented by the identification of four larval 
haemolymph and eight human serum proteins which exhibit binding affinity to A. 
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fumigatus conidia. Some of these have not been previously implicated in the clearance 
of pathogenic fungi from host tissue. The inhibition of conidia binding by two 
haemolymph and serum proteins when previously exposed to fumagillin demonstrates 
that inhibition to binding is protein specific and may imply that restrictions to pathogen 
recognition may confer immunosuppressive effects. Additionally, two homologous 
lipoproteins from haemolymph and serum (ApoLp III and apoE) also exhibit conidial 
binding but are not affected by the presence of fumagillin in vitro. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter 6 
 
 
Exposure to sub-lethal concentrations of 
Aspergillus fumigatus conidia primes the Galleria 
mellonella larval immune response to subsequent 
fungal infection 
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6.0 Introduction. 
 
Invertebrates, unlike vertebrates, rely solely on an effective innate immune 
system in response to infection. In recent years it has been demonstrated that not only is 
this response directed to the infecting micro-organism but it can also be influenced by 
pathogen subunit motifs (Mowlds et al., 2010). The increased density of circulating 
haemocytes, elevated synthesis of immunologically relevant proteins, activation of 
enzymatic cascades and altered expression of antimicrobial peptides all contribute to a 
diverse repertoire of responses which contribute to the localisation and eradication of 
pathogens within the host (Kavanagh and Reeves, 2004). However the interplay 
between cellular and humoral immune responses remains an area which needs to be 
comprehensively understood in order to utilise invertebrate models as an appropriate 
means of understanding the interaction of the innate immune response of G. mellonella 
larvae to opportunistic pathogens such as A. fumigatus.  
Immunological priming of insects prior to a harmful inoculum of a pathogenic 
micro-organism has provided a useful understanding of the potential to manipulate 
innate defence mechanisms against pathogens (Mowlds and Kavanagh, 2008). In order 
to understand the alterations in viability it is therefore necessary to investigate if 
increasing the larval capacity to combat a microbial stress results in a cost to other 
larval fitness traits as has been demonstrated in other invertebrate species (Jacot et al., 
2005).  
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6.1 Assessment of larval viability and haemocyte density resulting from non-lethal 
A. fumigatus priming. 
In Chapter 3 the pathogenicity of A. fumigatus ATCC 26933 in larvae was 
determined. It was demonstrated that infection of larvae with 1 x 107 conidia and 
incubation at 30ºC resulted in larval death. However concentrations from 1 x 106 
conidia larvae-1 and below did not result in larval death. In this section the effect of 
priming larvae with sub-lethal concentrations of conidia on larval viability prior to 
infection with a lethal inoculum of conidia was ascertained. The duration of priming 
with conidia was varied in order to determine if any protective effect was time 
dependent. In addition an analysis of alterations to haemocyte density was also 
performed. 
 
6.1.1 Determination of alterations in larval viability after 4, 24 and 48 hours 
immune priming. 
Larvae were injected with 1 x 104, 1 x 105 or 1 x 106 A. fumigatus conidia ATCC 
26933 20 µl-1, incubated at 30ºC and subsequently administered with a lethal 
concentration of conidia, (1 x 107), 4, 24, or 48 hours post immune priming. The 
viability of larvae was assessed at 24, 48, and 72 hours following the injection of the 1 x 
107 inoculum (Figure 6.1). As a control larvae were injected with sterile PBS prior to 
infection with 1 x 107 conidia. It was observed that all larvae primed with A. fumigatus 
and PBS remained viable and showed no evidence of declining fitness therefore any 
loss of larval viability was due to the infection of larvae with 1 x 107 conidia. 
Larvae primed with non-lethal concentrations of A. fumigatus 4 hours prior to 
receiving a 1 x 107 dose showed no loss in viability 24 hours post lethal infection at all 
pre-treatments. At 48 hours there were slight but not statistically significant variations 
in larval viability, (p  0.129). Analysis of larvae 72 hours post lethal infection revealed 
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Figure 6.1 Determination of immuno-protection after 4 hours priming with A. 
fumigatus conidia. 
Larvae were inoculated with PBS, 1 x 104, 1 x 105 or 1 x 106 A. fumigatus ATCC 26933 
conidia. Following 4 hours incubation at 30ºC larvae were injected with a lethal (1 x 
107) concentration of conidia and viability was recorded at 24, 48, and 72 hours. 
 
No statistically significant change in viability was recorded. 
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Figure 6.2 Determination of immuno-protection after 24 hours priming with A. 
fumigatus conidia. 
Larvae were inoculated with PBS, 1 x 104, 1 x 105 or 1 x 106 A. fumigatus ATCC 26933 
conidia. Following 24 hours incubation at 30ºC larvae were injected with a lethal (1 x 
107) concentration of conidia and viability was recorded at 24, 48, and 72 hours. 
 
*p < 0.05 relative to PBS treatment 
**p < 0.012 relative to PBS treatment 
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Figure 6.3 Determination of immuno-protection after 48 hours priming with A. 
fumigatus conidia. 
Larvae were inoculated with PBS, 1 x 104, 1 x 105, and 1 x 106 A. fumigatus ATCC 
26933 conidia. Following 48 hours incubation at 30ºC larvae were injected with a lethal 
(1 x 107) concentration of conidia and viability was recorded at 24, 48, and 72 hours. 
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non-significant changes in viability, (p  0.129) compared to control larvae. In addition 
the variations in larval viability between A. fumigatus priming treatments did not vary 
with all comparisons between treatments (p  0.228). 
Due to negligible effect of non-lethal doses of A. fumigatus over a period of 4 
hours it was necessary to evaluate if extending the duration of incubation was necessary. 
Larvae were pre-treated as before but were incubated for 24 hours prior to injection with 
1 x 107 A. fumigatus conidia (Figure 6.2) 
Larval viability did not change 24 hours post-infection. At 48 hours there was a 
notable change in survival with larval viability maintained at 100% when larvae were 
primed with a 1 x 104 conidia pre-injection compared to a 21.7 ± 3.1% reduction in 
viability, (p < 0.05) where larvae were pre-treated with PBS. Larvae primed with 1 x 
105 and 1 x 106 conidia decreased in viability by 13.3 ± 6.1%, (p = 0.230), and 23.3 ± 
4.2% respectively relative to the control treatment however this value was not 
considered significant. 
 Larvae inspected at 72 hours showed a marked alteration in viability depending 
on the pre-treatment. Larvae primed with PBS, 1 x 104, 1 x 105 and 1 x 106 conidia 
recorded viabilities of 13.3 ± 3.3%, 45 ± 4.3%, 23.3 ± 6.1%, and 5 ± 3.4% respectively. 
Larvae pre-treated with 1 x 104 conidia showed a significant increase in viability 
compared to PBS, 1 x 105 and 1 x106 inoculated larvae recording p - values of  0.012. 
However 1 x 105 and 1 x 106 injected larvae did not show a statistically significant 
change in viability compared to PBS injected larvae, (p  0.114). Taken together the 
data presented here show that larvae primed with 1 x 104 conidia prior to inoculation 
with 1 x 107 conidia 24 hours later demonstrate a significant increase in survival at 48 
hours which becomes even more pronounced at 72 hours. 
As a result of evident immune priming event that takes place 24 hours post-
infection with 1 x 104 conidia it became necessary to investigate if immunological 
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priming is maintained after 48 hours incubation (Figure 6.3). Larvae were inoculated 
with sub-lethal concentrations of conidia and incubated at 30ºC for 48 hours prior to 
administration with 1 x 107 conidia. Larval viability remained at 100% 24 hours post-
lethal infection. 
At the 48 hour timepoint larval viability was 36.6 ± 6.6%, 93.3 ± 6.6%, 80 ± 
5.7%, and 43.3 ± 8.8% for larvae injected with PBS, 1 x 104, 1 x 105 and 1 x 106 conidia 
respectively. Statistically, the 1 x 104 and 1 x 105 conidial treatments were the most 
significant compared to the PBS control, (p = 0 and 0.001 respectively), however larvae 
primed with 1 x 106 conidia did not display significant changes in survival, (p = 0.598). 
This marked decrease in larval survival was notable compared to the 1 x 104 and 1 x 105 
treated larvae, (p  0.003). Larval viability was recorded 72 hours post-infection as 6.7 
± 3.3%, 30 ± 5.7%, 33.3 ± 3.3%, and 10 ± 5.7% where larvae were primed with PBS, 1 
x 104, 1 x 105 and 1 x 106 conidia prior to the lethal inoculum. Statistical analysis of 
these data revealed p  0.02 at the 1 x 104 and 1 x 105 conidia priming treatments 
relative to the PBS control. Larvae primed with 1 x 106 conidia did not show any 
significant change in viability relative to the PBS control (p = 0.64).  
 
6.1.2 Effect of immune priming concentrations of A. fumigatus on haemocyte 
density. 
 G. mellonella larvae were injected with 1 x 104, 1 x 105 or 1 x 106 A. fumigatus 
conidia ATCC 26933 or were injected with sterile PBS as a control and incubated for 4, 
24 or 48 hours at 30ºC (Figure 6.4). Larvae were bled and haemocyte density was 
recorded by light microscopy. 
 Analysis of haemocyte density after four hours demonstrated a decrease in cell 
number in A. fumigatus conidia injected larvae relative to the PBS control falling from 
5.1 ± 0.35 x 103 cells µl-1 to 3.7 ± 0.75 x 103 cells µl-1, 3.35 ± 0.08 x 103 cells µl-1 and 
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4.6 ± 0.46 x 103 cells µl-1 in larvae injected with 1 x 104, 1 x 105 or 1 x 106 conidia, 
respectively. Significantly the reductions in haemocyte density recorded p – values  
0.041 relative to PBS injected larvae indicating a possible weakening of the host 
cellular immune response in the initial phase of self–protection against the fungus. It 
was found that the difference in haemocyte density between 1 x 105 and 1 x 106 conidia 
injected larvae was also significant at p = 0.045. This was not found to be the case in 
comparisons between 1 x 104 and 1 x105 injected larvae or 1 x 104 and 1 x 106 injected 
larvae (p  0.05).   
At 24 hours the changes in haemocyte densities were far more pronounced and 
showed a significant increase depending on the size of the initial fungal inoculum 
increasing from 3.94 ± 0.63 x 103 cells µl-1 in PBS injected larvae to 7.06 ± 1.27 x 103 
cells µl-1, 5.9 ± 0.55 x 103 cells µl-1 and 6.74 ± 0.74 x 103 cells µl-1 for 1 x 104, 1 x 105 
and 1 x 106 conidia injected larvae, respectively, (p  0.028). Analysis of haemocyte 
densities in larvae inoculated with priming concentrations of conidia demonstrated that 
no statistical significance in comparisons made between priming treatments existed (p  
0.05).  
 Larval haemocyte density was ascertained at 48 hours in order to understand if 
the impact of non-lethal fungal inoculation varied after 24 hours. Analysis of observed 
haemocyte densities revealed a decrease in the number of haemocytes to 3.62 ± 0.56 x 
103 cells µl-1, 3 ± 0.48 x 103 cells µl-1,  4.92 ± 0.81  x 103 cells µl-1 and 3.92 ± 0.31 x 103 
cells µl-1 for PBS, 1 x 104 , 1 x 105 and 1 x 106  primed larvae, respectively. Priming 
inoculations of conidia did not confer a statistically significant change in haemocyte 
density relative to the PBS control (p = 0.220). Larval haemocyte densities following 
injection with conidia did not vary significantly in comparisons made between infected 
treatments at this timepoint (p  0.063). Haemocyte densities decreased significantly in 
larvae that received 1 x 104 and 1 x 106 conidia from 24 to 48 hours (p = 0.036 and 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.4 Haemocyte densities in response to A. fumigatus.  
Larvae were injected with PBS or non-lethal concentrations of A. fumigatus conidia. 
Larvae were subsequently bled at 4, 24 or 48 hours and haemocyte densities were 
ascertained. 
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0.028 respectively) however this reduction was not significant in larvae injected with 1 
x 105 conidia (p = 0.445).  
 
6.1.3 Summary. 
 Examination of larval viability data demonstrated significant changes in larvae 
in receipt of non-lethal concentrations of A. fumigatus. The protective effect does not 
appear to occur in the early phase of immune priming (after four hours). Priming 
appears to peak at 24 hours with significant increases in viability in 1 x 104 conidia 
primed larvae. Surprisingly this priming event does not occur at higher non-lethal 
concentrations. Immunological priming of larvae for 48 hours with 1 x 104 conidia 
induces a significant increase in larval viability when subsequently infected with 1 x 107 
conidia. Larvae primed with 1 x 105 conidia for 48 hours demonstrated a statistically 
significant increase in viability at the 72 hour time-point. The priming responses appear 
to be dose-specific but do not increase correlating to the fungal burden to which the 
larvae are exposed.  In addition the 48 hour priming data suggest that the maximum 
protective effect of inoculating larvae with sub-lethal doses of conidia may be 
temporary (approximately 24 hours) with the onset of a return to increased 
susceptibility to fungal infection. The population of circulating haemocytes in G. 
mellonella haemolymph shows significant variations depending on concentration of 
conidial pre-treatment and the duration of time that the larvae were incubated. It was 
found that inoculation with 1 x 104 A. fumigatus conidia and incubation for 24 hours 
appeared to leave larvae highly primed at a cellular level as evidenced by the presence 
of the greatest number of circulating haemocytes at this time-point. 
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6.2 Detection of prophenoloxidase and apolipophorin III binding analysis. 
 Prophenoloxidase (PPO) and apolipophorin III (apoLp III) have been previously 
identified as major components of the humoral immune response in G. mellonella, 
(Whitten et al., 2004; Park et al., 2005). Whitten et al., (2004) identified a role for 
apoLp III as a pathogen recognition receptor of 1,3-glucan, a key component of the 
fungal cell wall. The immunological relevance of PPO has been well characterised in 
invertebrates as an effector protein in the limitation of microbial spread and synthesis of 
melanin (Schmidt et al., 2010). In this study an analysis of apoLp III binding to conidia 
from haemolymph isolated from larvae primed with conidia was performed. In addition, 
following from the results of Chapter 4 where it was found that human myeloperoxidase 
antisera demonstrated immunoreactivity for larval PPO an immunoblot analysis of 
whole haemolymph was necessary. It was hoped that this might lead to a quantitative 
assessment of PPO in whole haemolymph thus indicating the potential melanisation in 
insect haemolymph. 
 
6.2.1 Prophenoloxidase detection in larvae. 
G. mellonella larvae were injected with 1 x 104, 1 x 105 or 1 x 106 A. fumigatus 
ATCC 26933 conidia and were incubated at 30ºC for 4, 24 or 48 hours. Cell-free 
haemolymph was extracted following centrifugation and solubilised in 5X solubilisation 
buffer prior to being subjected to 1–D SDS–PAGE and immunoblotting with human 
MPO antisera which was demonstrated in Chapter 4 to be cross-reactive with G. 
mellonella prophenoloxidase. Upon development of Western blots (Figure 6.5) band 
reactivity (approximately 79 kDa) was analysed by densitometry (Figure 6.6). The band 
of interest was excised from the corresponding SDS-PAGE gel and subjected to trypsin 
digestion prior to LC/MS analysis and was identified as G. mellonella 
(A) 
 
 
(B) 
 
 
(C)  
 
 
(D) 
LC/MS analysis 
Prophenoloxidase (G.  mellonella) 
gi:14517795 
Mass: 79076 
Score: 259 
Matches: 4 
Coverage: 6% 
 
Figure 6.5 Immunoblot detection and LC/MS verification of haemolymph PPO.  
Western Blot detection of PPO at 4, 24 and 48 hours following conidial infection (A, B, 
and C) and Mascot verification of band following tryptic digestion coupled to LC/MS 
analysis. Analysis of 4 and 24 hours show detection of PPO band at various levels at 4 
and 24 hours. Analysis of 48 hours Western blots reveal loss of immunoreactivity at 79 
kDa but detection of possible breakdown products at approx. 58 kDa. 
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Figure 6.6 Densitometric analysis of PPO reactivity at 4 and 24 hours.  
Anti-PPO (79 kDa immunoreactive zymogen) profiles at 4 hours (A) and 24 hours (B) 
from Figure 6.5 (A) and (B) were analysed by densitometry. Larvae primed with PBS 
and 1 x 104 conidia for 4 hours expressed a significant increase in humoral PPO (p  
0.014). Larvae incubated with 1 x 104 conidia for 24 hours demonstrated increased PPO 
reactivity (p = 0.026) and those incubated with 1 x 106 conidia over the same incubation 
conditions (p = 0.014). 
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prophenoloxidase; (gi: 14517795, Mass: 79,076 Da, Score: 259, Matches: 4, Coverage: 
6%). 
At 4 hours there is a significant increase in the presence of PPO relative to 
untreated larvae (Figure 6.6 A). Larvae injected with PBS showed a significant increase 
in the presence of PPO at this timepoint increasing 2.1 fold, (p = 0.005). Larvae injected 
with non-lethal inocula of A. fumigatus conidia  showed an increased presence of PPO 
(p  0.014) with larvae injected with 1 x 104 conidia expressing the most significant 
increase (2.26 fold) relative to untreated larvae (p = 0.001). The observed PPO levels in 
larvae inoculated with 1 x 104 conidia after 4 hours at 30ºC relative to 1 x 105 and 1 x 
106 inoculations is notable as there is a 1.45 and 1.49 fold increase, respectively (p  
0.004). In addition larvae injected with PBS demonstrated significantly more PPO 
reactivity than larvae inoculated with 1 x 105 (p = 0.021) and 1 x 106 (p = 0.016) 
conidia. The data suggest that in the early phase of immune priming G. mellonella 
larvae synthesise or degranulate significantly more PPO in response to a pathogen or 
injury with a sterile stimulus such as PBS. Importantly at this time-point this arm of the 
innate immune system does not appear to be directed towards a specific dose of 
pathogen however the reduction in PPO levels in 1 x 105 and 1 x 106 conidia injected 
larvae would suggest a degradation of the native enzyme as part a function of the 
phenoloxidase (PO) pathway. 
At 24 hours (Figure 6.6 B) the relative levels of PPO show a notable variation to 
that observed at 4 hours. There is a noteworthy decrease in the reactivity of the PPO 
band in PBS injected larvae (p = 0.027) falling to 84.83% of that observed in untreated 
larvae. Surprisingly, only larvae injected with 1 x 104 conidia show a statistically 
significant increase in PPO reactivity increasing 1.97 fold  relative to the control (p = 
0.026). Larvae injected with 1 x 105 and 1 x 106 conidia present 1.7 (p = 0.071) and 1.1 
fold (p = 0.290) increases respectively relative to the control. In comparing the relative 
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presence of PPO reactivity of 1 x 104 conidia injected larvae to those administered with 
1 x 105 conidia there is a 13.8% reduction which is not regarded as significant (p = 
0.090) however larvae which received the 1 x 106 inoculum demonstrated a 43% 
reduction relative to larvae injected with 1 x 104 conidia (p = 0.014). Increases in PPO 
reactivity appear to correlate with immune sensing of conidia however this does not 
increase in a dose specific manner and seems to occur inversely to the level of infection.  
Prophenoloxidase levels in larvae which had been incubated for 48 hours 
(Figure 6.5 C) demonstrate an almost complete loss of band reactivity at approximately 
79 kDa. As a result it was not possible to perform comparative densitometric analysis of 
this band. There was a low detection of a 56-58 kDa band in untreated larvae. This was 
accompanied by the detection of lower molecular weight bands which were particularly 
prevalent in larvae that received the 1 x 105 conidial inoculum; however its presence 
appears greatly reduced in all other treatments.  
 
6.2.2 Apolipophorin III binding to conidia following 24 hours conidial priming. 
 Larvae were injected with PBS, 1 x 104, 1 x 105 or 1 x 106 conidia or remained 
untreated and were incubated at 30ºC for 24 hours. Larvae were bled and cell free 
haemolymph was extracted. The binding assay was performed as per Section 2.20.3. A 
10 µl aliquot of this extract was removed and subjected to 1-D SDS-PAGE and 
Colloidal Coomassie staining (Figure 6.7 A). Analysis of resulting gels showed 
variations in the level of protein which was solubilised from the conidial surface, 
(particularly at 20 kDa). The 20 kDa band was excised and subjected to tryptic digestion 
prior to LC/MS analysis as outlined in Section 2.13.3. The resulting analysis (Figure 6.7 
C) confirmed the band identity of apoLp III (Mass: 20.499 kDa, Score: 704, Sequences 
matched: 15, Coverage 71%). Densitometric analysis of the identified band (Figure 6.7 
B) revealed haemolymph of larvae in receipt of A. fumigatus inoculations displayed a 
A 
       
 B 
 
 
 
 
 
 
 
C 
 
 
Figure 6.7 Haemolymph protein binding profile from larvae primed with A. 
fumigatus conidia.  
SDS – PAGE and LC/MS analysis (A), densitometric analysis (B) of apoLp III binding 
to conidia after 24 hours immune priming in larvae. Amino acid sequence coverage 
(highlighted) obtained from LC/MS data confirming identity of apoLp III (C). 
 
  *    p = 0.048 relative to untreated larvae 
 
 
0
500
1000
1500
2000
2500
3000
3500
4000
R
el
a
tiv
e 
de
n
sit
o
m
et
ric
 
u
n
its
LC/MS analysis 
Apolipophorin III 
gi: 5915688 
Mass: 20.499 kDa 
Score: 704 
Matches: 15 
Coverage: 71% 
     1   MAAKYVFVVA ACSALAQAGI VRRDASTPLQ DLEKHAAEFQ KTFSEQLNAF  
    51  TNSKDTKEFN TALKEGSDSV LQQLNALASS LQKALNDANG KAKEALEQTR  
   101 TNLERTAEEL RRAHPDVERQ AGALRDRLQT AVQATVQETQ KLAKTVGANL  
   151 EETNKKLAPQ IKSAYDDFVK QAQEVQKKLH EAASKQ 
 
U.T         PBS      1 x 104   1 x 105    1 x 106 
  U.T            PBS           1 x 104        1 x 105        1 x 106 
* 
  * 
 161  
higher binding activity towards conidia than untreated or PBS injected larvae, (p  
0.028 and 0.048 respectively). Unlike analysis of the presence of PPO there was no 
significant change in apoLp III in comparisons between untreated and PBS injected 
larvae after 24 hours thus clarifying the observed changes were as a result of the initial 
microbial challenge and not as a result of physical insult. Larvae infected with 1 x 104, 1 
x 105 and 1 x 106 conidia demonstrated 1.89, 1.92 and 1.57 fold increases in the level of 
apoLp III binding  respectively compared to untreated larvae however only larvae 
injected with 1 x 104 and 1 x 105 conidia demonstrated a statistically significant increase 
in apoLp III (p  0.048).  
 
6.2.3 Summary. 
 Larvae injected with conidia demonstrated increased levels of PPO in cell free 
haemolymph 4 and 24 hours post-immune priming with 1 x 104 conidia. The detection 
of the 79 kDa PPO native zymogen appeared to be lost 48 hours post infection with the 
appearance of lower molecular weight reactivity. A conidial binding assay using 
haemolymph from larvae primed for 24 hours with 1 x 104 and 1 x 105 conidia 
demonstrated higher apoLp III binding to the conidia than other treatments.  
 
6.3 Proteomic analysis of G. mellonella cell free haemolymph following larval 
priming with A. fumigatus conidia. 
Cytrnska et al., (2007) and Mak et al., (2010) demonstrated the role of a diverse 
repertoire of low molecular weight proteins and peptides in response to fungal infection 
by utilising RP-HPLC and SDS–PAGE isolation and mass spectroscopy analysis to aid 
identification of factors demonstrating differential expression upon fungal or bacterial 
challenge. In this section it was sought to establish which peptides/low molecular 
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weight proteins demonstrated differential expression following sub-lethal infection with 
A. fumigatus conidia.  
In addition to this work a 2-D SDS-PAGE coupled to LC/MS approach was 
employed to identify proteins with altered expression following immune priming with 
A. fumigatus. 
 
6.3.1 RP-HPLC and SDS-PAGE of G. mellonella peptide extracts. 
 Untreated larvae (10) were bled and haemolymph peptides were extracted as per 
Section 2.10. Extracted peptides were analysed at 220 nm, 254 nm and 280 nm, for the 
detection of peptide bonds, disulphide bonding, or aromatic groups, (Figure 6.8 A). 
Overlaying the peaks demonstrated conservation of detection at certain retention times 
(e.g 11.388 mins) indicating the presence of all three components however other peaks 
(e.g 18.216 mins) indicated the absence of usually detectable residues such as 
tryptophan, or the absence of disulphide bonding adding to the complexity of the 
peptide/protein profile attained. It was clear from the analysis that at least 4 distinct 
peptide peaks are present and these were isolated by fraction collection and digested 
with trypsin for identification. 
The lyophilised peptide extract was subjected to 1–D SDS–PAGE under 
denaturing conditions on a 12.5 or 15% (w/v) acrylamide gel (Figure 6.8 B). The 
purpose of this step was to clarify the absence of higher molecular weigh proteins (> 30 
kDa). SDS-PAGE analysis demonstrated the loss of protein content above 30 kDa. The 
quality of band resolution increases with a higher percentage of acrylamide. It was 
subsequently decided to subject all peptide extractions to 15 % (w/v) acrylamide 1–D 
SDS–PAGE to aid improved resolution.  
 
(A) 
 
 
(B) 
 
 
(C) 
 
Figure 6.8 (A) Multiple wavelength analysis of peptide RP-HPLC profiles.  
RP- HPLC haemolymph peptide analysis from untreated larvae was performed initially 
using multiple wavelength DAD at 220nm (A) 254nm (B) and 280nm (C). Inspection of 
peptide bonds (A) indicated some peptides lacked disulphide bonding (B) and the 
presence of aromatic groups (C) thus indicating differential properties of peptides 
present in larval haemolymph.  
 
                     12.5% Acrylamide              15% Acrylamide 
                                               
Figure 6.8 (B). Visualisation of peptide extraction by SDS-PAGE.  
Lyophilised peptide extracts were subjected to 1–D SDS–PAGE under increasing (w/v) 
concentrations of acrylamide. The purpose of this step was to confirm the absence of 
high molecular weight proteins and peptides and assess the purity of the sample. At 12.5 
% acrylamide the absence of protein above 30 kDa is verified however it was found that 
improved visualisation was possible at higher concentrations of acrylamide.  
 
 
 30 kDa 	 
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6.3.2 RP–HPLC fractionation and LC/MS analysis of haemolymph peptides. 
 Peptides were extracted from larvae (Section 2.10) and a 50 µl sample was 
loaded on an Agilent C-18 column and fractionated based on peak retention time over 
an Acetonitrile gradient (Figure 6.9 and Table 6.1). Following lyophilisation and tryptic 
digestion all samples were analysed by LC/MS. As the first 5 minutes of the run uses an 
isocratic flow-through, all meaningful analysis takes place from the commencement of 
gradient elution. Major peaks at 11.089, 12.597, and 17.989 minutes and minor peaks at 
13.736 and 16.859 minutes were identified. These are presented in Figure 6.10 and 
Table 6.2.  
 Peak number one was identified as G. mellonella larval haemolymph protein. 
UNIPROT and BLAST analysis of the peptide sequence revealed larval haemolymph 
protein (lhp-1) to be a member of the invertebrate haemocyanin family which contains 
other methionine rich proteins with an affinity for copper binding. Analysis of this 
protein reveals a di-copper binding centre which is unlike most other insect 
haemocyanins which do not possess such a molecule (Jiravanichpaisal et al., 2006). 
Analysis of this family of proteins demonstrate that haemocyanins function as oxygen 
transporters in a manner analogous to haemoglobin, (Burmester, 2001) however unlike 
haemoglobin they are not associated with a particular type of cell but function unbound 
to transport oxygen around the haemocoel. 
 Peak number 2 was identified as anionic antimicrobial peptide 2, a 60 amino 
acid antimicrobial peptide which is secreted in response to microbial infection 
(Cytrynska et al., 2006). Recent work has demonstrated this peptide to be highly 
abundant in haemolymph however little change in abundance was recorded following 
infection with C. albicans or Fusarium oxysporum, (Mak et al., 2010). Cytrnska et al., 
(2007) noted that anionic antimicrobial peptide 2 appears lack to antifungal activity 
  
 
Figure 6.9 Peak fractionation by RP-HPLC. 
Peptides from untreated larvae were extracted and individual peaks were isolated and 
collected using RP-HPLC fractionation.  
 
 
 
Table 6.1 List collections from RP-HPLC analysis of G. mellonella peptides 
following faction collection. 
Fractions of interest from RP-HPLC chromatogram analysis (Figure 6.9) were collected 
in glass vials using a fraction collector. Following lyophilisation these fractions were 
subjected to tryptic digestion and LC/MS analysis. 
 
  
Figure 6.10 Labelling of identified peaks from RP-HPLC. 
The C-18 HPLC column was loaded with 50 µl of sample and fractionated by peak. 
Peaks which were subsequently identified by LC/MS analysis (Table 6.2) are 
highlighted by numbered arrows (
).  
 
 
 
Peak 
Number Identified gi 
M.W 
(Da) 
Mascot 
Score 
Peptides 
I.D 
Coverage 
(%) 
1 Larval haemolymph protein 110812735 13783 154 3 31 
2 Anionic antimicrobial peptide 2 156630460 6975 265 4 78 
3 Apolipophorin III 5915688 20499 286 6 26 
4 Apolipophorin III 5915688 20499 397 9 45 
5 Apolipophorin III 5915688 2499 479 16 48 
 
Table 6.2 Identification of fractionated peaks of interest by LC/MS analysis. 
Peaks highlighted in Figure 6.10 as being identified by LC/MS are presented according 
to a corresponding number. Peaks 1 and 2 were identified as lhp-1 and anionic 
antimicrobial peptide 2, respectively. It was found that peaks from 13.2 – 18 minutes 
identified as apoLp III however a significant apoLp III peak occurred at approx 17.989 
minutes which was present in all samples subjected to HPLC analysis.  
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except against P. pastoris and P. stipidis, and appeared to be induced by Gram-positive 
bacterial infection.   
Peaks three, four and five were all identified as apoLp III. Peak 5 (approx 18 
minutes) was identified as the main apoLp III peak present in the sample. The 
abundance of apoLp III is of interest as it plays a key role in mediating immune 
responses in G. mellonella where it has been shown to act as a pattern recognition 
receptor as a support to the cellular immune response as well as an activator of the 
phenoloxidase cascade in vitro, (Whitten et al., 2004, Park et al., 2005). The work of 
Mak et al., (2010) demonstrated a small increase in the abundance of an apoLp III 
derived peptide in response to fungal infection with C.albicans or F. oxysporum.  
 
6.3.3 Removal of lipids by n-hexane. 
 Cytrynska et al., (2006) performed lipid removal of initial larval haemolymph 
extracts prior to RP-HPLC analysis. Given the lipid rich nature of larval haemolymph it 
was necessary to investigate the effect of n-hexane removal on the extraction procedure 
and furthermore to understand if such removal could potentially remove peaks of 
interest from chromatogram analysis. Analysis of RP-HPLC profiles showed that the 3 
major peaks remain present after lipid removal however the size of these peaks changed 
(Figure 6.11 A). Larval haemolymph protein, anionic antimicrobial peptide 2 and 
apolipophorin III peak area values were reduced 2.1, 2.12, and 1.47 fold respectively. 
This raised the question of the requirement for lipid removal and more importantly the 
risk of error in preparing the samples. For subsequent analysis the extraction procedure 
was performed without lipid removal (as in Figure 6.11 B) to give a more precise 
reflection of the relative abundance of these peptides in response to larval infection.  
(A) 
 
 
 
 
(B) 
 
 
Figure 6.11 Changes to HPLC profiling following lipid removal. 
 Larval haemolymph peptide extracts from untreated larvae were lipid removed using n-
hexane and ethyl acetate (A). Chromatogram (B) shows the same extraction method 
with the exception of lipid removal demonstrating few notable differences in HPLC 
profiling.  
 
 
 
 
(A)                                                                              
        
      (B) 
        
     (C) 
       
      
     (D) 
       
 
 
Figure 6.12 HPLC profiles of untreated larvae and larvae inoculated with 1 x 107 
conidia at 4 and 24 hours. 
 RP-HPLC larval peptide analysis of larval peptides demonstrate changes to peptide 
profiles with A. fumigatus infection, [U.T 4 hrs (A) 1 x 107 4 hrs (B), U.T 24 hrs (C) 
and 1 x 107 24 hours (D)]. Peak identification was; 1. Lhp-1, 2. Anionic antimicrobial 
peptide 2, 3. ApoLp III. This result verified that intensity of the previously identified 
peaks of interest changed following infection with A. fumigatus.  
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6.3.4 Changes in peptide peak area as a result of lethal fungal inocula. 
Larvae were injected with 1 x 107 A. fumigatus ATCC 26933 conidia or with 
PBS, incubated for 4 or 24 hours at 30ºC and peptides were extracted for HPLC analysis 
as described (Section 2.10.2). Analysis of peaks of interest showed that at 4 hours larval 
haemolymph protein, anionic antimicrobial peptide 2, and apoLp III showed a 1.3, 1.01, 
and 1.29 fold increases in peak area in larvae infected with 1 x 107 conidia respectively 
(Figure 6.12). Such changes are minor but may point to an increase in initial proteomic 
responses following infection. In contrast the HPLC profiles obtained at 24 hours 
demonstrated larval haemolymph protein expression reduced 1.5 fold, anionic 
antimicrobial peptide 2 concentration did not change with apoLp III peak area increased 
1.5 fold. Such an alteration points to a possible variation of the immune response 
following fungal challenge and supports the initial finding that larval immune responses 
are most evident 24 hours post-infection. As a result subsequent proteomic analysis of 
priming concentrations of A. fumigatus conidia were focussed at 24 hours post-
infection. 
 
6.3.5 Non-lethal infection with A. fumigatus results in increased presence of 
peptides and proteins of interest at 24 hours.  
 Larvae were injected with PBS or 1 x104, 1 x 105 or 1 x 106 A. fumigatus conidia 
incubated at 30ºC for 24 hours and peptides were extracted and subjected to RP-HPLC 
and analysed at 220 nm for the relative abundance of proteins and peptides identified 
previously (Figure 6.13 and Table 6.3). Significantly, peak number 1 identified as larval 
haemolymph protein demonstrated a 2 and 2.1 fold increase (p  0.01) in abundance 
following priming with A. fumigatus ATCC 26933. Larvae injected with 1 x 106 conidia 
showed a decrease in this peak area relative to other priming doses. Considering the 
significant increases in viability conferred by 1 x 104 and 1 x 105 conidial inoculations 
(A)                                                         (B) 
 
 
(C)                                                         (D) 
 
 
(E) 
                              
                           1 x 104    1 x 105    1 x 106 
 
Figure 6.13 Changes to peptide peak area in response to priming doses of conidia 
and evidence of sample integrity.  
 HPLC profiles of haemolymph peptide analysis from larvae injected with PBS (A), 1 x 
104 (B), 1 x 105 (C) and 1 x 106 (D) conidia. SDS-PAGE (15%) clarification of sample 
integrity (E). Larvae injected with conidia did not demonstrate breakdown of 
apolipophorin III as verified by in gel digestion and LC/MS analysis.  A list of 
identified peaks and their fold expression to untreated control larvae is presented in 
Table 6.3. 
 
 
    12    3 
    

    
 
    12     3 
    

     
 
    12     3 
    

     
     12    3 
    

    
 
Apolipophorin III 
    Score: 444 
    Peptides Matched: 11 
    Coverage: 33% 
  
   Peak area fold change 
Peak No Peptide I.D Control 1 x 104 1 x 105 1 x106 
1 Larval haemolymph protein 1 2 2.1 1.58 
2 Anionic antimicrobial peptide 2 1 0.89 0.9 0.223 
3 Apolipophorin III 1 1.27 1.1 0.243 
 
 
Table 6.3 Fold change of identified larval peptides following infection with non-
lethal A. fumigatus inocula. 
Identified peak areas were expressed as a fold change relative to larvae injected with 
PBS from the HPLC analysis presented in Figure 6.13. Larvae that received doses of 1 x 
104 and 1 x 105 conidia demonstrated a significantly higher presence of larval 
haemolymph protein (p  0.01) but did not vary in the amount of anionic antimicrobial 
peptide 2 or apoLp III, (p  0.055 and 0.065). Priming with 1 x 106 conidia resulted in a 
significant decline in the presence of anionic antimicrobial peptide 2 and apoLp III, 
(0.002 and 0.0032 respectively).  
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to G. mellonella larvae after 24 hours and the association of these doses with the 
increased expression of larval haemolymph protein it may be possible that synthesis of 
this protein is increased in healthy larvae as a means of supporting the cellular immune 
response. 
 Anionic antimicrobial peptide 2 peaks decreased approximately 10% with fungal 
inoculation of 1 x 104 or 1 x 105 conidia (p  0.055) and by 77% when larvae were 
injected with 1 x 106 conidia (p = 0.002). This finding is particularly interesting as the 
work of Mak et al., (2010) and Cytrnska et al., (2007) demonstrated that induction of 
this protein in G. mellonella larvae took place upon bacterial challenge. It is therefore 
interesting that the decrease in abundance of this peptide in larvae challenged with A. 
fumigatus may be part of a specialisation of the host immune response in terms of 
targeting the infecting microbe. Alternatively this may be a result of proteolytic 
cleavage of host proteins by secreted extracellular proteases produced by A. fumigatus.  
 Peak number 3 identified as apoLp III was present in infected and non-infected 
larvae. The relative increase of apoLp III in larvae inoculated with 1 x 104 (1.27 fold, p 
= 0.065) and 1 x 105 (1.1 fold, p = 0.12) and subsequent decrease with 1 x 106 conidia 
(0.243 fold, p = 0.0032) was interesting as it pointed to a potential degradation of this 
protein over time. Such an occurrence has been observed previously in studies 
concerning apoLp III. Andreijko et al., (2008) demonstrated degradation of apoLp III in 
cell free haemolymph 24 hours post-infection with P. aeruginosa by the appearance of 
immunoreactive polypeptides at 15, 13.3, 12 and 9.5 kDa which was speculated to be 
the result of the production of a protease IV by P. aerunginosa for which apoLp III is a 
substrate, (Andrejko et al., 2005). In Figure 6.13 E there did not appear to be any 
significant breakdown associated with infection with 1 x 106 conidia larvae-1 therefore 
the reasons for reduction at this concentration may be linked to a subsequent decline in 
larval immunocompetence prior to further infection (Figure 6.2).  
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6.3.6 Identification of proteins with altered expression following immune priming, 
by 2-D electrophoresis and LC/MS analysis. 
The aim of this section was to analyse the changes in the humoral proteomic 
profile of G. mellonella larvae that were expressed in response to a non-lethal conidial 
inoculum. 
Larvae were left untouched or injected with PBS, 1 x 104 or 1 x 105 A. fumigatus  
ATCC 26933 conidia and incubated for 24 hours at 30ºC. Cell free hemolymph was 
extracted, subjected to 2-dimensional electrophoresis (Figure 6.14) and analysed using 
Progenesis software using a haemolymph profile from untreated larvae as a reference 
map (Figure 6.15). Following Progenesis analysis spots were excised and subjected to 
tryptic digestion and LC/MS analysis with database interrogation using the MASCOT 
search engine (Section 2.13). Initially all peptides of interest were searched for larval 
homology (Figure 6.16 and Table 6.4). Any spots which failed to yield identity were re-
searched for homology against all invertebrates (Figure 6.17 and Table 6.5) with an ion 
score cut-off of 48. Identified proteins are expressed relative to untreated larvae (U.T). 
Spot number 1, identified as having the highest level of change in response to 
non-lethal fungal stimuli was identified as hexamerin an 81.8 kDa protein which was 
shown to increase in expression 4.38 fold in larvae injected with 1 x 105 conidia. 
Hexamerin biosynthesis takes place in the fat body and is subsequently released into the 
haemolymph where it is considered to function as a source of amino acids, (Kanost et 
al., 1990; Burmester and Scheller, 1999). It has been demonstrated that hexamerins are 
endocytosed by fat body cells and act as storage proteins during larval feeding prior to 
metamorphosis, (Gilbert et al., 2000).  
Given the increase in hexamerin it is not surprising that a 7.3-fold increase in a 
homologous hexamerin receptor identified in Corcyra cephalonica is observed in larvae 
injected with 1 x 105 conidia (Spot number 2). The hexamerin receptor has been 
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Figure 6.14 Larval haemolymph proteomic profile with non-lethal A. fumigatus 
treatments. 
Larvae were left untreated (A) or injected with PBS (B), 1 x 104 (C) or 1 x 105 (D) A. 
fumigatus ATCC 26933 conidia and incubated at 30ºC for 24 hours. Protein was 
extracted and the proteomic profile was examined using 2-dimensional electrophoresis. 
All subsequent changes were compared to larvae that were incubated at 30ºC but were 
not injected with conidia. 
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Figure 6.15 Spots excised for fold change analysis from G. mellonella haemolymph 
profiles following immune priming. 
An unstimulated larval treatment was used to excise spots which showed alterations in 
expression as determined by Progenesis™ same spot analysis. Spots circled red (1-8) 
were identified in G. mellonella or other moth larvae. Spots circled blue (9-13) were 
identified to homologous proteins from other invertebrate species. 
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Figure 6.16 Individual larval haemolymph spot analyses of proteins which show 
differential abundance with immune priming.  
Gels were analysed using Progenesis™ “ Same spot”  software. Spots which showed 
differential expression (p  0.05) were excised and identified using LC/MS analysis 
(except juvenile hormone binding protein which did not change significantly (p  0.1)). 
The fold expression relative to untreated larvae (U.T) is also displayed.  
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Figure 6.17 Individual spot analysis identified in other species. 
In some cases it was not possible to attain spot identity in G. mellonella. Other 
invertebrate databases were searched for protein homologues to aid identification of 
spots of interest. The fold change in expression relative to untreated larvae (U.T) is also 
presented. 
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 Spot I.D gi Score Peptides 
matched Coverage 
Hexamerin 347090 183 5 8% 
Hexamerin receptor 282722536 96 2 2% 
Apolipophorin III 5915688 241 6 33% 
32 kDa ferritin 
subunit 17901818 270 7 25% 
Arylphorin 384243 340 7 14% 
Apolipophorin 50404098 132 3 28% 
Gallerin 1146408 169 2 12% 
Juvenile hormone 
binding protein 158515746 165 8 17% 
 
Table 6.4 Identified larval proteins data.  
MASCOT identification data from excised spots presented in Figure 6.16. All spots 
were associated with G. mellonella larvae except hexamerin receptor which was 
identified in Corcyra cephalonica (rice moth). A MASCOT score cut-off of 62 was 
used for positive identification of proteins. 
 
 
 
Spot I.D Organism gi Score Peptides 
matched Coverage 
GJ23138 D. virilis 195390311 64 2 3% 
GF17786 D. ananassae 190626532 54 1 6% 
GJ14984 D. virilis 195402607 52 1 1% 
GM22874 D. sechella 195345353 59 3 1% 
Arginine 
Kinase H. gammarus 585342 151 3 12% 
 
Table 6.5 Data of spots identified in other invertebrate species. 
MASCOT identification of spots presented in Figure 6.17. Peptide ions which were not 
identified in larvae were identified in Drosophila spp. and Homarus gammarus, 
(European lobster). A MASCOT score cut-off of 62 was used for positive identification 
of proteins. 
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identified as a member of the low density lipoprotein receptor superfamily, (Burmester 
and Scheller 1999) and functions as a binding site for hexamerin in fat body cells, 
(Zhou et al., 2006). 
Spot number 3, was identified as apoLp III which decreased in expression 0.67 
and 0.64 fold in larvae that received 1 x 104 and 1 x 105 conidia respectively but 
demonstrated a 1.44 fold increase in PBS injected larvae.  ApoLp III has been shown to 
bind 1,3-glucan (Whitten et al., 2004), and lipotechtoic acid in Gram positive bacteria, 
(Halwani et al., 2000).  ApoLp III has been previously shown in this Chapter to be 
particularly abundant in larval haemolymph, while the identified spot in this section is 
quite low in intensity. ApoLp III is an insect low density lipoprotein (LDL) which holds 
critical functions in terms of reversible lipid binding and transport characterised by 
amphipathic -helices which contribute to the presence of lipid bound and lipid free 
forms of apoLp III (Segrest et al., 1992; Weers and Ryan, 2006). It may be possible that 
the lipid binding nature of this protein caused a change in the surface charge of the 
protein thus causing a shift in isoelectric focussing of the spot.  
The fourth spot of interest was identified as a 32 kDa ferritin subunit. Cloning 
and expression studies of this protein initially demonstrated a high level of expression 
of this protein following iron feeding (Kim et al., 2002), as iron is toxic to host tissue 
due to its role in the formation of free radicals (You and Wang, 2005). Ferritin 
contributes to cellular iron ion homeostasis by sequestering free iron and has also been 
demonstrated to be increased in expression following bacterial infection in Drosophila 
melanogaster, (Vierstraete et al., 2004). Interestingly ferritin is also present in mammals 
where sequesterisation of iron is critical to limiting the spread of infection due to the 
necessity of microbes to access free iron (Haas et al., 2008; Schrettl et al., 2004). The 
role of ferritin is of particular importance in this case as inoculations with sub-lethal 
concentrations of A. fumigatus conidia results in increased expression of the 32 kDa 
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ferritin subunit. Larvae injected with 1 x 104 and 1 x 105 conidia exhibited 2.08 and 1.96 
fold increases in the expression of ferritin respectively. This finding strengthens the link 
between the control of the spread of fungal infection and the limitation of free iron 
accessible to the invading microbe. 
Spot number 5 was identified as arylphorin. Arylphorin is a member of the 
insect haemocyanin family and BLAST analysis of this protein indicates a high level of 
homology with other arylphorins and hexamerins from insect species (data not 
presented). Larvae injected with 1 x 104 conidia showed a significant increase in the 
expression of arylphorin 24 hours post infection compared to PBS and 1 x 105 injected 
larvae which showed a decrease in expression. At present there is no evidence to 
suggest a direct antifungal role for arylphorin in insect species rather its annotated role 
is as a storage protein and oxygen transporter activity. A proteomic approach to the 
effect of E. coli and M. luteus bacterial feeding in larvae of Trichoplusia ni 
demonstrated a significant increase in the presence of arylphorin as one of a number of 
key proteomic changes associated with resistance to further infection, (Freitak et al., 
2007). It may be possible that the lowest concentration of conidia injected into larvae 
stimulates a response similar to controlled low doses that would be possible with a 
feeding event however considering the relative change in expression relative to 
uninfected larvae it is likely that alterations in arylphorin expression is related to an 
antibacterial response. 
Spot number 6 was identified as apolipophorin (apo 1). Apo 1 was expressed 
1.44, 1.77 and 0.98 fold when injected with PBS or 1 x 104 and 1 x 105 conidia, 
respectively, compared to untreated larvae. While apo 1 is classed among the same 
family of lipophorin based apolipoproteins as apoLp III there appears to be no previous 
evidence to suggest that apo 1 is directly involved in the antifungal response of insects. 
Apo 1 has been demonstrated to display conserved functions with other proteins within 
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this family of lipid transport and lipoprotein metabolism, (Weers and Ryan, 2006). Apo 
1 does display functionality in response to bacterial challenge where coagulation of apo 
1 takes place to form a globular structure resulting from oligomeric interactions with 
LPS thus neutralising LPS from the surrounding environment (Ma et al., 2006).   
Spot number 7 was identified as gallerin. Larvae inoculated with 1 x 104 and 1 x 
105 A. fumigatus conidia display a 1.21 and 1.33 fold increase in gallerin expression 
relative to untreated larvae. Gallerin is annotated as a member of the calycin family of 
immunologically relevant proteins. Other members of this family include alpha-1-acid 
glycoprotein 1 which functions in the acute phase response to infection and regulates 
the immune system processes. This process is mediated in neutrophils by cytosolic Ca2+ 
through the binding of immunoglobulin-like lectins with the effect of inhibiting 
superoxide production (Laine et al., 1990; Gunnarson et al., 2007). The presence of a 
functionally similar protein in G. mellonella larvae is of particular interest as the precise 
role of gallerin in fungal infections is unknown. The expression of this protein increases 
with the level of fungal infection therefore pointing to a role in the regulation of the 
cellular immune response to pathogenic fungi. 
Spot number 8 was identified as juvenile hormone binding protein (JHBP) 
which did not show a statistically significant change in expression following fungal 
infection. JHBP is synthesised in fat body cells and serves a carrier protein for juvenile 
hormone (JH) which plays a key role in regulation of metamorphosis and development 
in insects, (Gilbert et al., 2000; Zalewska et al., 2009). Flatt et al., (2008), identified that 
juvenile hormone antagonistically regulates the production of antimicrobial peptides in 
D. melanogaster, however it remains unclear whether such a process is evident in G. 
mellonella.  
Certain spots which demonstrated significant alterations in expression were not 
identified in larvae but did show sequence homology with proteins in other 
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invertebrates (Figure 6.16 and marked as blue circles in Figure 6.15). There was a 6.9 
fold increase in the presence a protein homologous to DNA binding protein GJ23138 
identified from Drosophila virilis (Spot number 9) in 1 x 105 injected larvae. BLAST 
analysis of this protein identifies a GJ23138 to have a motif present in the pipsqueak 
protein of Drosophila which is a helix turn helix protein that binds to GAGA sequences 
(Lehmann et al., 1998). 
There was a 4.1 fold increase in an isochorismatase-like protein annotated as 
GF17786 from Drosophila ananassae (Spot number 10). An isochorismatase 
homologue occurs in E. coli and is known to be involved in the hydrolyzation reactions, 
(Hamano et al., 2006). 
A 1.53 fold increase in the presence of protein homologous to GJ14984 from D. 
virilis (Spot number 11) was observed when larvae were injected with 1 x 104 conidia. 
BLAST analysis of GJ14984 reveals 95% coverage with an organic anion transporting 
polypeptide from D. melanogaster which functions in the transport of macromolecules. 
A 2.76 and 1.8 fold increase in the expression of a protein homologous to 
GM22874 from Drosophila sechella was observed in 1 x 104 conidia injected larvae 
(Spot number 12). BLAST analysis of this protein displays 99% sequence homology 
with the dynein heavy chain at 16F protein from D. melanogaster. Dynein is a 
microtubule motor protein. Annotations for this protein indicate ATP binding and 
ATPase activity as critical functions of this protein (Asai and Wilkes, 2004). 
 Spot number 13 was identified as a protein showing sequence homology with 
Arginine kinase (AK) from Homarus gammarus (European Lobster). There was a 1.74 
fold increase in the expression of AK in larvae primed with 1 x 104 conidia relative to 
untreated larvae with larvae inoculated with PBS and 1 x 105 conidia demonstrating 
1.35 and 0.73 fold alterations in expression respectively. The identification and analysis 
of the expression of arginine kinase is particularly interesting as AK is the most 
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abundant phosphagen kinase in invertebrates, with the function of catalysing the 
transfer of a phosphoryl group to ADP thus forming ATP (Kotlyar et al., 2000).  
 
6.3.7 Summary. 
 In this section a comprehensive approach to elucidate changes in proteomic 
profile following infection with non-lethal conidial inocula was employed. RP-HPLC 
coupled to LC/MS analysis of G. mellonella peptides demonstrated the increase in 
expression of G. mellonella larval haemolymph protein which functions in oxygen 
transportation. This coincided with reduced expression of anionic antimicrobial peptide 
2 which functions in the bacterial response. Interestingly the expression of apoLp III did 
not appear to be greatly influenced by non-lethal conidial infection. Analysis of 
differential expression of haemolymph proteins by 2-dimensional electrophoresis 
coupled to LC/MS revealed the increased expression of proteins involved in 
macromolecule storage, iron sequesterisation, clotting, acute phase response and ADP 
phosphorylation following priming with 1 x 104 A. fumigatus conidia. 
 
6.4 RT-PCR analysis of G. mellonella AMP gene expression. 
 The expression and synthesis of antimicrobial peptides (AMPs) is a key 
component of the innate immune system of insects, (Bergin et al., 2006; Brown et al., 
2008). Recent work by Mowlds et al., (2009) demonstrated that the innate immune 
system of G. mellonella larvae could be effectively protected against C. albicans 
infection by utilising the priming response initiated by injecting larvae with -glucan. 
Such a response is interesting as it points to a short-term increase in the immune status 
of the host in advance of subsequent infection. Therefore, a study investigating whether 
non-lethal concentrations of A. fumigatus resulted in a significant increase in AMP gene 
expression was warranted. 
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6.4.1 RT-PCR analysis of larval AMP genes following inoculation with non-lethal 
conidial inocula. 
 Larvae were inoculated with PBS or 1 x 104, 1 x 105 or 1 x 106 conidia and 
incubated at 30ºC for 4, 24 and 48 hours. As an additional control larvae were left 
untreated. RNA extraction, cDNA synthesis and PCR amplification of transcribed genes 
of interest was performed as described (Section 2.21). Resulting PCR products were 
quantified by densitometry using ImageQuant software. All values were normalised by 
-actin and were expressed as a fold change relative to untreated larvae. 
Analysis of gene expression demonstrated only slight alterations in PCR product 
band intensity after 4 hours priming at 30ºC (Figure 6.18). There was no statistically 
significant change to the expression of galiomycin, transferrin or impi at this timepoint. 
Larvae injected with 1 x 105 conidia displayed a 12% increase in the expression of 
gallerimycin (p = 0.002) 4 hours post infection. This result was not surprising as low 
doses of A. fumigatus have been demonstrated to have a limited effect on larval viability 
when larvae are subsequently injected with lethal concentrations of A. fumigatus. 
At 24 hours there were clear differences in relative gene expression (Figure 
6.19).  Larvae injected with 1 x 104, 1 x 105 and 1 x 106 conidia demonstrated 2.29 ± 
0.096, 2.66 ± 0.11 and 3.03 ± 0.17 fold increases in gallerimycin expression 
respectively (p = 0.001). Galiomycin expression was not altered significantly at this 
timepoint with p  0.128 in all comparisons. The expression of transferrin was also 
significantly increased following larval infection showing 1.11 ± 0.04, 1.23 ± 0.04 and 
1.24 ± 0.04 fold (p  0.007) fold increases in expression following 1 x 104, 1 x 105 and 
1 x 106 conidial infection. In addition impi expression increased 1.11 ± 0.05 1.16 ± 0.05 
and 1.19 ± 0.05 fold (p  0.009) following the same rate of infection.  
At 48 hours, (Figure 6.20) gallerimycin expression was demonstrated to be 
significantly increased in larvae injected with 1 x 105 and 1 x 106 conidia relative to 
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Figure 6.18 RT-PCR analysis of G. mellonella cDNA extracted from whole larvae 
after 4 hours and separated on a 1% agarose gel. 
Larvae were injected with PBS or inoculated with 1 x 104, 1 x 105 or 1 x 106 A. 
fumigatus ATCC 26933 conidia or left untreated (U.T). Larvae were incubated for 4 
hours, RNA was extracted and cDNA was synthesised. PCR was performed using 
primers for -actin, gallerimycin, galiomycin, transferrin and impi. Resulting PCR 
products were visualised on a 1% agarose gel and bands were quantified using 
densitometry. -actin was used as a control which was demonstrated to show no change 
in expression and gene expression was calculated as a fold change from untouched 
larvae. Quantification was achieved by densitometric analysis of four independent PCRs 
for each gene. 
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Figure 6.19 RT-PCR analysis of G. mellonella cDNA extracted from whole larvae 
after 24 hours and separated on a 1% agarose gel. 
Larvae were injected with PBS or inoculated with 1 x 104, 1 x 105 or 1 x 106 A. 
fumigatus ATCC 26933 conidia or left untreated (U.T). Larvae were incubated for 24 
hours, RNA was extracted and cDNA was synthesised. PCR was performed using 
primers for -actin, gallerimycin, galiomycin, transferrin and impi. Resulting PCR 
products were visualised on a 1% agarose gel and bands were quantified using 
densitometry. -actin was used as a control which was demonstrated to show no change 
in expression and gene expression was calculated as a fold change from untouched 
larvae. Quantification was achieved by densitometric analysis of four independent PCRs 
for each gene. 
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Figure 6.20 RT-PCR analysis of G. mellonella cDNA extracted from whole larvae 
after 48 hours and separated on a 1% agarose gel. 
Larvae were injected with PBS or inoculated with 1 x 104, 1 x 105 or 1 x 106 A. 
fumigatus ATCC 26933 conidia or left untreated (U.T). Larvae were incubated for 48 
hours, RNA was extracted and cDNA was synthesised. PCR was performed using 
primers for -actin, gallerimycin, galiomycin, transferrin and impi. Resulting PCR 
products were visualised on a 1% agarose gel and bands were quantified using 
densitometry. -actin was used as a control which demonstrated to show no change in 
expression and gene expression was calculated as a fold change from untreated larvae. 
Quantification was achieved by densitometric analysis of four independent PCRs for 
each gene. 
*** p  0.003    * p  0.009 
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untreated larvae demonstrating relative increases of 1.2 ± 0.09 and 1.29 ± 0.02 fold (p  
0.003) however these values had dropped significantly compared to relative fold 
changes at 24 hours (Figure 6.19). Larvae injected with PBS or 1 x 104 conidia did not 
demonstrate any significant increase in expression at this time. Galiomycin expression 
was increased 1.13 ± 0.05 and 1.27 ± 0.05 fold at this timepoint in larvae injected with 1 
x 105 and 1 x 106 conidia respectively (p  0.009). Transferrin expression was not 
altered significantly after 48h displaying a return to baseline levels of expression at this 
timepoint. IMPI expression was significantly increased at 48 hours displaying a 1.14 ± 
0.02, 1.11 ± 0.02 and 1.15 ± 0.05 (p  0.006) fold increase over untreated larvae when 
injected with 1 x 104, 1 x 105 and 1 x 106 conidia, respectively. 
 
6.4.2 Summary. 
 The effect of infecting G. mellonella larvae with sub-lethal concentrations of A. 
fumigatus on AMP gene expression was investigated by RT-PCR in combination with 
densitometric analysis of resulting gel products. Analysis of galiomycin, gallerimycin, 
transferrin and impi expression at 4 hours post infection with 1 x 104, 1 x 105 and 1 x 
106 conidia demonstrated no significant change in expression. At 24 hours post 
infection there were highly significant increases in gallerimycin expression following 
immune priming (p  0.001). In addition there were also significant increases in 
transferrin and impi expression following conidial priming (p  0.007 and 0.009 
respectively). At 48 hours the levels of expression did not vary as much however there 
were significant increases in gallerimycin, galiomycin and impi expression (p  0.003, 
0.009 and 0.006 respectively). 
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6.7 Discussion. 
 The adaptability of the innate immune response of G. mellonella has been 
identified in recent years as being far more advanced than previously thought. Central to 
this are fluctuations in haemocyte density, synthesis of antimicrobial peptides and 
notable shifts in the proteome of the humoral immune response which effectively deal 
with pathogens, (Whitten et al., 2004; Bergin et al., 2006; Andrejko et al., 2009). 
The results presented here showed that non-lethal inocula with conidia conferred 
a significant protective response in larvae injected with 1 x 104 conidia but larvae 
injected with 1 x 105 or 1 x 106 conidia did not record statistically significant increases 
in viability when administered a follow-up injection of 1 x 107 conidia. This immune 
priming event is continued at 48 hours post infection with larvae inoculated with 1 x 104 
and 1 x 105 conidia and subsequently injected with 1 x 107 conidia demonstrating 
increased viability at the endpoint of this study (p  0.02). The 1 x 106 conidial 
inoculum did not prime larvae against subsequent fungal infection however this may be 
a result of a cumulative fungal burden over time. It is worth noting that the survival of 
larvae injected with PBS prior to subsequent infection with A. fumigatus was reduced in 
a stepwise manner 4, 24 and 48 hours. This is a key factor as it contributed to the 
significance of the data obtained. This a suprising result however it would appear to be 
correlated with a reduction in haemocyte density at the same timepoints as observed in 
Figure 6.4. The reasons for this occurrence are as yet unclear. 
 To fully understand the key changes in the balance of the immune status 
corresponding to priming events and the fluctuations that take place over time, a study 
identifying changes to different parameters of the immune response was employed. 
Larvae injected with conidia demonstrated a statistically significant increase in the 
number of circulating haemocytes µl-1 of haemolymph increasing 1.79, 1.49, and 1.71 
fold 24 hours post-infection with 1 x 104, 1 x 105 and 1 x 106 conidia respectively (p  
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0.028). It was particularly interesting to note that the number of circulating haemocytes 
had declined rapidly by 48 hours. Such a reduction in the number of haemocytes is 
indicative of a possible return to a normalised immune state. It has been previously 
demonstrated that a priming event initiated by physical stress results in haemocyte 
densities approximately 2.3 fold greater than control larvae after 48 hours (Mowlds et 
al., 2008). Initial investigations of the importance of an adequate number of circulating 
haemocytes and general larval fitness in G. mellonella demonstrated that highly 
pathogenic yeast isolates cause a reduction in the number of haemocytes thus assisting 
in the proliferation of the microbe throughout the insect (Bergin et al., 2003) due to the 
fact that haemocytes bind to yeast cells. Considering the improved viability of G. 
mellonella primed with 1 x 104 conidia for 24 hours (Figure 6.2) and the observation 
that haemocyte density of larvae peaks 24 hours following inoculation with the same 
dose (Figure 6.4) it is not unreasonable to suggest that there is a strong link between the 
two. Dean et al., (2004) demonstrated the appearance of a class of haemocyte in M. 
sexta with extreme spreading ability with the additive effect of forming nodules which 
limit the proliferation and spread of an invasive pathogen. Given the functional 
similarities demonstrated between the immune system of both of G. mellonella and M. 
sexta it would be interesting to investigate if such process is present in G. mellonella. 
Furthermore a study of such a fluctuation in response to natural infection and targeted 
injection of non-lethal doses is warranted. 
 The work of Whitten et al., (2004), demonstrated a role for the lipoprotein 
apoLp III in protection against fungal infection with lipid associated form of the protein 
thus acting as a pattern recognition receptor (PRR) within the haemocoel. The additive 
effect of apoLp III binding to conidia is enhanced cell attachment and spreading. From 
the data presented here there appears to be small alterations in levels of apoLp III in 
larvae as detected by RP-HPLC following infection with 1 x 104 and 1 x 105 inocula of 
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conidia at 24 hours, (Figure 6.13 and Table 6.1), however the presence of apoLp III in 1 
x 106 conidia injected larvae appears drastically reduced. It may be possible that apoLp 
III levels are intrinsically linked to larval immunological health in response to fungal 
pathogens. Critically, haemolymph of larvae primed for 24 hours with A. fumigatus 
conidia demonstrate a higher affinity for conidia as presented in Figure 6.5. 
Haemolymph from larvae primed with 1 x 104 and 1 x 105 conidia showed significant 
increases in apoLp III binding at this timepoint (p  0.048). These findings along with 
the work of others (Zakarian et al., 2002) strengthens the assertion that apoLp III plays 
a critical role in linking the cellular and humoral immune responses with the additive 
effect of improving larval resistance to invading fungal pathogens. However, further 
work is necessary to understand if apoLp III binding is altered when larvae are 
incubated at 4 or 48 hours as this would place this occurrence of the immune response 
into context. 
 Prophenoloxidase (PPO), a 79 kDa zymogen (in its native form) plays a critical 
role in initiating melanisation and limitation of microbial proliferation upon infection, 
(Kavanagh and Reeves, 2004). The activation of this response is mediated by controlled 
serine protease cleaving of PPO with the combined effect of forming melanin within the 
haemocoel which is toxic to the microbe, and to the host at high concentrations. Figures 
6.6 and 6.7 demonstrate that not only is the presence of PPO increased upon fungal 
stimulation at 4 and 24 hours post-infection but there is a significant (1.97 fold) increase 
in the  relative expression of PPO at 24 hours in larvae infected with 1 x 104 conidia (p 
= 0.026). At 48 hours there was evidence of a complete breakdown of native PPO with 
the detection of lower molecular weight bands indicating cleavage of the native protein 
therefore any protective effect native PPO could play in the eradication of subsequent 
infection is diminished. This is further supported by the non-specific cleavage of the 
enzyme as is evidenced by the breakdown products in haemolymph from untreated and 
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PBS injected larvae when probed for PPO. The work presented here emphasises the role 
of an abundance of PPO in haemolymph as being a critical factor in the priming of the 
immune state thus contradicting the previous assertion made by Hung and Boucias, 
(1996) that strong activation of the PO cascade was critical to immunoprotection.  
 Analysis of the RP-HPLC profile coupled to LC/MS identification of peaks also 
identified a key factor in the reduction in peak area associated with anionic 
antimicrobial peptide 2. At 24 hours following injections with 1 x 104, 1 x 105 and 1 x 
106 conidia there was a marked decrease in the abundance of this peptide in the larval 
peptide profile. This finding is particularly interesting as anionic antimicrobial peptide 2 
does not display any activity against Aspergilli, (Cytrnska et al., 2007). The observed 
reduction in the abundance of this peptide point to a specialisation of the immune 
response against a fungal pathogen following infection. However it remains to be fully 
understood if this process is as a result of differential signalling through a Toll receptor 
pathway (Lemaitre et al., 1996). 
 The increased expression of larval haemolymph protein (lhp-1) in response to 
immunoprotective fungal priming and the association between high titres of the peptide 
and larval survival is of great interest. Electronic annotation of this peptide points to a 
role in oxygen transport due to the presence of a haemocyanin di-copper binding 
domain. Such a role for a low molecular weight protein is novel as the impact of 
microbial infection and oxygen transport within larvae receives little attention. It 
remains to be understood what transcriptional regulation takes place in response to 
fungal microbe sensing in order to cause enhanced synthesis of this product however the 
abundance of this peptide appears to be intrinsically linked to larval fitness in advance 
of a subsequent infection. Another role for enhanced oxygen transport could be to 
support the cellular immune response which it has been demonstrated to form a 
functional NADPH oxidase-like complex, with the resulting formation of superoxide 
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(Renwick et al., 2007). It is worth noting that the decrease in lhp-1 and anionic 
antimicrobial peptide 2 in larvae  injected with 1 x 106 conidia relative to larvae injected 
with 1 x 104 or 1  x 105 conidia may be  as a direct result of injection proteolytic 
cleavage cuased by secreted extracellular proteases produced by A. fumigatus. 
Extracellular proteases produced by A. fumigatus are important virulence factors (Alp 
and Arikan, 2008, Behnsen et al., 2010 and Birch et al., 2004) therefore it is possible 
that the heavier fungal burden may have resulted in the accumulation of such an effect 
in larvae. 
The observed cellular and metabolic shifts observed in the data presented here 
are further supported by LC/MS data. Spots identified as hexamerin, hexamerin 
receptor, 32 kDa ferritin subunit, apolipophorin and gallerin and arginine kinase show 
marked increases in expression 24 hours post infection with 1 x 105 conidia. 
Considering the role of hexamerin as a storage protein which is endocytosed by fat body 
cells (Gilbert et al., 2000) it is perhaps surprising that such an emphasis on the storage 
of amino acids and nutrients is evidenced at the proteomic level. As a result of the fold 
increase in hexamerin synthesis following fungal inoculation it may be possible that as 
well as functioning as a storage  protein particularly high expression of hexamerin may 
be a biomarker for a respiratory shift at the onset of more acute larval infection but not 
necessarily efficient priming of the immune response. It is noted that both the 
expression of hexamerin and hexamerin receptor are greatly reduced in larva injected 
with 1 x 104 conidia relative to infection with 1 x 105 conidia. This finding is perhaps 
surprising considering the impact of higher fungal inocula. However the “ trade off”  
between larval fitness and effective immune priming has been documented by Freitak et 
al., (2007) in a study of priming in Trichoplusia ni larvae. Effective priming of larvae 
resulted in a negative impact on “ fitness-traits”  such as mass and pupal development 
which is interesting considering the work of Zalewska et al., (2009) where it was 
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demonstrated that hexamerin binds juvenile hormone and thus plays a role in the 
development of larvae form the larval to the pupal stage. Therefore the effective 
priming of larvae induced by 1 x 104 conidia viewed elsewhere in this Chapter may 
have a side-effect of reducing conventional larval fitness with the benefit of a more 
efficient immune system aimed at certain pathogens.  
The approximate two-fold increase in expression of the 32 kDa ferritin subunit 
is an interesting development in understanding the balance between priming larvae 
appropriately for fungal infection and maintaining physiologically sustainable levels of 
available iron within the haemocoel. This balancing of iron levels has been 
demonstrated by others to play a key role in the immune system/fungal iron 
seqesterisation balance (Vierstraete et al., 2004: Schrettl et al., 2004). From the data 
presented in Figure 6.16 it is proposed that enhanced synthesis of ferritin as a means of 
sequestering any free iron from Aspergillus siderophores plays a key role in protecting 
the host against the higher fungal inoculum by effectively depleting the fungus of its 
iron requirement. 
The increased expression of apolipophorin (apo 1) is interesting in the light of 
work presented by Ma et al., (2006) as it may suggest a role for apo 1 in the 
neutralisation and localisation of A. fumigatus within the haemocoel. The process of apo 
1 based neutralisation of LPS is a means of immunoprotection that has yet to be studied 
for fungi however the increased expression of this protein in response to an 
immunoprotective concentration of conidia may warrant further research.  The increase 
in the expression of gallerin is an interesting finding considering that this protein has 
been annotated a functional role in the acute phase response of fungal infections, a trait 
that is conserved with human alpha-1-acid glycoprotein 1. Laine et al., (1990) identified 
that alpha-1-acid glycoprotein 1 plays a role in inhibiting superoxide production. This 
observation, considering the increase in gallerin expression 24 hours post-infection with 
 181  
a sub-lethal fungal inoculum may point to a functionally conserved role between 
vertebrates and invertebrates as superoxide production at unchecked levels is damaging 
to host tissue. 
Arginine kinase (AK) plays a highly conserved role in the phosphorylation of 
ADP (Kotlyar et al., 2000), and the 1.74 fold increase in expression observed following 
immunoprotective stimulation (1 x 104 conidial inoculum) points to a significant change 
in the metabolic profile of larvae in an immune priming event. It is proposed that 
enhanced synthesis of ATP as evidenced by the change in AK expression is indicative 
of an altered rate of respiration with the effect of serving a protective role to larvae, in 
parallel with other factors such as reduction in hexamerin expression and the energy 
requirement posed by an increase in circulating haemocytes (Figure 6.4). 
The observed changes in gallerimycin expression 24 hours post infection with 
non-lethal A. fumigatus inocula are particularly interesting as it points to the synthesis 
of an antimicrobial peptide immune response which serves as an addition to changes in 
proteomic profile, protein activity, and cellular processes commented upon in this 
Chapter. In light of the work of Schuhmann et al., (2003) it is clear that expression of 
gallerimycin (Figure 6.19) and related peptide genes in other invertebrates is influenced 
by the detection of a filamentous fungus, to which it is a potent fungicidal agent. This 
finding is particularly interesting as the work of Schuhmann et al., (2003) demonstrated 
that the G. mellonella gallerimycin peptide which shows sequence similiarity with 
drosomycin and heliomycin showed activity against the filamentous fungi Metarhizum 
anisopliae but demonstrated negligible activity against yeast or bacteria.  The authors of 
this article and Mowlds et al., (2010) demonstrate the use of priming larvae with LPS or 
-glucan as a means of understanding upregulation of the immune response 
corresponding to infection with a pathogen subunit. These findings while particularly 
valuable to advancing the understanding of larval innate immune responses do not 
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distinguish between different classes of microorganisms and the specifically tailored 
immune responses required for the effective eradication of the infecting microbe as is 
demonstrated in the work of Bergin et al., (2006). It is therefore postulated that upon 
infection with A. fumigatus conidia a significant increase in the expression of 
gallerimycin selectively through activation of the Toll pathway targets the immune 
response to the pathogen of interest. Given the immunoprotective effect which these 
non-lethal doses confer to larvae to subsequent infection and the timing of this response 
it is clear that a specialisation of the immune response takes place which is not 
accounted for by injecting with pathogen subunits alone. In interpreting the changes in 
expression for other genes a note of caution must be sounded. While the changes in 
expression were found to be statistically significant it may not hold significance at a 
biological level. For future work it would be necessary to analyse the changes in 
expression using quantitative PCR (q-PCR).  
The data presented in this Chapter demonstrate that larval immune priming 
responses against A. fumigatus appear to peak 24 hours following non-lethal infection. 
This immune priming effect however appears to reduce slightly at 48 hours. In 
summary it is proposed that sensing of specific low doses of pathogen mediate 
protective responses but the scale of this response is not necessarily dose dependent. 
Injections with 1 x 104 conidia result in an increase in the number of circulating 
haemocytes. As a result increase PPO levels within the haemolymph as PPO is 
exocytosed during the cellular response (Kavanagh and Reeves, 2004). This process is 
supported by the enhanced binding activity of apoLp III to conidia and presence of 
larval haemolymph protein (lhp-1) which functions as an oxygen transporter for the 
humoral response. As the antifungal priming event takes place anti-bacterial activity of 
haemolymph is reduced as evidenced by a lowering of anionic antimicrobial peptide 2. 
There is a notable metabolic shift as demonstrated by increased arginine kinase 
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expression but a significant reduction in hexamerin and hexamerin receptor which in 
turn may affect conventional fitness of larvae. However the protective effect further 
mediated by sequesterisation of iron and increased expression of specific antifungal 
peptides point to a specific immune response to the pathogen of interest.  
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7.1 Discussion 
 Aspergillus fumigatus is a significant pathogen among the 
immunocompromised, organ transplant recipients, asthmatics and cystic fibrosis 
patients (Tekaia and Latgé, 2005). The treatment of ABPA, aspergilloma or invasive 
aspergillosis has many drawbacks such as the economic cost of chemotherapy, the toxic 
side-effects of antifungals, the invasive nature of fungal ball removal and the time limit 
imposed by the rapid growing and debilitating nature of fungal pathogenesis. 
Additionally the use of corticosteroids in the treatment of ABPA may leave individuals 
more susceptible to subsequent microbial infection. In recent years the overuse of 
antifungal chemotherapy coupled to the emergence of azole resistance originally as a 
result of mutations in the cyp51A gene however it is now believed that other genes may 
be responsible for this (Verweij et al., 2009; Bueid et al., 2010).  
The testing of pathogenic microbes has previously centred on the use of murine 
models of infection however in recent years larvae of the greater wax moth G. 
mellonella have been demonstrated as an efficient high throughput model of invasive 
aspergillosis with A. fumigatus isolates of attenuated virulence (Slater et al., 2010). 
Such findings support a growing body of work in this area which demonstrated the use 
of G. mellonella as an alternative high throughput model for examining the relative 
virulence of C. albicans, Burholderia cepacia and Yersinia pseudotuberculosis  
(Brennan et al., 2002; Seed and Dennis 2008; Champion et al., 2009). In Chapter 3 the 
use of G. mellonella as an alternative model to study the pathogenicity A. fumigatus 
isolates was assessed. Incubation of larvae at 37ºC results in lower rates of larval 
survival than at 30ºC. Mowlds and Kavanagh, (2008) comprehensively demonstrated 
that incubation of larvae at 37ºC primed the immune response of larvae against 
subsequent infection relative to incubation at 30ºC. Considering this and the similar 
survival rates obtained when infecting larvae with 1 x 106 conidia and incubating at 
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37ºC or infecting with 1 x 107 conidia and incubating at 30ºC the latter infection 
conditions were employed. Screening of A. fumigatus AF293 and the gene deletant 
strains ftmA, psoA and laeA in larvae demonstrated attenuated virulence in all 
mutant strains. Considering the work of Bok et al., (2005) the scale of attenuation of 
laeA was perhaps quite low considering that laeA is a global regulator of secondary 
metabolite biosynthesis and murine data suggested significantly reduced virulence. 
Infection of larvae with differentially matured conidia of clinical and environmental 
isolates of A. fumigatus demonstrated that larval viability was variable depending on the 
source of the isolate and the level of conidial maturation. Three day old conidia 
demonstrated higher virulence than 14 and 28 day old conidia in clinical and 
environmental isolates. However there was some evidence to suggest that larvae 
injected with 14 or 28 day old clinical A. fumigatus conidia demonstrated slightly 
reduced viability on average relative to environmental isolates. An analysis of the 
pathogenicity of A. flavus, A. terreus and A. niger was also performed. A. flavus was 
highly pathogenic in G. mellonella larvae and appeared to grow aggressively through 
the larval cuticle with clear evidence of conidiophore formation. A. flavus has been 
described as an entamopathogen of variable pathogenic potential (Lage de Morales et 
al., 2001). In this study A. flavus is demonstrated as severely pathogenic in G. 
mellonella. The reasons for this are not entirely clear however Renwick et al., (2006) 
did demonstrate that conidial size is inversely correlated with phagocytosis. A. flavus 
does demonstrate pathogenicity in humans however it is normally associated with 
complications of the upper respiratory tract (Pasqualotto, 2009). The validation of G. 
mellonella as an in vivo tool to assess the pathogenicity of A. flavus complements the 
work of Scully and Bidochka, (2005) where it was shown that A. flavus demonstrated 
host specialisation in larvae following serially repeated infection. A. terreus and A. 
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niger also demonstrated virulence in larvae with A. terreus significantly attenuated with 
increased conidial maturation. 
In this study mycotoxin production in 72 hour culture filtrates was assessed in 
clinical and environmental A. fumigatus isolates and revealed a high level of variability 
among different strains with fumagillin production being higher on average in 
environmental isolates. Gliotoxin production, while variable between different strains, 
was statistically similar in clinical and environmental A. fumigatus isolates. Watanabe et 
al., (2003) demonstrated that A. fumigatus culture filtrate did not directly result in 
murine mortality however exposure to culture filtrate and conidia caused increased 
larval mortality. The results presented in this study demonstrate that injection of culture 
filtrates from clinical and environmental A. fumigatus isolates rendered larvae 
susceptible to subsequent infection however it is unclear if specific mycotoxins are 
directly responsible for this. It would appear that culture filtrate mediated 
immunosuppression is multi-faceted and future work will require a comprehensive 
analysis of the synergistic effects of A. fumigatus virulence factors in vivo. In vitro 
growth of A. fumigatus has been correlated to in vivo virulence (Paisley et al., 2005). In 
this study clinical and environmental isolates of A. fumigatus demonstrated variable 
growth on AMM and milk agar. Environmental A. fumigatus isolates demonstrated 
better average growth on AMM relative to clinical isolates indicating improved growth 
on minimal nutrient requirements which may be attributable as a virulence factor. 
Growth on milk agar while showing isolate variability did not distinguish isolates in 
terms of protease capacity. It must be cautioned however that this is a relatively small 
study of the growth of A. fumigatus on different media. It is possible that a wider study 
utilising a greater number of isolates may demonstrate a greater difference between both 
isolate sources.  
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 Reeves et al., (2004) demonstrated that in vivo gliotoxin production reached 
levels of approximately 2400 ng larval tissue g-1.  In this study it was demonstrated that 
gliotoxin production reached similar levels 48 hours post infection. An analysis of in 
vivo fumagillin production demonstrated high levels of mycotoxin production 24 hours 
post-infection with none detected at 72 hours. This finding was particularly interesting 
as the production of fumagillin in vivo during A. fumigatus pathogenesis has not been 
addressed in previous literature and may be representative of the early phases of 
invasive fungal pathogenesis. 
The significant production of fumagillin after 24 hours prompted a study to 
investigate the effect of fumagillin on neutrophil function. An investigation of the 
immunosuppressive effect of fumagillin in G. mellonella larvae demonstrated that 
injection with 2 µg fumagillin 20 µl-1 increased larval susceptibility to A. fumigatus 
infection. Fumagillin (2 µg ml-1) significantly reduced the killing ability of neutrophils 
and haemocytes in vitro without inducing necrotic effects. It was notable that killing 
was not adversely affected by pre-exposing neutrophils or haemocytes to fumagillin 
however it was evident that the inhibitory effect was not observed at all time-points but 
was significant 60 minutes post-incubation. Incubation of larvae with fumagillin caused 
a reduction in phagocytosis coupled to a decrease in oxygen consumption in PMA 
stimulated neutrophils and haemocytes. Bergin et al., (2005) and Renwick et al., (2006) 
demonstrated sequence and functional similarities between the cytosolic components of 
neutrophil NADPH oxidase complex and G. mellonella haemocytes. The proteomic 
conservation of the NADPH oxidase complex between the two cell types aided the 
identification of reduced p47 translocation in haemocytes from the cytosol to the 
membrane. This complements the findings of Renwick et al., (2007) as it would appear 
that mycotoxin mediated inhibition of NADPH oxidase formation is conserved between 
both cell types thus extending the similarities between both immune responses. It must 
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be noted that the data presented here conflict with the findings of Tsunawaki et al., 
(2004). In their work a concentration of 128 µg fumagillin ml-1 was required to inhibit 
superoxide production. It is possible that the methodology used in that paper may have 
been lacking in sensitivity as 2 µg gliotoxin ml-1 was required to inhibit superoxide 
production. Subsequent work by Renwick et al., (2007) demonstrated reduced 
neutrophil p47phox translocation after exposure to 0.25 µg gliotoxin ml-1. This 8-fold 
difference coupled to the fact that neutrophils were exposed to mycotoxin for only 7 
minutes as opposed to the 25 minute mycotoxin-phagocyte incubation time used in the 
results presented here may partially explain the results obtained by Tsunawaki et al., 
(2004).  
NADPH oxidase formation co-incides with degranulation, with MPO forming a 
major component of this process. Neutrophils exposed to fumagillin demonstrated 
reduced extracellular myeloperoxidase following PMA stimulation relative to positive 
controls. This finding was further supported by the decreased myeloperoxidase 
mediated peroxidation activity from degranulated extracts using the same protocols. In 
contrast the process of degranulation in G. mellonella haemocytes is poorly understood. 
Haemocytes incubated with fumagillin demonstrated reduced exocytosis of PPO which 
was cross reactive with MPO antisera. ClustalW analysis of MPO and  PPO revealed 
amino acid matching, conservation and semi-conservation in peptide sequence 
alignments however it is unknown if these proteins are related. This may explain 
antibody cross-reactivity between both proteins however a study of conserved epitope 
binding would be required to fully understand the reasons for this. Zhan et al., (2004) 
demonstrated that F-actin assembly coupled to the interaction p47phox with moesin 
initiated the early events of translocation leading to the formation of a fully functional 
NADPH oxidase complex. The data presented here demonstrate that F-actin assembly 
was reduced in fumagillin treated neutrophils following PMA stimulation. This in turn 
 189  
may explain the observed inhibition of translocation as well as the failure of neutrophils 
to engage in effective phagocytosis. The application of the same method in haemocytes 
did not demonstrate any change in F-actin assembly irrespective of PMA stimulation of 
pre-treatment with fumagillin. LC/MS analysis did reveal the increased degranulation of 
cofilin in PMA stimulated cells however the level of cofilin was significantly reduced in 
fumagillin treated cells. Adachi et al., (2002) demonstrated that reduction of cofilin 
expression in vitro resulted in increased phagocytosis and NADPH oxidase formation 
thus indicating an antagonistic effect on F-actin formation. It is proposed that increased 
turnover of F-actin resulting from sequesterisation of cofilin may result in decreased 
p47 translocation and phagocytosis in haemocytes. 
The humoral immune response of insects represents a complex mixture of cell 
free responses which include clotting, melanisation, production of antimicrobial 
peptides and proteins which confer host protection either through acting as pattern 
recognition receptors in support of the cellular response or in detoxification (Kavanagh 
and Reeves, 2004). In Chapter 5 the effect of fumagillin on the humoral component of 
G. mellonella immune response was assessed. A 2-dimensional electrophoresis coupled 
to LC/MS approach identified a number of changes in the proteome of larval 
haemolymph which are indicative of the presence of oxidative stress. Wang et al., 
(2008) and Fang et al., (2010) demonstrated the increased expression of peroxiredoxins 
following oxidative stress in vivo. Ito et al., (1996) also demonstrated the increased 
expression of GAPDH in the presence of oxidative stress. The increased expression of 
GAPDH and the functionally related AHP and PRX proteins in haemolymph obtained 
from larvae injected with fumagillin is indicative of the presence of such oxidative 
stresses. Mycotoxin mediated lipid peroxidation has been demonstrated for gliotoxin 
(Schütze et al., 2010) and TNP-470, a synthetic analogue of fumagillin, has also been 
demonstrated to initiate lipid peroxidation (Okroj et al., 2005). The increased 
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expression of an aldo-keto reductase in fumagillin injected larvae further suggests that 
oxidative stress as a result of lipid peroxidation is the cause of the increased expression 
of these proteins. It is possible that the occurrence of lipid peroxidation may cause 
damage to tissues in larvae which, while not fatal, may weaken host responses through 
damage to cell membranes. Such a finding has been previously identified in G. 
mellonella larvae following endotoxin exposure in vivo (Dubovskiy et al., 2008) and 
demonstrates another element of the harmful effects of fumagillin.  
The decreased expression of ferritin in larvae injected with fumagillin may also 
account for the substantial loss of viability in larvae injected with fumagillin and 
subsequently challenged with A. fumigatus ATCC 26933. Ferritin plays a key role in the 
sequesterisation of iron in vivo and the limitation of free iron to microbes is an 
important element in reducing growth (Schrettl et al., 2004). In Chapter 6 priming of G. 
mellonella larvae with A. fumigatus conidia resulted in increased ferritin expression. 
These two studies clearly demonstrate that ferritin levels are correlated with 
susceptibility to subsequent fungal infection. This finding is an interesting development 
in understanding the larval immune response and may have the potential to be viewed 
as a biomarker of insect immunological status.  
The temperature mediated activation of the phenoloxidase pathway independent 
of microbial infection is an interesting finding. Cerenius and Soderhall, (2004) 
previously identified that exposure to peptidoglycan, lipopolysaccharide or glucan is 
required to activate the phenoloxidase cascade. In this study phenoloxidase activity was 
initiated through larval incubation at 37ºC. In light of the data presented by Mowlds and 
Kavanagh, (2008) where it was shown that such incubation primed larvae against 
subsequent infection this finding further exemplifies the issues of incubating larvae at 
37ºC thus leading to temperature mediated effects which may lead to erroneous data. 
The reduced phenoloxidase activity in larval haemolymph following injection with 
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fumagillin demonstrated another damaging effect mediated by fumagillin. The 
implication of this is reduced pathogen recognition and exacerbation of fungal 
colonisation in vivo.  
A novel approach to understanding the interaction between the larval immune 
response and A. fumigatus conidia was performed through the haemolymph binding 
assay. The results show the binding of four proteins (apo 1, arylphorin, PPO and apoLp 
III) of immunological relevance which may explain the initiation of the humoral 
immune response. Ma et al., (2006) and Schmidt et al., (2010) demonstrated that apo1 
functions in the neutralisation of LPS in insects. In Chapter 6 immunoprotective 
priming of larvae with A. fumigatus conidia resulted in the increased expression of apo 
1. The findings from both of these studies are interesting as they indicate that apo 1 may 
play a role in the limitation of fungal dissemination in vivo and that the expression of 
this protein may be induced through fungal priming thus conferring a protective effect 
to the host from subsequent infection. The observed interaction between 
prophenoloxidase subunit 2 and conidia is particularly interesting given the important 
function of the PO pathway in vivo. The activation of the phenoloxidase cascade is a 
tightly regulated process as quinines are toxic to host tissue (Ashida, 1990). The 
observed association of prophenoloxidase with A. fumigatus conidia may represent 
another mechanism where the humoral response is localised to specific sites of infection 
therefore directing melanin production to specific sites of infection. Inhibition of this 
binding activity in haemolymph exposed to fumagillin may cause dysregulation of 
immunological cascades therefore leading to impaired responses to infection and the 
induction of oxidative stress.  
ApoLp III and its mammalian homologue apo E have been demonstrated as 
having conserved functions in innate immune defences to fungal infection. Furthermore 
Whitten et al., (2004) identified that apoLp III was capable of acting as a pattern 
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recognition receptor to 1,3-glucan. The finding that both apo E and apoLp III bind to 
A. fumigatus conidia complements previous research and may have implications for 
other immune responses such as cell adhesion, encapsulation, phagocytosis, reactive 
oxygen intermediate production and prophenoloxidase activation. Incubation of serum 
or haemolymph with fumagillin resulted in negligible effects on apoLp III and apo E 
binding however larval priming with immunoprotective concentrations of A. fumigatus 
conidia resulted in increased apoLp III binding activity 24 hours post infection which 
was directly correlated with increased larval survival. Vonk et al., (2004) demonstrated 
that apo E deficient mice were more susceptible to C. albicans infection. The results 
presented in Chapters 5 and 6 indicate that the functionally related lipoproteins may 
play a role in protection against fungal colonisation through their binding efficacy and 
stimulation of cellular and humoral immune responses in vertebrates and invertebrates.  
The application of the same binding technique to serum as was performed with 
larval haemolymph identified several proteins of interest, two of which 
(angiotensinogen and immunoglobulin kappa light chain) demonstrated reduced binding 
following exposure to fumagillin. As both proteins are recognised by neutrophils 
through the presence of receptors on the cell surface (Gordon et al., 1986; Cutler et al., 
1991; Ito et al., 2001) the inhibition of binding in serum exposed to fumagillin implies 
that neutrophil recognition of a pathogenic target may be reduced by this mycotoxin. 
The observed binding of apolipoprotein C-III and A-IV also demonstrated the possible 
roles of apolipoproteins in inflammation and acute phase responses to infections as has 
been previously described (Khovidhunkit et al., 2004; Kawakami et al., 2008). Future 
work may need to focus on murine models of infection deficient in these proteins to 
understand their role in the pathogen pathogenesis of A. fumigatus.  
The experimental design in Chapter 6 was based on recent developments in the 
area of immunological priming (Mowlds and Kavanagh 2008; Mowlds et al., 2008; 
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Mowlds et al., 2010). In order to fully exploit the G. mellonella model to it is clear that 
an understanding on the immune response to specific microbes is warranted. The work 
of Mowlds et al., (2010) while invaluable in understanding larval responses to fungal 
challenge does not discern the specific microbe of interest as glucan is an ubiquitous 
element of fungal microflora. Infection of larvae with non-lethal concentrations of A. 
fumigatus conidia resulted in protection in a manner that did not increase in a dose 
responsive manner. Larval priming for 24 hours appeared to elicit the strongest priming 
relative to priming for 4 hours and 48 hours. The time dependent increase in immune 
priming is evidenced by increased haemocyte density 24 hours post-infection which 
decreased at the 48 hour timepoint. Bergin et al., (2003) showed that the higher 
haemocyte densities were indicative of improved larval health. Furthermore infection 
with pathogenic yeast isolates are directly correlated with decreased haemocyte density.  
The decrease in circulating haemocytes may be a result of efficient cellular attachment 
to microbes leaving larvae more susceptible to subsequent infection. This has been 
previously demonstrated by Bogús et al., (2007) as G. mellonella larvae were shown to 
effectively engage in cellular attachment and encapsulation of entamopathogenic fungi. 
It is proposed that the immunoprotective increases in haemocyte density are initiated by 
increased cellular detachment from the haemocoel coupled to lower fungal loading 
therefore resulting in improved competence to subsequent infection. The increase in 
PPO as quantified by immunoblot and densitometric analysis may also be linked to this 
process. PPO binding to A. fumigatus conidia was demonstrated in Chapter 5. The 
reduced levels of PPO detected by Western blotting following infection with 1 x 106 A. 
fumigatus conidia may be indicative of increased binding to A. fumigatus conidia. 
Furthermore the breakdown of PPO at 48 hours may be as a result of the same 
temperature mediated activation of the PO pathway observed in Chapter 5 as the normal 
storage temperature of G. mellonella is 15ºC.  
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 RP-HPLC and 2-dimensional electrophoresis of larval haemolymph coupled to 
LC/MS analysis identified several alterations in the metabolic and immunological status 
of G. mellonella larvae following conidial priming. The increased expression of larval 
haemolymph protein (electronically annotated as an oxygen transporter) in larvae 
injected with 1 x 104 conidia is indicative of the increased demand for oxygen in 
haemocyte mediated superoxide production in response to haemocyte activation as 
demonstrated by Renwick et al., (2007). Anionic antimicrobial peptide 2 has been 
described as having antibacterial activity (Cytrnska et al., 2007). The decreased 
expression of this peptide in larvae challenged with conidia indicates a reduction in 
immunocompetence to bacterial infection possibly through differential signalling 
through the Toll pathway (Lemaitre et al., 1996). This tailoring of the immune response 
is further evidenced by the previously discussed increases in ferritin and apo 1 
expression thus leading to effective protection against fungal infection. A change in the 
metabolic profile of G. mellonella larvae is evidenced by the increased expression of 
arginine kinase (AK). As AK functions in ADP phosphorylation in invertebrates 
(Kotlyar et al., 2000) the discovery of a homologous protein in G. mellonella 
haemolymph may indicate an increase in ATP output in response to immune priming 
thus supporting the cellular and humoral responses to infection. RT-PCR analysis of 
larvae challenged with A. fumigatus conidia demonstrated a significant dose responsive 
increase in gallerimycin expression following conidial challenge. Schuhmann et al., 
(2003) identified that the gallerimycin peptide is specifically active against filamentous 
fungi.  In Drosophila a homologous protein drosomycin is expressed through activation 
of the Toll pathway in response to fungal infection (Lemaitre et al., 1996). 
 The results presented in this thesis clearly demonstrate the benefits of using the 
G. mellonella model as a high throughput model to assess the pathogenicity of 
Aspergillus isolates, the production of mycotoxins in vivo and the immunosuppressive 
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effects of culture filtrates. This study has demonstrated a possible role for fumagillin in 
the pathogenesis of A. fumigatus as a mycotoxin that is produced in the early stages of 
invasive fungal colonisation. Furthermore it was found that fumagillin inhibited the 
function of neutrophils and haemocyte thus extending the parallels between both cell 
types. Fumagillin elicited inhibitory effects on cellular killing through restrictions to 
phagocytosis, NADPH oxidase complex formation and degranulation. It is speculated 
that these effects may be as a result of a diminution in F-actin formation. In support of 
this a comparative study of cell-free haemolymph and human serum demonstrated the 
decreased expression and activity of elements in the humoral immune response 
following exposure to fumagillin. Previous mycotoxin research in A. fumigatus has 
focused on the in vivo production of gliotoxin. As gliotoxin is a highly potent molecule 
this approach is merited however it is evident that a wider approach to mycotoxin 
production in the study of A. fumigatus pathogenesis is warranted. Furthermore a re-
evaluation of the functions of serum and haemolymph proteins may be required. 
The immune response of G. mellonella larvae to fungal infection was also 
addressed. Larvae were effectively primed against subsequent infection following 
infection with low concentrations of A. fumigatus. The application of proteomic 
methods demonstrated a role for several proteins involved in pathogen recognition, 
immunological cascades and macromolecule storage culminating in the specific 
tailoring of the larval immune response. These findings are a valuable addition to a 
growing body of information validating the use of G. mellonella as an alternative model 
in the study of human pathogens. 
 
7.2 Future work. 
 The work presented in this thesis has revealed future area of work which needs 
to be addressed. The use of the G. mellonella model of infection is clearly a valuable 
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tool in the assessment of the pathogenicity of A. fumigatus. Although there is a growing 
body of work correlating murine pathogenicity with that of larvae more work needs to 
be done to describe the development of genetic mutants of A. fumigatus in larvae. Also 
there is a requirement to develop an alternative infection method with A. fumigatus 
conidia. A. fumigatus infections are not initiated at an invasive level therefore a natural 
method of infection possibly through feeding conidia to larvae needs to be developed. 
This thesis demonstrates the application of organic extraction coupled to RP-HPLC 
analysis to the identification of the presence of mycotoxins in vivo. The multi-faceted 
nature of virulence factors of A. fumigatus and gene deletant strains of the fungus may 
be assessed for production in vivo using G. mellonella therefore offering further insights 
into the pathobiology of the fungus.  
 The identification of fumagillin as an immunosuppressant is an area which 
requires further research. To date there has been a surprising lack of literature outlining 
a pathway for the biosynthesis of fumagillin aside from the finding that laeA functions 
as a regulator of its production. It is suggested that future work should be directed 
towards the identification of such a pathway in the manner that has been applied for 
gliotoxin. In addition the production of fumagillin at the early stages of invasive 
aspergillosis should also be addressed in light of the findings of high levels of 
fumagillin 24 hours post-infection in G. mellonella. It may be possible that fumagillin 
may also be produced in the early stages of invasive aspergillosis in mammals and the 
application of murine infection coupled to biochemical analysis of its prevalence in vivo 
may offer an additional insight to the understanding of interaction between mycotoxins 
and host tissue. It is also suggested that the application of neutropenic or chemically 
immunosuppressed mice may be of worth in understanding these interactions. To date 
the entry of fumagillin into the cell is an area which has not been addressed. While such 
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mechanisms have been identified in gliotoxin uptake the identification of the cellular 
target of fumagillin would offer further insights into this molecule.  
 This thesis has identified several proteins or peptides which are expressed 
differentially depending on the exposure of larvae to fumagillin or low levels of fungal 
infection. Currently, the genome sequence of G. mellonella has not been made publicly 
available. Considering the substantial use of G. mellonella in studies of microbial 
pathogenesis and the potential offered by applying modern molecular and proteomic 
techniques there is an increasing need for such a database. The identification of protein 
homologues with other species in this thesis further validates this urgent requirement in 
the understanding of G. mellonella and would substantially increase scientific output in 
this area of research. 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Chapter 8 
 
 
Bibliography 
 198  
Abney, E.R., Cooper, M.D., Kearney, J.F., Lawton, A.L. and R.M.E. Parkhouse, 
(1978). Sequential expression of immunoglobulin on developing mouse B 
lymphocytes: a systematic survey that suggests a model for the generation of 
immunoglobulin isotype diversity. Journal of Immunology, 120: 2041-2049. 
 
Abu Nabah, Y.N., Malteo, T., Estelles, R., Mata, M., Zagorski, J., Sarau, H., 
Cortijo, J., Morcillom E.J., Jose, P.J., and M.J. Sanz, (2004). Angiotensin II induces 
neutrophil accumulation in vivo through generation and release of CXC chemokines. 
Circulation, 110: 3581-3586. 
 
Adachi, R., Takeuchi, K. and K. Suzuki, (2002). Antisense oligonucleotide to cofilin 
enhances respiratory burst and phagocytosis in opsonised zymosan stimulated 
mouse macrophage J774.1 cells. The Journal of Biological Chemistry, 277: 45566-
45571. 
 
Aderem, A. and D.M. Underhill, (1999). Mechanisms of phagocytosis in 
macrophages. Annual Review in Immunology, 17: 593-623. 
 
Adrio, J.L. and A.L. Demain, (2003). Fungal Biotechnology. International 
Microbiology, 6: 191-199. 
 
Agarwal, R., (2009). Allergic Bronchopulmonary Aspergillosis. CHEST, 135: 805-
826. 
 
Ahmed, R. and D. Gray, (1996). Immunological memory and protective immunity: 
understanding their full relation. Science, 272: 54-60. 
 
Allen, R.C. and J.R. Stephens Jr, (2011). Myeloperoxidase Selectively binds and 
selectively kills microbes. Infection and Immunity, 79: 474-485. 
 
Alp, S. and S. Arikan, (2008). Investigation of extracellular elastase, acid proteinase 
and phospholipase activities as putative virulence factors in clinical isolates of 
Aspergillus species. Journal of Basic Microbiology, 48: 1-7. 
 
 199  
Amitani, R., Murayama, T., Nawada, R., Lee, W.J., Niini, A., Suzuki, K., Tanaka, 
E. and F. Kuze, (1995). Aspergillus culture filtrates and sputum sols from patients 
with pulmonary aspergillosis cause damage to human respiratory ciliated epithelium 
in-vitro. European Respiratory Journal, 8: 1681-1687. 
 
Amitani, R., Tayor, G., Elezis, E-N., Llewellyn-Jones, C., Mitchell, J., Kuze, F., 
Cole, P.J. and R. Wilson, (1995). Purification and characterization of factors 
produced by Aspergillus fumigatus which affect human ciliated respiratory 
epithelium. Infection and Immunity, 63: 3266-3271. 
 
Anaissie, E.J., Stratton, S.L., Dignani, M.C., Summerbell, R.C., Rex, J.H., Monson, 
T.P., Spencer, T., Kasai, M., Francesconi, A. and T.J. Walsh, (2002). Cleaning 
patient shower facilities: a novel approach to reducing patient exposure to 
aerosolised Aspergillus species and other opportunistic molds. Clinical Infectious 
Diseases, 35: 86-88. 
 
Andleeb, S., Atiq, N., Ishtiaq Ali, M., Razi-Ul-Hussnain, R., Shafique, M., Ahmad, 
B., Ghumro, P.B., Hussain, M., Hameed, A. and S. Ahmad, (2010). Biological 
Treatment of Textile Effluent in Stirred Tank Bioreactor. International Journal of 
Agriculture and Biology, 12: 256-260. 
 
Andrejko, M., Cytrynska, M., and T Jakubowicz, (2005). Apolipophorin III is a 
substrate for protease IV from Pseudomonas aeruginosa. FEMS Microbiology 
Letters, 243: 331-337. 
 
Andrejko, M., Mizerska-Dudka, M., and T. Jakubowicz, (2008). Changes in 
Galleria mellonella Apolipophorin III level during Pseudomonas aeruginosa 
infection. Journal of Invertebrate Pathology, 97:14-19. 
 
Aratani, Y., Kura, F., Watanabe, H., Akagawa, H., Takano, Y., Suzuki, K., Maeda, 
N. and H. Koyama, (2000). Differential host susceptibility to pulmonary infections 
with bacteria and fungi in mice deficient in myeloperoxidase. Journal of Infectious 
Diseases, 182: 1276-1279. 
 
 200  
Asai, D.J., and D.E. Wilkes, (2004). The Dynein Heavy Chain Family. Journal of 
Eukaryote Microbiology, 51: 23-29. 
 
Ashida, M., (1990). The prophenoloxidase cascade in insect immunity. Research in 
Immunology, 141: 908-910. 
 
Aufauvre-Brown, A., Brown, J.S. and D.W. Holden, (1998). Comparison of 
virulence between clinical and environmental isolates of Aspergillus fumigatus. 
European Journal of Clinical Microbiology and Infectious Diseases, 17: 778-780. 
 
Babior, B.M., Kipnes, R.S., and J.T Curnette, (1973). Biological defence 
mechanisms: the production by leukocytes of superoxide, a potent bactericidal 
agent. Journal of Clinical Investigation, 52: 741-744. 
 
Baker, S.E., (2006). Aspergillus niger genomics: Past, present and into the future. 
Medical Mycology, 44: 17-21. 
 
Bates, D.W., Su, L., Yu, D.T., Chertow, G.M., Seger, D.L., Gomes, D.R.J., 
Dasbach, E.J. and R. Platt, (2001). Mortality and costs of acute renal failure 
associated with amphotericin B therapy. Clinical Infectious Diseases, 32: 686-693. 
 
Beck, G., Ellis, T.W., Habicht, G.S., Schluter, S.F. and J.J. Marchalonis, (2002). 
Evolution of the acute phase response: iron release by echinoderm (Asterias 
forbesei) coelomocytes, and cloning of an echinoderm ferritin molecule. 
Developmental and Comparative Immunology, 26 (1): 11-26. 
 
Behnsen, J., Hartmann, A., Schmaler, J., Gerke, A., Brakhage, A.A. and P.F. Zipfel, 
(2008). The opportunistic human pathogenic fungus Aspergillus fumigatus evades 
the host complement system. Infection and Immunity, 76: 820-827. 
 
Behnsen, J., Lessing, F., Schinder, S., Wartenberg, D., Jacobsen, I.D., Thoen, M., 
Zipfel, P.F. and A.A. Brackhage, (2010). Secreted Aspergillus fumigatus protease 
Alp1 degrades human complement proteins C3, C4 and C5. Infection and Immunity, 
78: 3585-3594. 
 
 201  
Beintema, J.J., Stam, W.T., Hazes, B. and M.P. Smidt, (1994). Evolution of 
Arthropod Hemocyanins and Insect Storage Proteins (Hexamerins). Molecular 
Biology and Evolution, 11: 493-503. 
 
Bellochio, S., Moretti, S., Peruccio, K., Fallarino, F., Bozza, S., Montagnol, C., 
Mosci, P., Lipford, G.B., Pitzurra, L. and L. Romani, (2004). TLRs govern 
neutrophil activity in aspergillosis. Journal of Immunology 173: 7406-7415. 
 
Ben-Ami, R., Lewis, R.E. and D.P. Kontoiannis, (2010). Enemy of the 
(immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus 
infection. British Journal of Haematology, 150: 406-417. 
 
Bennet, J.W and M. Klich, (2003). Mycotoxins. Clinical Microbiology Reviews, 16: 
497-516. 
 
Bergin, D., Brennan, M., and K. Kavanagh, (2003). Fluctuations in haemocyte 
density and microbial load may be used as indicators of fungal pathogenicity in 
larvae of Galleria mellonella. Microbes and Infection, 5:1389-1395. 
 
Bergin, D., Murphy, L., Keenan, J., Clynes, M., and K. Kavanagh, (2006). Pre-
exposure to yeast protects larvae of Galleria mellonella from a subsequent lethal 
infection by Candida albicans and is mediated by the increased expression of 
antimicrobial peptides. Microbes and Infection, 8: 2105-2112.  
 
Bergin, D., Reeves, E.P., Wientjes, F.B., and K. Kavanagh, (2005). Superoxide 
production in Galleria mellonella haemocytes: Identification of proteins 
homologous to the NADPH oxidase complex of human neutrophils. Infection and 
Immunity, 73: 4161-4170. 
 
Bernardo, P.H., Brasch, N., Chai, C.L. and P. Waring, (2003). A novel redox 
mechanism for the glutathione-dependent reversible uptake of a fungal toxin in 
cells. Journal of Biological Chemistry, 278: 46549-46555. 
 
Bertout, S., Badoc, C., Mallie, M., Giaimis, J., and J-M Bastide, (2002). Spore 
diffusate isolated from some strains of Aspergillus fumigatus inhibits phagocytosis 
 202  
by murine alveolar macrophages, FEMS Immunology and Medical Microbiology, 
33: 101-106. 
 
Bhabhra, R. and D.S. Askew, (2005). Thermotolerance and virulence of Aspergillus 
fumigatus: role of the fungal nucleolus. Medical Mycology, 43: 87-93. 
 
Birch, M., Denning, D.W. and G.D. Robson, (2004). Comparison of extracellular 
phospholipase activities in clinical and environmental Aspergillus fumigatus 
isolates. Medical Mycology, 42: 81-86. 
 
Blanco, J.L., Hontecillas, R., Bouza, E., Blanco, I., Pelaez, T., Munoz, P., Molina, 
J.P. and M.E. Garcia, (2002). Correlation between elastase activity index and 
invasiveness of clinical isolates of A. fumigatus. Journal of Clinical Microbiology, 
40: 1811-1813. 
 
Bogús, M., Kedra, E., Bania, J., Szczepanik, M., Czygier, M., Jabloski, P., 
Pasztaleniec, Samborski, J., Mazgajska, J. and A. Polanowski, (2007). Different 
defense strategies of Dendrolimus pini, Galleria mellonella, and Calliphora vicina 
against fungal infection. Journal of Insect Physiology, 53: 909-922. 
 
Bok, J.W. and N.P. Keller, (2004). LaeA, a regulator of secondary metabolism in 
Aspergillus spp. Eukaryotic Cell, 3: 527-535. 
 
Bok, J.W., Balajee, S.A., Marr, K.A., Andes, D., Nielsen, K.F., Frisvad, J.C. and 
N.P. Keller, (2005). LaeA, a regulator of morphogenetic fungal virulence factors. 
Eukaryotic Cell, 4: 1574-1582. 
 
Bonfante, L., Nalesso, F., Cara, M., Antonello, A., Malagoli, A., Pastori, G., 
Guizzo, M., D’ angelo, A. and G. Gambardo, (2005). Aspergillus fumigatus 
peritonitis in ambulatory peritoneal dialysis: A case report and notes on the 
therapeutic approach. Nephrology, 10: 270-273. 
 
Bonnett, C.R., Cornish, E.J., Harmsen, A.G. and J.B. Burritt, (2006). Early 
neutrophil recruitment and aggregation in the murine lung inhibit germination of 
Aspergillus fumigatus conidia. Infection and Immunity, 74: 6528-6539. 
 203  
Böröczky, K., Park, K.C., Minard, R.D., Jones, T.H., Baker, T.C. and J.H. 
Tumlinson, (2008). Differences in cuticular lipid composion of the antennae of 
Helicoverpa zea, Heliothis virescens and Maduca sexta. Journal of Insect 
Physiology, 54: 1385-1391. 
 
Boyer, P.D., (1997). The ATP synthase-a splendid molecular machine. Annual 
Review of Biochemistry, 66: 717-749. 
 
Brenier-Pinchart, M-P., Labeau, B., Quesada, J-L., Mallaret, M.R., Borel, J-L., 
Mollard, A., Garban, F., Brion, J-P., Molina, L., Bosson, J-L., Cahn, J-Y., Grillot, R. 
and H. Pelloux, (2009). Influence of internal and outdoor factors on filamentous 
fungal flora in haematology wards. American Journal of Infection Control, 37: 631-
637. 
 
Brennan, M., Thomas, D.Y., Whiteway, M. and K. Kavanagh, (2002). Correlation 
between virulence of Candia albicans mutants in mice and Galleria mellonella 
larvae. FEMS Immunology and Medical Microbiology, 34: 153-157.  
 
Brown, S.E., Howard, A., Kasprzak, A.B., Gordon, K.H., and P.D. East, (2002). The 
discovery and analysis of a diverged family of novel antifungal moricin-like 
peptides in the wax moth Galleria mellonella. Insect Biochemistry and Molecular 
Biology, 38: 201-212. 
 
Bruns, S., Seidler, M., Albrecht, D., Salvenmoser, S., Remme, N., Hertweck, C., 
Brackhage, A.A., Kniemeyer, O. and F-M.C. Müller, (2010). Functional genomic 
profiling of Aspergillus fumigatus biofilm reveals enhanced production of the 
mycotoxin gliotoxin. Proteomics, 10: 3097-3107.  
 
Bucki, R. Byfield, F.J., Kulakowska, A., McCormick, M.E., Drozdowski, W., 
Namiot, Z., Hartung, T. and P.A. Janmey, (2008). Extracellular gelsolin binds 
lipotechtoic acid and modulates cellular response to proinflammatory bacterial wall 
components. The Journal of Immunology, 181: 4936-4944. 
 
 204  
Bueid, A., Howard, S.J., Moore, C.B., Richardson, M.D., Harrison, E., Bowyer, P. 
and D.W. Denning, (2010). Azole antifungal resistance in Aspergillus fumigatus: 
2008 and 2009. Journal of Antimicrobial Chemotherapy, 65: 2116-2118.  
 
Burczynski, M.E., Sridhar, G.R., Palackal, N.T. and T.M. Penning, (2001). The 
Reactive Oxygen Species- and Michael Acceptor-inducible Human Aldo-Keto 
Reductase AKR1C1 reduces the ,-Unsaturated Aldehyde 4-Hydroxy-2-nonenal to 
1,4-Dihydroxy-2-nonene. The Journal of Biological Chemistry, 276: 2890-2897. 
 
Burmester, T., (2001) Molecular evolution of the arthropod hemocyanin 
superfamily. Molecular Biology and Evolution. 18: 184-195. 
 
Burmester, T.and K. Scheller, (1999). Ligands and Receptors: Common theme in 
insect storage protein transport. Naturwissenschaften, 86: 468-474. 
 
Camus, M., Anyfantakis, V., Dammak, A., Riche, A., Delouane, H., Roblot, F. and 
G. Guillet, (2010). Primary cutaneous aspergillosis in an immunocompetent 
farmworker. Annales de dermatologie et de vénérologie, 137: 373-376. 
 
Carrell, R.W., Jeppsson, J-A., Laurell, C-B., Brennan, S.O., Owen, M.C., Vaughan, 
L. and D.R. Boswell, (1982). Structure and variation of human 1-antitrypsin. 
Nature, 298: 329-334. 
 
Carvalho, M.D., Tobias, V.E., Vendrame, C.M., Shimabukuro, A.F., Gidlund, M. 
and E.C. Quintao, (2000). Lipoproteins modify the macrophage uptake of 
triacylglycerol emulsion and of zymosan particles by similar mechanisms. Lipids, 
35: 55-59. 
 
Cerenius, L. and K. Soderhall, (2004). The prophenoloxidase activating system in 
invertebrates. Immunological Reviews, 198: 116-126. 
 
Chae, H.Z., Kim, H.J., Kang, S.W., and S.G. Rhee, (1999). Characterization of three 
isoforms of mammalian peroxiredoxin that reduced peroxides in the presence of 
thioredoxin. Diabetes Research and Clinical Practice, 45: 101-112. 
 
 205  
Chakrabarti, A., Chatterjee, S.S., Das, A. and M.R. Shivaprakash, (2011). Invasive 
aspergillosis in developing countries. Medical Mycology, 49: 35-47. 
 
Champion, L., Durrbach, A., Lang, P., Delahousse, M., Chauvet, C., Sarfati, C., 
Glotz, D, and J.M. Molina, (2010). Fumagillin for treatment of intestinal 
microsporidiosis in renal transplant recipients. American Journal of 
Transplantation, 10: 1925-1930. 
 
Champion, O.L., Cooper, I.A.M., James, S.L., Ford, D., Karlyshev, A., Wren, B.W., 
Duffield, M., Oyston, P.C.F. and R.W. Titball, (2009). Galleria mellonella as an 
alternative infection model for Yersinia pseudotuberculosis. Microbiology, 155: 
1516-1522. 
 
Cheema, M.S. and J.K. Christians, (2011). Virulence in an insect model differs 
between mating types in Aspergillus fumigatus. Medical Mycology, 49: 202-207. 
 
Chen, S.C. and D.P. Kontoyiannis, (2010). New molecular and surrogate biomarker-
based tests in the diagnosis of bacterial and fungal infection in febrile neutropenic 
patients. Current Opinion in infectious Diseases, 23: 567-577. 
 
Chen, Y., Lasaitene, D. and P. Friberg, (2004). The rennin angiotensin system in 
kidney development. Acta Physiologica Scandanavica, 181: 529-535. 
 
Chew, G.L., Wilson, J., Rabito, F.A., Grimsley, F., Iqbal, S., Reponen, T., 
Muilenberg, M.L., Thorne, P.S., Dearborn, D.G. and R.L. Morley, (2006). Mold and 
endotoxin levels in the aftermath of Hurricane Katrina: A pilot project of homes in 
New Orleans undergoing renovation. Environmental Health Perspectives, 114: 
1883-1889. 
 
Choi-Mura, N.H., Takahashi, K., M. Yoda, Saito, K., Hori, M., Ozaki, H., Mazda, 
T. and M. Tomita, (2000). The novel acute phase protein IHRP inhibits actin 
polymerisation and phagocytosis of polymorphonuclear cells. Inflammatory 
Research, 49: 305-310. 
 
 206  
Cole, K.D., Fernando-Warnakulasuriya, G.J.P., Boguski, M.S., Freeman, M., 
Gordon, J.I., Clark, W.A., Law, J.H. and M.A. Wells, (1987). Primary structure and 
comparative sequence analysis of an insect apolipoprotein: apolipophorin III from 
Manduca sexta.  Journal of Biological Chemistry, 262: 11794-11800. 
 
Comera, C., Andre, K., Laffitte, K., Collet, X., Galtier, P., and I. Maridonneau-
Parini, (2007). Gliotoxin from Aspergillus fumigatus affects phagocytosis and 
organisation of the actin cytoskeleton by distinct signalling pathways in human 
neutrophils. Microbes and Infection, 9: 47-54. 
 
Cotter, G., Doyle, S., and K. Kavanagh, (2000). Development of an insect model for 
the in vivo pathogenicity testing of yeasts. FEMS Immunology and Medical 
Microbiology, 27: 163-169.  
 
Cowell, B.A., Twining, S.S., Hobden, J.A., Kwong, M.S.F. and S.M.J. Fleiszig, 
(2003). Mutation of lasA and lasB reduces Pseudomonas aeruginosa invasion of 
epithelial cells. Microbiology, 149: 2291-2299. 
 
Cowen, L.E., Singh, S., Köhler, J.R., Collins, C., Zaas, A.K., Schell, W.A., Aziz, 
H., Mylonakis, E., Perfect, J.R., Whitesell, L. and S. Lindquist, (2009). Harnessing 
Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal 
infectious disease. Proceedings of the National Academy of Sciences, USA, 106: 
2818-2823. 
 
Cross, A.R. and A.W. Segal, (2004). The NADPH oxidase of professional 
phagocytes-prototype of the NOX electron transport chain systems. Biochemica et 
Biophysica Acta – Bioenergetics, 1657: 1-22. 
 
Curnette, J.T., Kuver, R. and B.M. Babior, (1987). Activation of the respiratory 
burst oxidase in a fully soluble system from human neutrophils. Journal of 
Biological Chemistry, 262: 6450-6452. 
 
Cutler, C.W., Kalmar, J.R. and R.R. Arnold, (1991). Phagocytosis of virulent 
Porphyromonas gingivalis by human polymorphonuclear leukocytes requires 
specific immunoglobulin G. Infection and Immunity, 59: 2097-2104. 
 207  
Cytrynska, M., Mak, P., Zdybicka-Barabas, A., Suder, P. and T. Jakubowicz, 
(2007). Purification and characterisation of eight peptides from Galleria mellonella 
immune haemolymph. Peptides, 28: 533-546. 
 
da Silva, C.C., Dunphy, G. and M.E. Rau, (2000). Interation of Xenorhabdus 
nematophilus (Enterbacteriaceae) with anti-microbial defences in the house cricket, 
Acheta domesticus. Journal of Invertebrate Pathology, 76: 285-292. 
 
Dagenais, T.R.T. and N.P. Keller, (2009). Pathogenesis of Aspergillus fumigatus in 
Invasive Aspergillosis. Clinical Microbiology Reviews, 22: 447-465. 
 
Dang, P.M., Cross, A.R., Quinn, M.T. and B.M. Babior, (2002). Assembly of the 
neutrophil respiratory burst oxidase: a direct interaction between p67phox and 
cytochrome b558 II. Proceedings of the National Academy of Sciences, USA, 99: 
4262-4265. 
 
Das, S., Nikolaidis, N., Klein, J. and M. Nei, (2008). Evolutionary redefinition of 
immunoglobulin light chain in tetrapods using molecular markers. Proceedings of 
the National Academy of Sciences USA, 105: 16647-16652.  
 
Datta, B., Majumdar, A., Datta, R. and R. Balusu, (2004). Treatment of cells with 
the angiogenic inhibitor fumagillin results in increased stability of eukaryotic 
initiation factor 2-associated glycoprotein, p67, and reduced phosphorylation of 
extracellular signal-related kinases. Biochemistry, 43: 14821-14831. 
 
Davies, J.C., (2002). Pseudomonas aeruginosa in cystic fibrosis: pathogenesis and 
persistence. Paediatric Respiratory Reviews, 3: 128-134. 
 
de Bont, M.N., Netea, M.G., Demacker, P.N., Kullberg, B.J., van der Meer, J.W., 
and A.F. Stalenhoef, (2000). Apolipoprotein E deficient mice have an impaired 
immune response to Klebsiella pneumoniae. European Journal of Clinical 
Investigation, 30: 818-822. 
 
 208  
De Gregorio, E., Spellman, P.T., Tzou, P., Rubin, G.M. and B. Lemaitre, 
(2002).The Toll and Imd pathways are the major regulators of the immune response 
in Drosophila. The EMBO Journal, 21: 2568-2579. 
 
Dean, P., Richards, E.H., Edwards, J.P., Reynolds, S.E., and K. Charnley, (2004). 
Microbial infection causes the appearance of haemocytes with extreme spreading 
ability in monolayers of the tobacco hornworm Manduca sexta. Developmental and 
Comparative Immunology, 28: 689-700. 
 
DeShazer, D., Brett, P.J., Burtnick, M.N. and D.E. Woods, (1999). Molecular 
characterisation of genetic loci required for secretion of exoproducts in 
Burkholderia pseudomallei. Journal of Bacteriology, 181: 4661-4664. 
 
Diesenhouse, M.C., Wilson, L.A., Corrent, G.F., Visvesvara, G.S., Grossniklaus, 
H.E. and R.T. Bryan, (1993). Treatment of microsporidial keratoconjunctivitis with 
topical fumagillin. American Journal of Opthalmology, 115: 293-298. 
 
Dong, D.J., Wang, J.X., and X.F. Zhao, (2009). A eukaryotic initiation factor 5C is 
upregulated during metamorphosis in the cotton bollworm, Helicoverpa armigera. 
BMC Developmental Biology, 9: 19-30. 
 
Dubovskiy, I.M., Martemyanov, V.V., Vorontsova, Y.L., Rantala, M.J., Gryzanova, 
E.V. and V.V. Glupov, (2008). Effect of bacterial infection on antioxidant activity 
and lipid peroxidation in the midgut of Galleria mellonella L. larvae (Lepidioptera, 
Pyralidae). Comparative Biochemistry and Physiology, Part C, 148: 1-5. 
 
Dunphy, G. and A. Halwani, (1997). Haemolymph proteins of Galleria mellonella 
detoxify endotoxins of the insect pathogenic bacteria Xenorhabdus nematophilus 
(Enterobactericiae). Journal of Insect Physiology, 43: 1023-1029. 
 
Dunphy, G., Morton, D., Kropinski, A. and J. Chadwick, (1986). Pathogenicity of 
lipopolysaccharide mutants of Pseudomonas aeruginosa for larvae of Galleria 
mellonella: bacterial properties associated with virulence. Journal of Invertebrate 
Pathology, 47: 48-55. 
 
 209  
Eggiman, P., Chevrolet, J-C., Starobinski, M., Majno, P., Totsch, M., Chapuis, B. 
and D. Pittet, (2006). Primary invasive aspergillosis of the digestive tract: Report of 
two cases and review of the literature. Infection, 34: 333-338. 
 
Eichner, R.D., Al Salami, M., Wood, P.R. and A. Mullbacher (1986). The effect of 
gliotoxin upon macrophage function. International Journal of 
Immunopharmacology, 8: 789-797. 
 
Falvey, D.G. and A.J. Streifel, (2007). Ten-year air sample analysis of Aspergillus 
prevalence in a university hospital. Journal of Hospital Infection, 67: 35-41. 
 
Fan, W., Idnurm, A., Breger, J., Mylonakis, E. and J. Heitman, (2007). Eca1, a 
sarcoplasmic/endoplasmic reticulum Ca2+ ATPase, is involved in stress tolerance 
and virulence in Cryptococcus neoformans. Infection and Immunity, 75: 3394-3405. 
 
Fang, Q., Wang, L., Zhu, J., Li, Y., Song, Q., Stanley, D.W., Akhtar, Z. and G. Ye, 
(2010). Expression of immune-response genes in lepidopteran host is suppressed by 
venom from an endoparisitoid, Pteromalus puparum. BMC Genomics, 11: 484-501. 
 
Feingold, K.R., Funk, J.L., Moser,A.H., Shigenaga, J.K., Rapp, J.H. and C. 
Grunfeld, (1995). Role for circulating lipoproteins in protection from endotoxin 
toxicity. Infection and Immunity, 63: 2041-2046. 
 
Festini, F., Buzzetti, R., Bassi, C., Braggion, C., Salvatore, D., Tacetti, G., and G. 
Mastella, (2006). Isolation measures for the prevention of infection with respiratory 
pathogens in cystic fibrosis: a systematic review. Journal of Hospital Infection, 64: 
1-6. 
 
Flatt, T., Heyland, T., Rus, F., Porpglia, E., Sherlock, C., Yamamoto, R., Garbuzov, 
A., Palli, S.R., Tatar, M., and N. Silverman, (2008). Hormonal regulation of the 
humoral innate immune response in Drosophila melanogaster. Journal of 
Experimental Biology, 211: 2712-2724. 
 
 210  
Franquet, T., Muller, N.L., Gimenez, A., Guembe, P., de La, T.J and S. Baque, 
(2001). Spectrum of pulmonary aspergillosis: histologic, clincial and radiological 
findings. Radiographics, 193: 383-388. 
 
Freitak, D., Wheat, C.W., Heckel, D.G., and H. Vogel, (2007). Immune system 
responses and fitness costs associated with the consumption of bacteria in larvae of 
Trichoplusia ni. BMC Biology 5:56-69. 
 
Fuchs, B., and E. Myolonakis, (2006). Using non-mammalian hosts to study fungal 
virulence and host defence. Current Opinion in Microbiology, 9: 346-351. 
 
Fuguet, R. and A. Vey, (2004). Comparative analysis of the production of 
insecticidal and melanising macromolecules by strains of Beauveria bassiana in in 
vivo studies. Journal of Invertebrate Pathology, 85: 152-167. 
 
Fuguet, R. and A. Vey, (2004). Comparative analysis of the production of 
insecticidal and melanizing macromolecules by strains of Beauvaria spp: in vivo 
studies. Journal of Invertebrate Pathology, 85: 152-167. 
 
Gallin, J.I. and K. Zarember, (2007). Lessons about the pathogenesis and 
management of aspergillosis from studies in chronic granulatamous disease. 
Transactions of the American Clinical and Climatological Association. 
 
Gardiner, D.M. and B.J. Howlett, (2005). Bioinformatic and expression analysis of 
the putative gliotoxin biosynthetic cluster of Aspergillus fumigatus. FEMS 
Microbiology Letters, 248: 241-248. 
 
Gefter, W.B., (1992). The spectrum of pulmonary aspergillosis. Journal of Thoracic 
Imaging, 7: 56-74. 
 
Gifford, A.H., Klippenstein, J.R. and M.M. Moore, (2002). Serum stimulates growth 
of and proteinase secretion by Aspergillus fumigatus. Infection and Immunity, 70: 19 
– 26.  
 
 211  
Gilbert, L.I., Granger, N.A., and R.M Roe, (2000). The juvenile hormones: 
historical facts and speculations on future research directions. Insect Biochemistry 
and Molecular Biology, 30: 617-644.  
 
Gillespie, J.P., Kanost, M.R. and T. Trenczek, (1997). Biological mediators of insect 
immunity. Annual Review of Entomology, 42: 611-643. 
 
Golmia, R., Bello, I., Marra, A., Hamerschlak, N., Osawa, A. and M. Scheinberg, 
(2010). Aspergillus fumigatus joint infection: A review. Seminars in arthritis and 
rheumatism, PMID: 20843541. 
 
Gordon, D.L., Johnson, G.M. and M.K. Hostetter, (1986). Ligand-receptor 
interactions in the phagocytosis of virulent Streptococcus pneumoniae by 
polymorphonuclear leukocytes. Journal of Infectious Diseases, 154: 619-626. 
 
Gorelik, O., Cohen, N., Shpirer, I., Almoznino-Sarafian, D., Alon, I., Koopfer, M., 
Yona, R. and D. Modai, (2000). Fatal haemoptysis induced by invasive pulmonary 
aspergillosis in patients with acute leukaemia during bone marrow and clinical 
remission: report of two cases and review of the literature. The Journal of Infection, 
41: 277-282. 
 
Göttlich, E., van der Lubbe, W., Lange, B., Fiedler, S., Melchert, I., Reifenrath, M., 
Flemming, H-C. and S. de Hoog, (2002). Fungal flora in groundwater-derived 
public drinking water. International Journal of Hygiene and Environmental Health, 
205: 269-279. 
 
Greenberger, P.A., (2002) Allergic bronchopulmonary aspergillosis. Journal of 
Allergy and Clinical Immunology. 110: 685-692. 
 
Greene, R., (2005). The radiological spectrum of pulmonary aspergillosis. Medical 
Mycology, 43: 147-154. 
 
Guinea, J., Peláez, T., Alcalá, L. and E. Bouza, (2006). Outdoor environmental 
levels of Aspergillus spp. conidia over a wide geographical area. Medical Mycology, 
44: 349-356. 
 212  
 
Gunnarson, P., Levander, L., Pahlsson, P., and M. Grenegard, (2007). The acute 
phase protein 1-acid glycoprotein (AGP) induces rises cytosolic Ca2+ in neutrophil 
granulocytes via sialic acid dinding to immunoglobulin-like lectins (Siglecs). The 
FASEB Journal, 21 4059-4069. 
 
Haas, H., (2003). Molecular genetics of fungal siderophore biosynthesis and uptake: 
the role of siderophores in iron uptake and storage. Applied Microbiology and 
Biotechnology, 62: 316-330.  
 
Haas, H., Eisendle, M. and B. Gillian Turgeon, (2008). Siderophores in Fungal 
Physiology and Virulence. Annual Review of Phytopathology, 46: 149-187. 
 
Haine, E.R., Rolff, J. and M.T. Siva-Jothy, (2007). Functional consequences of 
blood clotting in insects, Developmental and Comparative Immunology, 31: 456-
464. 
 
Halwani, A.E., Niven, D.F. and G.B. Dunphy, (2000). Apolipophorin III and the 
interactions of lipotechtoic acids with the immediate immune responses of Galleria 
mellonella. Journal of Invertebrate Pathology, 76: 233-241. 
 
Hamamoto, H., Kurokawa, K., Kaito, C., Kamura, K., Manitra Razanajatovo, I., 
Kushura, H., Santa, T. And K. Sekimizu, (2004). Quantitiative evaluation of the 
thereapeiutic effects of antibiotics using silworms infected with human pathogenic 
microorganisms. Antimicrobial Agents and Chemotherapy, 48: 774-779. 
 
Hamamoto, H., Tonoike, A., Narushima, K., Horie, R. And K. Sekimizu, (2009). 
Silkworm as a model animal to evaluate drug candidate toxicity and metabolism. 
Comparative Biochemistry and Physiology. Toxicology anf Pharmacology, 149: 
334-339. 
 
Hamano, Y., Matsura, N., Kitamura, M., and H. Takagi, (2006). A novel enzyme 
conferring strepthricin resitance alters the toxicity of streptothricin D from broad 
spectrum to bacteria specific. The Journal of Biological Chemistry, 281: 16842-
16848. 
 213  
 
Hampton, M.B., Kettle, A.J. and C.C. Winterbourn, (1998). Inside the neutrophil 
phagosome: oxidants, myeloperoxidase and bacterial killing. Blood, 92: 3007-3017. 
 
Hayes, D., Murphy, B.S., Lynch, J.E. and D.J. Feola, (2010). Aerosolized 
amphotericin for the treatment of allergic bronchopulmonary aspergillosis. Pediatric 
Pulmonology, 45: 1145-1148. 
 
Hayette, M-P., Christiaens, G., Mutsers, J., Barbier, C., Huynen, P., Melin, P. and P. 
de Mol, (2010). Filamentous fungi recovered from the water distribution system of a 
Belgian university hospital. Medical Mycology, 48: 969-974. 
 
Hill, R.L., Delaney, R., Fellows, R.E. and H.E Lebovitz, (1966). The evolutionary 
origins of Immunoglobulins. Proceedings of the National Academy of Sciences 
USA, 56: 1762-1769. 
 
Hilliard, T., Edwards, S., Buchdahl, R., Francis, J., Rosenthal, M., Balfour-Lynn, I., 
Bush, A. and J. Davies, (2005). Voriconazole therapy in children with cystic 
fibrosis. Journal of Cystic Fibrosis, 4: 215-220.  
 
Hobson, R.P., (2000). The effects of diffusates from the spores of Aspergillus 
fumigatus and A. terreus on human neutrophil, Naegleria gruberi and 
Acanthamoeba castellanii. Medical Mycology, 38: 133-141. 
 
Hof, H. and C. Kupfahl, (2009). Gliotoxin in Aspergillus fumigatus: an example that 
mycotoxins are potential virulence factors. Mycotoxin Research, 25: 123-131. 
 
Hoffmann, J.A. and J.M. Reichhart, (2002). Drosophila innate immunity: an 
evolutionary perspective. Nature Immunology, 3: 121-126. 
 
Hosken, N.A., Shibuya, K., Heath, A.W., Murphy, K.M. and A. O’ Garra, (1995). 
The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell 
receptor-alpha beta-transgenic model. Journal of Experimental Medicine, 182: 
1579-1584. 
 
 214  
Hultmark, D., (2003). Drosophila immunity: paths and patterns. Current Opinion in 
Immunology, 15: 12-19. 
 
Hummel, M., Spiess, B., Kentouche, K., Niggeman, S., Böhm, C., Reuter, S., Kiehl, 
M., Mörz, H., Hehlmann, R. and D. Buchheidt, (2006). Detection of Aspergillus 
DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested 
PCR assay. Journal of Clinical Microbiology, 44: 3989-3993. 
 
Hung, S.Y. and D.G. Boucias, (1996). Phenoloxidase activity in hemolymph of 
naïve and Beauvaria bassiana-infected Spodoptera exigua larvae. Journal of 
Invertebrate Pathology, 67:  35-40. 
 
Hurne, A.M., Chai, C.L. and P. Waring, (2000). Inactivation of rabbit mucle 
creatine kinase by reversible formation of an internal disulphide bond induced by 
the fungal toxin gliotoxin. Journal of Biological Chemistry, 275: 25202-25206. 
 
Huxham, I.M., Lackie, A.M. and N.J. McCorkingdale, (1989). Inhibitory effects of 
cyclodepsipeptides, destruxins from the fungus Matarhizium anisophilae, on 
cellular immunity in insects. Journal of Insect Physiology, 35: 97-105. 
 
Ingber, D., Fujita, T. Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H. and J. 
Folkman, (1990). Synthetic analogues of fumagillin that inhibit angiogenesis and 
suppress tumour growth. Nature, 348: 555-557. 
 
Ishiwika, M., Ninomiya, T., Akabane, H., Kushida, N., Tsujiuchi, G., Ohyama, M., 
Gomi, S., Shito, K. and T. Murata, (2009). Pseurotin A and its analogues as 
inhibitors of immunogluline E production. Bioorganic and Medicinal Chemistry 
Letters, 19: 1457-1460. 
 
Ito, H., Takemori, K. and T. Suzuki, (2001). Role of angiotensin II type 1 receptor 
in the leukocytes of brain microvessels in the pathogenesis of hypertensive cerebral 
injury. Journal of Hypertension, 19: 591-597. 
 
 215  
Ito, Y., Pagano, P.J., Tornheim, K., Brecher, P., and R.A. Cohen, (1996). Oxidative 
stress increases glyceraldehyde-3-phosphate dehydrogenase mRNA levels in 
isolated rabbit aorta. AJP-Heart and Circulatory Physiology, 270: 81-87. 
 
Jackson, J.C., Higgins, L.A. and X. Lin, (2009). Conidiation color mutants of 
Aspergillus fumigatus are highly pathogenic to the heterologous insect host Galleria 
mellonella. PLos One, 4 (1): 4224-4238. 
 
Jacobson, F.S., Morgan, R.W., Christman, M.F. and B.N. Ames, (1989). An alkyl 
hydroperoxide reductase from Salmonella typhimurium involved in the defence of 
DNA against oxidative damage: purification and properties. Journal of Biological 
Chemistry, 264: 1488-1496. 
 
Jacot, A., Scheuber, H., Kurtz, J., and M.W.G., Brinkof, (2005). Juvenile immune 
system activation induces a costly upregulation of adult immunity in field crickets 
Gryllus campestris. Proceedings of the Royal Society, 272: 63-69. 
 
Jafari, R., Goldasteh, S. and S. Afrogheh, (2010). Control of the wax moth Galleria 
mellonella L., (Lepidoptera Pyralidae) by the male sterile technique (MST). 
Archives of Biological Sciences, Belgrade, 62: 309-313. 
 
Jahn, B., Boukhallouk, F., Lotz, J., Langfelder, K., Wanner, G. and A.A. Brackhage, 
(2000). Interaction of human phagocytes with pigmentless Aspergillus conidia. 
Infection and Immunity, 68: 3736-3739. 
 
Jahn, B., Koch. A., Schmit, A., Wanner, G., Gehringer, H., Bhakdi, S. and A.A. 
Brackhage, (1997). Isolation and characterisation of a pigmentless-conidium mutant 
of Aspergillus fumigatus with altered conidial surface and reduced virulence. 
Infection and Immunity, 65: 5110-5117. 
 
Janciauskiene, S., Larsson, S., Larsson, P., Virtala, R., Jansson, L. and T. Stevens, 
(2004). Inhibition of lipopolysaccharide-mediated human monocytes activation, in 
vitro, by 1-antitrypsin. Biochemical and Biophysical Research Communications, 
321: 592-600. 
 
 216  
Janeway, C.A. and R. Medzhitov, (2002). Innate Immune Recognition. Annual 
Review of Immunology, 20: 197-216. 
 
Jez, J.M., Bennet, M.J., Schlegel, B.P., Lewis, M. and T.M. Penning, (1997). 
Comparative anatomy of the aldo-keto reductase superfamily. Biochemical Journal, 
326: 625-636. 
 
Jiravanichpaisal, P., Lee, B.L., and K. Soderhall, (2006). Cell-mediated immunity in 
arthropods: Hematopoeisis, coagulation, melanisation and opsonisation. 
Immunobiology, 211: 213-236. 
 
Johansson, M.W. and K. Söderhall, (1985). Exocytosis of the prophenoloxidase 
activating system from crayfish haemocytes. Journal of Comparative Physiology B, 
156: 175-181. 
 
Joyce, S.A. and C.G. Gahan, (2010). The molecular pathogenesis of Listeria 
monocytogenes in the alternative host Galleria mellonella. Microbiology, 156: 
3456-3468. 
 
Kamei, K. and A. Watanabe, (2005). Aspergillus mycotoxins and their effect on the 
host. Medical Mycology. 43: 95-99. 
 
Kanost, M.R., Kawooya, J.K., Law, J.H., Ryan, R.O., Van Heudsen, M.C., and R. 
Ziegler, (1990). Insect haemolymph proteins. Advances in Insect Physiology, 22: 
299-396 
 
Kanu, A. and K. Patel, (2008). Treatment of allergic bronchopulmonary 
aspergillosis (ABPA) in CF with anti-IgE antibody (omalizumab). Pediatric 
Pulmonology, 43: 1249-1251.  
 
Kato, N., Suzuki, H., Takagi, H., Asami, Y., Kakeya, H., Uramato, M., Usui, T., 
Takahashi, S., Suigmoto, Y. and H. Osada, (2009). Identification of cytochrome 
P450s required for fumitremorgin biosynthesis in Aspergillus fumigatus. 
Chembiochem, 10: 920-928. 
 
 217  
Kato, Y., Motoi, Y., Taniai, K., Kadono-Okuda, K., Yamamoto, M., Higashino, Y., 
Shimabakuro, M., Chowdhury, S., Xu, J., Sugiyama, M., Hiramatsu, M. and M. 
Yamakawa, (1994). Lipopolysaccharide-lipophorin complex formation in insect 
haemolymph: a common pathway of lipopolysaccharide detoxification both in 
insects and mammals. Insect Biochemistry and Molecular Biology, 24 (6):547-555. 
 
Kavanagh, K., and E.P. Reeves, (2004). Exploiting the potential of insects for in-
vivo pathogenicity testing of microbial pathogens. FEMS Microbiology Reviews, 28: 
101-112. 
 
Kawakami, A., Osaka, M., Aikawa, M., Uematsu, S., Akira, S., Libby, P., 
Shimakado, K., Sacks, F.M. and M. Yoshida, (2008). Toll-like receptor 2 mediates 
Apolipoprotein C-III Induced Monocyte Activation. Circulation Research, 103: 
1402-1409. 
 
Kawamura, S., Maesaki, S., Tomono, K., Tashiro, T. and S. Kohno, (2000). Clincial 
evaluation of 61 patients with pulmonary aspergilloma. Internal Medicine, 39: 209-
212. 
 
Kelly, J. and K. Kavanagh, (2010). Caspofungin primes the immune response of 
larvae of Galleria mellonella and induces a non-specific antimicrobial response. 
Journal of Medical Microbiology, 60: 189-196. 
 
Kern, I. and A. Lopert, (2010). Allergic bronchopulmonary aspergillosis with 
coexistant aspergilloma: a case report. Journal of Medical Case Reports, 4: 309-314. 
 
Kettle, A.J and C.C Winterbourn, (2001). A kinetic analysis of the catalase activity 
of myeloperoxidase. Biochemistry, 40: 10204-10212. 
 
Khoufache, K., Puel, O., Loiseau, N., Delaforge, M., Rivollet, D., Coste, A., 
Cordonnier, C., Escudier, E., Botterel, F. and S. Bretagne, (2007). Verruculogen 
associated with Aspergillus fumigatus hyphae and conidia modifies the 
electrophysical properties of human nasal epithelial cells. BMC Microbiology, 7: 5-
16. 
 
 218  
Khovidhunkit, W., Duchateau, P.N., Medzihradszky, K.F., Moser, A.H., Naya-
Vigne, J., Shigenaga, J.K., Kane, J.P., Grunfeld, C. and K.R. Feingold, (2004). 
Apolipoproteins A-IV and A-V are acute-phase proteins in mouse HDL. 
Atherosclerosis, 176: 37-44. 
 
Kim, B.S., Lee, C.S., Seol, J.Y., Yun, C.Y. and H.R Kim, (2002). Cloning and 
expression of 32 kDa ferritin from Galleria mellonella. Archives of Insect 
Biochemistry and Physiology, 51: 80-90. 
 
Knoops, B., Loumaye, E., and V. Van der Eecken, (2007). Evolution of the 
peroxiredoxins. Subcellular Biochemistry, 44: 27-40.  
 
Kolattukudy, P.E., Lee, J.D., Rogers, L.M. Zimmerman, P., Ceselski, S., Fox, B., 
Stein, B. and E.A. Copelan, (1993). Evidence for possible involvement of an 
elastolytic serine protease in aspergillosis. Infection and Immunity, 61: 2357-2368. 
 
Kosalec, I. and S. Pepeljnjak, (2005). Mycotoxigencity of clinical and 
environmental Aspergillus fumigatus and A. flavus isolates. Acta Pharmaceutica, 
55: 365-375. 
 
Kosalec, I., Pepeljnjak, S. and M. Jandrli, (2005). Influence of media and 
temperature on gliotoxin production in Aspergillus fumigatus strains. Arhiv za 
higijenu rada I toksikologiju, 56: 269-273. 
 
Kothary, M.H., Chase, T. and J.D. McMillan, (1984). Correlation of elastase 
production by some strains of Aspergillus fumigatus with ability to cause pulmonary 
invasive aspergillosis in mice. Infection and Immunity, 43: 320-325. 
 
Kotylyar, S., Weirrauch, D., Paulsen, R.H., and D.W. Towle, (2000). Expression of 
arginine kinase enzymatic activity and mRNA in gills of eurylhaline crabs Carcinus 
maenas and Callinectes sapidus. The Journal of Experimental Biology, 203: 2395-
2404. 
 
 219  
Kraemer, R., Deloséa, N., Ballinari, P., Gallati, S. and R. Crameri, (2006). Effect of 
Bronchopulmonary Aspergillosis on lung function in children with cystic fibrosis. 
American Journal of Respiratory and Critical Care Medicine, 174: 1211-1220. 
 
Kurata, S., Arili, S., and S. Kawabata, (2006). Recognition of pathogens and 
activation of immune responses in Drosophila and horseshoe crab innate immunity. 
Immunobiology, 211 (4) 237-249. 
 
Kwiatkowski, D.J., (1999). Functions of gelsolin: motility signalling apoptosis, 
cancer. Current Opinion in Cell Biology, 11: 103-108. 
 
Kwon-Cung, K.J. and J.A. Sugui, (2009). What do we know about the role of 
gliotoxin in the pathobiology of Aspergillus fumigatus? Medical Mycology, 47: 97-
103. 
 
Lage de Morales, A.M., Lara da Costa, G., Ziccardi de Camargo Barcellos, M., 
Lourenço de Oliveira, R. and P. Cunha de Oliveira, (2001). The entomopathogenic 
potential of Aspergillus spp. in mosquitoes vectors of tropical diseases. Journal of 
Basic Microbiology, 41: 45-49. 
 
Laine, E., Coudrec, R., Roch-Arveller, M., Vasson, M.P., Giround, J.P., and D. 
Raichvard, (1990). Modulation of human polymorphonuclear neutrophil functions 
by alpha-1-glycoprotein. Inflammation, 14: 1-9. 
 
Lamberti, A., Caraglia, M., Longo, O., Marra, M., Abbruzzese, A. and P. Arcari, 
(2004). The translation elongation factor 1A in tumorigenesis, signal transduction 
and apoptosis. Amino Acids, 26: 443-448. 
 
Latgé, J-P., (1999). Aspergillus fumigatus and Aspergillosis. Clinical Microbiology 
Reviews, 12: 310-350. 
 
Latgé, J-P., (2001). The pathobiology of Aspergillus fumigatus. TRENDS in 
Microbiology, 9: 382-389. 
 
 220  
Lavine, M.D. and M.R. Strand, (2001). Surface characteristics of foreign targets that 
elicit an encapsulation response by the moth Pseudoplusia includens. Journal of 
Insect Physiology, 47: 965-974. 
 
Lehmann, M., Siegmund, T., Lintermann, K.G. and G. Korge, (1998). The 
pipsqueak protein of Drosophila melanogaster binds to GAGA sequences through a 
novel DNA binding domain. Journal of Biological Chemistry 273: 28504-28509. 
 
Lemaitre, B. and J. Hoffmann, (2007). The host defence of Drosophila 
melanogaster. Annual Review in Immunology, 25: 697-743. 
 
Lemaitre, B., Nicholas, E., Michuaut, L., Reichhart, J.M. and J.A. Hoffman, (1996). 
The dorsoventral regulatory gene cassestte Spaetzle/toll/cactus controls the potent 
antifungal response in Drosophila adults. Cell, 86: 973-983. 
 
Lemaitre, B., Nicolas, E., Michaut, L., Reichart, J-M, and J.A. Hoffmann, (1996). 
The dorsoventral regulatory gene cassette spaezle/toll/cactus controls the potent 
antifungal response in Drosophila adults. Cell, 88: 973-983. 
 
Lewis, R.E., Wiederhold, N.P., Lionakis, M.S., Prince, R.A. and D.P. Kontoyiannis, 
(2005). Frequency and species distribution of gliotoxin-producing Aspergillus 
isolates recovered from patients at a tertiary-care cancer centre. Journal of Clinical 
Microbiology, 43: 6120-6122. 
 
Li, O.W. and C.S. Yang, (2004). Fungal contamination as a major contributor to 
Sick Building Syndrome. Advances in Applied Microbiology, 55: 32-112. 
 
Lian, J., Ma, Y., Cai, J., Wu, M., Wang, J., Wang, X. and Z. Xu, (2008). High level 
expression of soluble subunit b of F1F0 ATP synthase in Escherichia coli cell-free 
system. Applied Microbiology and Biotechnology, 85: 303-311. 
 
Ling, E. and X.Q. Yu, (2006). Haemocytes from the tobacco hornworm Manduca 
sexta have distinct functions in phagocytosis of foreign particles and self dead cells. 
Developmental and Comparative Immunology, 30: 301-309. 
 
 221  
Liu, C.H., Yeh, S.T., Cheng, S.Y. and J.C Chen, (2004). The immune response of 
the white shrimp Litopenaeus vannamei and its susceptibility to Vibrio infection in 
relation with the moult cycle. Fish and Shellfish Immunology, 16: 151-161. 
 
Lowenberger, C., (2001). Innate response of Aedes aegyptii. Insect Biochemistry 
and Molecular Biology, 31: 219-229. 
 
Luisetti, M., Piccioni, P.D., Dyne, K., Donnini, M., Bulgheroni, A., Psturenzi, L., 
Donnetta, A.M. and V. Peona, (1991). Some properties of the alkaline proteinase 
from Aspergillus mellus. International Journal of Tissue Reactions, 13: 187-192. 
 
Ma, G., Hay, D., Li, D., Asgari, S., and O. Schmidt, (2006). Recognition and 
inactivation of LPS by lipophorin particles. Developmental and Comparative 
Immunology, 30: 619-626. 
 
Mabey, J.E., Anderson, M.J., Giles, P.F., Miller, C.J., Attwood, T.K., Paton, N.W., 
Bornberg-Bauer, E., Robson, G.D., Oliver, S.G. and D.W. Denning, (2004). 
CADRE: the Central Aspergillus Data REspoitory. Nucleic Acids Research, 32: 
Database Issue: D401-D405. 
 
MacCabe, A.P., Orejas, M. and D. Ramón, (2001). Aspergillus nidulans as a model 
organism for the study of the expression of genes encoding enzymes of relevance in 
the food industry. Applied Mycology and Biotechnology, 1: 239-265. 
 
Mah, J-H. and J-H. Yu, (2006). Upstream and downstream regulation of asexual 
development in Aspergillus fumigatus. Eukaryotic Cell, 5: 1585-1595. 
 
Maiya, S., Grundmann, A., Li, S-M. and G. Turner, (2006). The Fumitremorgin 
gene cluster of Aspergillus fumigatus: Identification of a gene encoding 
Brevianamide F Synthetase. ChemBioChem, 7: 1062-1069. 
 
Maiya, S., Grundmann, A., Li, X., Li, S.M. and G. Turner, (2007). Identification of 
a hybrid PKS/NRPS required for pseurotin A biosynthesis in the human pathogen 
Aspergillus fumigatus. Chembiochem, 8: 1736-1743. 
 
 222  
Mak, P., Zdybicka-Barabas, A. and M. Cytrynska, (2010). A different repertoire of 
Galleria mellonella antimicrobial peptides in larvae challenged with bacteria and 
fungi. Developmental and Comparative Immunology, 34: 1129-1136. 
 
Malani, A.N. and C.A. Kauffman, (2007). Changing epidemiology of rare mould 
infections: implications for therapy. Drugs, 67: 1803-1812. 
 
Malech, H.L. and W.M. Nauseef, (1997). Primary inherited defects in neutrophil 
function: etiology and treatment. Seminars in Hematology, 34, 279-290. 
 
Mansfield, S.G., Cammer, S., Alexander, S.C., Muehleisen, D.P., Gray, R.S., 
Tropsha, A., and W.E. Bollenbacher, (1998). Molecular cloning and characterisation 
of an invertebrate cellular retinoic acid binding protein. Proceedings of the National 
Academy of Sciences USA, 95: 6825-6830. 
 
Masser, E., (2004). Significance of reductases in the detoxification of the tobacco 
specific carcinogen NNK. Trends in Pharmacological Sciences, 25: 225-237. 
 
McCowen, M.C., Callender, M.E. and J.F. Lawis, (1951). Fumagillin (H3) a new 
antibiotic with amaebicidal properties. Science, 113: 202-203. 
 
Mezger, M., Einsele, H. and J. Loeffer, (2010). Genetic susceptibility to infections 
with Aspergillus fumigatus. Critical Reviews in Microbiology, 36: 168-177. 
 
Misu, M., Furukawa, H., Kwon, H.J., Shikinaka, K., Kakugo, A., Satoh, T., Osada, 
Y., and J.P. Gong, (2009). Photo-induced in situ formation of various F-actin 
assemblies with a photoresponsive polycation. Journal of Biomedical Materials 
Research, 89: 424-431. 
 
Mitchell, C.G., Slight, J. and K. Donaldson, (1997). Diffusible component from the 
spore surface of the fungus Aspergillus fumigatus which inhibits the macrophage 
oxidative burst is distinct from gliotoxin and other hyphal toxins. Thorax, 52: 796-
801. 
 
 223  
Mitchell, P., (1961). Coupling of phosphorylation to electron and hydrogen transfer 
by a chemiosmotic type mechanism. Nature, 191: 144-146. 
 
Molina, J.M, Goguel, J., Sarfati, C., Michiels, J.F., Desportes-Livage, I., Balkan, S., 
Chastang, C., Cotte, L., Maslo, C., Struxiano, A., Derouin, F. and J.M Decazes, 
(2000). Trial of oral fumagillin for the treatment of intestinal microsporidiosis in 
patients with HIV infection. AIDS, 14: 1341-13488. 
 
Momany, M. and I. Taylor, (2000). Landmarks in the early duplication cycles of 
Aspergillus fumigatus and Aspergillus nidulans: polarity, germ tube emergence and 
septation. Microbiology, 146: 3279-3284. 
 
Mondon, P., De Champs, C., Donadille, A., Ambroise-Thomas, P. and R. Grillot, 
(1996). Variation in virulence of Aspergillus fumigatus strains in a murine model of 
invasive pulmonary aspergillosis. Journal of Medical Microbiology, 45: 186-191. 
 
Morris, G., Kokki, M.H., Anderson, K. and M.D. Richardson, (2000). Sampling of 
Aspergillus spores in air. Journal of Hospital Infection, 44: 81-92.   
 
Mowlds, P. and K. Kavanagh, (2008). Effect of pre-incubation temperature on 
susceptibility of Galleria mellonella larvae to infection by Candida albicans. 
Mycopathologia 165: 5-12.  
 
Mowlds, P., Barron, A., and K. Kavanagh, (2008). Physical stress primes the 
immune response of Galleria mellonella to infection by Candida albicans. Microbes 
and Infection, 10: 628-634. 
 
Mowlds, P., Coates, C., Renwick, J., and K. Kavanagh, (2010). Dose-dependent 
cellular and humoral responses in Galleria mellonella larvae following -glucan 
inoculation. Microbes and Infection, 12: 146-153. 
 
Mullins, R.D., Stafford, W.F. and T.D. Pollard, (1997). Structure, Subunit 
Toplology, and Actin-binding Activity of the Arp/23 Complex from Acanthamoeba. 
The Journal of Cell Biology, 136: 331-343. 
 
 224  
Mylonakis, E., Moreno, R., El, Khoury, J.B., Idnurm, A., Heitman, J., Calderwood, 
S.B., Ausubel, F.M. and A. Diener, (2005). Galleria mellonella as a model system 
to study Cryptococcus neoformans pathogenesis. Infection and Immunity, 73: 3842-
3850. 
 
Nakamura, A., Stiebler, R., Fantappie, M.R., Fialho, E., Masuda, H. and M.F. 
Oliviera, (2007). Effects of retinoids and juvenoids on moult and on phenoloxidase 
activity in the blood-sucking insect Rhodnius prolixus. Acta tropica, 103: 222-230. 
 
Nauseef, W.M., (2007). How human neutrophils kill and degrade microbes. 
Immunological Reviews, 219: 88-102. 
 
O’ Gorman, C., Fuller, H.T. and P.S. Dyer, (2009). Discovery of a sexual cycle in 
the opportunistic fungal pathogen Aspergillus fumigatus. Nature, 457: 471-475. 
 
Okroj, M., Kamysz, K., Slominska, E.M., Mysliwski, A. and J. Bigda, (2005). A 
novel mechanism of action of the fumagillin analog, TNP-470, in the B16F10 
murine melanoma cell line. Anti-Cancer Drugs, 16: 817-823. 
 
Paisley, D., Robson, G.D. and D.W. Denning, (2005). Correlation between in vitro 
growth rate and in vivo virulence in Aspergillus fumigatus. Medical Mycology, 43: 
397-401. 
 
Panaccione, D.G. and C.M. Coyle, (2005). Abundant respirable ergot alkaloids from 
the common airborne fungus Aspergillus fumigatus. Applied and Environmental 
Microbiology, 71: 3106-3111. 
 
Panagopoulou, P., Filioti, J., Petrikkos, G., Giakouppi, P., Anatoliotaki, M., 
Farmaki, E., Kanta, A., Apostolakou, H., Aviami, A., Samonis, G. and E. Roilides, 
(2002). Environmental surveillance of filamentous fungi in three tertiary care 
hospitals in Greece. Journal of Hospital Infection, 52: 185-191. 
 
Paris, S., Boisvieux-Ulrich, E., Crestani, B., Houcine, O., Taramelli, D., Lombardi, 
L. and J-P. Latgé, (1997). Internalisation of Aspergillus fumigatus conidia by 
epithelial and endothelial. Infection and Immunity, 65: 1510-1514. 
 225  
 
Paris, S., Debeaupuis, J.P., Crameri, R., Carey, M., Charlès, F., Prévost, M.C., 
Schmitt, C., Phillipe, B. and J.P. Latgé, (2003). Conidial hydrophobins of 
Aspergillus fumigatus. Applied Environmental Microbiology, 69: 1581-1588. 
 
Park, S.Y., Kim, C.H., Jeong, W.H., Lee, J.H, Seo, S.J., Han, Y.S., and I.H. Lee, 
(2005). Effects of two haemolymph proteins on humoral defense reactions in the 
wax moth, Galleria mellonella. Developmental and Comparative Immunology, 29: 
43-51. 
 
Pasqualotto, A.C., (2009). Differences in pathogenicity and clinical syndromes due 
to Aspergillus fumigatus and A. flavus. Medical Mycology, 47: 261-270.  
 
Patterson, T.F., (2006). Treatment of invasive aspergillosis: Polyenes, echnocandins, 
or azoles? Medical Mycology, 44: 357-362. 
 
Perkhofer, S., Kehrel, B.E., Dierich, M.P., Donnelly, J.P., Nussbaumer, W., 
Hofmann, J., von Eiff, C. and C. Lass-Flörl, (2007). Human platelets attenuate 
Aspergillus species via granule-dependent mechanisms. Journal of Infectious 
Diseases, 198: 1243-1246. 
 
Perrin, R.M., Fedorova, N.D., Bok. J.W., Cramer, R.A., Wortman, J.R., Kim, H.S., 
Nierman, W.C. and N.P. Keller, (2007). Transcriptional regulation of chemical 
diversity in Aspergillus fumigatus by LaeA. Plos Pathogens, 3: 50-60. 
 
Pestova, T.V. and C.U.T. Hellen, (2000). The structure and function of initiation 
factors in eukaryotic protein synthesis.  Cellular and Molecular Life Sciences, 57: 
651-674. 
 
Phillipe, B., Ibrahim-Granet, O., Prevost, M.C., Gougerot-Pocidalo, M.A., Sanchez, 
P.M., Van der Meeren, A. and J.P. Latgé, (2003). Killing of Aspergillus fumigatus 
by alveolar macrophages is mediated by reactive oxidant intermediates. Infection 
and Immunity, 71: 3034-3042. 
 
 226  
Phipps, D.J., Chadwick, J.S. and W.P. Aston, (1994). Gallysin-1, an antibacterial 
protein isolated from haemolymph of Galleria mellonella. Developmental and 
Comparative Immunology, 18: 13-23. 
 
Pihet, M., Carrere, J., Cimon, B., Chabasse, D., Delhaes, L., Symoens, F. and J.P. 
Bouchara, (2009). Occurrence and relevance of filamentous fungi in respiratory 
secretions of patients with cystic fibrosis-a review. Medical Mycology, 47: 387-397. 
 
Pineiro, M., Alava, M.A., Gonzalez-Ramon, N., Osada, J., Lasierra, P., Larrad, L., 
Pineiro, A. and F. Lampreauve, (1999). ITIH4 serum concentration increases during 
acute phase processes in human patients and is upregulated by interleukin 6 in 
hepatocarcinoma HepG2 cells. Biochemical and Biophysical Research 
Communications, 263: 224-229. 
 
Pineiro, M., Andres, M., Itturalde, M., Carmona, S., Hirvonen, J., Pyorala, S., 
Heegaard, P.M.H., Tjornehoj, K., Lampreauve, F., Pineiro, A. and M.A. Alava, 
(2004). ITIH4 (Inter-Alpha-Trypsin Inhibitor Heavy Chain 4) is a new acute phase 
protein isolated from cattle during experimental infection. Infection and Immunity, 
72: 3777-3782. 
 
Pini, G., Faggi, E., Donato, R., Sacco, C. and R. Fanci, (2008). Invasive pulmonary 
aspergillosis in neutropenic patients and the influence of hospital renovation. 
Mycoses, 51: 117-122. 
 
Porrini, M.P., Audisio, M.C., Sabaté, D.C., Ibarguren, C., Medici, S.K., Sarlo, E.G., 
Garrido, P.M. and M.J. Eguaras, (2010). Effect of bacterial metabolites on 
microsporidian Nosema ceranae and on its host Apis mellifera. Parasitology 
Research, 107: 381-388. 
 
Price, C.D. and N.A. Ratcliffe, (1974). A reappraisal of insect haemocyte 
classification by the examination of blood form fifteen insect orders. Zeitschrift für 
Zellforachung und Mikroskopische Anatomy, 147: 537-549. 
 
 227  
Pryor, W.A. and G.L. Squadrito, (1995). The chemistry of peroxynitrite: a product 
from the formation of nitric oxide and superoxide. American Journal of Physiology, 
268: 699-722. 
 
Rashid, M., Khalil, S., Ayub, N., Ahmed, W. and A. Ghaffer Khan, (2008). 
Categorization of Aspergillus flavus and Aspergillus parasitcus isolates of stored 
wheat grains into Aflotoxinogenics and Non-Aflotoxinogenics, Pakistan Journal of 
Botany, 40: 2177-2192. 
 
Ratcliffe, N., (1985). Invertebrate Immunity – a primer for the non-specialist. 
Immunology Letters, 10: 253-270. 
 
Recalde, D., Ostos, M.A., Badell, E., Garcia-Otin, A-L., Pidoux, J., Castro, G., 
Zakin, M.M. and D. Scott-Algara, (2004). Human apolipoprotein A-IV reduces 
secretion of proinflammatory cytokines and atherosclerotic effects of chronic 
infection mimicked by lipopolysaccharide. Arteriosclerosis, Thrombosis, and 
Vascular Biology, 24: 756-761. 
 
Reeves, E.P., Lu, H., Jacobs, H.L., Messina, C.G., Bolsover, S., Gabella, G., Potma, 
E.O., Warley, A., Roes, J. and A.W. Segal, (2002). Killing activity of neutrophils is 
mediated through activation of proteases by K+ flux. Nature, 416: 291-296. 
 
Reeves, E.P., Messina, C.G.M., Doyle, S. and K. Kavanagh, (2004). Correlation 
between gliotoxin production and virulence of Aspergillus fumigatus in Galleria 
mellonella. Mycopathologia, 158: 73-79. 
 
Reeves, E.P., Reiber, K., Neville, C., Scheibner, O., Kavanagh, K. and S. Doyle, 
(2006). A nonribosomal peptide synthetase (Pes 1) confers protection against 
oxidative stress in Aspergillus fumigatus. FEBS Journal, 273: 3038-3053. 
 
Rementeria, A., López-Molina, N., Ludwig, A., Vivanco, A.B., Bikandi, J., Pontón, 
J. And J. Garaizar, (2005) Genes and molecules involved in Aspergillus fumigatus 
virulence. Revista Iberoamerica Micología. 22:1-23. 
 
 228  
Renwick, J., Daly, P., Reeves, E.P. and K. Kavanagh, (2006). Susceptibility of 
Galleria mellonella larvae to infection by Aspergillus fumigatus is dependant upon 
stage of conidial germination. Mycopathologia, 161: 377-384. 
 
Renwick, J., Reeves, E.P., Wientjes, F.B., and K. Kavanagh, (2007). Translocation 
of proteins homologous to human neutrophil p47phox and p67phox to the cell 
membrane in activated haemocytes of Galleria mellonella larvae. Developmental 
and Comparative Immunology, 31: 347-359. 
 
Reumaux, D., de Boer, M., Meijer, A.B., Duthilleul, P. And D. Roos, (2003). 
Expression of myeloperoxidase (MPO) by neutrophils is necessary for their 
activation by anti-neutrophil cytoplasm autoantibodies (ANCA) against MPO. 
Journal of Leukocyte Biology, 73: 841-849. 
 
Rhodes, J.C., (2006). Aspergillus fumigatus: Growth and virulence. Medical 
Mycology, 44: 77-81. 
 
Ribeiro, C. and M. Brehélin, (2006). Insect haemocytes: What type of cell is that? 
Journal of Insect Physiology, 52: 417-429. 
 
Richie, D.L., Hartl, L., Aimanianda, V., Winters, M.S., Fuller, K.K., Miley, M.D., 
White, S., McCarthy, J.W., Latge, J.P., Feldmesser, M., Rhodes, J.C. and D.S. 
Askew, (2009). A role for the unfolded protein response (UPR) in virulence and 
antifungal susceptibility in Aspergillus fumigatus. PLos Pathogens, 5: e1000258-
1000275. 
 
Riddell, D.R., Graham, A. and J.S. Owen, (1997). Apolipoprotein E inhibits platelet 
aggregation through the L-Arginine:Nitric Oxide pathway: Implications for vascular 
disease. Journal of Biological Chemistry, 272: 89-95 
 
Rivera, A., Van Epps, H.L., Hohl, T.M., Rizzuto, G. and E.G. Palmer, (2005). 
Distinct CD4+-T-Cell responses to live and heat-inactivated Aspergillus fumigatus 
conidia. Infection and Immunity, 73: 7170-7179. 
 
 229  
Robson, G.D., Huang, J., Wortman, J. and D.B. Archer, (2005). A preliminary 
analysis of the process of protein secretion and the diversity of putative secreted 
hydrolases encoded in Aspergillus fumigatus: insights from the genome. Medical 
Mycology, 43: 41 – 47. 
 
Roos, D., van Bruggen, R. and C. Meischl, (2003). Oxidative killing of microbes by 
neutrophils. Microbes and Infection, 5: 1307-1315. 
 
Rowan, R., Moran, C., McCann, M. and K. Kavanagh, (2009). Use of Galleria 
mellonella to evaluate the in vivo antifungal activity of [Ag2(mal)(phen)3]. 
Biometals, 22: 461-467. 
 
Sable, C.A., K.M. Strohmaier and J. A. Chodakewitz, (2008). Advances in 
antifungal therapy. Annual Review of Medicine, 59: 361-379. 
 
Sagan, D. and K. Gozdziuk, (2010). Surgery for pulmonary aspergilloma in 
immunocompetent patients: No benefit from adjuvant antifungal pharmacotherapy. 
The Annals of Thoracic Surgery, 89: 1603-1611. 
 
Sagan, D., Gozdziuk, K. and E. Korobowicz, (2010). Predictive and prognostic 
value of preoperative symptoms in the surgical treatment of pulmonary 
aspergilloma. Journal of Surgical Research, 163: 35-43.  
 
Salzet, M., (2001). Vertebrate innate immunity resembles a mosaic of invertebrate 
immune responses. Trends in Immunology, 22: 285-288. 
 
Santi, L., Silva, W.O., Pinto, A.F., Schrank, A. and M.H. Vainstein, (2010). 
Metarhizum anisopliae host-pathogen interaction: differential immunoproteomics 
reveals proteins involved in the infection process of arthropods. Fungal Biology, 
114: 312-319. 
 
Schmidt, O., Soderhall, K., Theopold, U. and I. Faye, (2010). Role of adhesion in 
arthropod immune recognition. Annual Review of Entomology, 55: 485-504. 
 
 230  
Schmolz, E., Geisenheyner, S., Schricker, B. and I. Lamprecht, (1999). Heat 
dissipation of flying wax moths (Galleria mellonella) mesured by means of direct 
calorimetry. Journal of Thermal Analysis and Calorimetry, 56: 1185-1190. 
 
Schoofs, L., Hoffman, G.M., Hayes, T.K., Nachman, R.J., and A. De Loof, (1990). 
Locusta tachykinin I and II, two novel insect neuropeptides with homology to 
peptides from the vertebrate tachykinin family. FEBS Letters. 261: 397-401. 
 
Schrettl, M., Bignell, E., Kragl, C., Joechl, C., Rodgers, T., Arst, A.N., Haynes, K., 
and H. Haas, (2004). Siderophore biosynthesis but not reductive iron assimilation is 
essential for Aspergillus fumigatus virulence. Journal of Experimental Medicine, 
200: 1213-1219. 
 
Schrettl, M., Bignell, E., Kragl, C., Sabiha, Y., Loss, O., Eisendle, M., Wallner, A., 
Arst, H.N., Haynes, K. and H. Haas, (2007). Distinct roles for intra- and 
extracellular siderophores during Aspergillus fumigatus infection. PLoS Pathogens, 
3: 1195-1207. 
 
Schrettl, M., Carberry, S., Kavanagh, K., Haas, H., Jones, G.W., O’ Brien, J., Nolan, 
A., Stephens, J., Fenelon, O. and S. Doyle, (2010). Self protection against gliotoxin- 
A component of the gliotoxin biosynthetic cluster, GliT, completely protects 
Aspergillus fumigatus against exogenous gliotoxin. PLoS Pathogens, 6: e10000952. 
 
Schuhmann, B., Seitz, V., Vilcinskas, A., and L. Podsiadlowski, (2003). Cloning 
and expression of gallerimycin, an antifungal peptide expressed in immune response 
of greater wax moth larvae, Galleria mellonella. Archives of Insect Biochemistry 
and Physiology, 53: 125-133. 
 
Schütze, N., Lehmann, I., Bönisch, U., Simon, J.C. and T. Polte, (2010). Exposure 
to mycotoxins increases the allergic immune response in a murine asthma model. 
American Journal of Respiratory and Critical Care Medicine, 181: 1188-1199. 
 
Scully, L.R.  and M.J. Bidochka, (2005). Serial passage of the opportunistic 
pathogen Aspergillus flavus through an insect host yields decreased saprobic 
capacity. Canadian Journal of Microbiology, 51: 185-189. 
 231  
 
Seed, K.D. and J.J. Dennis, (2008). Development of Galleria mellonella as an 
alternative infection model for the Burkholderia cepacia complex. Infection and 
Immunity, 76: 1267-1275. 
 
Segal, A.W., (1996). The NADPH oxidase and chronic granulatomous disease. 
Molecular Medicine Today, 2: 129-135. 
 
Segal, A.W., (2005). How neutrophils kill microbes. Annual Review in Immunology, 
23: 197-223. 
 
Segal, A.W., Dorling, J. and S. Coade, (1980). Kinetics of fusion of the cytoplasmic 
granules with phagocytic vacuoles in human polymorphonuclear leukocytes. 
Biochemical and morphological studies. Journal of Cell Biology, 85: 42-59. 
 
Segrest, J.P., Jones, M.K., De Loof, H., Brouillette, C.G., Venkatachalapathi, Y.V, 
and G.M. Anantharamaiah, (1992). The amphipathic helix in the exchangeable 
apolipoproteins: a review of secondary structure and function. Journal of Lipid 
Research, 33: 141-166. 
 
Seiberling, K. and P.J. Wormaid, (2009). The role of itraconazole in recalcitrant 
fungal sinusitis. American Journal of Rhinology and Allergy, 23: 303-306. 
 
Seifert, M., Nairz, M., Schroll, A., Schrettl, M., Haas, H. and G. Weiss, (2008). 
Effects of the Aspergillus fumigatus siderophore systems on the regulation of 
macrophage immune effector pathways and iron homeostasis. Immunobiology, 213: 
767-778. 
 
Shevchenko, A., Tomas, H., Havlis, J., Olsen, J.V. and M. Mann, (2007). In-gel 
digestion for mass spectrometric characterization of proteins and proteomes. Nature 
Protocols, 1: 2856-2860. 
 
Sirover, M.A., (1996). Emerging new functions of the glycolytic protein 
glyceraldehydes-3-phosphate dehydrogenase, in mammalian cells. Life Sciences, 58: 
2271-2277. 
 232  
 
Sirover, M.A., (1999). New insights into an old protein: the functional diversity of 
mammalian glyceraldehyde-3-phosphate dehydrogenase. Biochimica et Biophysica  
Acta, 1432: 159-184. 
 
Slater, J.L., Gregson, L., Denning, D.W. and P.A. Warn, (2010). Pathogenicity of 
Aspergillus fumigatus mutants assessed in Galleria mellonella matches that in mice. 
Medical Mycology, 49: 107-113. 
 
Smedbold, H.T., Ahlen, C., Unimed, S., Nilsen, A.M., Norbäck, D. and B. Hilt, 
(2002). Relationships between indoor environments and nasal inflammation in 
nursing personnel. Archives of Environmental Health, 57: 155-161. 
 
Smith, J., (1993). Construction and pathogenicity of Aspergillus fumigatus mutants 
that do not produce the ribotoxin restrictocin. Molecular Microbiology, 9: 1071-
1077.  
 
Soderhall, K. and L. Cerenius, (1998). Role of phenoloxidase activating system in 
invertebrate immunity. Current Opinion in Immunology, 10: 23-28. 
 
Soderhall, K. and L. Cerenius, (1998). Role of phenoloxidase-activating system in 
invertebrate immunity. Current Opinion in Immunology, 10: 23-28 
 
Søndergaard, L., (1993). Homology between the mammalian liver and the 
Drosophila fat body. Trends in Genetics, 9: 193 
 
Spitznagel, J.K., (1990). Antibiotic proteins of human neutrophils. Journal of 
Clinical Investigation, 86: 1381-1386. 
 
Sritunyalucksana, K. and K. Soderhal, (2000). The proPO and clotting system in 
crustaceans. Aquaculture, 191: 53-59. 
 
St Leger, R,J., Cooper R.M. and A.K. Charnley, (1988). The effect of melanisation 
of Manduca sexta cuticle growth and infection by Metarhizum anisopliae. Journal 
of Invertebrate Pathology, 52: 459-470. 
 233  
 
St Leger, R.J., Charnely, A.K. and R.M. Cooper, (1987). Characterization of cuticle-
degrading proteases produced by the entamopathogen Metarhizum anisopliae. 
Archives of Biochemistry and Biophysics, 253: 221-232. 
 
Stan, S., Delvin, E., Lambert, M., Seidman, E. and E. Levy, (2003). Apo A-IV: an 
update on regulation and physiological functions. Biochimica et Biophysica Acta, 
17: 177-187. 
 
Standish, A.J., and J.N. Weiser, (2009). Human neutrophils kill Streptococcus 
pneumoniae via serine proteases. Journal of Immunology, 183: 2602-2609. 
 
Steinbach, W.J. and D.A. Stevens, (2003). Review of newer antifungal and 
immunomodulatory strategies for invasive aspergillosis. Clinical Infectious 
Diseases, 37: 157-187. 
 
Stevanovic, J., Stanimirovic, Z., Radakovic, M. and V. Stojic, (2008). In vitro 
evaluation of the clastogenicity of fumagillin. Environmental and Molecular 
Mutagenesis, 49: 594-601.   
 
Storz, G., Jacobson, F.S., Tartaglia, L.A., Morgan, R.W., Silveira, L.A., and B.N. 
Ames, (1989). An alkyl hydroperoxide reductase induced by oxidative stress in 
Salmonella typhimurium and Escherichia coli: Genetic characterisation and cloning 
of ahp. Journal of Bacteriology, 171: 2049-2055. 
 
Sumimito, H., Hata, K., Mizuki, K., Ito, T., Kaga, Y., Sakaki, Y., Fukumaki, Y., 
Nakamura, M., and K. Takeshige, (1996). Assembly and activation of the phagocyte 
NADPH oxidase. Specific interaction of the N-terminal Src homology 3 domain of 
p47phox with p22phox is required for activation of the NADPH oxidase. Journal of 
Biological Chemistry, 271: 22152-22158. 
 
Sumimoto, H., Hata, K., Mizuki, K., Ito, T., Kage, Y., Sakaki, Y., Fukumaki, Y., 
Nakamura, M., and K. Takeshige, (1996). Assembly and activation of the 
phagocytic NADPH oxidase. Specific interaction of the N-terminal Src homology 3 
 234  
domain of p47phox with p22phox is required for the activation of the NADPH oxidase. 
Journal of Biological Chemistry, 271: 22152-22158. 
 
Sung, H.H., Chang, H.J., Her, C.H., Chang, J.C. and Y.L. Song, (1998). 
Phenoloxidase activity of haemocytes derived from Penaeus monodon and 
Macrobrachium rosenbergii. Journal of Invertebrate Pathology, 71: 26-33. 
 
Sutton, P., Waring, P. and A. Mullbacher, (1996). Exacerbation of invasive 
aspergillosis by the immunosuppressive fungal metabolite gliotoxin. Immunology 
and Cell Biology, 74: 318-322.  
 
Szewczyk, E. and S. Krappmann, (2010). Conserved regulators of mating are 
essential for Aspergillus fumigatus cleistothecium formation. Eukaryotic Cell, 9: 
774-783. 
 
Tekaia, F., and J.P. Latgé, (2005). Aspergillus fumigatus: saprophyte or pathogen. 
Current Opinion in Microbiology, 8: 385-392. 
 
Telfer, W.M., (1991). The function and evolution of insect storage proteins. Annual 
Review of Entmology, 36: 205-228. 
 
Tempkin, A.D., Sobonya, R.E., Seeger, J.F. and E.S. Oh, (2006). Cerebral 
Aspergillosis: Radiologic and pathologic findings. Ragiographics, 26: 1239-1242. 
Terr, A.I., (2009). Sick Building Syndrome: is mould the cause? Medical Mycology, 
47: 217-222. 
 
Theopold, U., Li, D., Fabri, M., Scherfer, C. and O. Schmidt, (2002). The 
coagulation of insect haemolymph. Cellular and Molecular Life Sciences, 59: 363-
372. 
 
Thompson, G.R. and T.F. Patterson, (2008). Pulmonary Aspergillosis. Seminars in 
Respiratory and Critical Care Medicine, 28: 103-110. 
 
Thornton, C.R., (2010). Detection of Invasive Aspergillosis. Advances in Applied 
Molecular Biology, 70: 187-216. 
 235  
Thrasher, A.J., Keep, N.H., Wientjes, F.B., and A.W Segal, (1994). Chronic 
granulomatous disease. Biochimica et Biophysica Acta 1227: 1-24. 
 
Thrasher, J.D. and S. Crawley, (2009). The biocontaminants and complexity of 
damp indoor spaces: more than what meets the eye. Toxicology and Industrial 
Health, 25: 583-615. 
 
Tillie-Leblond, I. and A-B., Tonnel, (2005). Allergic bronchopulmonary 
aspergillosis. Allergy, 60: 1004-1013. 
 
Tomee, J.F. and T.S. van der Werf, (2001). Pulmonary aspergillosis. Netherlands 
Journal of Medicine, 59: 244-258. 
 
Truman, J.W. and L.M. Riddiford, (1999). The origins of insect metamorphosis. 
Nature, 401: 447-452. 
 
Tsunawaki, S., Yoshida, L., Nishida, S., Kobayashi, T. and T. Shimoyama, (2004). 
Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst 
NADPH oxidase. Infection and Immunity, 72: 3373-3382. 
 
van der Ent, C.K., Hoekstra, H. and G.T. Rijkers, (2007). Successful treatment of 
allergic bronchopulmonary aspergillosis with recombinant Ig E antibody. Thorax, 
62: 276-277. 
 
Van der Horst, D.J., (2003). Insect adipokinetic hormones: release and integration of 
flight energy metabolism. Comparative Biochemistry and Physiology. Part B, 26: 
119-129. 
 
Van der Horst, D.J., van Hoof, D., van Marrewijk, W.J.A. and K.W. Rodenburg, 
(2002). Alternative lipid mobilisation: the insect shuttle system. Molecular and 
Cellular Biochemistry, 239: 113-119. 
 
Velagapudi, R., Hsueh, Y-P., Geunes-Boyer, S., Wright, J.R. and J. Heitman, 
(2009). Spores as Infectious Propagules of Cryptococcus neoformans. Infection and 
Immunity, 77: 4345-4355. 
 236  
Vermani, M., Vijayan, V.K., Kausar, M.A. and M.K. Agarwal, (2010). 
Quantification of airborne Aspergillus allergens: Redefining the approach. Journal 
of Asthma, 47: 754-761. 
 
Verweij, P.E., Snelders, E., Kema, G.H.J., Mellado, E. and W.J.G. Melchers, 
(2009). Azole resistance in Aspergillus fumigatus: a side effect of environmental 
fungicide use. The Lancet Infectious Diseases, 9: 789-795. 
 
Vickers, I., Reeves, E.P., Kavanagh, K.A. and S. Doyle, (2007). Isolation, activity 
and immunological characterisation of a secreted aspartic protease, CtsD, from 
Aspergillus fumigatus. Protein expression and purification, 53: 216-224. 
 
Vierstrate, E., Verleyen, P., Baggerman, G., D’ Hertog, W., Van den Bergh, W., 
Arckens, L., De Loof, A., and L. Schoofs, (2004). A proteomic approach for the 
analysis of instantly released wound and immune proteins in Drosophila 
melanogaster haemolymph. Proceedings of the National Academy of Sciences USA, 
101: 470-475. 
 
Vilcinskas, A., Matha, V. and P. Götz, (1997). Effects of the entamopathogenic 
fungus Metarhizum anisopliae and its secondary metabolites on morphologyand 
cytoskeleton of plasmatocytes isolated from the Greater Wax moth, Galleria 
mellonella. Journal of Insect Physiology, 43: 1149-1159. 
 
Vilmos, P. and E. Kurucz, (1998). Insect Immunity: evolutionary roots of the 
mammalian innate immune system. Immunology Letters, 62: 59-66. 
 
Vonk, A.G., de Bont, N., Netea, M.G., Demacker, P.N.M., van der Meer, J.,  
Stalenhoef, A. and B.J. Kullberg, (2004). Apolipooprotein E deficient mice exhibit 
an increased susceptibility to disseminated candidiasis. Medical Mycology, 42: 341-
348. 
 
Wallach, T. and A.W Segal, (1996). Stoichiometry of the subunits of 
flavocytochrome b558 of the NADPH oxidase of phagocytes. Biochemistry Journal, 
320: 33-38. 
 
 237  
Walsh, T.J., (1998). Primary cutaneous aspergillosis-an emerging infection among 
immunocompromised patients. Clinical Infectious Diseases, 27: 453-457. 
 
Wang, Q., Chen, K., Yao, Q., Zhao, Y., Li, Y., Shen, H. and R. Mu, (2008). 
Identification and characterisation of a novel 1-Cys peroxiredoxin from silkworm, 
Bombyx mori. Comparative Biochemistry and Physiology, 149 (1) 176-182. 
 
Wang, X-J., Chen, J., Lv, Z-B., Nie, Z-M., Wang, D., Shen, H-D, Wang, X-D., Wu, 
X-F. and Y-Z Zhang, (2007). Expression and functional analysis of the cellular 
retinoic acid binding protein from silkworm pupae (Bombyx mori). Journal of 
Cellular Biochemistry, 102: 970-979. 
 
Warren, L.O. and P. Huddleston, (1962). Life history of the Greater wax moth 
Galleria mellonella L., in Arkansas. Journal of Kansas Entamological Society, 35: 
212-216. 
 
Warris, A., Gaustad, P., Meis, J.F., Voss, A., Verweij, P.E. and T.G. Abrahamsen, 
(2001). Recovery of filamentous fungi from water in paediatric bone marrow 
transplantation unit. Journal of Hospital Infection, 47: 143-148.  
 
Warris, A., Klaassen, C.H.W., Meis, J.F.G.M., de Ruiter, M.T., de Valk, H.A., 
Abrahamsen, T.G., Guastad, P and P.E. Verweij, (2003). Molecular epidemiology of 
Aspergillus fumigatus isolates recovered from water, air and patients shows two 
clusters of genetically different strains. Journal of Clinical Microbiology, 41: 4101-
4106. 
 
Warris, A., Onken, A., Gaustad, P., Janssen, W., van der Lee, H., Verweij, P.E. and 
T.G. Abrahamsen, (2010). Point-of–use filtration method for the prevention of 
fungal contamination of hospital water. Journal of Hospital Infection, 76: 56-59. 
 
Warris, A., Voss, A., Abrahamsen, T.G., and P.E. Veirweij, (2002). Contamination 
of hospital water with Aspergillus fumigatus and other molds. Clinical Infectious 
Diseases, 34: 1159-1160.  
 
 238  
Wasylnka, J.A., Simmer, M.I. and M.M. Moore, (2001). Differences in sialic acid 
density in pathogenic and non-pathogenic Aspergillus species. Microbiology, 147: 
869-877. 
 
Watanabe, A., Kamei, K., Sekine, T., Waku, M., Nishimura, K., Miyaji, M. and T. 
Kuriyama, (2003). Immunosuppressive substances in Aspergillus fumigatus culture 
filtrate. Journal of Infection and Chemotherapy, 9: 114-121.  
 
Weers, P.M.M., and R.O. Ryan, (2006). Apolipophorin III: Role model 
apolipoprotein. Insect Biochemistry and Molecular Biology, 36: 231-240. 
 
Wheeler, M.A., Smith, S.D., Garcia-Cardena, G., Nathan, C.F., Weiss, R.M., and 
W.C. Sessa, (1997). Bacterial infection induces nitric oxide synthase in human 
neutrophils. Journal of Clinical Investigation, 99: 110-116 
 
Whitten, M.M.A, Tew I.F., Lee, B.L. and N.A. Ratcliffe, (2004). A novel role for an 
Insect apolipoprotein (Apolipophorin III) in {beta}-1,3-glucan Pattern Recognition 
and cellular encapsulation reactions. Journal of Immunology, 172: 2177-2185. 
 
Wientjes, F.B. and A.W. Segal, (2003). PX domain takes shape. Current Opinions 
in Hematology, 10: 2-7. 
 
Wientjes, F.B., Hsuan, J.J., Totty, N.F. and A.W Segal, (1993). p40phox, a third 
activation complex of the NADPH oxidase to contain SH3 domains. Biochemistry 
Journal. 296: 557-562. 
 
Wiesener, A., Losen, S., Kopacek. P., Weise, C. and P. Gotz, (1997). Isolated 
apolipophorin III from Galleria mellonella stimulates the immune response of this 
insect. Journal of Insect Physiology, 43: 383-391. 
 
Wodja, I., Kowalski, P. and T. Jacubowicz (2009). Humoral immune response of 
Galleria mellonella larvae after infection with Beauvaria bassiana under optimal 
and heat-shock conditions. Journal of Insect Physiology, 55: 525-531. 
 
 239  
Wojda, I. and T. Jakubowicz, (2007). Humoral immune response upon mild heat-
shock conditions in Galleria mellonella larvae. Journal of Insect Physiology, 53: 
1134-1144. 
 
Wood, Z.A., Schroeder, E., Harris, J.R. and L.B. Poole, (2003). Structure, 
mechanism and regulation of peroxiredoxins. Trends in Biochemical Sciences, 28: 
32 – 40. 
 
Wostön, H.A.B and M.L. de Vocht, (2000). Hydrophobins, the fungal coat 
unravelled. Biochimica et Biophysica Acta, 1469: 79-86. 
 
Wright, J.R., (2005). Immunoregulatory functions of surfactant proteins. Nature 
Reviews Immunology, 5: 58-68. 
 
Yang, W., Kim, W.S., Fang, A. and A.L. Demain, (2003). Carbon and Nitrogen 
Source Nutrition of Fumagillin Biosynthesis by Aspergillus fumigatus. Current 
Microbiology, 46: 275-279. 
 
Yin, H.L., and T.P. Stossel, (1979). Control of cytoplasmic actin gel-sol 
transformation by gelsolin, a calcium dependant regulatory protein. Nature, 281: 
583-586. 
 
You, S.A. and Q. Wang, (2005). Ferritin in atherosclerosis. Clinica Chimica Acta, 
357: 1-16. 
 
Yürüker, B., and V. Niggli, (1992). -Actinin and vinculin in human neutrophils: 
reorganisation during adhesion and relation to the actin network. Journal of Cell 
Science, 101: 403-414. 
 
Zakarian, R.J., Dunphy, G.B., Albert, P.J. and M.E.Rau, (2002). Apolipophorin-III 
affects the activity of haemocytes of Galleria mellonella larvae. Journal of Insect 
Physiology, 48: 715-723. 
 
Zalewska, M., Kochman, A., Esteve, J.P., Lopez, F., Chaoui, K., Susini, C., Ozyhar, 
A., and M. Kochman, (2009). Juvenile hormone binding protein traffic interaction 
 240  
with ATP synthase and lipid transfer proteins. Biochimica et Biophysica Acta 1788: 
1695-1705. 
 
Zambare, V., (2010). Solid state fermentation of Aspergillus oryzae for 
Glucoamylase Production on Agro Residues. International Journal of Life Sciences, 
4: 16-25. 
 
Zarember, K.A., Sugui, J.A., Chang, Y.C., Kwong-Chung, K.J. and J.I. Gallin, 
(2007). Human polymorphonuclear leukocytes inhibit Aspergillus fumigatus 
conidial growth by lactoferrin-mediated iron depletion. Journal of Immunology, 
178: 6367-6373. 
 
Zhan, Y., He, D., Newburger, P.E., and G.W Zhou, (2004). p47phox PX Domain of 
NADPH Oxidase Targets Cell Membrane Via Moesin-Mediated Association with 
the Actin Cytoskeleton. Journal of Cellular Biochemistry, 92: 795-809 
 
Zhan, Y., Virbasius, J.V., Song, X., Pomerleau, D.P., and G.W. Zhou, (2002). The 
p40phox and p47phox domains of NADPH oxidase target cell membranes via direct 
and indirect recruitment of phosphoinositides. Journal of Biological Chemistry 277: 
4512-4518. 
 
Zhang, P., Aso, Y., Yamamoto, K., Banno, Y., Wang, Y., Tsuchida, K., Kawaguchi, 
Y. and H. Fujii, (2006). Proteome analysis of silk gland proteins from the silkworm 
Bombyx mori. Proteomics, 6: 2586-2599. 
 
Zhou. X., Oi, F.M., and M.E. Scharf, (2006). Social exploitation of hexamerin: 
RNAi reveals a major caste-regulatory factor in termites. Proceedings of the 
National Academy of Sciences USA, 103: 4499-4504. 
 
Zmeili, O.S. and A.O. Soubani, (2007). Pulmonary aspergillosis: a clinical update. 
Quarterly Journal of Medicine, 100: 317-334. 
 
 
